Doomstead Diner Newz Channels => Marathon Man Newz => Topic started by: Eddie on October 13, 2016, 07:36:54 AM

Title: The Potfolio
Post by: Eddie on October 13, 2016, 07:36:54 AM
In the old days, you could save up a tidy sum, say $650K, and retire at age 65, with the expectation that you could put your money in risk-free bank CD's and draw over $4000 per month (when interest was 5%) and expect your nest egg to last until you were 85.

Most pension funds (including 401K's) still calculate retirement along those lines. Actually they figure you'll be in bonds and stocks and get 7% or better. With the asset bubbles the Fed has blown up, some funds have actually still achieved this return in recent years, but the risk factor has gone way up. In any case, there is no reason to expect this kind of return will happen at all going forward. "Risk-free" CD's are not risk free in a world that is constantly on the edge of a complete world-wide banking collapse, and they only pay slightly over 2% anyway.

So....is there an alternative to traditional investing that makes any sense? Traditionally, what have been called Sin Stocks (booze and cigarettes and gambling companies) have been one strategy to get reasonable returns in equities, the idea being that such businesses are somewhat insulated from economic recession, and might even do better in hard times, as people turn to vice on their way to rack and ruin.

Marijuana stocks sort of fall into this category, in my book, even though the legalization of cannabis has been achieved by those who claim medical benefits (of which there certainly are some, but far more people are interested in smoking pot as a recreational activity.) I use the term recreational loosely, understanding that much of this might be considered self-medication for stress.

In any case, pot is now legal as medicine in several places in the US and everywhere in Canada, and legal for recreational use in a few states in the US and looks to be legalized completely in Canada within a year or two.

In my opinion, even in a time of diminishing returns and economic turmoil, the early winners in the pot market, the companies that have managed to negotiate their way into legitimate medical marijuana licenses and are growing pot legally already, are poised to grow by leaps and bounds, even as global GDP drops toward zero.

Some people are so anti-capitalism that maybe they don't want to put money in any corporation. Others might have some kind of moral or ethical problem with making money off a substance that we've been jailing people for smoking for half a century. Others might simply look at the shaky financials of these fledgling companies and decide the risk is too high to put money into them. If you fall into one or more of those categories, this thread is not for you, so read no further.

For those who might have an interest, I have made a watch list on Yahoo Finance of nine companies that look better than the rest to me (right now), and I'll be following them for a while to see if I'm right about the kind of gains they're capable of making. I will add to the list as I see fit. Suggestions and discussion are welcomed. Those wishing to participate anonymously are welcome to PM me.

I intend to take each of these stocks and write something more in depth about their individual business models and their financials (although I'm no trained analyst when it comes to judging a company's fundamentals). Some of them are already mini-conglomerates, having bought out their competitors and positioned themselves to participate in more than one part of the grow/distribute/sell chain.

For the moment, here's a link to the nine stocks that look to me like they might go somewhere. As you can see, they are quite volatile, and they don't always move together. (Today they are, but the entire market is getting hammered this morning.)




For future reference, I will record the current prices for the potfolio today.

BE.CN  1.13

ACBFF 1.56

OGI.V  2.33

GRNH  .0759

MJNA  .063

EMH.V  .85

APH.V  3.43

MT.V   3.77

CGC.TO  5.49


As usual, my interest in these companies should not be interpreted as financial advice, or as encouragement to piss away the rent money on dodgy fly-by-night companies started by dope fiends. Do your own due diligence, etc.


As this thread has developed, I've had to go back and remove some links to my personal Yahoo Finance watchlist, because it made a backdoor portal into my personal email.....oops. If you should happen to find one I missed, please leave me a comment and tell me what page of the thread it's on. For your convenience, here is a link to a recent post with a complete list of the current Potfolio stocks, as of January13, 2017. Scroll down to comment #181.

http://www.doomsteaddiner.net/forum/index.php/topic,8128.180.html (http://www.doomsteaddiner.net/forum/index.php/topic,8128.180.html)
Title: Re: The Potfolio
Post by: RE on October 13, 2016, 11:11:58 AM
In the old days, you could save up a tidy sum, say $650K, and retire at age 65, with the expectation that you could put your money in risk-free bank CD's and draw over $4000 per month (when interest was 5%) and expect your nest egg to last until you were 85.

Most pension funds (including 401K's) still calculate retirement along those lines. Actually they figure you'll be in bonds and stocks and get 7% or better. With the asset bubbles the Fed has blown up, some funds have actually still achieved this return in recent years, but the risk factor has gone way up. In any case, there is no reason to expect this kind of return will happen at all going forward. "Risk-free" CD's are not risk free in a world that is constantly on the edge of a complete world-wide banking collapse, and they only pay slightly over 2% anyway.

So....is there an alternative to traditional investing that makes any sense? Traditionally, what have been called Sin Stocks (booze and cigarettes and gambling companies) have been one strategy to get reasonable returns in equities, the idea being that such businesses are somewhat insulated from economic recession, and might even do better in hard times, as people turn to vice on their way to rack and ruin.

Marijuana stocks sort of fall into this category, in my book, even though the legalization of cannabis has been achieved by those who claim medical benefits (of which there certainly are some, but far more people are interested in smoking pot as a recreational activity.) I use the term recreational loosely, understanding that much of this might be considered self-medication for stress.

In any case, pot is now legal as medicine in several places in the US and everywhere in Canada, and legal for recreational use in a few states in the US and looks to be legalized completely in Canada within a year or two.

In my opinion, even in a time of diminishing returns and economic turmoil, the early winners in the pot market, the companies that have managed to negotiate their way into legitimate medical marijuana licenses and are growing pot legally already, are poised to grow by leaps and bounds, even as global GDP drops toward zero.

Some people are so anti-capitalism that maybe they don't want to put money in any corporation. Others might have some kind of moral or ethical problem with making money off a substance that we've been jailing people for smoking for half a century. Others might simply look at the shaky financials of these fledgling companies and decide the risk is too high to put money into them. If you fall into one or more of those categories, this thread is not for you, so read no further.

For those who might have an interest, I have made a watch list on Yahoo Finance of nine companies that look better than the rest to me (right now), and I'll be following them for a while to see if I'm right about the kind of gains they're capable of making. I will add to the list as I see fit. Suggestions and discussion are welcomed. Those wishing to participate anonymously are welcome to PM me.

I intend to take each of these stocks and write something more in depth about their individual business models and their financials (although I'm no trained analyst when it comes to judging a company's fundamentals). Some of them are already mini-conglomerates, having bought out their competitors and positioned themselves to participate in more than one part of the grow/distribute/sell chain.

For the moment, here's a link to the nine stocks that look to me like they might go somewhere. As you can see, they are quite volatile, and they don't always move together. (Today they are, but the entire market is getting hammered this morning.)


https://finance.yahoo.com/portfolio/p_0/view?bypass=true

I thought you were out of the Stock Investing game?

If you think Pot is the Future, wouldn't your philosophy of hard assets dictate you start growing ganga yourself?

You could buy some land up here in Alaska.  They have a course for people to take for legal growing, I'll take the course and manage the pot farm.  :icon_sunny:

RE
Title: Re: The Potfolio
Post by: Eddie on October 13, 2016, 11:22:31 AM
I'm a believer in slow collapse.  ;D I'm also approaching retirement age, and am starting a new 401K (for tax reasons) as advised by my new expensive practice consultant.

My general feeling has been that we will see gold resume its steady appreciation against the USD and other fiat toilet paper, and that it might finally be time to think about putting a small stake in mining stocks, which have appreciated tremendously this year (although they are taking it on the chin again right now).

On due consideration, my feeling is that a good run in mining stocks might net a 10X return over the next several years.

Marijuana stocks, on the other hand, while riskier, might do much better...maybe 100X. Therefore....

I think it makes more sense right now to put money on people who are already experts, and just as importantly, people who have successfully learned to negotiate the bureaucracy, which is a minefield.

Title: Re: The Potfolio
Post by: RE on October 13, 2016, 11:34:35 AM
If your Consultant is Expensive, he must be good.

I wish you the best of luck!

RE
Title: Re: The Potfolio
Post by: Eddie on October 13, 2016, 11:39:04 AM
I'll know how good he is when I see my 2015 tax return, which should be by tomorrow.
Title: Re: The Potfolio
Post by: RE on October 13, 2016, 12:12:16 PM
I'll know how good he is when I see my 2015 tax return, which should be by tomorrow.

2015?  I gather this is a demonstration of how much you would have saved if he had done your taxes in 2015 rather than whoever did do them?

How do you know though if the IRS wouldn't have Audited this return?

Also, does tax expertiese necessarily make you an expert in what to invest in?  How do you know what kind of average return his clients get on their portfolios, other than what he tells you they get?

As a whole, the Stock Market is highly over valued, so I don't see how mining stocks are going anywhere but further down.  They're all highly leveraged with a lot of debt, and with contracting credit in the banking industry, when they can't roll over their debt many more will go tits up with total equity wipeouts.

However, it is your money so do as you please.

I look forward to another I told you so moment however.

RE
Title: Re: The Potfolio
Post by: Eddie on October 13, 2016, 12:53:27 PM
I'll know how good he is when I see my 2015 tax return, which should be by tomorrow.

2015?  I gather this is a demonstration of how much you would have saved if he had done your taxes in 2015 rather than whoever did do them?

How do you know though if the IRS wouldn't have Audited this return?

Also, does tax expertise necessarily make you an expert in what to invest in?  How do you know what kind of average return his clients get on their portfolios, other than what he tells you they get?

As a whole, the Stock Market is highly over valued, so I don't see how mining stocks are going anywhere but further down.  They're all highly leveraged with a lot of debt, and with contracting credit in the banking industry, when they can't roll over their debt many more will go tits up with total equity wipeouts.

However, it is your money so do as you please.

I look forward to another I told you so moment however.

RE

No, my 2015 tax return is due next Monday (6 month extension). I have not seen the completed return, nor do I know what my shortfall might be.  I was given the expectation that my total IRS bill would be maybe half what I paid last year. That would be nice. I have discovered that my prior accountant failed to take at least 10K in straightforward deductions for the 2014 tax year, which is part of the reason I got raped so badly.

My practice consultant is not giving me investment advice. I can give my 401K money over to their portfolio managers, or choose to direct it myself. My choice. He did convince me that putting money into the 401K was a good tax dodge, even if it sat in money market funds and gained me nothing.

Some mining ETF's are up nearly 200% for 2016, and yet are still selling for a discount to net asset value. They are not overvalued, having been beaten down for the last several years. I wouldn't bet the farm on them, of course. Gold is a manipulated market. A small stake is all I'm considering, an amount I can afford to lose and still not end up living under a bridge.

Pot stocks look like a growth story to me. Markets are not monolithic. At the current prices these companies look attractive to me. I doubt the portfolio managers at the expensive consulting firm would recommend either miners or pot stocks...

I haven't taken any losses over your last I told you so, therefore it was an academic exercise only. :)

Title: Re: The Potfolio
Post by: Eddie on October 13, 2016, 01:59:45 PM
Some people regard a recommendation by TheStreet.Com as an automatic indication to go short on whatever they're hawking, and I wouldn't argue with that logic most of the time...but today they're touting two of the companies in the Potfolio, so I'm going to cut and paste this, fwiw. Great photo, in any case.

(https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/3cdfbd50-90a8-11e6-bb34-6d8cda8c8582_600x400.jpg)

Marijuana Stocks That Could Quadruple in Price

 These marijuana stocks are ready for huge growth, particularly if November is a successful month for legalization.

 William Romov William Romov  Follow Oct 13, 2016 3:38 PM EDT

     
California and five other states will vote on whether to legalize recreational marijuana this November. In addition, Arkansas and Florida will vote on whether to legalize marijuana for medical purposes.

Marijuana usage is on the rise.

Consider that over the last 30 days, the S&P 500 has fallen 2.5% from 2,186.5 to 2133. Yet over that same period, the North American Marijuana Index increased 42%. Investors might want to add marijuana stocks to their portfolios.

Canopy Growth (CGC.TO) and Aurora Cannabis (ACBFF) are two of the 23 constituents that form the Marijuana Index. These companies already have racked up market-beating gains, which will continue in November and beyond if marijuana legalization is successful. Watch these stocks and be ready to buy on dips as volatile markets head into earnings season.

A vote to legalize in California and Florida could have a major impact nationally on the industry. California has over 12% of the total U.S. population. Florida is the country's third most populated state at 6.3%.

Legalization in Florida was narrowly defeated in 2014 by 2%.

Arizona and Massachusetts, which have encountered pushback from anti-legalization groups, and Maine and Nevada are other states weighing legalization.

Canopy Growth

Canopy Growth on Monday announced that it would continue to work with XIB Consulting, which consults on corporate initiatives like acquisitions, networking, and market awareness.

In partnership with rapper Snoop Dogg's "Leafs" brand, Canadian-based Canopy Growth is ready to roll out three new strains of marijuana across Canada by the end of the month. That's exciting news for the recreational marijuana user in Canada but what does it mean for the company's earnings? The answer decides whether investors should expect significant share price gains.

Snoop's endorsement would give Canopy Growth an edge against its Canadian peers once recreational markets become available. This advantage would become especially pronounced once Canadian marijuana producers start looking to recreational markets in the United States.

Although Canopy Growth hasn't been profitable in the last three quarters, its sales growth is attractive. Over the last nine quarters the company's total sales have grown on average 57% per quarter from $176,000 in the second quarter of 2014 to $5.38 million in the same period for 2016.
     


Aurora Cannabis

Canadian cannabis producer, Aurora Cannabis is one of the only producers turning a profit at $427,000 and $1.95 million, respectively in the fourth quarter of 2015 and the first quarter of 2016.

Aurora Cannabis achieved two major milestones in the last 30 days that you would expect of a budding young growth stock. First, the company's shares were moved to the Toronto Stock Exchange's Venture Exchange. CEO Terry Booth said that this milestone reflects "remarkably rapid operational and commercial progress."


Second, the company announced on Monday that it would issue up to $25 million in convertible debt. Booth said that this offering makes Aurora one of the "best capitalized companies, with one of the strongest balance sheets in the cannabis sector."

Following the offering, the company will convert $10 million of pre-existing convertible debt into about 8.7 million shares of stock. The dilution of the company's outstanding shares is currently providing investors with an opportunity to buy the stock below $1.70.


https://www.thestreet.com/story/13850908/1/2-inexpensive-marijuana-stocks-that-could-quadruple-in-price.html (https://www.thestreet.com/story/13850908/1/2-inexpensive-marijuana-stocks-that-could-quadruple-in-price.html)
Title: Re: The Potfolio
Post by: Petty Tyrant on October 13, 2016, 03:27:04 PM
Nice title Ed, whats the law in Nevada? I ask because a friend went to inspect a rental property there and tenants were growing for 'medicinal use', but said the whole house smells so strong its unbearable. So thats not a personal amount...

RE, using land to grow is so 20th Century, all hydroponic now.
Title: Re: The Potfolio
Post by: RE on October 13, 2016, 04:10:57 PM
RE, using land to grow is so 20th Century, all hydroponic now.

You still need land to put the hydroponics ON.

This Alaska.  All indoor growing.

I'm thinking a nice 60' Monolithic Pot Hydroponic Grow Dome.  :icon_mrgreen:

RE
Title: Re: The Potfolio
Post by: Eddie on October 13, 2016, 06:10:51 PM
Nice title Ed, whats the law in Nevada? I ask because a friend went to inspect a rental property there and tenants were growing for 'medicinal use', but said the whole house smells so strong its unbearable. So thats not a personal amount...

RE, using land to grow is so 20th Century, all hydroponic now.

Apparently Nevada has "decriminalized" pot, although there that just means it's a misdemeanor for possession of less than an oz. Any sale, or cultivation of more than 12 plants is still a felony. Of course, it all has a lot to do with whether state and local cops actually enforce those laws, and I don't know about NV.

When I was much younger, like in college, here in Austin it was not unusual for people to smoke pot in nightclubs. The cops just didn't enforce the existing laws. It is less wide open now than it was 30 years ago, from what I know. (I don't get around much anymore.)

http://www.youtube.com/v/GMzilyGZrHI&fs=1
Title: Re: The Potfolio
Post by: RE on October 13, 2016, 06:58:46 PM
With all this Ganga talk, I am tempted to refit my bedroom as a Hydroponic Pot Growing Center!  :icon_mrgreen:  I don't really need that space, I could just as easily sleep on the Futon-Couch in the Living Room.

"RE's Matanuska-Susitnta River Valley Thunderfuck"  :icon_sunny:

Too bad I don't enjoy smoking the shit myself much anymore.  :(

RE
Title: Re: The Potfolio
Post by: K-Dog on October 14, 2016, 12:47:46 AM
With all this Ganga talk, I am tempted to refit my bedroom as a Hydroponic Pot Growing Center!  :icon_mrgreen:  I don't really need that space, I could just as easily sleep on the Futon-Couch in the Living Room.

"RE's Matanuska-Susitnta River Valley Thunderfuck"  :icon_sunny:

Too bad I don't enjoy smoking the shit myself much anymore.  :(

RE

The light therapy might be good.


And it is not all indoors:


Alaskan Thunder Fuck


Alaskan Thunder Fuck (also referred to as ATF, Matanuska Thunder Fuck or Matanuska Tundra) is a legendary sativa-dominant strain originating in the Matanuska Valley area of Alaska.  According to the legend, it was originally a Northern California sativa crossed with a Russian ruderalis, but sometime in the late 70s it was crossed with Afghani genetics to make it heartier.  ATF usually presents large, beautifully frosted buds with incredibly strong odors of pine, lemon, menthol, and skunk.  Known for possessing a relaxing yet intensely euphoric high, it is also described as having a “creeper” effect as well as pronounced appetite enhancement.
Title: Re: The Potfolio
Post by: Eddie on October 17, 2016, 07:13:47 AM
Two more stocks have been added to the Potfolio watchlist....CANN and CBDS.



Update at market close 10-17-2016:

I should have bought instead of watching.  CANN and CBDS up over 30% IN ONE DAY (today) and two other stocks in the potfolio up over 20% today. These big moves are tied to speculation that pot will be legalized in several new states in a few weeks. I expect the crazy gains will subside after the election. We shall see.
Title: Re: The Potfolio
Post by: Eddie on October 18, 2016, 08:06:38 AM
Most of the potfolio is up again substantially this morning, anwhere from 5 to nearly 15 percent in less than one trading day. BE.CN and EMH.V have been down substantially while the others are literally on fire....I may drop them from the watchlist if they continue to underperform.

The broad markets are supposed to be breaking down, according the the technical analysts I follow. A hard down day would probably drive these high flyers down far enough to make a decent entry point...but it seems wrong tactically to buy any stock that has gained 25 to 30 percent in two days. A correction should be imminent.



Title: Re: The Potfolio
Post by: K-Dog on October 18, 2016, 12:56:55 PM
All the kings horses and all of he kings men, ...
Title: Re: The Potfolio
Post by: Eddie on October 19, 2016, 07:44:25 AM
The Potfolio is mixed this morning, but the two biggest gainers are down substantially as traders take money off the table.

Title: Re: The Potfolio
Post by: RE on October 19, 2016, 10:30:15 AM
The Potfolio is mixed this morning, but the two biggest gainers are down substantially as traders take money off the table.

https://finance.yahoo.com/portfolio/p_0/view?bypass=true

Have you actually dropped any money down at the Casino or are you just ogling?

RE
Title: Re: The Potfolio
Post by: Eddie on October 19, 2016, 10:45:48 AM
I took a tokin' token position in CAAN, CBDS, OGI.V, MJNA, and CGC.TO.
Title: Re: The Potfolio
Post by: RE on October 19, 2016, 10:54:19 AM
I took a tokin' token position in CAAN, CBDS, OGI.V, MJNA, and CGC.TO.

Give us periodic reports on your percentage profits/losses.  Or even better, make a chart!  :icon_sunny:

RE
Title: Re: The Potfolio
Post by: Eddie on October 19, 2016, 06:12:15 PM
For reference.

10-19-2016
Bought

 CAAN @ 4.87
 OGI.V @2.26
 CBDS @7.67
 MJNA@ .081
 CGC.TO@5.22

10-20-2016
Bought

 CBIS @ .0719
 TRTC @ .445

10-25-2016
Bought

MSRT @ .935
GRNH @ .154
ACBFF @ 1.7629


10-26-2016
Bought:

CGRW @ 2.27

11-14-2016
Bought:

ERBB @ .0021
CNBX @ .75
AGTK @ .038
MNTR @ 1.1193

11-15-2016
Bought:

CNAB @ 1.815

11-16-2016
Bought:

AMMJ @ 1.01
MCOA @ .0851


12-14-2016
Bought:

APHQF @ 4.2362
MQTRF @ 5.49655

1-19-2017
Bought:

OWCP @ .575

MCPI @ .28372

MCIG @ .345


2-21-2017
Bought:

ACAN @ 4.20
MRPHF @ 1.17

3-20-17

Bought:

NXTTF @ .2099

LXRP @ .38



3-22-17

Bought PRMCF @ 1.899



3-23-17

Bought PRMCF @ 1.996



3-31-17

Bought:

SPRWF @ 1.1517

SRNA @ .189



4-3-17

Sold:

MJNA @ 1.26

MNTR @ 2.14

CBIS @ .082

CNBX @ 3.00

OWCP @ 1.05

MSRT @ .90


Bought:

KSHB @ 2.53

ACBFF @ 1.93

APHQF @ 5.0507

OGRMF @ 1.8987

GRWG @ 2.17

NXTTF @ .1944

TWMJF @ 7.847



4-4-17

Bought:

APHQF @ 50414

4-6-17

Bought:

KSHB @ 2.48

4-7-17

Sold:

CANN @ 2.1301

GRNH @ .0751

MCPI @ .075

MCOA @ .052

AGTK @ .022

ERBB @ .0015



Bought:

PRMCF @ 2.35

OGRMF @ 2.35

HYYDF @ 1.646

EMBBF @ 1.714



4-11-2017

Sold:

CBDS @ 6.03

AMMJ @ .68

CNAB @ 1.43

HYYDF @ 2.0552


Bought:

EMMBF @ 2.5151

ICCLF @ 1.2683

APHQF @ 5.8515


4-12-2017


Bought:

EMMBF @ 2.2181

Sold:

EMMBF @ 2.2633

ACBFF @ 2.2725

LXRP @ .44

APHQF @ 5.8601


4-13-2017

Bought:

EMMBF @ 2.2084

APHQH @ 5.7327

MGWFF @ .5116

ICCLF @ .9889



5-1-2017

Bought:

MRRCF @ 1.4569

5-5-2017

Bought MRRCF @ 1.2724

Bought HRVOF @ 0.6678

Bought MGWFF @ 0.4162



5-17-2017

Bought CBICF @ .4156



5-22-2017

Bought OGRMF @ 1.93












Title: Re: The Potfolio
Post by: RE on October 19, 2016, 06:37:34 PM
For reference.

Bought

 CAAN @ 4.87
 OGI.V @2.26
 CBDS @7.67
 MJNA@ .081
 CGC.TO@5.22

Will Eddie become a Ganga Billionaire?

(http://thenortheasttoday.com/wp-content/uploads/2015/06/Ganja-sadhu.jpg)

RE
Title: Re: The Potfolio
Post by: Eddie on October 20, 2016, 05:19:52 AM
Adding CBIS to the watch list.


Also adding TRTC to the watch list.
Title: Re: The Potfolio
Post by: Eddie on October 20, 2016, 11:20:42 AM
The Potfolio is mostly in the green today, but the dollar spike took all the real momentum out of equities this morning, and pot stocks stalled out with everything else.

Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 10:04:31 AM
A down day for the herb stocks today, with the USD continuing to spike, touching 98.81 earlier. If the dollar breaks 100 on the upside, it could spike much higher. Gold bullion spot is holding up okay for such a strong dollar spike, but the miners are off a bit.

I was going to take advantage of the red ink day to make entry on the remaining four pot stocks on the watch list, but I have to wait, because the online broker put a hold on my money. Not sure why they put a three day hold on an electronic cash transfer that I requested Wednesday and they posted yesterday. I thought those cleared immediately.

You can't buy these OTC stocks with margin, got to have cash money. I suppose that's a good thing, but it's a pain in the ass.

One or two of the stocks on the list were down in the 10-20% range earlier in the day, but it looks like most of them have firmed up. Still, a ten percent move down in a day appears to be fairly normal for these micro-caps.

All of these stocks are trading at extremely high volumes over the last few days, compared to their historic norms. I don't think the ride is finished. It will be interesting to see if they poop out after the election. Until then it's game on, imho.







Title: The Potfolio: Know When to Hold 'Em, Know When to Toke 'Em
Post by: RE on October 21, 2016, 10:24:20 AM
A down day for the herb stocks today, with the USD continuing to spike, touching 98.81 earlier. If the dollar breaks 100 on the upside, it could spike much higher. Gold bullion spot is holding up okay for such a strong dollar spike, but the miners are off a bit.

I was going to take advantage of the red ink day to make entry on the remaining four pot stocks on the watch list, but I have to wait, because the online broker put a hold on my money. Not sure why they put a three day hold on an electronic cash transfer that I requested Wednesday and they posted yesterday. I thought those cleared immediately.

You can't buy these OTC stocks with margin, got to have cash money. I suppose that's a good thing, but it's a pain in the ass.

One or two of the stocks on the list were down in the 10-20% range earlier in the day, but it looks like most of them have firmed up. Still, a ten percent move down in a day appears to be fairly normal for these micro-caps.

All of these stocks are trading at extremely high volumes over the last few days, compared to their historic norms. I don't think the ride is finished. It will be interesting to see if they poop out after the election. Until then it's game on, imho.


http://www.youtube.com/v/Jj4nJ1YEAp4

RE
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 11:23:00 AM
The Potfolio Strategy

It might look like gambling, and I wouldn't necessarily contradict that view, but I will take a minute or two to talk about what I consider the right way to play in the cannabis stocks.

First, the watch list has been constructed by picking stocks that are all currently
 making higher highs on good volume, and only selected from cannabis companies that actually are doing business and making sales currently. Some are growers. These are all already licensed to sell medical grade pot to dispensaries. The licensing process takes years to get through, and that bottleneck will make these companies more competitive in the market over the next year or two, at least, as new players struggle to get legal. Some of these companies also own dispensaries.

Other companies are involved in support services, selling things growers need, like lights and greenhouses and even soil. These companies will profit from the huge expansion taking place as more growers enter the market and existing companies expand.

In addition to these, there are a couple that make some kind of products from hemp, like health and beauty products, and have a working business with cash flow.

I have studiously avoided one part of this sector. That is biotech companies that are working on drugs made from cannabis. I consider these stocks to be overvalued already, and their business model is not one that I understand well enough to parse out anyway.

Because the Potfolio stocks ARE riskier than most,  the Potfolio strategy is to buy small stakes in as many of these small corporate businesses as I can identify as having decent potential, and to then to dollar cost average into the ones that do well, and to weed out (no pun intended) the ones that don't keep moving.

Here's an important point. I am not day trading. I intend to hold anything I buy long enough to have the gains or losses to fall into the long-term category. I think trading these stocks is possible, but that is not the Potfolio strategy. The idea is to build a small portfolio of rock solid companies that are going to grow and mature until some bigger fish decides to EAT them.

What we see now is that Big Alcohol and Big Tobacco are fighting pot legalization. That will surely change. In a couple of years it's likely that every stock in the Potfolio (that survives) will become a buy-out candidate by the likes of some behemoth like RJ Reynolds or Anheuser-Busch. That's when the real money will be made.

In the time that I have been dabbling in markets, I don't think I can remember an opportunity that looked like a better time to get in on the ground floor of what will surely end up being a hundred billion dollar industry. And it's basically recession proof, and might do better in really hard times than just about anything else (left) in the world of  business.

In order to participate in this stellar opportunity, some risk does have to be taken. I have to buy the stocks that are available. I am not going to become a start-up myself.

Hedging the risk IS important. The way you hedge this one, imho, is to:

1. Take an appropriate position size. Only put a tiny fraction of your assets into it. If you have a million dollar portfolio, then I'd consider $10K to be the maximum amount to risk.

2. Buy as many good companies as you can find, and keep the growing ones and sacrifice those that stall out. Keep looking for good companies, and add one when you shed a loser.

3. Avoid setting stops that will cash you out in the event of a market crash. These stocks are too volatile to play with stops, and the idea is buy and hold, not trade in and out. Trades cost money and create tax liabilities.

4. Dollar cost average over time into the companies that show promise. Reset the portfolio yearly to get rid of the real laggards.

Is that gambling?  Maybe.....but I don't see much future in holding CD's and Treasury Bonds. You have to adjust your strategy to prosper in these changing times.



Title: Re: The Potfolio
Post by: azozeo on October 21, 2016, 01:32:19 PM
This ad just aired last night during the Packers/Bears game here in Az.

http://www.youtube.com/v/7MlkvJ5PjoQ&fs=1
Title: Re: The Potfolio
Post by: azozeo on October 21, 2016, 01:52:01 PM
So do you see a cannabis bubble similar to the dot com bubble.
Even tulips become worthless...
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 03:28:34 PM
So do you see a cannabis bubble similar to the dot com bubble.
Even tulips become worthless...

In my limited  experience, stocks in decent companies are all about revenue growth. For a while, there will be lots and lots of growth in these companies, lots of buy-outs, but a  few will be mismanaged and go bust.

But in terms of a bubble, I don't think so...at least not for a period of years. There is a huge demand for cannabis, and legalization completely changes everything. The legal cannabis  market is in its infancy. Legalization is not just occurring in the US and Canada, either. Many other countries are changing their laws as well.

I think it will eventually be something like beer. A staple product with a high, steady demand.
Title: Re: The Potfolio
Post by: RE on October 21, 2016, 04:03:19 PM
The Potfolio Strategy

It might look like gambling, and I wouldn't necessarily contradict that view, but I will take a minute or two to talk about what I consider the right way to play in the cannabis stocks.
...
Is that gambling?  Maybe.....but I don't see much future in holding CD's and Treasury Bonds. You have to adjust your strategy to prosper in these changing times.

Looks like a duck, swims like a duck, quacks like a duck, it's a duck.  :icon_mrgreen:

Since there is no way to know in advance who will succeed and who will fail, who will grow and who will disappear, you're just taking a kind of shotgun crapshoot approach here and hoping you pick more winners than losers.  You hedge the downside risk by not making it a huge percentage of the total portfolio, but that will limit any upside potential even if the stocks do well.  If you really wanna make some $MONEY$, you gotta go ALL IN and also leverage up and bet the McMansion on pot too!  You can't make any money at the $2 Blackack table even if you are a card counter with a photographic memory.  You gotta play at the $100 minimum bet table with the big boys.

As to whether Pot stocks are better than USTs, the problem here is that when the USTs tank, since the Pot stocks are denominated in dollars, they'll tank right along with them.

RE
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 04:12:21 PM
(https://s-media-cache-ak0.pinimg.com/564x/82/01/fa/8201fa0872856132738dcf5773455840.jpg)
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 04:18:34 PM
you're just taking a kind of shotgun crapshoot approach here and hoping you pick more winners than losers.  You hedge the downside risk by not making it a huge percentage of the total portfolio, but that will limit any upside potential even if the stocks do well.  If you really wanna make some $MONEY$, you gotta go ALL IN and also leverage up and bet the McMansion on pot too!  You can't make any money at the $2 Blackack table even if you are a card counter with a photographic memory.  You gotta play at the $100 minimum bet table with the big boys.

Hoping to pick nearly all winners, but expecting a few to fizzle, is more like it. I am only picking the cream of the crop. Excessive leverage is not a winning strategy, most of the time. Besides, I don't need to be a billionaire. I'd be happy to parlay a 50K investment, made over five or ten years, into five million. Very doable, and if the world ends before then, it just does.
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 04:36:07 PM
Here's a decent look at Aurora Cannabis (ACBFF). I have not bought this one but it's on the list.

http://smallcappower.com/analyst-articles/aurora-cannabis-stock-continues-to-smoke/
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 04:47:26 PM
Canopy Growth (CGI.TO) is perhaps the strongest pot company of all of them, This analyst thinks the price is "frothy". I think he might get gobsmacked.

http://www.cantechletter.com/2016/10/canopy-growth-corp-looking-frothy-says-m-partners/
Title: Re: The Potfolio
Post by: RE on October 21, 2016, 04:48:04 PM
I'd be happy to parlay a 50K investment, made over five or ten years, into five million.

Let's check in in 6 months and see how much closer to $5M you are on Ganga Investments.  :icon_mrgreen:

RE
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 04:58:51 PM
Mettrum Health (MT.V) according to this tout, has a one year price outlook of nine bucks and change. Today it's at $4.06

http://friscofastball.com/2016/10/20/how-analysts-feel-about-mettrum-health-corp-after-reaching-52-week-high/

More on Mettrum

http://investingnews.com/company-profiles/mettrum-health-medical-cannabis-oil-hemp/
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 05:07:13 PM
I'd be happy to parlay a 50K investment, made over five or ten years, into five million.

Let's check in in 6 months and see how much closer to $5M you are on Ganga Investments.  :icon_mrgreen:

RE

I think one of two things will happen. This current hot streak will fizzle after the election, and all these stocks will settle back down for some time, or....and especially if most the initiatives pass, they will just keep right on blowing out for a while. Either is possible. I think if CA passes recreational MJ, that's huge.

Another big milestone will be national recreational legalization for Canada, which is said to be in the works and expected to happen within 2 years.
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 05:59:36 PM
Cannabis Science Inc. (CBIS) is sort of a biotech, but at $.06/share it  has some room to appreciate. They are aiming for the non-recreational, medical stuff that doesn't get you high, which is what was recently okayed even here in Texas.


http://oracledispatch.com/2016/10/20/cannabis-science-inc-otcmktscbis-bull-run/ (http://oracledispatch.com/2016/10/20/cannabis-science-inc-otcmktscbis-bull-run/)
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 06:24:32 PM
Terra Tech (TRTC) started out as a hydroponic company growing organic veggies, but they got pulled into the pot business because the money is better.

https://terratechderekpeterson.wordpress.com/tag/derek-peterson/

https://www.insiderfinancial.com/a-close-look-at-terra-tech-corp-otcmktstrtc-second-quarter/116762/

Title: Re: The Potfolio
Post by: azozeo on October 21, 2016, 06:38:00 PM
Here's a thought....
Settin' up shop selling the THC in gel-tab form for cancer patients that don't
like the harshness of smoke in their throats would be a community benefit.
There isn't much to the process. Drying the bud material, screening, running
the powdered material through alcohol, vaporizing the alcohol, poring into
gel caps.
An extra bedroom or garage lab is all you need.
Title: Re: The Potfolio
Post by: Eddie on October 21, 2016, 06:39:38 PM
Cannabis Sativa Inc. (CBDS) As the symbol would suggest, they are another maker of the non-euphoric medical CBD's. Good branding.

https://finance.yahoo.com/news/cannabis-sativa-exhibits-state-marijuana-082000858.html

http://www.leafscience.com/2014/02/23/5-must-know-facts-cannabidiol-cbd/
Title: Re: The Potfolio
Post by: RE on October 21, 2016, 06:59:18 PM
OK, sign me up as an Investor in this Portfolio.  I am sold.

I will send you a check for $5000 tomorrow.  I want to get in early on this Ponzi!

You are now a Reefer Hedge Fund Manager.

RE

Title: Re: The Potfolio
Post by: Eddie on October 24, 2016, 11:21:04 AM
The dollar continues to bump up against resistance, looking plenty strong. Apparently the Chinese are reacting by devaluing the yuan today (because when the dollar goes up, the dollar pegged yuan does too, which is not good for a country with an export based economy).

One of my cycle counters has proposed an alternative cycle count that suggests that the dollar cycle actually made a bottom last May, and that we may be on the first leg (up leg) of a new yearly cycle.

https://likesmoneycycletrading.wordpress.com/

Gold popped this morning early, but then got creamed. The VIX Index got slammed too. BAU by the PPT boys.

The Potfolio is mostly green, with some big movers, and even the laggards are barely down for the day.



Title: Re: The Potfolio
Post by: Eddie on October 24, 2016, 11:57:45 AM
Adding MSRT to the watchlist.

https://finance.yahoo.com/news/seethruequity-initiates-coverage-massroots-inc-130000193.html



Title: Re: The Potfolio
Post by: Eddie on October 25, 2016, 08:40:24 AM
TPTB are working hard to goose stocks into November 8. No bad news allowed until Hillary is back in the Clinton bedroom at 1600 Pennsylvania Avenue. After that I look for a rally into years end, as Wall Street celebrates looking forward to another 4 years of butt-raping the country for fun and profit.

(https://blog.smartmoneytrackerpremium.com/wp-content/uploads/cotd-107.png)

I'm not saying we'll get that far. I look for the shit to deepen on all fronts, including the economic front.

Title: Re: The Potfolio
Post by: Eddie on October 25, 2016, 10:01:02 AM
The broad markets in equities are down this morning, and the Potfolio is mostly in the red.

There are 14 stocks on the watch list, and I'm holding ten of them. The only stellar performer so far is MJNA, which is up 50 percent since I bought it five days ago. Overall, I'm down a hundred bucks including commissions, which, for ten buys, is a hundred bucks.

So far i have not pulled the trigger on BE.CN, EMH.V, APH.V, or MT.V.

Aphria (APH.V) and Mettrum (MT.V) I do still plan to add for sure.


Title: Re: The Potfolio
Post by: Eddie on October 25, 2016, 04:28:19 PM
Business Insider is getting on the bandwagon. They mention a few that aren't on the watchlist. I will check them out.

Marijuana stocks are going crazy ahead of elections that could transform their industry


Nine states will vote in November on whether to legalize medical or recreational marijuana, or both.

Leading up to the elections, the industry's penny stocks are trading as if most states will say yes to legalization.

Shares of marijuana firms that trade over-the-counter — not via central exchanges like the Nasdaq — are rallying in the run-up to the votes.

Companies in the industry struggle to get approved to list on the major exchanges partly because marijuana is still illegal under federal law.

Here's General Cannabis Corp., which leases space for companies to grow the plant:

(http://static5.businessinsider.com/image/580f9e5f362ca41c258b4787-960/screen%20shot%202016-10-25%20at%202.02.54%20pm.png)

And here's Cannabis Sativa, which Libertarian presidential candidate Gary Johnson was CEO of until he resigned in January. It has a subsidiary that makes moisturizers and lip balm.

(http://l.yimg.com/ny/api/res/1.2/KgKXvn4xKyufZLzWfw5gmw--/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9NjUwO2g9Mjk4/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_SILICONALLEY_H_LIVE/Marijuana_stocks_are_going_crazy-212928b66e2880367d87dd1874696583)

Here's United Cannabis Corp., a provider of medical cannabis treatments:

(http://l1.yimg.com/ny/api/res/1.2/aJ3USi.w9oKnMyx6fKMbFA--/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9NjUwO2g9Mjk3/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_SILICONALLEY_H_LIVE/Marijuana_stocks_are_going_crazy-e3546ffdcd6201c4a4f4b56a8b250d57)

A number of other marijuana penny stocks — priced below $5 a share — have run-ups like these, which are speculative in nature. Briefing Trader shared the following set of charts on Twitter:

(follow the link) https://twitter.com/TraderInPlay/status/790970625032458240/photo/1?ref_src=twsrc%5Etfw (https://twitter.com/TraderInPlay/status/790970625032458240/photo/1?ref_src=twsrc%5Etfw)

The results of the votes next month could be a huge deal for the industry. California's vote is considered the most crucial given the state's size; its economic output in 2015 made it the sixth largest economy in the world, ahead of countries like France.

Earlier in October, Pew Research published a poll that showed that 57% of US adults say marijuana use should be legalized. A decade ago, just 32% were in favor of legalization.

The best companies would stand to profit even more in the industry, which is projected to grow to nearly $21 billion by 2020, according to Arcview Market Research.


http://finance.yahoo.com/news/marijuana-stocks-going-crazy-ahead-185722531.html (http://finance.yahoo.com/news/marijuana-stocks-going-crazy-ahead-185722531.html)
Title: Re: The Potfolio
Post by: azozeo on October 25, 2016, 04:49:40 PM

Activist Post

By John Vibes

Food Services of America, a subsidiary of Services Group of America is funding efforts to keep marijuana illegal. It makes sense, considering that a vast majority of America’s prisoners are locked in prison on marijuana charges, and the company stands to gain a lot of business from the laws staying the same.

Marijuana.com reported that the company donated $80,000 to a campaign committee opposing the legal cannabis measure on Arizona’s November ballot.

Services Group of America has been criticized in the past for providing food to prisons that failed to meet basic nutritional requirements.

The report also indicated that the Arizona state Chamber of Commerce contributed $498,000 to the same campaign week. The effort also received a half million dollar donation from opioid maker Insys Therapeutics as well as sizeable contributions from various players in the alcohol industry.

The influence that the alcohol and pharmaceutical industries have on keeping marijuana illegal has been well documented, but the influence of prison contractors is rarely discussed.

The prison industry is one of the fastest growing and top-earning businesses in the United States. In the past three decades, this enterprise has grown into a monstrous system of oppression that now houses over 2 and a half million people in the US. This number is, by far, the largest prison population in the world. No country on earth has as many inmates as the “land of the free.”

Ironic isn’t it? Since 1991 the violent crime rate in America has dropped at least 20%, while the amount of people in prison has increased by 50% in that time. These numbers show that the rapid growth in the prison population is primarily due to over prosecution of nonviolent crimes.

This has nothing to do with “cleaning up the streets” or making our society safer — it is all about money and control. The prison system as it stands now does not make our society any safer but instead turns average nonviolent offenders into hardened criminals by exposing them to such a harsh environment.

The sad truth is that the way our prison system has been structured has actually outlawed more than half of the US population. Nonviolent offenders have no place behind bars. The savage conditions of prison will turn most people into violent offenders once they get out. Which is exactly what the prison establishment wants – return customers.

This establishment is the collection of state and quasi-state/private industries that make up the “prison industrial complex.” Billions of dollars are made every year in this industry. One company, Wackenhut Corrections, makes over a billion dollars a year and they aren’t even the biggest prison service in the country.

These numbers also don’t take into consideration the many satellite businesses that surround this industry. There are over 1,000 vendors that specifically sell correctional paraphernalia. Even local phone companies cash in on the operation. The companies install payphones for free because those phones can generate $15,000 per year from each inmate making a phone call every day.

Those companies are just the tip of the iceberg. That isn’t even counting the police, lawyers, wardens, politicians and food distributors that line their pockets through the incarceration of peaceful Americans.

All of these organizations have a distinct interest in keeping nonviolent people in jail. So, it should come as no surprise a prison contractor is working to keep marijuana illegal.
John Vibes is an author and researcher who organizes a number of large events including the Free Your Mind Conference. He also has a publishing company where he offers a censorship free platform for both fiction and non-fiction writers. John writes for TheFreeThoughtProject.com, where this article first appeared. You can contact him and stay connected to his work at his Facebook page. John is currently battling cancer naturally, without any chemo or radiation, and will be working to help others through his experience, if you wish to contribute to his treatments please donate here.
Title: Re: The Potfolio
Post by: agelbert on October 25, 2016, 06:12:18 PM
List of good and bad politicians (Grades A to F  ;D) in the fight for Drug Laws sanity.

http://www.drugpolicyaction.org/voter-guide/list.php (http://www.drugpolicyaction.org/voter-guide/list.php)


Title: Re: The Potfolio
Post by: Eddie on October 26, 2016, 07:06:58 AM
Adding the following to the watch list:

CGRW
CNAB
AMMJ
Title: Re: The Potfolio
Post by: Eddie on October 28, 2016, 07:57:03 AM
By the time Forbes is writing about a hot sector, it's usually time to go short.

The reality is that the stocks in the Potfolio have shot up so fast they've become a target for swing traders, many of whom are taking some money off the table before the election, which is too "risk on" for their tastes.

Marijuana Stocks Light Up Before Election


Debra Borchardt ,   CONTRIBUTOR
I write about retail and cannabis. 

Opinions expressed by Forbes Contributors are their own.

(http://blogs-images.forbes.com/debraborchardt/files/2016/10/MJindex.jpg?width=960)
Marijuana stocks are getting lit ahead of the election.

With nine states voting to legalize marijuana in some form, many investors are betting these cannabis companies will benefit. The Marijuana Index has more than doubled in the last month and half and that was largely driven by volume.

“The average volume was 8x higher in October than January through September of this year,” said Dan Nicholls, vice president of the Marijuana Index. “It is really pushing prices to crazy highs.” Nichols’ Index only includes 23 stocks from the U.S. and Canada as he set very high standards in order for the companies to be included. “There are more than 200 plus marijuana stocks, but we only track the top performers. The overwhelming majority are pretty low quality. There’s a lot of pump and dump.”


Nicholls believes there has been a lot of speculative trading and that the high volumes have caused the stocks to double, triple and even quadruple in price. The stocks in his U.S. index have risen 57% in the past month and 137% year-to-date. The top performer is American Cannabis Co. Inc. which has jumped 188% in one month.

420 Investor cannabis stock index 7/25/16 - 10/25/16.
420 Investor cannabis stock index 7/25/16 – 10/25/16. (Courtesy of 420 Investor)


Alan Brochstein of 420 Investor has also witnessed an increase in pot stock interest. “Since September, my subscribers have increased by a third and my page views have experienced a 40% increase over the previous month,” he said. All year he has been pointing to the election season as a potential catalyst for cannabis stocks.

“If one buys into the premise that there will be an election trade, the question becomes which stock to buy,” he said. “This has always been a tough call.” He noted that there are a lot of garbage companies that are smoke and mirrors and subject to Over-The-Counter penny stock traders.”

He thinks GW Pharmaceuticals could benefit from all the media attention even though legalization doesn’t have much bearing on the company. “Terra Tech Corp.  is probably the best play given its exposure to California and Nevada,” he said.

Adam Bierman, chief executive officer of MedMen, a private equity group that specializes in cannabis investing said he is seeing an increase in interest in the group ahead of the elections. He agreed that there have been some sketchy players in the past but he also noted that there are more real businesses that are drawing institutional investor interest.

“Are people making longer plays? Yes,” he said. “It’s not just about the pink sheet Over-the-counter marijuana stocks. It’s about GW Pharmaceutical or The Scotts Miracle-Gro Company. If you look at Scotts, it has been a home run stock over the last few months.” The stock has risen 23% over the past six months and is sometimes associated with cannabis because of its indoor growing products.

There professionals though are very cautious as to whether these stock prices are sustainable. Brochstein said, “A lot of people look and think this is normal. It’s not normal. When things happen like this and if they’re not tied to fundamentals – it’s not a happy ending.”

Nicholls thinks the stocks haven’t reached their peak, but he also believes there will be a correction after the election. He warns, “There’s a ton of volatility and its very risky.”


http://www.forbes.com/sites/debraborchardt/2016/10/27/marijuana-stocks-light-up-before-election/#115d7c855971 (http://www.forbes.com/sites/debraborchardt/2016/10/27/marijuana-stocks-light-up-before-election/#115d7c855971)



Title: Re: The Potfolio
Post by: Eddie on October 28, 2016, 12:33:20 PM
Plenty of double digit gains in the Potfolio today. The last couple of days have been brutal down days for many pot stocks, however. I am still slightly underwater.






Title: Re: The Potfolio
Post by: Eddie on October 29, 2016, 04:21:31 PM
The only winners over the last week in the Potfolio are MJNA and TRTC. It will be interesting to see if they continue to outperform the rest, or whether the others will play catch-up.

The charts of some of the others still look pretty positive.

https://finance.yahoo.com/portfolio/p_0/view/dv?bypass=true
Title: Re: The Potfolio
Post by: azozeo on October 29, 2016, 04:24:08 PM
The only winners over the last week in the Potfolio are MJNA and TRTC. It will be interesting to see if they continue to outperform the rest, or whether the others will play catch-up.

The charts of some of the others still look pretty positive.

https://finance.yahoo.com/portfolio/p_0/view/dv?bypass=true


Have you pulled the trigger & thrown some fiat ass-wipe at these puppies yet ?
Title: Re: The Potfolio
Post by: Eddie on October 29, 2016, 04:40:48 PM
I am holding a small stake in 11 of the 17 stocks on the watchlist, at this point. On page two of this thread there is a post, which I am keeping updated, as to when and what has been bought, and at what price.

http://www.doomsteaddiner.net/forum/index.php/topic,8128.15.html (http://www.doomsteaddiner.net/forum/index.php/topic,8128.15.html)
Title: Re: The Potfolio
Post by: azozeo on October 29, 2016, 05:04:42 PM
I am holding a small stake in 11 of the 17 stocks on the watchlist, at this point. On page two of this thread there is a post, which I am keeping updated, as to when and what has been bought, and at what price.

http://www.doomsteaddiner.net/forum/index.php/topic,8128.15.html (http://www.doomsteaddiner.net/forum/index.php/topic,8128.15.html)

My purse strings are pinched closed right now, however, if we are all still here in early 2017
& the market is still a market I'd like to buy into (create my own acct) the potfolio.
Will ten Benjamin's do this ?
It's been almost 10 years since I've played the global casino schtick.
Title: Re: The Potfolio
Post by: Eddie on October 29, 2016, 05:15:41 PM
I would only play with real casino money, not money I was going to need to take care of the family.

Ten Benjamins would buy 10,000 shares of some of these companies. We're talking penny stocks here, although some of them have been bid up to a few bucks a share. The most expensive stock on the list right now is at 6 bucks and change.

I think early 2017 would be a good time to look at it. Wait and see if these stocks fold up like a circus tent after the elections. They might. If they keep building steadily through the end of the year, I'd consider that a good sign.
Title: Re: The Potfolio
Post by: Eddie on October 30, 2016, 05:47:40 PM
Adding MNTR to the watch list.

http://investorshub.advfn.com/Mentor-Capital-Inc-MNTR-17095/ (http://investorshub.advfn.com/Mentor-Capital-Inc-MNTR-17095/)
Title: Re: The Potfolio
Post by: RE on October 30, 2016, 05:49:50 PM
Can we get some charts on all these "watch" list Potfolio stocks?  Maybe with some little Gold Star next to the ones you actually are invessted in and not just watching?

RE
Title: Re: The Potfolio
Post by: Eddie on October 30, 2016, 07:52:53 PM
Charts mostly available here.

(Yahoo finance)

Not going to do custom charts, or mark which ones I'm in. Too much busy work. See page two of this thread to see the buys. I expect to be in all of them anyway, eventually. There are a couple that are maybes.
Title: Re: The Potfolio
Post by: RE on October 30, 2016, 09:11:05 PM
Charts mostly available here.

https://finance.yahoo.com/portfolio/p_0/view/dv?bypass=true

Not going to do custom charts, or mark which ones I'm in. Too much busy work. See page two of this thread to see the buys. I expect to be in all of them anyway, eventually. There are a couple that are maybes.

LOL.  I'm not into it that much that I am going to follow your links to follow all these stocks.  You gotta have at least a dozen here already.

For your own self though, I would think charting them all on one graph for comparative purposes would be in order.  If I was doing this kind of investing, I would spend the time to do that.

As of now for me, this is really telling me nothing other than that you are enthusiastic about Pot Stocks.  Hard to make much comment on that.

RE
Title: Re: The Potfolio
Post by: Eddie on October 31, 2016, 04:19:43 AM
That link that you are too lazy to click on puts 17 charts at your fingertips. Not that much work, really, to click a mouse.

What I'm doing here is vetting a number of possible companies and evaluating them over the next several months, at least. They may soar...or they may tank. But if any of them turn out to be doing extremely well, I'll share that.

Hopefully it might turn out to be a worthwhile pursuit.
Title: Re: The Potfolio
Post by: g on October 31, 2016, 05:23:40 AM
That link that you are too lazy to click on puts 17 charts at your fingertips. Not that much work, really, to click a mouse.

What I'm doing here is vetting a number of possible companies and evaluating them over the next several months, at least. They may soar...or they may tank. But if any of them turn out to be doing extremely well, I'll share that.

Hopefully it might turn out to be a worthwhile pursuit.

Eddie, Nothing Ventured, Nothing Gained.

Let me laud your attempt to make some dough by investing and doing some independent thinking and research.

The stock market is one of the best places IMO for a person to arise from the miserable state of poverty and take care of himself and his beloved family. It is one of the good things of the Capitalist system available to most citizens with a strong desire to better their financial situation.

It's not easy, plenty of pitfalls,  discipline and hard work is also involved. I love seeing someone besides myself engaging in investing and projecting their ideas.

You may take pride Eddie, as I see you have piqued the interest of Diner AZ in your venture and he plans to participate soon.

Let me wish you gentlemen the greatest of success, but always remember my friends, Wall Street is a TWO WAY street NORTH and South. Always keep a stash for another venture.                                                                                           Regards, GO


                                                    (https://g.foolcdn.com/editorial/images/210882/stock-market_gettyimages-522646895_large.jpg)


Title: Re: The Potfolio
Post by: Eddie on October 31, 2016, 05:50:45 AM
Thanks, GO.

There are a number of reasons I feel the Potfolio offers a unique opportunity to turn a modest investment into a decent nest egg. For one thing, there are only about 55 companies in this space, and they are all still micro-caps (one or two exceptions).

The playing field couldn't be more unlevel, with the government heavily regulating the nascent industry. So companies who have a niche now are more likely to continue to grow, imho.

I do understand that the fundamentals of most of these companies are not great. But with our current dilemma, the hot money is going to be pouring into this sector anyway.

These stocks popped in 2014, and then fell back to earth. It might happen again. However, I do see more attention being paid to them by people I consider to be good traders. Clive Maund has a brand new (free) "green paper" out. He has been trading and recommending a few of these stocks since early in 2016. For those who might like to read his take, follow the link below. I will tell you that he concentrates on trading what he considers the best five.

CANN
BLOZF
CBDS
OGI.V
AMMJ

BLOZF, while interesting, I have not added to the watchlist. The company, Cannabix, is the one developing a cannabis breathalyzer. I expect this stock to be a darling for a while, but maybe not for the long haul. I expect it to be like Taser, basically. Besides, I don't support the use of breathalyzers in general.

The others are on the watchlist and in my fledgling portfolio.

https://www.clivemaund.com/landing.php?id=1 (https://www.clivemaund.com/landing.php?id=1)

I am no longer interested in trading. I am holding these stocks "old turkey". No stops, no plans to sell. I will set stops eventually when there is something to save. For now I'd prefer not to be stopped out by the wild swings these stocks are taking.

I am a little worried that I might influence Az or anybody else to follow me here. I certainly recommend only playing with money you can afford to lose.

I don't think I will try to follow more than twenty of these, long term. I will start weeding (hehe) them out when I get to 20.
Title: Re: The Potfolio
Post by: Eddie on October 31, 2016, 06:23:55 AM
I see Clive Maund has a new (not free) article about GRNH, which is also one of mine. I can't read it behind his paywall, but I think it's a good guess he's recommending it to be bought now. FYI.
Title: Re: The Potfolio
Post by: Eddie on October 31, 2016, 04:37:06 PM
I ran across several more pot stocks that are popping, so I am adding them to the list, at least temporarily. I intend to pare this list down, and I don't know much about these new ones except that people are buying them on volume at the moment.

CBNX, AGTK, ERBB, MCOA

I am removing BE.CN from the Potfolio. It did not rate a buy at this time, imho.

Charts here for all the 21 stocks on the list now. On one page for RE's instant perusal.









Title: Re: The Potfolio
Post by: Eddie on November 02, 2016, 06:19:48 AM
So far, three stocks have really out-shown the rest. MJNA (Medical Marijuana Inc) continues to shine. It's actually almost doubled since I bought it. That's the beauty of a stock bought for 8 cents a share. I don't expect it to keep up this pace, but it does seem like a solid gainer.

TRTC (Terra Tech) is up a decent 10%. MSRT (Mass Roots) is up about 6%.

The other 8 are still in the red. Not tanking, but not surging ahead, as of yet.

I have removed EMH.V from the watch list.

Update: Canopy Growth is finally going green this morning too. (CGI.TO)...aka TWMJF on the OTC Market.

For the moment, at least, the overall Potfolio (the 11 stocks already bought) is in positive territory, for the first time. (11-2-2016). We will see if it holds.
Title: Re: The Potfolio
Post by: Eddie on November 02, 2016, 07:27:02 AM
Nice puff piece on MJNA. LOL.

Medical Marijuana (MJNA) Soars Ahead of Pivotal U.S. Elections

inShare
 
 Ryan Allway

 November 2nd, 2016

 News

The upcoming elections on November 8th could be a watershed moment for the cannabis industry. With five states voting to legalize recreational marijuana and four others voting to legalize medical marijuana, investors could see the legal market for cannabis and related technologies significantly expand next year. Advocates are also hoping that California’s decision could be the tipping point needed to force the federal government to alter its antiquated views regarding the medicinal aspects of cannabis.

In this article, we will take a look at a stock that has tripled over the past several months. This stock still represents one of the most compelling opportunities in its sector with potential upside for speculative-minded investors.

Leader in the Space

Medical Marijuana Inc. (OTC Pink: MJNA) is diversified conglomerate focused on the emerging cannabis industry. With a focus on the extraction and formulation of cannabinoid-based products, the company targets pharmaceutical, nutraceutical, and cosmeceutical industries. These products are distributed across a growing number of countries around the world, including Mexico, Brazil, Paraguay, and Puerto Rico.

The company owns a portfolio of eight companies focused on cannabinoid-based pharmaceuticals and medications using hemp as a source, including:

HempMeds® (100% owned) – A distribution company focused on bringing high quality CBD hemp oil products like its RSHO™ product line to global markets.
Axim Biotech (45.5% owned) – A biotech company focused on cannabinoid-based pharmaceuticals and supplements like Canchew® gum through clinical trials.
Kannalife (16.7% owned) – A biomedical company focused on the antioxidant and neuroprotective properties of cannabinoids with an exclusive right to the ‘507’ patent.
Kannaway (100% owned) – A direct marketing company focused on bringing cannabis products to consumers through brand ambassadors.
MPS International (50% owned) – The nation’s first security and armored transport service provider to the cannabis industry with clients across the country.
HempMeds Brasil (100% owned) – The first provider of legal medical cannabis products and the exclusive distributor of RSHO™ in Brazil.
HempMeds Mexico (100% owned) – The exclusive distributor of RSHO™ in Mexico and the first company to have a medical cannabis product approved for import.
Wellness Managed Services (100% owned) – A provider of comprehensive business services to cooperatives, collectives, dispensaries, and related cannabis facilities.
This portfolio provides investors with built-in diversified exposure to the cannabis industry in a single publicly-traded entity. For example, AXIM Biotechnologies (OTCQB: AXIM) and Kannalife provide exposure to the biotech side of the industry while HempMeds and Kannaway are focused on the consumer side.

Reaching a Tipping Point

Medical Marijuana Inc.’s stock has soared more than 140% over the past few weeks, as the market begins to realize the company’s potential. This, coupled with the “November Election Factor,” has led a turnaround in many out-of-favor cannabis stocks over the past weeks.  The prior cycle, MJNA peaked at 48 cents based on future speculation of cannabis law reform.  The advance this period is partly based on speculation – but there are now significant fundamental forces taking hold.

In October, the company announced that Axim Biotech acquired the funding needed to continue its clinical trials across multiple indications. Its MedChew cannabinoid-medicated chewing gum, for example, will soon undergo clinical trials in Europe for pain and spasticity in multiple sclerosis patients. Its Cannabigerol topical cream will similarly undergo European trials evaluating its safety and efficacy and psoriasis and eczema.

Earlier this year, the company successfully expanded its HempMeds distribution into several countries including Mexico, Brazil, Paraguay, and Puerto Rico. In Mexico, Dr. Carlos G. Aguirre Velazquez also conducted a study that evaluated the effectiveness of CBD oil in helping treat refractory epilepsy. The findings showed that 16% of the participants were completely free of seizures with average seizure reduction of 67% with zero adverse side effects.  This compares extremely favorably to US based pharmaceutical development for refractory epilepsy.

The news from these portfolio companies could provide further catalysts for the stock over the coming quarters as the company seeks to enter new markets, launch new products, and secure approvals from health regulators around the world. At the same time, the legalization of cannabis in the United States across several states – and potentially nationwide – could open the door to significantly higher revenue in many areas of the industry.

Looking Ahead

Medical Marijuana Inc. represents a compelling opportunity to profit from the burgeoning cannabis industry, particular with U.S. elections potentially opening the door to new markets. With its highly diversified presence in the space, investors benefit from diversification across multiple areas of the industry with a steady stream of potential catalysts for the stock price.

For more information, visit the company’s website at www.medicalmarijuanainc.com (http://www.medicalmarijuanainc.com).


http://www.cannabisfn.com/medical-marijuana-mjna-soars-ahead-of-pivotal-u-s-elections/ (http://www.cannabisfn.com/medical-marijuana-mjna-soars-ahead-of-pivotal-u-s-elections/)
Title: Re: The Potfolio
Post by: azozeo on November 02, 2016, 08:19:33 AM
I just hope the length of time for general acceptance doesn't take as long as woman's suffrage has taken.
80 - 100 years is a bit much.
Title: Re: The Potfolio
Post by: Eddie on November 02, 2016, 08:27:41 AM
The percentage of people who admit to smoking pot has doubled in three years.

The percentage of Americans who say they currently smoke marijuana has nearly doubled since 2013, a new survey finds. Thirteen percent of adults in the U.S. now say they currently smoke pot — up from 7 percent in 2013, according to the new Gallup poll.Aug 8, 2016

http://www.livescience.com/55689-marijuana-use-doubled-americans.html (http://www.livescience.com/55689-marijuana-use-doubled-americans.html)

Interesting demographics.
Title: Re: The Potfolio
Post by: Eddie on November 02, 2016, 01:59:33 PM
Mass Roots gave back its gains and then some. Only three stocks in the 11 I'm currently holding were green today. But GET THIS....MJNA was up an incredible 44% today and CBIS notched up 18%, so the Potfolio ended up still in the green for the day!

Yipppeee!

The broad market was puking all day, although the miners looked stronger until gold gave up its gains at the end of the session.

This is the seventh down day in a row for the S&P. Looks like its on life support. People seem to be worried about a guy named Trump winning the election. If this keeps up, the markets will fall hard, I expect.
Title: Re: The Potfolio
Post by: Eddie on November 03, 2016, 08:04:57 AM
Some of the new ones I added to the watch list namely MCOA and ERBB, are really taking off. I am not holding either one yet, unfortunately. The actual Potfolio is still green, but many of my picks are still slightly down at the moment.

The broad markets are mixed this morning, gold is up, the dollar down but now bouncing off support at 97. The election uncertainty is liable to make things very volatile for the next few days, and non-farm payrolls are out on Friday. The markets expect them to be flat or slightly up.

I expect the PPT is on duty, and if the waterfall starts, they'll be buying futures and smacking the VIX hard. I don't look for a real serious correction this week. If Hillary takes the election the markets will likely perk up, until reality sets back in.

The short term outlook for pot stocks depends a lot, imho, on whether the ballot proposals for legalization pass. if they ALL pass, I expect another pop in these stocks. There are probably a lot of traders who have cashed out this week and are on the sidelines waiting to see which way the wind is going to blow.



Title: Re: The Potfolio
Post by: Eddie on November 04, 2016, 02:45:50 PM
A fairly brutal couple of days for the Potfolio. The stocks currently owned are now underwater by exactly 9%. It might have been worse, but CGRW was up 15% today, MSRT up 12.37%, ACBFF up 5%, and APH.V closed in the green at .79%. The strategy of buying small stakes in a lot of companies (eleven, so far) seems to be helping hedge the losses on these days when the broader markets are pissing blood.

Only MJNA and MSRT are still actually in the green at the moment, and even those two have given up some of their gains. The stock market is looking sicker by the day, and I'm not even sure a Hillary win will save it from a serious correction. Still, I don't think we're looking at The Big One...not yet.

Of the stocks on the watch list but not yet in the Potfolio, only MCOA was up today, with a gain of 6.6%

The election is the thing making the markets nervous right now. A Trump win is bearish news. A Clinton win might be bearish news too, now that TPTB seem to be thinking she's become a liability. I'm not sure.





Title: The Potfolio Crashes
Post by: RE on November 04, 2016, 03:14:20 PM
A fairly brutal couple of days for the Potfolio.

It's "that moment" again.  :icon_mrgreen:

I TOLD YOU SO
(https://craigmotor.files.wordpress.com/2012/10/advice.jpg)

RE
Title: Re: The Potfolio
Post by: Eddie on November 04, 2016, 03:33:40 PM
A 9% drawdown, on penny stocks that sometimes move more than 20% in a day , is not catastrophic, by any means.

I am being steadfastly honest and reporting the bad days, and not just the good ones. Most pundits don't do that. At least my readers will be able to trust me. This is a real experiment, not a pump and dump operation.

Way too soon to say I told you so. Better hold that in abeyance for a while. These stocks still might make me shockingly rich, and then you'd look pretty foolish. :)

The things I want to stress to any readers out there are as follows:

Don't play pot stocks with money you might truly need. I consider 1% of my portfolio to be a reasonable position at this point.

Don't put money in any one company. Better to spread the risk over 5 or 10...or even 20. The watch list now has 20 stocks, and I consider them the best to buy, until proven otherwise. I'd be holding all 20, but I'm waiting until after the election so see if these stocks suddenly tank. They might.

If the broader markets really tank after the election, in my opinion that might be a great entry point to acquire some of these companies on the cheap.

Don't trade in and out. Buy and forget about it, if you can. Make adjustments in six months or a year. Give it some time. Don't set stops, at least until you have a substantial equity to protect. Even then, close stops on these stocks are a bad idea, imho.

It will take time for the profits to roll in. Even if recreational use passes in CA, it will be 2018 before any recreational pot hits the market, because da gooberment is involved.
Title: Re: The Potfolio
Post by: RE on November 04, 2016, 03:38:59 PM
A 9% drawdown, on penny stocks that sometimes move more than 20% in a day , is not catastrophic, by any means.

I am being steadfastly honest and reporting the bad days, and not just the good ones. Most pundits don't do that. At least my readers will be able to trust me. This is a real experiment, not a pump and dump operation.

Way too soon to say I told you so. Better hold that in abeyance for a while. These stocks still might make me shockingly rich, and then you'd look pretty foolish. :)

The things I want to stress to any readers out there are as follows:

Don't play pot stocks with money you might truly need. I consider 1% of my portfolio to be a reasonable position at this point.

Don't put money in any one company. Better to spread the risk over 5 or 10...or even 20. The watch list now has 20 stocks, and I consider them the best to buy, until proven otherwise. I'd be holding all 20, but I'm waiting until after the election so see if these stocks suddenly tank. They might.

If the broader markets really tank after the election, in my opinion that might be a great entry point to acquire some of these companies on the cheap.

Don't trade in and out. Buy and forget about it, if you can. Make adjustments in six months or a year. Give it some time. Don't set stops, at least until you have a substantial equity to protect. Even then, close stops on these stocks are a bad idea, imho.

It will take time for the profits to roll in. Even if recreational use passes in CA, it will be 2018 before any recreational pot hits the market, because da gooberment is involved.

You forgot the Disclaimer:

I am not a professional financial advisor and this should not be construed as investment advice.  lol.

Yea, OK, a 9% hit in 2 days isn't THAT bad.  ::)

I'm sure they will rebound nicely and you will be a fabulously rich Master of the Universe betting on Ganga.

RE
Title: Re: The Potfolio
Post by: Eddie on November 06, 2016, 08:27:41 AM
With the election nearly here, Pot Stock floggers are coming out of the woodwork. I'm linking a couple of these, just for grins. When I read these it made me wonder how long it will be before Doug Casey and Porter Stansfield get into  the Pot Newsletter biz.

http://www.wdrb.com/story/33635083/california-marijuana-legalization-may-spark-a-historic-rally-in-marijuana-stocks (http://www.wdrb.com/story/33635083/california-marijuana-legalization-may-spark-a-historic-rally-in-marijuana-stocks)

http://moneymorning.com/on-nov-8-the-marijuana-market-goes-legit-and-these-pot-stocks-are-poised-to-go-vertical/ (http://moneymorning.com/on-nov-8-the-marijuana-market-goes-legit-and-these-pot-stocks-are-poised-to-go-vertical/)

I looked at several of the stocks they mentioned and weeded them out of the Potfolio in advance. You just can't trust anybody these days. LOL.

If pot stocks do pop again on election news, it will still be due to speculation, at this point. As I said before, if Cali passes recreational use, it will be over a year before it goes on sale (legally) anywhere there.

Title: Re: The Potfolio
Post by: Eddie on November 06, 2016, 11:16:59 AM
The first link above takes you to a site called AllMarijuanStocks.com, which has some nice charts all on one page, and lists what the site owner thinks are 5 Star and 4 Star pot stocks. There is a real dearth of info about exactly who runs this site, but the contact person is listed as a "Dr. Kartchner".

Not sure, but wonder if it might be this AZ physician, Dr. Wade Kartchner, who had this to say in 2012. This Dr. Kartchner was someone providing services to Navajo county, but seems to have retired.

12/12/2012

Medical marijuana- the Arizona scam
There appears to be a public health disaster looming of epic proportions, one that apparently will dwarf the impact of smallpox, HIV/AIDS, heart disease, or even bed bugs.  The statistics are startling, yet the American public seems to be blithely ignorant of the problem.  As a public health official in Arizona, I consider it my duty to warn folks of the impending catastrophe that may befall us if we do not take measures soon.  According to the Arizona Department of Health Services website, this concern afflicts fully 89% of the 33,633 successful applicants to the Arizona Medical Marijuana program.  I, for one, was not aware of the enormity of the problem.

What might this scourge be?  A horrible infectious disease?  An environmental health disaster?  Nah, nothing so prosaic.

Chronic pain.

You got it.

Chronic pain.

What is even more interesting from an epidemiological standpoint is that most of these afflicted with this dreaded chronic pain fall in the younger set; 46% of the applicants are 40 years old or younger.  A full 26% are younger than 30 years of age.  According to these figures there are seemingly hordes of young adults running around acutely suffering from chronic pain.  I would have thought that chronic pain would be something that increases with age.  Apparently not.  Well, color me skeptical, but I suspect that this set of numbers probably coincides with the percentages of each age group that light up marijuana currently.  Prior to the passage of the medical marijuana act in Arizona, the 18-40 year old demographic was far more likely to be smoking weed than your cuddly old grandmother-type with cancer.  Methinks this same group has just been transplanted onto the medical marijuana rolls, with a likely huge increase in the “chronic pain” diagnosis.  All this “new” chronic pain among our younger population is going to be such a heavy burden for society to bear!   

Is this a diatribe against the use of medical marijuana?  Not really.  I only decry the use of the rubric “medical” to promulgate the legal use of marijuana in my state.  I have somewhat more respect for those who were recently advocating the legalization of marijuana in Colorado, as there was a modicum of honesty in their presentation.

Where will this end?  I have no idea.  However, given the likely rise in consumption of munchies in Arizona, I feel my portfolio could use a strategic Frito-Lay buy...

  Cheetos

 Dr. K

 Posted at 02:41 PM in Food and Drink, Medicine, Public Health, ■Healthcare Policy, ■Politics, ■The Practice of Medicine | Permalink


I have not tried to confirm that this is the same Dr.Kartchner, but I wonder. No disrespect, Dr. K., if I'm wrong.

(admin, I'll leave it to you to determine whether this post stays up. Don't want to get the Diner in legal trouble.)
Title: Re: The Potfolio
Post by: Eddie on November 06, 2016, 11:36:33 AM
The second link above takes you to this guy, Michael Robinson, who is very proud to list his credentials as a tech stock guru. I guess he's branching out. His pamphlet, The Roadmap to Marijuana Millions (a $499 Value) is your for free if you do something (like maybe let him put you on his spam list).


(http://moneymappress.com/wp-content/uploads/2015/09/MichaelRobinsonPic-250x290-min.png)

https://purchases.moneymappress.com/NVXMJJ5/WNVXSB06/index.htm?pageNumber=2&_ga=1.105732608.2096955337.1476118816 (https://purchases.moneymappress.com/NVXMJJ5/WNVXSB06/index.htm?pageNumber=2&_ga=1.105732608.2096955337.1476118816)

He's a typical pitch man who has a long and shady track record. Pot stocks just appear to be his latest scam.

http://www.stockgumshoe.com/tag/michael-robinson/ (http://www.stockgumshoe.com/tag/michael-robinson/)

His "book" is easily confused with another well-reviewed book with a similar title, called "Marijuana Millions: Your Foundation for Success" by Alexa Divett.
Title: Re: The Potfolio
Post by: Eddie on November 07, 2016, 10:43:40 AM
With Hillary off the hook with the FBI (at the moment anyway) the broader markets have had a blow-out day. The Dow Index is up 350 points for the day, as of right now.

A rising tide lifts all boats they say, and it seems to be true for the Potfolio today. Only one stock (MCOA) is down for the day, and I count ten double digit gainers on the watch list.

I'm no longer underwater. Looks like I'm in the green by 10% or so at the moment on the Potfolio. It's a wild ride.

Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 10:50:13 AM
The biggest loser in the Potfolio so far is GRNH. This is a hydroponics company with good revenue growth, and its chart looked promising when I bought in. However, it is the one Potfolio member that has disappointed from day one. It's now down 34%.

(https://chart.finance.yahoo.com/c/1y/GRNH?lang=en-US&region=US)

I'm inclined to think it's just basing again, and maybe it isn't quite as hot right now as the real pot growers. It's obvious I picked a poor entry point, but hindsight is always 20/20. I have no plans to cut it, it's way too soon....but I wouldn't recommend buying it right now either.
Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 02:09:14 PM
Clive Maund is one of my favorite TA guys, a candle-stick chartist who is quick to get in and out of trades, and who sells his advice to a lot of people for $600 a year. I used to pay that, but now I just check his site for the occasional freebie. I do consider him to be a fairly straight-up guy, as he is just as quick to go short as long, if that's what the charts say to do. Not a pumper, but he can change his outlook overnight if conditions change.

This is his take on pot stocks going into the election. Pretty much agrees with what I've been thinking.

THE CANNABIS SECTOR AFTER THE VOTE - BOOM OR BUST??...
originally published Tuesday, November 08, 2016

Marijuana U.S. Stocks

Note only do we have the US elections today, we also have voting in 8 States on the legalization of cannabis, including the all-important State of California, which just by itself is one of the biggest economies in the world. The outcome of this vote is of crucial importance to the future of this fledgling industry, although all the indications are that it will be favorable.
In attempting to determine the immediate course of the cannabis sector right after the vote, there are two major factors to consider. One is the actual outcome of the vote, and whether it exceeds or fails to meet market expectations and what this will lead to. The other is the heavy buying of the sector ahead of the vote, that has caused huge runups in many stocks, making it vulnerable to a wave of profit taking on the vote, especially if it fails to meet expectations.

We already made big, and in some cases huge gains as a result of the boom in cannabis stocks over the past month or two, and were in the vanguard of the wave of profit taking across the sector last week, caused by understandable nervousness ahead of the vote. However, it is important to understand that this still very young industry stands on the threshold of a massive boom, which if the vote goes well as expected, will be comparable to the boom in the liquor industry when prohibition was lifted back in the 30’s, and the stocks of the best companies will go on to make spectacular gains. So it is now thought that, assuming the vote goes at least as well as expected, any post vote bout of profit taking will be short-lived and followed by a reversal and a strong and sustained rally as this industry booms – and the spreading legalization of cannabis in the US will have a knock-on effect around the world. This is the reason why, after we took profits in many stocks last week, we started rotating back into the best ones on Friday and on Monday.

So what tactics should investors and speculators employ at this juncture, especially those who are new on the scene? Firstly, after yesterday’s rally, there is so little time left before the outcome of the vote is known that it probably makes sense to wait for the results. Then, if we do see an immediate wave of “sell on the news” profit taking, it will be viewed as throwing up a major buying opportunity, especially if the vote generally meets or exceeds expectations. If a positive vote triggers a wave of buying, this may then be followed by a bout of profit taking that briefly drives prices lower, perhaps quite a lot lower, again providing an opportunity to step up to the plate and buy the better stocks. The key point to keep in mind is that if the vote goes well, especially in California, then we are on the threshold of a massive one-off boom in this sector and fortunes will be made, with the best stocks multiplying in value perhaps 10 or 20 times over the next year or two.


I notice he is analyzing Growblox (GBLX and Aerogrow (AERO), two MJ related stocks NOT in the Potfolio. The articles are behind his paywall, but I would guess he is waiting for any entry point to buy them.

Sometimes he makes his private articles public after some time passes. Here's a link to a mid-October article on MassRoots. Lots of good info.

https://www.clivemaund.com/free.php?id=3938 (https://www.clivemaund.com/free.php?id=3938)
Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 07:40:23 PM
First news I've read on the referendums has medical marijuana passing in Florida. That's one.
Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 07:48:45 PM
Michigan passes recreational marijuana. That's two.
Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 07:53:53 PM
Recreational pot leading in Maine (51% Yes with 31% of precincts in). Also leading in Massachusetts (53% with 48% of precincts in). Might be close on both of those.

Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 08:08:29 PM
North Dakota looks to be passing medical MJ.

Medical MJ ahead in Montana, but only 3% reporting so far.

Medical MJ ahead (barely) in Arkansas.

Recreational being voted down in Nevada, but only 1% of precincts reporting so far. Too soon to call it.

Nothing on AZ or CA as of yet.

Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 08:24:08 PM
Arizona voting recreational pot down, so far, with 30% reporting. That's a surprise. 53% no vote at present.

California 53% for, but only 4% reporting so far.
Title: Re: The Potfolio
Post by: Eddie on November 08, 2016, 08:52:15 PM
Now looks like 8 out of 9 initiatives will pass, with Arizona being the exception. However, with only 36% reporting, that could possibly still turn.

Overall, a good day for dope in America.
Title: Re: The Potfolio
Post by: RE on November 08, 2016, 09:08:06 PM
We can all Toke Up with the Donald!

RE

https://www.washingtonpost.com/news/wonk/wp/2016/11/08/medical-marijuana-sails-to-victory-in-florida/ (https://www.washingtonpost.com/news/wonk/wp/2016/11/08/medical-marijuana-sails-to-victory-in-florida/)
Title: Re: The Potfolio
Post by: Eddie on November 09, 2016, 04:25:30 AM
I figure the Donald's first executive order will be to legalize meth for the people who voted for him.
Title: Re: The Potfolio
Post by: Eddie on November 09, 2016, 07:39:29 AM
Selling on the news. The Potfolio is having a red day, although it's not too horrible yet. The broader markets are looking for their footing. I expected stocks to sell  off hard in the days and weeks ahead if Trump were elected, so there will probably be a Santa Claus rally right through the end of the year.  ;D

I see a buying opportunity coming in pot stocks, but it isn't here yet. The election outcome is highly favorable from a cannabis POV.



Title: Re: The Potfolio
Post by: K-Dog on November 09, 2016, 08:21:22 AM
I figure the Donald's first executive order will be to legalize meth for the people who voted for him.


All it would take to free the weed is an executive order.  If I were Trump the ink on it would be drying now.
Title: Re: The Potfolio
Post by: K-Dog on November 09, 2016, 08:28:54 AM
Of course one has to be sworn in first so right now he is grabbing pussy.
Title: Re: The Potfolio
Post by: agelbert on November 09, 2016, 11:36:41 AM
I figure the Donald's first executive order will be to legalize meth for the people who voted for him.

GOOD ONE!  :emthup:

His team might come up with a (electronic only - mailing stuff costs money, ya know) graphic sent to his base showing an equal sign between his loyal supporters and, uh, see, below:




(http://static1.squarespace.com/static/54641690e4b0f2a48d5aefce/t/546989eee4b027698c28c2dd/1441065999361/?format=1500w)

Title: Re: The Potfolio
Post by: Eddie on November 10, 2016, 06:47:41 AM
About half the Potfolio stocks I own are going green this morning. It looks like the selling might be over. I'm about even right now.

Title: Re: The Potfolio
Post by: Eddie on November 10, 2016, 07:41:30 AM
Lots of articles coming out about the economic and financial aspects of the successful MJ referendums. Follow the link to see a lot of graphics I didn't bother to copy.

http://qz.com/832370/marijuana-legalization-succeeded-in-the-2016-elections-despite-the-results-of-the-presidential-race/ (http://qz.com/832370/marijuana-legalization-succeeded-in-the-2016-elections-despite-the-results-of-the-presidential-race/)



One in every five Americans is about to get legally high AF after this election


Elijah Wolfson & David Yanofsky November 09, 2016

In the early hours of Nov. 9, Americans found out that their next president is Donald Trump; they also learned that marijuana’s slow drive to nationwide legality had shifted into the next gear.
These two facts may seem incongruous, but that’s only if you’re stuck in 20th-century politics. In 2016, marijuana has become one of the least contentious matters in US partisan politics, and is likely the issue on which most liberals find Trump to be least offensive.
On Nov. 8, which included not only presidential and congressional elections but ballot initiatives in 35 states, voters in Arkansas, Florida, and North Dakota made it legal for doctors to prescribe medical marijuana to their patients. Montana voted to ease recent restrictions on its decade-old medical marijuana law. That, for the first time, means smoking weed is legal, at least for medical and in some cases for recreational purposes, in 29 states.

Perhaps more importantly, four states voted to pass new laws that make marijuana use equivalent to liquor consumption. In California, Massachusetts, Maine, and Nevada, it is now legal for anyone over 21 years old to smoke pot.

Those states join Alaska, Colorado, Oregon, Washington, and the District of Columbia in a sort of loose coalition strongly challenging the federal government, which still classifies marijuana as a Schedule I drug, meaning it has “no currently accepted medical use” and a “high potential for abuse.” The Nov. 8 votes create a strong western bloc—the entire Pacific coastline is now on board with legal weed—and establishes a stronghold in the northeast, where Massachusetts could set the agenda for other liberal states.
Of the nine states where weed was on the ballot, eight made access to the plant easier. Only in Arizona—where medical marijuana is already legal, and which was considering legalizing recreational use—did a new law not pass.

That’s less surprising than it seems at first glance. Legalization of marijuana is one of the few issues on which Republicans and Democrats appear to be coming together. While Democrats and Independents are still far more likely than Republicans to favor legalizing recreational use, support in both parties is increasing sharply:

This shift is due largely to growing research into marijuana and awareness that it can have health benefits and few risks. But it’s also in part due to a growing recognition that legalizing a robust underground pot industry could provide serious fuel for local economies.
Just last month, the Marijuana Policy Group published a report (pdf) crediting legal weed in Colorado with creating some 18,000 full-time jobs and adding about $2.4 billion to the state’s economy in 2015. The five states that just legalized weed could therefore be in for a financial windfall. All of the new laws passed on Nov. 8 include state taxes on retail marijuana sales: 15% in California and Nevada, 10% in Maine, and 3.5% in Massachusetts.

It’s not entirely clear where president-elect Donald Trump stands on the issue. He has said he believes “100%” in the medical value of marijuana, and has also made clear that he wouldn’t interfere with states’ rights to set their own marijuana-related laws and agendas.
But what about the federal restrictions? The CARERS Act, introduced in the Senate in March 2015, would move marijuana from Schedule I to Schedule II, allowing doctors to prescribe it, but it has been stuck in committee. Since the Drug Enforcement Administration (DEA) is part of the executive branch of government, a Trump appointee as DEA head could bypass the legislative branch and make the schedule change directly. But Trump hasn’t made made his drug policy (or many others) clear yet.
Even moving marijuana to Schedule II would still be a far cry from allowing it for recreational use, though. And it would still trail behind changing public opinion. According to Pew Research, in 2015, 53% of Americans supported legalizing marijuana for medical or recreational use, and 44% were opposed.

The bipartisan support for legal recreational weed may make its continued federal criminalization untenable. On Nov. 4, President Barack Obama explained on TV the challenges the new legalization laws would create for federal regulators:
“You’ll now have a fifth of the country that’s operating under one set of laws and four-fifths in another. The Justice Department, DEA, FBI, for them to try to straddle and figure out how they’re supposed to enforce laws in some places and not in others, they’re going to guard against transporting these drugs across state lines—you’ve got the entire Pacific Corridor where this is legal. That is not going to be tenable.”
Given the financial incentives, and the fact that over 21% of Americans now live in a state that says they have the legal right to get high for fun, it’s likely now a question of when, and not if, the rest of the country will follow suit.
Meanwhile, all nine states and districts where weed is is now legal—California, Massachusetts, Maine, Nevada, Alaska, Colorado, Oregon, Washington, and DC—voted for the losing candidate, Hillary Clinton, last night. At least they will now have a way to ease the anxiety of life under Republican leadership.
Title: Re: The Potfolio
Post by: Eddie on November 10, 2016, 08:17:01 AM
(http://www.zerohedge.com/sites/default/files/images/user3303/imageroot/2016/11/09/20161110_weed_0.jpg)

More jawboning, this time on ZH.

http://www.zerohedge.com/news/2016-11-10/and-winner-2016-election-weed (http://www.zerohedge.com/news/2016-11-10/and-winner-2016-election-weed)
Title: Re: The Potfolio
Post by: MKing on November 10, 2016, 08:27:40 AM
(http://www.zerohedge.com/sites/default/files/images/user3303/imageroot/2016/11/09/20161110_weed_0.jpg)

More jawboning, this time on ZH.

http://www.zerohedge.com/news/2016-11-10/and-winner-2016-election-weed (http://www.zerohedge.com/news/2016-11-10/and-winner-2016-election-weed)

Bring on the weed!
Title: Re: The Potfolio
Post by: Eddie on November 10, 2016, 09:26:52 AM
I think it represents a fairly harmless way to make some money, if one can identify the right companies to put a few bucks into.

Title: Re: The Potfolio
Post by: MKing on November 10, 2016, 10:08:27 AM
I think it represents a fairly harmless way to make some money, if one can identify the right companies to put a few bucks into.

I have zero objection to recreational dope use. But unless insurance companies and the feds change the rules on who can be hired based on what drug testing regimes, it will just make decent jobs continue to go without available employees,and will create more qualified and pissed off younger folks, who can't get employed because they smoke dope because like, dude, its legal!

Title: Re: The Potfolio
Post by: Eddie on November 10, 2016, 02:07:59 PM
Ended up being a real down day for lots of pot stocks, but I do think it might not be a bad entry point for these guys.


(https://chart.finance.yahoo.com/c/1y/MNTR?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MSRT?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/TRTC?lang=en-US&region=UShttps://chart.finance.yahoo.com/c/1y/ACBFF?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MT.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CGC.TO?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/APH.V?lang=en-US&region=US)
Title: Re: The Potfolio
Post by: Eddie on November 11, 2016, 02:05:48 PM
Even though gold is in the toilet and the broader stock indexes were mixed today, the Potfolio of green herb stocks was mostly in the green by the end of the day. I am still underwater, but I feel better.

Title: Re: The Potfolio
Post by: Eddie on November 12, 2016, 11:31:19 AM
These are the Potfolio stocks I'd like to buy next.  I am looking for entry points on all seven. Even though some of them have been beaten down, they were all green again on Friday, with the exception of MNTR, which looks like the strongest chart anyway, to me.



(https://chart.finance.yahoo.com/c/1y/AGTK?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MNTR?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/ERBB?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNAB?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNBX?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MCOA?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/AMMJ?lang=en-US&region=US)
Title: Re: The Potfolio
Post by: Eddie on November 12, 2016, 12:46:47 PM
A more in-depth look at the charts I listed above, looking at volume and candlesticks, which I'm not good at copying here, indicates that ALL the particular stocks listed below were (on Friday).....(a) up on decent volume, (b) have RSI's turning up and (c) are showing bullish crossovers on the stochastic chart.

That's about as good a buy signal as you're ever likely to get. I look for all these to do well for a few days, at least. Because of the bullish charts, the traders should pile back into these on Monday, barring some kind of horrible news from Europe or Asia that takes the whole equites market down.


GRNH, MJNA, CBDS, CGRW, MSRT, TRTC, CBIS (I already own a small stake in these)

AGTK, ERBB, CNBX, MCOA, CNAB, AMMJ ( Not yet owned, and currently flashing a buy signal)


The link below will show you MCOA, which is the most bullish of all of them today.

https://finance.yahoo.com/chart/MCOA?p=MCOA#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

From that page you can just click on the watch list symbols on the right of the page to view the others.

Please understand that these are super high beta stocks that rise AND fall in spectacular fashion. My approach is a buy and hold, and I wouldn't be surprised to see them back down in a week or two weeks. You have to resist the urge to sell when that happens, if you're planning to stay in for the long haul.

Trading in and out is a different approach. It is a valid way to make money in pot stocks, and people are out there doing it. But that's NOT what I'm doing. If you want to play that game, buy a subscription to Clive Maund and get the app that gives you real time trade signals to your iPhone. This thread isn't going to do that.

Traders love high beta stocks, and when the RSI and Stochastics turn the other way in a week or two, they'll all try to sell at the same time.

Still, it pays to enter at a time when the odds favor some immediate upside, rather than buying and watching one's new acquisitions lose 20% the next day. That's why I study the charts.





Title: Re: The Potfolio
Post by: azozeo on November 12, 2016, 12:51:33 PM
I see an uptrend in these penny stocks in general as we now know
who's running the show for the next 4 years. Fear & ego run the markets. Party on Garth, Party on Wayne  :icon_sunny:  :emthup:
Title: Re: The Potfolio
Post by: Eddie on November 12, 2016, 01:04:06 PM
I see an uptrend in these penny stocks in general as we now know
who's running the show for the next 4 years. Fear & ego run the markets. Party on Garth, Party on Wayne  :icon_sunny:  :emthup:

http://www.youtube.com/v/-nphIkEVmzQ&fs=1
Title: Re: The Potfolio
Post by: Eddie on November 13, 2016, 11:10:34 AM
Here's an article on Canopy Growth, a Canadian company which is in the Potfolio and trades as CGC on the Toronto Exchange, but has the symbol TWMJF on the OTC Exchange.

As this article points out, it has more to recommend it than most stocks in the sector. Namely it has good fundamentals.


The Only Marijuana Stock to Buy That Isn’t Going to Pot
NOVEMBER 5, 2016 BY NANALYZE 5 COMMENTS

We just saw this morning that cannabis investor Privateer Holdings has taken in an additional $40 million in funding for investing in the increasing legalization of marijuana. Legal cannabis sales are expected to hit over $6 billion this year and are expected to approach $22 billion by 2020. This had us thinking, is there any good pure-play marijuana stock out there?

People didn’t seem to appreciate the several articles we wrote earlier this year warning investors about not investing in OTC marijuana stocks. We thought it was important to warn investors because FINRA warned about this and they’re… well, OTC stocks which no serious investor would touch with a ten foot pole. Nonetheless, we received some serious verbal backlash and some examples of this critical commentary can be seen below:

CGC +50% up and on TSX now. This was shitty article
Totally missed the mark on this one bud. Back to class for you.
Absurd article. Internet trash.


Stoners. You just can’t seem to get through to them (rolls eyes). Now while legalizing marijuana didn’t make the cut in our list of 30 emerging technologies investors should watch, we’re going to grandfather it in in because it has some serious potential as a disruptive market and there is some huge interest in this theme from a whole bevy of stoned investors. And let’s be frank, these are some of the investors that need help the most. Plus, marijuana stocks are just a whole lot of fun to write about because you can interject all kinds of dope puns into your writing (see what we did there?).

So we took the advice of one of our lovely readers and decided to take a closer look at a marijuana stock called Canopy Growth Corporation (TSE:CGC) that has began trading on the TSX. Note that Canopy Growth also continues to trade on the OTC market under the symbol TWMJF. Since CGC began trading on the TSX, shares are up +115%. We must be careful not to confuse share price appreciation with a good long term investment as people are often prone to do. Let’s take a closer look at what sort of company lies underneath these rapidly appreciating CGC shares. (Note: All numbers below are in USD).

(http://www.nanalyze.com/app/uploads/2016/11/Canopy-Growth-Logo.jpg)

The significance of Canopy Growth is that they claim to be the first federally regulated, publicly traded cannabis producer in North America and the only cannabis company listed on a major global stock exchange. From what we’ve seen, there seems to be no reason to disagree with that statement. Let’s not forget that marijuana is illegal in most U.S. States and in a majority of countries around the world so we’re a long way away from seeing our first marijuana IPO. Canopy Growth operates four production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The first thing we noticed when looking at this $600 million company is that they are selling a lot of weed.

(http://www.nanalyze.com/app/uploads/2016/11/Marijuana-Stock-Pot-Sales.jpg)

So in their best month this year so far they sold 661 pounds of marijuana. With 16,500 customers this works out to 18 grams a month or 5.2 eights a month which is a lot of weed being consumed. Marijuana is not technically legal in Canada so these are all “medical marijuana” users. Since last year they added 12,800 customers so there must be something in the water that’s making everyone get so sick all of a sudden. On April 20, 2016, the Canadian Federal Government announced its intention to introduce, by the Spring of calendar year 2017, legislation to legalize the recreational use of marijuana in Canada. Canopy Growth sees this as a 7-10 billion dollar market. The Company is also starting to pursue an international expansion and they’ve even partnered with Snoop D O Double G which bodes well for an expansion into the U.S.:

(http://www.nanalyze.com/app/uploads/2016/11/Snoop-Dogg-Canopy-Growth.jpg)

Considering that they only sold their first bag of weed as recent as 2014, CGC appears to be on a tear. A peek into CGC’s last financial filing as of June 2016 shows that they have $14.5 million in cash on hand with just $2.6 million in long term debt. Their last fiscal quarter shows they took in revenues of $5.2 million and incurred losses of around $3 million.

If you’re thinking about investing in marijuana stocks, there aren’t many options available. As Canopy Growth claims, they seem to be the only pure-play marijuana stock traded on a major stock exchange at the moment. The biggest takeaway here is that this is a legitimate company from what we can tell that sells a lot of weed which is exactly what you want from an investment theme that focuses on the proliferation of weed. With increasing legalization, Canopy Growth stands to benefit as the only pure-play marijuana stock around.

We feel the need to remind everyone that you should never put all your eggs in one basket with any stock and that this marijuana stock should just be part of a diversified portfolio and not the only stock you hold. If it comes crashing down after the recent run, don’t panic. As an investor you should be in this for the long run. If CGC blows up and you lose all your money, just take the advice of a wise sage named Calvin Cordozar Broadus Jr. who once said “Sometimes a loss is the best thing that can happen. It teaches you what you should have done next time“.
Title: Re: The Potfolio
Post by: Eddie on November 13, 2016, 12:59:14 PM
Constellation Brands is an 800 pound gorilla in the wine and liquor biz, with a $30 Billion market cap. They aren't the biggest, but they're plenty big. Guess what?  They'd like to put dope in your alcohol.

They're going to need to buy out some smaller player. At this point, the likeliest candidate might be Dixie Brands, a privately held cannabis drink company in Colorado.....but ultimately, MOST of the Potfolio is likely to bought out by these larger players. The big fish will eat the little fish, especially if the Feds will stop busting people in the pot biz.

There's a lot of buzz, no pun intended, about how The Donald will influence this. He went more hard line during the election, but in my view, that might have been just to get the extreme Righties to cast their ballots his way....I expect we'll see just how anti-pot he turns out to be within a year or so. He does believe medical MJ has real benefits, according to what i've been reading.

At one time, years ago, he said all drugs should be legalized, which is way too sensible a position for a POTUS to take. He backed way off on that, changing his position on that in a a similar way to the way he reversed himself from pro-choice to pro-life. He did what he had to do to get elected. Now? Well, nobody really knows, but with Rudy Guiliani or Chris Christie as AG, the hands-off policy of the later days of Obama could be dropped, and they could start hassling growers again.

Constellation High

Constellation Brands, Inc.
STZ 0.31%
, one of the alcoholic beverages producers of the US – responsible for Corona beer and Svedka vodka, recently announced it was considering a venture in the legal cannabis industry.

"There are going to be alcoholic beverages that will also contain cannabis,” CEO Rob Sands declared in a recent interview. “Why wouldn't big business, so to speak, be acutely interested in a category of that magnitude? (…) If there's a lot of money involved, it's not going to be left to small mom-and-pops," he added.

“Maybe the whole thing will work out synergistically,” Sands concluded, discussing weed and alcohol consumption and cannibalization.



http://www.benzinga.com/trading-ideas/long-ideas/16/11/8687616/reads-for-the-weed-kend-beyond-marijuana-stocks-new-opportuni (http://www.benzinga.com/trading-ideas/long-ideas/16/11/8687616/reads-for-the-weed-kend-beyond-marijuana-stocks-new-opportuni)
Title: Re: The Potfolio
Post by: Eddie on November 14, 2016, 12:24:07 PM
A more in-depth look at the charts I listed above, looking at volume and candlesticks, which I'm not good at copying here, indicates that ALL the particular stocks listed below were (on Friday).....(a) up on decent volume, (b) have RSI's turning up and (c) are showing bullish crossovers on the stochastic chart.

That's about as good a buy signal as you're ever likely to get. I look for all these to do well for a few days, at least. Because of the bullish charts, the traders should pile back into these on Monday, barring some kind of horrible news from Europe or Asia that takes the whole equites market down.


GRNH, MJNA, CBDS, CGRW, MSRT, TRTC, CBIS (I already own a small stake in these)

AGTK, ERBB, CNBX, MCOA, CNAB, AMMJ ( Not yet owned, and currently flashing a buy signal)


The link below will show you MCOA, which is the most bullish of all of them today.

https://finance.yahoo.com/chart/MCOA?p=MCOA#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

From that page you can just click on the watch list symbols on the right of the page to view the others.

Please understand that these are super high beta stocks that rise AND fall in spectacular fashion. My approach is a buy and hold, and I wouldn't be surprised to see them back down in a week or two weeks. You have to resist the urge to sell when that happens, if you're planning to stay in for the long haul.

Trading in and out is a different approach. It is a valid way to make money in pot stocks, and people are out there doing it. But that's NOT what I'm doing. If you want to play that game, buy a subscription to Clive Maund and get the app that gives you real time trade signals to your iPhone. This thread isn't going to do that.

Traders love high beta stocks, and when the RSI and Stochastics turn the other way in a week or two, they'll all try to sell at the same time.

Still, it pays to enter at a time when the odds favor some immediate upside, rather than buying and watching one's new acquisitions lose 20% the next day. That's why I study the charts.

CNAB, MCOA, and AMMJ popped before I could get on board this morning, so I decided not to chase them. There will be better opportunities. I did take small positions in CNBX, MNTR,ERBB, AND AGTK.

I have no plans to acquire any other MJ stocks once I have positions in the last three. Once that's done I will add to the best performers over time, if they do anything.

Today almost all the watch list was green, with  14 out of 20 in double digits.

e

Title: Re: The Potfolio
Post by: Eddie on November 14, 2016, 01:07:28 PM
A more in-depth look at the charts I listed above, looking at volume and candlesticks, which I'm not good at copying here, indicates that ALL the particular stocks listed below were (on Friday).....(a) up on decent volume, (b) have RSI's turning up and (c) are showing bullish crossovers on the stochastic chart.

That's about as good a buy signal as you're ever likely to get. I look for all these to do well for a few days, at least. Because of the bullish charts, the traders should pile back into these on Monday, barring some kind of horrible news from Europe or Asia that takes the whole equites market down.


GRNH, MJNA, CBDS, CGRW, MSRT, TRTC, CBIS (I already own a small stake in these)

AGTK, ERBB, CNBX, MCOA, CNAB, AMMJ ( Not yet owned, and currently flashing a buy signal)


The link below will show you MCOA, which is the most bullish of all of them today.

https://finance.yahoo.com/chart/MCOA?p=MCOA#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

From that page you can just click on the watch list symbols on the right of the page to view the others.

Please understand that these are super high beta stocks that rise AND fall in spectacular fashion. My approach is a buy and hold, and I wouldn't be surprised to see them back down in a week or two weeks. You have to resist the urge to sell when that happens, if you're planning to stay in for the long haul.

Trading in and out is a different approach. It is a valid way to make money in pot stocks, and people are out there doing it. But that's NOT what I'm doing. If you want to play that game, buy a subscription to Clive Maund and get the app that gives you real time trade signals to your iPhone. This thread isn't going to do that.

Traders love high beta stocks, and when the RSI and Stochastics turn the other way in a week or two, they'll all try to sell at the same time.

Still, it pays to enter at a time when the odds favor some immediate upside, rather than buying and watching one's new acquisitions lose 20% the next day. That's why I study the charts.

CNAB, MCOA, and AMMJ popped before I could get on board this morning, so I decided not to chase them. There will be better opportunities. I did take small positions in CNBX, MNTR,ERBB, AND AGTK.

I have no plans to acquire any other MJ stocks once I have positions in the last three. Once that's done I will add to the best performers over time, if they do anything.

Today almost all the watch list was green, with  14 out of 20 in double digits.



A quick tally...I'm just slightly underwater on the overall Potfolio. I have three real winners so far, TWMJF, MJNA, and OGRMI . The rest are lagging, but not badly. I do have one that is seriously underwater,and that is GRNH (Down 37.7%). It's way too soon to cull anything, though. In fact, once I fill the last three positions, I might let this thread rest for a few months, unless there is real news to report.
Title: Re: The Potfolio
Post by: Eddie on November 15, 2016, 12:28:21 PM
GreenGro Technologies is the worst laggard in the Potfolio. Reading about the company, I'm inclined to hang in there. I wonder if the problem is that they do business in Arizona, which didn't pass its recent initiative. Shouldn't matter, since their business there was and is on the Medical MJ side.

This is a typical pumper article, but reading it leads me to believe GRNH is a decent pick. Just gonna have to give it some time.

An Update On GreenGro Technologies Inc (OTCMKTS:GRNH)
By Alex Carlson / in Momentum Stocks, Sector Watch, Stocks / on Tuesday, 15 Nov 2016 05:17 AM / 0 Comment / 449 views
cannabis 4 pic

GreenGro Technologies Inc (OTCMKTS:GRNH) is a name that we at Insider Financial have been covering all year. We said at the beginning of the year that the company could have a big 2016. While the stock is higher than where it started the year, GRNH has lagged behind other big players like Terra Tech Corp (OTCMKTS:TRTC). We think GRNH has some catching up to do and that looks to benefit investors that get in on the coming wave.



First up, a little background on the company. GreenGro describes itself as “a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.”

Last Tuesday, voters approved recreational marijuana initiatives in California, Massachusetts and Nevada, making California the largest populated state in the nation to legalize the recreational use of marijuana. Considering the size of the state’s economy (approximately 12 percent of the U.S.) and the economic impact of the marijuana industry there, the approval of the ballot measure provides a foundation for the Company to now safely build, invest and expand to serve the largest market for cannabis products in the U.S.

One of the ways GreenGro looks to capitalize is through its wholly-owned subsidiary CBD Ventures. CBD Ventures will provide turnkey cannabis extraction labs and launch a line of CBD (cannabinoid derived) nutraceutical products in early 2017. These announcements are the first of several strategic advancements the Company has been developing to service the new cannabis industry in California.

There’s also GreenGro subsidiary Vertical HydroGarden, Anaheim, Calif., which is a premier retailer of year-round hydroponic supplies as well as the Company’s Franchise Model for businesses in the field of controlled environment agriculture. Vertical HydroGarden is an industry leader in modular automated hydroponic grow-rooms, portable grow-containers, greenhouses, hydroponic and aquaponics supplies and cultivation consulting services.

Last month, GreenGro announced the sale of a $7.5 million BP Gardens Glass Greenhouse Franchise to FoodRaiser Corporation, Dublin, Ohio, a noted trailblazer in health conscious fundraising. FoodRaiser provides schools, clubs, teams, bands, nonprofits, churches and numerous other organizations with organic product based fundraising opportunities. Through the BP Gardens franchise agreement, FoodRaiser has committed to raising the capital to fund the $7.5 million purchase over the next six months. The companies expect to be breaking ground on the Ohio-based facility between the second and third quarters of 2017.

Greengro Technologies and FoodRaiser have entered into an agreement for FoodRaiser to purchase a Glass Greenhouse Franchise marketed by Greengro Technologies’ subsidiary BP Gardens, Inc., a controlled environment agriculture company that specializes in the use of leading-edge technologies and production methods. The Glass Greenhouse Franchise offering includes a turnkey, two-acre greenhouse facility designed to produce up to nine million heads of lettuce per year.

Also last month, GreenGro announced a joint venture agreement with Cannabrands AG, an Austrian-based private equity company specializing in cannabis industry investments. Cannabrands is listed on the Berlin Stock Exchange under ticker symbol: (BERLIN: JPK1:GR). The joint venture is based on the franchising of GreenGro subsidiary Vertical HydroGarden. This partnership enables Cannabrands to establish a working model for franchising Greengro’s Vertical Hydrogarden Stores throughout the European region, attracting international exposure through the use of state-of-the-art grow facilities. GRNH CEO James Haas said:

“Together with our storefront Vertical Hydrogarden franchises appearing throughout Europe, this joint venture initiates a project offering ‘student immersion’ courses for Europeans to take advantage of a campus-like course of study in the U.S. focusing on CEA growing systems and techniques in anticipation of expected worldwide growth of the legalized cannabis market.”
Currently trading with a market cap of $12 million, GRNH has overall been rather quiet this year on the news front. However, things have been picking up over the last few months and we expect this trend to continue going forward. There are certainly plenty of tailwinds to push GRNH and the cannabis industry forward. GRNH just needs to capitalize on one of the fastest-growing sectors in the U.S. right now.


https://www.insiderfinancial.com/an-update-on-greengro-technologies-inc-otcmktsgrnh/118247/ (https://www.insiderfinancial.com/an-update-on-greengro-technologies-inc-otcmktsgrnh/118247/)

Bought into CNAB today. That leaves AMMJ and MCOA still to add. Maybe next week. Out of powder for today, for this project, anyway.

The Potfolio has nine stocks up and eleven down at the moment, in afternoon trading. Some of the gainers are doing quite well today though.



Canopy Growth is starting to come on strong. I'm currently up 88.9% on that one.

https://finance.yahoo.com/chart/CGC.TO?ltr=1#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 (https://finance.yahoo.com/chart/CGC.TO?ltr=1#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)

Title: Re: The Potfolio
Post by: Eddie on November 15, 2016, 01:39:07 PM
From the GRNH Yahoo message board, not the best of sources, but this comment is well reasoned, imho.

WHY GRNH WILL BE A 25-BAGGER THIS FALL

Upon evaluation of prior response to sector catalysts, as history is one of the best predictors of the future in terms of price action in a similar situation -- GRNH historically vastly outperforms the sector on any major catalyst.

GRNH was a 40-bagger in 6 trading days in January 2014 and an 8-bagger in 7 weeks this March/April -- that is best in the sector for each of those catalysts during their respective time periods.

Size of the "tradable float": this is obviously determined by subtracting out insider shares from total shares BUT there are a lot of other metrics that really influence this number besides % of insider ownership.

If one thinks of the float as the effective supply, then how tightly shareholders hold onto their shares during a rally is a very important metric -- and the rabidity of the shareholders has an outsized effect on this -- GRNH shareholders are very confident and passionate during a rally and are not quick to sell for a measly double or triple -- this effectively shrinks the float

The MMs who trade in this stock are of a similar mindset due to their prior experiences so there is also less MM churning of shares in GRNH in comparison to most other MJ stocks during a runup

There is no convertible debt so there will not be any new shares hitting the float during the rally, which obviously shrinks the float relative to most stocks down here
In addition, convertible debt invariably causes the owners of said debt to short all rallies in the stock so they can drive the stock price down, convert their debt and use those shares to cover at the bottom -- the less shorting that goes on, the smaller the tradable float

There are other certainly other factors that influence the size of the tradable float which certainly impact the supply of GRNH shares available to buy (and short) during a rally but the above are some of the larger ones

And then I like to think about the demand side of the equation:

GRNH is an old MJ stock, one of the original guard... So it is extremely well-known and popular... It is a huge favorite of those that follow the sector

Dollar volume is the single most important metric in regard to direct measurement of demand and GRNH's dollar volume is extremely high relative to the small float -- this is the perfect storm

The superior liquidity in GRNH, driven by the popularity of the ticker, further serves to drive demand and interest in the stock -- a huge reason why it is my largest holding

The CEO understands PR and knows how to create hype and excitement with press releases

Although true fundamentals in this situation are significantly less important, I do believe that GRNH essentially moved a ton of revenue from Q2 into Q3 so their mid-November report, the one all new prospective shareholders will be reading/following, should show a pretty significant increase in revenues and the all-important press release summarizing the quarterly results should come across as pretty impressive

The comparative superiority of GRNH as a stock with money-making potential becomes a self-fulfilling prophesy as buyers gravitate to this equity over other options

In the end, the supply/demand ratio in combination with the superior liquidity in this stock will not only attract a large number of new shareholders this fall, but even more importantly, it will attract a large number of deep-pocketed individuals and groups who are not just looking for a quick flip on the double -- and in the end, big money is what really drives share prices in these types of scenarios

As for the comparison between GRNH in 2016 vs 2014:

On the supply side, the float is about 10X larger

On the demand side, the daily dollar volume is 10-20X greater

On the price side, the takeoff point should be about .25 compared to .04 or 6X higher

You put all the factors together and it appears that the ratio of demand/supply is greater in 2016 than what we saw in 2014 and the price launchpoint is obviously in a different stratosphere

Now throw in the comparison of the significance of the catalyst -- Colorado launching sales of recreational pot vs. 5 states, including California and Massachusetts passing legalization of recreational pot -- I think 2016 is clearly a bigger catalyst

Now look at the readiness of investors to throw money into the sector -- The amount of money flowing into these MJ stocks in 2016 should absolutely dwarf the amount we saw in 2014 as the sector is a lot more mature, the risk of being federally illegal is virtually gone and the history of the bubble in 2014 serves as another motivating factor to buy up these stocks in 2016 so one doesn't miss out on the monster returns that MJ stock bubbles create

The only factor that favors 2014 over 2016 is the float size, which is a huge factor -- and that is why I can't be absolutely certain -- but I am reasonably sure that GRNH approaches the $1 level and has a very realistic chance at taking out its old highs of $1.20 this fall
Title: Re: The Potfolio
Post by: Eddie on November 15, 2016, 02:24:39 PM
Three charts shaping up nicely. Wish more of them looked like these. No accident that these are companies that actually grow and sell pot directly.

https://finance.yahoo.com/chart/CGC.TO?ltr=1#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


https://finance.yahoo.com/chart/MT.V?p=MT.V#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

https://finance.yahoo.com/chart/APH.V?p=APH.V#eyJzaG93QXJlYSI6ZmFsc2UsInNob3dMaW5lIjpmYWxzZSwibXVsdGlDb2xvckxpbmUiOmZhbHNlLCJzaG93Q2FuZGxlIjp0cnVlLCJib2xsaW5nZXJVcHBlckNvbG9yIjoiI2UyMDA4MSIsImJvbGxpbmdlckxvd2VyQ29sb3IiOiIjOTU1MmZmIiwic2hvd1NtYSI6dHJ1ZSwic21hQ29sb3JzIjoiI2YwMTI2ZiIsInNtYVBlcmlvZHMiOiI1MCIsInNtYVdpZHRocyI6IjEiLCJzbWFHaG9zdGluZyI6IjAiLCJzaG93RW1hIjp0cnVlLCJlbWFDb2xvcnMiOiIjMWFjNTY3IiwiZW1hUGVyaW9kcyI6IjUiLCJlbWFXaWR0aHMiOiIxIiwiZW1hR2hvc3RpbmciOiIwIiwibWZpTGluZUNvbG9yIjoiIzQ1ZTNmZiIsIm1hY2REaXZlcmdlbmNlQ29sb3IiOiIjZmY3YjEyIiwibWFjZE1hY2RDb2xvciI6IiM3ODdkODIiLCJtYWNkU2lnbmFsQ29sb3IiOiIjMDAwMDAwIiwic2hvd1JzaSI6dHJ1ZSwicnNpTGluZUNvbG9yIjoiI2ZmYjcwMCIsInJzaUxpbmVXaWR0aCI6IjIiLCJzaG93U3RvY2giOnRydWUsInN0b2NoS0xpbmVDb2xvciI6IiNmZmI3MDAiLCJzdG9jaERMaW5lQ29sb3IiOiIjNDVlM2ZmIiwibGluZVR5cGUiOiJjYW5kbGUiLCJyYW5nZSI6IjFtbyJ9

Title: Re: The Potfolio
Post by: Eddie on November 16, 2016, 10:18:35 AM
I was wondering how long it would take Google to figure out I'm interested in pot stocks. This was in my Google News feed this morning. Coincidence? I doubt it.

What’s in Canopy Growth Corp After Today’s Gap Up?

November 15, 2016 Richard Conner
   
 What's in Canopy Growth Corp After Today's Gap Up?


(http://2l71k134rh661tzj4wus9d4f.wpengine.netdna-cdn.com/wp-content/uploads/2016/11/Whats-in-Canopy-Growth-Corp-After-Todays-Gap-Up.jpg)


The stock of Canopy Growth Corp (TSE:CGC) gapped up by $0.02 today and has $17.84 target or 36.00% above today’s $13.12 share price. The 8 months technical chart setup indicates low risk for the $1.82 billion company. The gap was reported on Nov, 15 by Barchart.com. If the $17.84 price target is reached, the company will be worth $655.20 million more.
Gaps up are useful for using as a support level and to some extent as a tradeable event. If investors already hold the stock and experience a price gap up, then its usually a good idea to hold the stock for a stronger up move. Back-tests of these patterns indicate that two-thirds of the times the stock performance improves after the gap. The area gaps close 89% of the time, the breakaway gaps, 2%, the continuation gaps 4% and the exhaustion gaps 61%. About 6.67 million shares traded hands or 33.94% up from the average. Canopy Growth Corp (TSE:CGC) has risen 348.19% since April 11, 2016 and is uptrending. It has outperformed by 344.27% the S&P500.

More recent Canopy Growth Corp (TSE:CGC) news were published by: Reuters.com which released: “BRIEF-Canopy Growth Corp reports Q2 revenue c$8.5 mln” on November 14, 2016. Also Bloomberg.com published the news titled: “Snoop Dogg Partnership Sends Canadian Weed Stock to Epic High” on October 06, 2016. Reuters.com‘s news article titled: “BRIEF-Canopy Growth Corp renews agreement with XIB Consulting Inc” with publication date: October 11, 2016 was also an interesting one.

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The company has a market cap of $1.82 billion. The Company, through its subsidiaries Tweed Inc. , Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It currently has negative earnings. It is also focusing on producing and selling marijuana in the recreational market in Canada.


http://friscofastball.com/2016/11/15/whats-in-canopy-growth-corp-after-todays-gap-up/ (http://friscofastball.com/2016/11/15/whats-in-canopy-growth-corp-after-todays-gap-up/)
Title: Re: The Potfolio
Post by: Eddie on November 16, 2016, 10:31:16 AM
I went ahead and pulled the trigger on AMMJ and MCOA, the last two stocks on the Potfolio watch list.

The Dow is down nearly 90 points at mid-day, the S&P is off 7 points. The Potfolio is still largely green, however.  ;D



Now, if the damn miners could get a break!  ;D Roll over, Uncle Buck.

http://www.youtube.com/v/kT3kCVFFLNg&fs=1
Title: Re: The Potfolio
Post by: Eddie on November 16, 2016, 01:56:31 PM
Only one real purty chart set-up today.

https://finance.yahoo.com/chart/ACBFF?p=ACBFF#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

Most of the stocks I'm following look like they're gonna lose steam, based on declining volume. The pot rush may not keep running. We'll see.



Title: Re: The Potfolio
Post by: Eddie on November 17, 2016, 04:10:16 PM
The Potfolio was largely in the red today, with some notable exceptions. Companies that actually sell medical marijuana are doing better than the ancillary industries, since the election.





Title: Re: The Potfolio
Post by: Eddie on November 17, 2016, 04:59:03 PM
Top Five Pot Stocks as listed today on Benzinga. The Potfolio has the first four. THC Biomed is not in the Potfolio. I will consider adding it to the watchlist.

5 Best Marijuana Stocks Of 2016

Benzinga   
Wayne Duggan
BenzingaNovember 16, 2016

View photos
Marijuana scored huge victories in eight out of nine states on Election Day. California, Nevada, Massachusetts, Maine, Florida, North Dakota, Arkansas and Montana all legalized medial and/or recreational marijuana use.

Although marijuana remains illegal in the United States on a federal level, the marijuana legalization movement is clearly gaining momentum. Unfortunately, the federal ban makes marijuana investing risky and treacherous business for U.S. investors.

The Top 5

This year, however, marijuana stocks have been on fire. Of all the stocks in the The Marijuana Index’s comprehensive list of North American marijuana-related stocks, these five names have been the best performers of the year:

1. APHIRA INC NPV (OTC: APHQF) +460.3 percent.

2. AURORA CANNABIS IN COM NPV (OTC: ACBFF) +518.0 percent.

3. General Cannabis Corp (OTC: CANN) +669.1 percent.

4. Cannabis Sativa Inc (OTC: CBDS) +762.9 percent.

5. THC BIOMED INTL LT COM NPV (OTC: THCBF) +1,370 percent.

THC Biomed is the only 2016 10-bagger in the marijuana space. The Canadian company is a licensed marijuana producer and also performs marijuana-related research and development.
Title: Re: The Potfolio
Post by: Eddie on November 18, 2016, 05:33:58 AM
Jeff Sessions as AG is probably NOT good for the Potfolio.

When it comes to The War on Drugs, he's like a Japanese soldier still hiding out in the jungle who doesn't know the war is over and his side lost.

On the other hand, none of the other choices were much better.

3) Jeff Sessions: The Pot Prude

Jeff Sessions
Jeff Sessions is a fierce opponent of legalizing cannabis. (Rob Crandall/Shutterstock)

Yes, at least one American politician is worse than Governor Christie on the cannabis issue. Alabama Senator Jeff Sessions is so backward on marijuana reform, he doesn't even want people talking about it.

“You can't have the President of the United States of America talking about marijuana," Sessions said during a Senate meeting last March. "You are sending a message to young people that there is no danger in this process. It is false that marijuana use doesn't lead people to more drug use. It is already causing a disturbance in the States that have made it legal.”

Senator Sessions is basically a talking time-capsule of the 1970s War on Drugs. The notion that marijuana leads people to abuse harder drugs has been debunked. And despite fears that loosening drug laws would increase consumption, states like Colorado haven't seen a spike in drug use following legalization.

But Sessions isn't budging on the issue. Recently, he hosted a Senate hearing on marijuana that the Drug Policy Alliance dubbed a prohibitionist party. Which sounds like skipping the night out and going straight for the hangover. At the hearing, Sessions presented prohibition as a moral crusade, not just a matter of public health and criminal justice.

He called on his colleagues to spread the message "that this drug is dangerous, you cannot play with it, it is not funny, it's not something to laugh about... and to send that message with clarity that good people don't smoke marijuana."

So he's opposed to cannabis, as well as stoner comedies and Senator Ted Cruz, who loves making pot brownie jokes. No wonder Sessions received an F in NORML's congressional grades.


https://www.civilized.life/articles/heres-where-trumps-rumored-attorney-general-candidates-stand-on-cannabis/ (https://www.civilized.life/articles/heres-where-trumps-rumored-attorney-general-candidates-stand-on-cannabis/)
Title: Re: The Potfolio
Post by: RE on November 18, 2016, 05:43:58 AM
What % are you UP/DOWN from your initial investment?

RE
Title: Re: The Potfolio
Post by: Eddie on November 18, 2016, 06:22:03 AM
Currently down 2.82 percent. Holding 18 stocks in the Potfolio.

Currently have 6 stocks in positive territory, 11 stocks down (only one real dog though...GRNH). and 1 stock even.
Title: Re: The Potfolio
Post by: Eddie on November 18, 2016, 05:55:50 PM
Canopy Growth: Is Now the Time to Join the Marijuana Stock Craze?

 By Moe Zulfiqar, BAS | November 18th, 2016
     

More Upside for Marijuana Stocks?

Canopy Growth Corp (TSE:CGC, CVE:CGC) stock has seen a rise of over 72% following the election of Donald Trump as U.S. president, but investors are concerned whether this marijuana stock is selling too hot, too fast.

And when we say too fast, we mean it. The TSX Venture Exchange activated its “circuit breaker,” halting trading in extremely active issuers for 10 minutes. This is meant to cool transactional volume as the stocks surged.

“Aphria Inc., Mettrum Health Corp., Organigram Holdings Inc., Supreme Pharmaceuticals Inc., Aurora Cannabis Inc. and Canopy Growth Corp. were all halted for five-minute intervals Wednesday — some of them multiple times,” reported Sunny Freeman on Wednesday. (Source: “‘The valuations are really stupid’: Marijuana stocks spike trip circuit breakers, temporarily halted,” Financial Post, November 16, 2016.)

But just because marijuana stock is a hot commodity right now, it doesn’t mean there aren’t investors who are more bearish on the shares.

Some are concerned over just how high the valuations have shot up. Canopy Growth Corp—Canada’s largest marijuana company—reached a valuation of $2.0 billion (double its worth) on Friday when it reached the $1.0 billion mark for the first time. While analysts are confident that, in the long term, marijuana stock will rise, right now it might be trading at too high a price for short-term investors.

Others are concerned about the volatility of the market. For instance, political constraints could hamper the success of marijuana stock. While the current Canadian government has promised to legalize the product, the legislative process is slow and there are a number of treaties that prevent the government from trading the good internationally. Not to mention that only four of the G20 nations have legalized marijuana, constraining the market for international trade.

On top of that, there’s the issue of marijuana stocks’ value not reflecting the current size of the market, which could ultimately lead to the shares’ downfall.

All in all, there’s a lot to consider when thinking about going all-in on marijuana stocks. The question is whether this is the ground floor of lucrative investment or instead a case of over-hype by investors.


https://www.lombardiletter.com/canopy-growth-now-time-join-marijuana-stock-craze/3067/ (https://www.lombardiletter.com/canopy-growth-now-time-join-marijuana-stock-craze/3067/)
Title: Re: The Potfolio
Post by: Eddie on November 19, 2016, 01:35:12 PM
My gut feeling, based on what I've been seeing over the last week, is that pot stocks are going to cool back off, for the most part. Volume is down on most of the stocks in the Potfolio, and they appear to be drifting lower.

The best ones left are the companies who are already growing and selling medical marijuana. Aphria, Mettrum, Canopy Growth, and Aurora Cannabis all had a decent week, although the volume on those has tapered some.

If I were interested in buying a pot stock, I'd buy one of those four. If I add money to my account, I will spend it on those.

(https://chart.finance.yahoo.com/c/1y/CGC.TO?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MT.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MT.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/APH.V?lang=en-US&region=US)

Title: Re: The Potfolio
Post by: Eddie on November 21, 2016, 10:47:13 AM
A vicious down day for pot stocks, which doesn't surprise me, given the declining volume and generally lackluster performance last week. My guess is that traders, expecting some downside in the broader indexes, are going short on pot stocks, because they ran up so fast.

These OTC stocks are particularly susceptible to the kind of pump and dump action that all high beta stocks are prone to in a volatile market. It doesn't help that Trump's new AG is known to be on the same page as Nancy Reagan, when it comes to marijuana use.
Title: Re: The Potfolio
Post by: MKing on November 21, 2016, 11:54:02 AM
A vicious down day for pot stocks, which doesn't surprise me, given the declining volume and generally lackluster performance last week. My guess is that traders, expecting some downside in the broader indexes, are going short on pot stocks, because they ran up so fast.

These OTC stocks are particularly susceptible to the kind of pump and dump action that all high beta stocks are prone to in a volatile market. It doesn't help that Trump's new AG is known to be on the same page as Nancy Reagan, when it comes to marijuana use.

https://finance.yahoo.com/portfolio/p_0/view/v1

Well, there is no requirement for people to endorse dopers, right? Sure, it seems to be a more politically correct position nowadays, to feel bad about those who require self medicating routines, but when the folks voted, they certainly didn't pick a PC President-elect.
Title: Re: The Potfolio
Post by: Eddie on November 21, 2016, 12:14:40 PM
63% of Americans polled favor legalization. 28 states and DC have made medical pot legal, and 60% of Americans live in states where MJ is legal in some form.

Sessions is a big proponent of states rights, from what I'm told. It'll be interesting to see if we get States Rights Jeff, or Just Say No Jeff. The two positions are not compatible, at least outside Alabama.
Title: Re: The Potfolio
Post by: MKing on November 21, 2016, 12:39:02 PM
63% of Americans polled favor legalization. 28 states and DC have made medical pot legal, and 60% of Americans live in states where MJ is legal in some form.

Slavery was once quite popular as well. Doesn't make it right. 77% of Americans believe in Angels. You ever seen one, because they must be here somewhere, the idea being so popular.

I don't get why dopers can't be dopers, we let people drink themselves into alcoholism, why not let folks smoke themselves into happiness? Damned if I know. My only real worry is that it is just another gateway drug, and I figure it will lead to more hard drug use in general, and that ups the odds that I'll end up back in court someday for exercising my rights to keep strangers from visiting my house looking for my stuff to steal and sell to support their habit.

Quote from: Eddie
Sessions is a big proponent of states rights, from what I'm told. It'll be interesting to see if we get States Rights Jeff, or Just Say No Jeff. The two positions are not compatible, at least outside Alabama.

State's rights are good. An administration advocating it is better than one determined to make us all look like the coastal citadels of the progressive democans. The only real benefit I see out of a Trump administration is his kow-towing to the NRA might finally create a national carry system so that trained and vetted folks like me aren't excluded from carrying wherever we want.
Title: Re: The Potfolio
Post by: azozeo on November 21, 2016, 12:51:29 PM
A vicious down day for pot stocks, which doesn't surprise me, given the declining volume and generally lackluster performance last week. My guess is that traders, expecting some downside in the broader indexes, are going short on pot stocks, because they ran up so fast.

These OTC stocks are particularly susceptible to the kind of pump and dump action that all high beta stocks are prone to in a volatile market. It doesn't help that Trump's new AG is known to be on the same page as Nancy Reagan, when it comes to marijuana use.

https://finance.yahoo.com/portfolio/p_0/view/v1

Well, there is no requirement for people to endorse dopers, right? Sure, it seems to be a more politically correct position nowadays, to feel bad about those who require self medicating routines, but when the folks voted, they certainly didn't pick a PC President-elect.


All that time in the "can" & your still dumb as a stump !
Put that loaded weapon of an index finger back in its holster & don't pull it out again until your complete cranium has been extracted from your anus, Barney Fife  :icon_mrgreen:
Glad your back Moriarty, lets get with the program here bub...
Title: Re: The Potfolio
Post by: Eddie on November 21, 2016, 01:00:21 PM
My only real worry is that it is just another gateway drug, and I figure it will lead to more hard drug use in general,

That whole gateway drug concept is a canard. In general, people are either going to try whatever drug they get offered, or they're going to decline, based on their toilet training and sense of adventure (or lack thereof). Some people are born cautious, and some are not.

Some drugs are highly addictive, don't get me wrong. But you don't get people turning to a life of crime to support their weed habit, for the most part. Heroin, yes. Crack yes. Meth, yes. But pot doesn't lead them there, any more than beer and cigarettes lead them there.

Slavery was once quite popular as well. Doesn't make it right. 77% of Americans believe in Angels. You ever seen one, because they must be here somewhere, the idea being so popular.

At the height of slavery in the US, only 1.4% of white Americans owned slaves.

All devout Christian people believe in Angels.  They just disagree amongst themselves on how many can dance on the head of a pin.



Title: Re: The Potfolio
Post by: MKing on November 21, 2016, 01:40:37 PM
My only real worry is that it is just another gateway drug, and I figure it will lead to more hard drug use in general,

That whole gateway drug concept is a canard.

Well, good reason to take the scientists opinion on it rather than us regular folk.

Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135-142.

Quote from: Eddie
Some drugs are highly addictive, don't get me wrong. But you don't get people turning to a life of crime to support their weed habit, for the most part. Heroin, yes. Crack yes. Meth, yes. But pot doesn't lead them there, any more than beer and cigarettes lead them there.

Well, when the scientists declare it to be jim dandy fine as a non-gateway drug, I will sleep better at night. I'm not much of a fan of the self medicating crowd, and that includes alcohol.

Quote from: Eddie
Slavery was once quite popular as well. Doesn't make it right. 77% of Americans believe in Angels. You ever seen one, because they must be here somewhere, the idea being so popular.

At the height of slavery in the US, only 1.4% of white Americans owned slaves.

Sure..but the idea of it was such that 258,000 men died defending the rights of the minority. Sort of like smoking or riding a motorcycle without a helmet, sure, either might not be popular but I would fight for the right for those people to do it, same as I hope they would fight for my right not to be forced into a union or denied representation in court. Popular ideas, even if a majority of us aren't directly involved with them.

Quote from: Eddie
All devout Christian people believe in Angels.  They just disagree amongst themselves on how many can dance on the head of a pin.

I don't know the difference between a devout Christian and a sect or cult leader, considering that it was so called Christians who, upon the arrival of Jesus and his presence in Waco Texas during the 2nd Coming, decided that the answer was to burn him alive this time instead of crucifying him. Cults are cults, the only good thing being that in this country we are free to buy into whichever one we wish.
Title: Re: The Potfolio
Post by: Eddie on November 21, 2016, 02:29:00 PM
Well, good reason to take the scientists opinion on it rather than us regular folk.

Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135-142.



I haven't looked at the study you cited, but suffice it to say that there are a lot of them out there, and they don't all agree on the point in question. As you no doubt are aware, a lot of scientists get money from people wanting to get particular results, and with such a politically charged subject, you can find a study somewhere to back whatever view you prefer. There are many people with agendas, who very much wish marijuana was a gateway drug. Job security.

Sure..but the idea of it was such that 258,000 men died defending the rights of the minority. Sort of like smoking or riding a motorcycle without a helmet, sure, either might not be popular but I would fight for the right for those people to do it, same as I hope they would fight for my right not to be forced into a union or denied representation in court. Popular ideas, even if a majority of us aren't directly involved with them.

Sort of like all the poor white trash that vote for a billionaire, because he's a rich TV star? Maybe it might rub off on them, somehow?



Title: Re: The Potfolio
Post by: MKing on November 21, 2016, 03:36:11 PM
I haven't looked at the study you cited, but suffice it to say that there are a lot of them out there, and they don't all agree on the point in question.

It is science. It is the very anathema of group think. So no, there is no requirement for agreement. Just look at the science of peak oil. I can list chapter and verse of Hook's publications in journals as to when it would happen and after it didn't happen? Crickets.

But you said weed as a gateway drug was a canard, when obviously there are some scientists who disagree. And you didn't quote any science, just an opinion. When offered one, versus the other, most folks know which side to fail over to.

Quote from: Eddie
As you no doubt are aware, a lot of scientists get money from people wanting to get particular results, and with such a politically charged subject, you can find a study somewhere to back whatever view you prefer. There are many people with agendas, who very much wish marijuana was a gateway drug. Job security.

Sure. And then there are published scientists who don't take money for results. John has gone through my published work, and now that I've met him in person he can comment all he likes on the money I haven't taken to write what I do. No one can claim I've done anything like this, which means that there are others, and they could just as likely be these folks I've referenced as other scientists.

Quote from: Eddie
Sure..but the idea of it was such that 258,000 men died defending the rights of the minority. Sort of like smoking or riding a motorcycle without a helmet, sure, either might not be popular but I would fight for the right for those people to do it, same as I hope they would fight for my right not to be forced into a union or denied representation in court. Popular ideas, even if a majority of us aren't directly involved with them.

Sort of like all the poor white trash that vote for a billionaire, because he's a rich TV star? Maybe it might rub off on them, somehow?

People fell for peak oil, even after being informed what a crock it was by experts who knew better, so sure sheeple are dumb enough to have hopes that something might rub off on them from a billionaire real estate developer, sure.

And my wife isn't poor white trash. And she didn't vote for him because he is a TV star.
Title: Re: The Potfolio
Post by: Eddie on November 21, 2016, 04:33:38 PM
But you said weed as a gateway drug was a canard, when obviously there are some scientists who disagree. And you didn't quote any science, just an opinion. When offered one, versus the other, most folks know which side to fail over to.


It is my informed opinion that marijuana is not much of a gateway drug. All the meta-studies in all the journals out there would not convince me otherwise. You know what's a gateway drug? Valium. Alcohol. Alcohol is the biggest gateway drug there is.

I am basing my opinion on having observed a great deal of alcohol and drug consumption by a variety of acquaintances, over many decades. I don't need to read studies.

And my wife isn't poor white trash. And she didn't vote for him because he is a TV star.

Of course not. She probably voted against the corrupt candidate proffered by the other party. Or she voted for the conservative party because she considers herself a conservative.

I'm a conservative. I voted for Ron Paul. I don't like it that Trump is turning out to be something quite a bit different than what he claimed to be. I'm not too surprised, but I'm disgusted, and other sensible conservatives should be too. He's a clever chameleon, and the country is going to swing way, way to the right, it looks like.



Title: Re: The Potfolio
Post by: MKing on November 21, 2016, 05:26:15 PM
But you said weed as a gateway drug was a canard, when obviously there are some scientists who disagree. And you didn't quote any science, just an opinion. When offered one, versus the other, most folks know which side to fail over to.


It is my informed opinion that marijuana is not much of a gateway drug.

Sort of like Trump's informed opinion that all Mexicans are rapists! Yes, lets hear it for informed opinions!

Quote from: Eddie
All the meta-studies in all the journals out there would not convince me otherwise.

Of course. We've discussed this before, you believe what you want first, and then proceed to the rationalization. It is an alien concept, to us scientists.

Quote from: Eddie
You know what's a gateway drug? Valium. Alcohol. Alcohol is the biggest gateway drug there is.

I don't have a study on that one, but if I were a betting man (and I occasionally am), I would bet with you on this one.

Quote from: Eddie
I am basing my opinion on having observed a great deal of alcohol and drug consumption by a variety of acquaintances, over many decades. I don't need to read studies.

I would base my opinion on the same. And of course once an opinion is formed, you don't need studies. What good is science once we've formed an opinion!!

Eddie, can you name some other people who disavow contradictory results that are derived from science over their personal opinion on the topic? Bannon perhaps? I'm betting Trump does it. Every Christian in the world perhaps?

Quote from: Eddie
And my wife isn't poor white trash. And she didn't vote for him because he is a TV star.

Of course not. She probably voted against the corrupt candidate proffered by the other party. Or she voted for the conservative party because she considers herself a conservative.

It was part party loyalist, and the rest was voting against the Democan, yup. My mom and step dad, both god fearing democrats and union members, aren't poor white trash either, both of them did it because they figure throwing a bomb into Washington was a good idea.

I say the Trump election was more about the bomb throwers, and I found a great article on him being the first US independent President, which makes the most amount of sense to me.

https://www.washingtonpost.com/politics/donald-trump-americas-first-independent-president/2016/11/19/b09e1cc6-ade2-11e6-8b45-f8e493f06fcd_story.html (https://www.washingtonpost.com/politics/donald-trump-americas-first-independent-president/2016/11/19/b09e1cc6-ade2-11e6-8b45-f8e493f06fcd_story.html)

Quote from: Eddie
I'm a conservative. I voted for Ron Paul. I don't like it that Trump is turning out to be something quite a bit different than what he claimed to be. I'm not too surprised, but I'm disgusted, and other sensible conservatives should be too. He's a clever chameleon, and the country is going to swing way, way to the right, it looks like.

I'm older, so just based on what happens to us as we age, I am also conservative. It is also why most doomers are older as well, the good ol' days effect, our opportunities being mostly in our past, etc etc. Pretty natural actually.
Title: Re: The Potfolio
Post by: Eddie on November 22, 2016, 06:26:54 AM
But you said weed as a gateway drug was a canard, when obviously there are some scientists who disagree. And you didn't quote any science, just an opinion. When offered one, versus the other, most folks know which side to fail over to.


It is my informed opinion that marijuana is not much of a gateway drug.

Sort of like Trump's informed opinion that all Mexicans are rapists! Yes, lets hear it for informed opinions!

Quote from: Eddie
All the meta-studies in all the journals out there would not convince me otherwise.

Of course. We've discussed this before, you believe what you want first, and then proceed to the rationalization. It is an alien concept, to us scientists.

Quote from: Eddie
You know what's a gateway drug? Valium. Alcohol. Alcohol is the biggest gateway drug there is.

I don't have a study on that one, but if I were a betting man (and I occasionally am), I would bet with you on this one.

Quote from: Eddie
I am basing my opinion on having observed a great deal of alcohol and drug consumption by a variety of acquaintances, over many decades. I don't need to read studies.

I would base my opinion on the same. And of course once an opinion is formed, you don't need studies. What good is science once we've formed an opinion!!

Eddie, can you name some other people who disavow contradictory results that are derived from science over their personal opinion on the topic? Bannon perhaps? I'm betting Trump does it. Every Christian in the world perhaps?

Quote from: Eddie
And my wife isn't poor white trash. And she didn't vote for him because he is a TV star.

Of course not. She probably voted against the corrupt candidate proffered by the other party. Or she voted for the conservative party because she considers herself a conservative.

It was part party loyalist, and the rest was voting against the Democan, yup. My mom and step dad, both god fearing democrats and union members, aren't poor white trash either, both of them did it because they figure throwing a bomb into Washington was a good idea.

I say the Trump election was more about the bomb throwers, and I found a great article on him being the first US independent President, which makes the most amount of sense to me.

https://www.washingtonpost.com/politics/donald-trump-americas-first-independent-president/2016/11/19/b09e1cc6-ade2-11e6-8b45-f8e493f06fcd_story.html (https://www.washingtonpost.com/politics/donald-trump-americas-first-independent-president/2016/11/19/b09e1cc6-ade2-11e6-8b45-f8e493f06fcd_story.html)

Quote from: Eddie
I'm a conservative. I voted for Ron Paul. I don't like it that Trump is turning out to be something quite a bit different than what he claimed to be. I'm not too surprised, but I'm disgusted, and other sensible conservatives should be too. He's a clever chameleon, and the country is going to swing way, way to the right, it looks like.

I'm older, so just based on what happens to us as we age, I am also conservative. It is also why most doomers are older as well, the good ol' days effect, our opportunities being mostly in our past, etc etc. Pretty natural actually.

I really don't think you're a scientist at all, frankly. No real scientist would be such a slave to the data that he lets it trump common sense and observation.

I know whole schools where every peer reviewed published article is so obviously biased towards the belief system of some senior faculty, that you have to take every one of them with a large grain of salt.

I've spent many years of my life separating the wheat from the chaff, with regards to things that are published in peer-reviewed journals, and the truth is that an awful lot of it is total crap. So get off your high horse.

Your smug superiority wears thin after a while. This forum is not a scientific journal, and the opinions of the posters here are usually far more valid than that of most of the idiots in charge of the world. You're ability to cut and paste doesn't impress me. The internet is full of "scientists" trolling around.

Title: Re: The Potfolio
Post by: Eddie on November 22, 2016, 08:01:51 AM
But neither you, nor anyone else here, has been able to refute a single piece of my published works, let alone find a misspelled word within it, to use as ammunition against me as a scientist. It would seem to me that this alone lends credence to what I do for a living, and directly contradicts your opinion. But I've said it before and it is still true, you are allowed your informed opinions, regardless of evidence to the contrary.


You've never cited your work here, ever, as far as I know. You're dissembling again.

I understand. But tell me, if you published your work across the entire known world, and other scientists have each their own resources to refute it, and have had no more luck at discrediting it then folks here have, don't you think a smug superiority is justified? If you do a root canal poorly, something just doesn't work, maybe a crown falls off, your patient comes back and you fix them right up. Sometimes, you might even not charge them, to fix something you did. I don't have that luxury. I get it wrong, I get crucified across science rags everywhere, I get people standing up at conferences calling me a liar or fraud, my income but more importantly my reputation that has required decades to establish, dry up and blow away. I don't have your ability to fix a small problem, my problems are hung out for thousands of other scientists to see, should they exist.

Ultimately, I am paid to be right, and I am very good at what I do.


Yeah, yeah. Heard it all before.

My only limited real world experience with you, which is really a non-experience, is the story about you showing up in SC to visit the SUN booth, where you had every opportunity to meet and converse with all of us, but instead chose to remain completely anonymous and then brag about it online afterwards.

Millenials have a word for that. You're a creeper.

Title: Re: The Potfolio
Post by: Eddie on November 22, 2016, 06:04:15 PM
The potfolio had another major sell-off today. The good news is that this might represent a major buying opportunity. I don't think it's time, quite yet, but at the appropriate time I do intend to increase my stake in what I consider the four very best of the best. Those are still Canopy Growth, Aphria, Mettrum, and Aurora Cannabis.

A sell-of after the election was one scenario suggested by analyst Clive Maund. But he suggested that the long term outlook for these stocks is still stellar. Right now, I think all eyes are on Trump and his minion Sessions, who is a troglodyte. Unless he is reigned in, there will be a big legal fight between the states that are reaping the bounty of pot taxes, and the federal government.
Title: Re: The Potfolio
Post by: Eddie on November 23, 2016, 10:25:58 AM
I think all the punters must have closed their shorts yesterday, for the holiday. Pot stocks have drifted back up dramatically, albeit on low volume.  Several stocks in the portfolio are up more than 30% in one day, with MCOA currently up 43.65% for the day, so far.

This kind of beta is sure to keep traders interested in pumping and dumping. It's gonna be a wild ride, for a while. Several pot stocks posted their financials this week. Frankly, I haven't taken the trouble to pore over them. I think momentum and future expectations have more influence than earnings, at this point. I might get to those reports over the holiday weekend.





Title: Re: The Potfolio
Post by: Eddie on November 26, 2016, 09:07:24 AM
Pot stocks were absolutely hammered on Monday and Tuesday of last week. I wasn't sure why that happened at the time, but this was likely a big part of it.

http://www.bnn.ca/pot-stocks-tumble-as-ottawa-tightens-reimbursement-rules-for-veterans-1.614521 (http://www.bnn.ca/pot-stocks-tumble-as-ottawa-tightens-reimbursement-rules-for-veterans-1.614521)

COMMODITIES
 
Canada
Nov 22
Pot stocks tumble as Ottawa tightens reimbursement rules for veterans
The Canadian Press
 

The federal government is limiting the amount of medical cannabis that veterans will be reimbursed for to three grams a day. The announcement contributed to another day of dramatic moves for Canada's pot stocks, which have been on a wild ride recently — including one trading session last week that saw multiple trading halts triggered by circuit breakers.
Veterans Affairs Minister Kent Hehr says the cost of reimbursing veterans has increased with many using up to 10 grams a day.
The new limit announced Tuesday at a military and veterans health research forum in Vancouver is for dried cannabis or the equivalent of oil and fresh marijuana.

The number of veterans who were being reimbursed for medical cannabis rose to more than 3,000 in eight years. Hehr said he was surprised the former Conservative government began paying for it with no policy in place.
Three grams a day is the upper limit of use in guidelines from the college of physicians, Hehr said.
Under the new policy, veterans who are already claiming for more than three grams per day of dried marijuana will continue to be reimbursed at that level until May 21.

Veterans whose health practitioner authorizes more than three grams a day of dried marijuana or its equivalent can apply for an exception to the policy, which also fixes the rate of reimbursement to a maximum of $8.50 per gram.
"While the limits were stricter than expected, we don’t see the changes having a material impact on licensed producers in the long term, unless their long-term strategy was medical-only and targeting veterans," said M Partners Research Analyst Mason Brown in a report to clients.

Canopy Growth Corporation (CGC.TO), whose stock tumbled 21.3 per cent on Tuesday, noted in a statement that veterans account for two per cent of its client base, and said it doesn't expect the new policy will have a "material impact" on sales or customer growth. 
"With cost overruns and allegations of unethical price inflation, it was possible that the government could have ended all insurance coverage, so we are pleased that Veterans Affairs will continue to offer our veterans access to this emerging therapeutic option, and that coverage has been extended to oils as well," said Canopy CEO Bruce Linton in a statement. 
According to Brown at M Partners, Aphria Inc. (APH.V) and OrganiGram Holdings Inc. (OGI.V) have "sizeable" exposure to veterans; their shares closed down 19.6 and 17.8 per cent, respectively. 

Veterans Affairs says the new daily limit is consistent with the amount of medical cannabis used by average Canadians, which Health Canada indicates is an authorized amount of 2.6 grams per day.
Israel and the Netherlands have also done research on marijuana for medical purposes. Israel's average use of cannabis is 1.5 grams per day, while in the Netherlands it is 0.68 grams.
Hehr said Veterans Affairs and the Canadian Armed Forces are also launching a study on the medical effects of cannabis, adding that scientific research is inconclusive.

"The safety and well-being of our veterans was the fundamental consideration in the development of this reimbursement policy," he said.


The good news (for the Potfolio) is that Wednesday and Friday much of the losses were recovered. But with trading volumes in the pot stocks running lower than pre-election, volatility is likely to continue.

I think fear about Trump and his redneck AG is making US investors wary until they see some sign that Sessions won't reverse the Obama position of letting states sort out their own MJ decisions.

As of today, the Potfolio is down 16.5 %, according to my back of the napkin estimate. Sounds like a lot, but these are stocks that move that much in a day. The outlook for pot will explode if and when Canada announces a plan to make recreational pot legal nationwide, which is expected sometime in 2017. Trump won't affect that.
Title: Re: The Potfolio
Post by: g on November 26, 2016, 10:00:25 AM
Hi again Eddie, My studies on the matter led me to believe the reaction is fear of our new AG, that is my impression from various sites I visit generally. He is anti weed according to many.   :dontknow:
Title: Re: The Potfolio
Post by: Eddie on November 26, 2016, 10:09:24 AM
Nice thing about 10Q's....if you don't read them, someone who still believes in fundamentals probably will, sooner or later.

Here's a few reports. CBIS gets a bad report card, let's call it a D- . TWMJF gets a good report card (A+) . MNTR gets a B+.

Cannabis Science, Inc. (CBIS) Financial Results

The one cannabis company that reported results this week that showed no signs of growth was CBIS. Cannabis Science filed its 10-Q with the SEC this week for Q3'16 showing 2x the operating loss of the same quarter last year, in addition to an increase in liabilities, and a decrease in assets. Meanwhile, the number of common shares outstanding for CBIS has gone almost doubled, leaving shareholders further diluted.

With share prices down approximately -16% over the last 5 trading days, we believe that this could either be the pullback that technical traders as well as long-term contrarian investors use to establish a buying base, or just the start of a pessimistic sell-off.


Canopy Growth Corporation (TWMJF) Financial Results

Canopy Growth reported fiscal Q2'17 financial results this week, with some really positive growth shown. The growth for Canopy includes continual revenue growth over last quarter as well as the same quarter last year. This amounts to roughly $8.5 million in revenues for Canopy. This ended in $5.4 million in net income for the quarter which is compared to $3.9 million for the same quarter last year. Up over 80% in the last 5 trading days, we are waiting for pullbacks to establish a long position.


Mentor Capital, Inc. (MNTR) Financial Results

Mentor Capital filed its 10-Q this week for Q3 2016 ending on September 30th, 2016. Revenues for Q3 this year were $725,709 compared to $669,263 for the same quarter last year. Beyond the revenue growth announced in the results, MNTR announced a 26% increase in book value to $4,249,942 vs. $3,374,882 last year.

Additionally, a judge has granted MNTR's "request for contract rescission and ordered Bhang Chocolate Company to return Mentor's $1,500,000 plus approximately $352,000 in interest." With operations headed in the right direction, and the court case ending favorably, we will be watching MNTR share prices closely to determine a favorable entry point.



One company I looked at but did not add to the Potfolio, MCIG, continues to look very promising.

mCig, Inc. (MCIG) Financial Results

mCig announced a record quarter of net sales, net income, and more for their fiscal Q2'17. Reporting a 126% increase in revenues from the same quarter last year, mCig generated over $620,000 in revenues this quarter. CFO of mCig, Michael Hawkins, said it best: "For the second straight quarter MCIG has achieved an adjusted net income. This will be a landmark quarter in the history of MCIG as the company achieves a net profit for the first time in its history."

We believe that as mCig turns net profits, more long-term investors will see the value proposition in the company due to the scalable nature of their operations. mCig's wholesale division especially is set to balloon due to recent election results. With share prices down around -2.5% in the last 5 trading days, this may be a good entry point for a long-term bullish position in MCIG.



http://seekingalpha.com/article/4024029-7-pot-stocks-reported-earnings-week?page=2 (http://seekingalpha.com/article/4024029-7-pot-stocks-reported-earnings-week?page=2)



Title: Re: The Potfolio
Post by: Eddie on November 26, 2016, 10:26:06 AM
Hi again Eddie, My studies on the matter led me to believe the reaction is fear of our new AG, that is my impression from various sites I visit generally. He is anti weed according to many.   :dontknow:

Definitely anti-weed. But supposedly pro-states rights. So...which will win out? It shouldn't take long to find out. The Federal cops are slathering at the mouth to declare open season on pot growers and dispensaries. It's only Obama that's held them back.
Title: Re: The Potfolio
Post by: Eddie on November 26, 2016, 10:33:45 AM
Canada is key.

http://www.youtube.com/v/Fc3OO0IUPjE&fs=1
Title: Re: The Potfolio
Post by: Eddie on November 28, 2016, 02:38:33 PM
Marijuana advocates sceptical about Canada path to legal pot
By Jessica Murphy
BBC News, Toronto
27 November 2016

(http://ichef.bbci.co.uk/news/660/cpsprodpb/10793/production/_92657476_gettyimages-55373758.jpg)
 Marijuana advocate Marc Emery addresses a crowd of 400 at an anti-extradition rally held for him in front of the US Consulate on September 10, 2005 in Vancouver, Canada.Image copyrightGETTY IMAGES

Pot activist Marc Emery does not trust the government when it comes to legalising cannabis.

Canada will soon introduce legislation to legalise recreational marijuana. Pot advocates are not as happy as you might think.
The Cannabis Culture dispensary in downtown Toronto gets a steady stream of foot traffic around noon on a weekday.
But Marc Emery, who helped set up the franchise that flouts Canadian drug laws by selling pot to anyone over 19, is annoyed.
The dispensary had been raided the day before by Toronto police.

"It's the government's intention to legalise it. So why is the government still arresting people?" he asks.
Mr Emery is just one of many owners of illegal marijuana storefronts that have mushroomed in cities across Canada after the federal Liberals were elected in 2015.
The Liberals have committed to legalising recreational marijuana in Canada and plan to introduce marijuana law reforms on the sale, cultivation and distribution in parliament next spring.

Marijuana advocates are now pushing the legal boundaries in the grey zone between prohibition and permission.
Former Toronto police chief turned federal politician Bill Blair, who is the Liberal's point man on legalisation, is having none of it.
"The only system for control is the existing legal regime. And we're a society of laws," he says.
Mr Blair says Ottawa has consulted US states like Colorado and Washington that have had legal recreational cannabis for a few years now.

The lesson learned? "It's easier to ease up later than to get strict later," he says.

But advocates like Mr Emery, who has dedicated much of his life to fighting against marijuana prohibition and spent five years in a US jail for selling marijuana seeds to Americans, say they have lost patience.

"We already have everything settled," he says. "We know how to sell pot. We know how to grow it. We know how to buy it, we know how to smoke it."

And they do not give much credibility to the politicians, law enforcement officers, public health officials and academics being consulted on the legalisation process.

"Here's all these non-smokers telling us how it's going to be," Mr Emery says. "It's like straight people telling gay people how they're going to live their lives."

The end of marijuana prohibition in Canada will also introduce an entirely new sector into the country's economy.

'Evil profiteers'

The current domestic black market for marijuana is CA$5bn ($3.7bn; £3bn).
Chris Horlacher is president of Jade Maple, a consulting agency in the cannabis industry and one of the founding members of the Cannabis Growers of Canada (CGC). They represent small- and medium-sized entrepreneurs trying to establish Canada's "craft cannabis" industry.

He says there is frustration and fear that the federal government will simply allow already established legal medical marijuana suppliers to take over the recreational marketplace.

"The government has created this brand new camp that is trying to gain its share of the market and they don't necessarily understand the product, the culture," Mr Horlacher says.
"We have all these people who are actually newcomers who don't have any experience with the product and now they're saying: 'We're the legitimate ones and you're the evil profiteers.'"

Medical marijuana is legal in Canada but, since 2014, registered patients can only get their cannabis shipped from licensed large-scale suppliers. They have also recently been allowed to grow their own.
There are currently 36 licensed growers in Canada. Many are openly positioning for the eventual legal recreational market.

"Everyone is just eyes on Ottawa," Mr Horlacher says.

One Vancouver marijuana dispensary has experimented with pot vending machines.
Canadians, especially its youth, are among the world's biggest pot users.
Ottawa says legal pot under a new "strict regulation" regime will make it easier to keep it away from young people, to pull profits from organised crime, to reduce the burden on police and the justice system, and to improve public health.
A federal legalisation task force is wrapping up its work and is expected to send its recommendations to the government soon.
Pain specialist Dr Mark Ware is on that task force. He has researched medicinal marijuana for some 16 years and acknowledges that "there's a culture associated with cannabis use and cannabis users".\

"This has become a drug that found a place in our society that's quite unique but it's also been shaped by its illegality."
Task force members were repeatedly asked about the harm linked to marijuana use, from driving high to its impact on developing brains and mental health, he says.

"There are these big broad areas of concerns that legitimately deserve a lot of attention," says Dr Ware.
But he notes that because of prohibition, the benefits of the drug "medically or socially or spiritually" have not been well researched.

He says the legal framework will spur research but that Canadians will need time to adjust to a new way of seeing marijuana outside of prohibition.

"This is a long experiment that will continue for many, many years to come," he says.


Another modestly decent up day for pot stocks. Twelve stocks in the Potfolio up, six down, on a day when the broader indices were all down a fraction of a percent.

Title: The Potfolio: Hunter S. Thompson Brand Ganga!
Post by: RE on November 29, 2016, 11:13:25 PM
Certified Hunter Ganga!  A sure WINNER!

RE

https://www.theguardian.com/books/2016/nov/29/hunter-s-thompson-marijuana-supply-widow (https://www.theguardian.com/books/2016/nov/29/hunter-s-thompson-marijuana-supply-widow)

 Hunter S Thompson's widow wants to get you high on his personal supply

(https://i.guim.co.uk/img/media/ef364494138f976cf112c4bcba04d03c8374093a/0_221_3436_2062/master/3436.jpg?w=620&q=55&auto=format&usm=12&fit=max&s=1db84e744acb3df2032aee5c93eb46cc)
Anita Thompson says she has ‘found a legal method’ to extract DNA from six of the gonzo journalist’s personal strains of
Hunter S Thompson: soon you can get high on his supply. Photograph: Matthew Naythons/Time Life Pictures/Getty Images

Nicole Puglise
@nicolepuglise

Tuesday 29 November 2016 16.27 EST

Fans of gonzo journalist Hunter S Thompson may one day get to smoke his own brand of marijuana, thanks to the efforts of his widow, Anita Thompson.

Anita told the Aspen Times that she has six strains of her late husband’s preferred marijuana saved and is working with a cannabis company to grow them for public sale.

“I have found a legal method to extract the DNA from Hunter’s personal marijuana and hashish that I saved for 12-15 years,” Anita claimed in a post on her Facebook page. “I am in the process of making the strains available to those who would like to enjoy the authentic Gonzo strains in legal states.”

Recreational marijuana became legal in Colorado, where Anita lives, in 2012 – one of the first states to legalize the drug, alongside Washington.

Before deciding to become a “drug lord”, as Anita jokingly told the Aspen Times, she said she had been approached multiple times by growers looking to use her husband’s name on their product and follow in the footsteps of other celebrity brands such as the controversial Bob Marley-referencing strain, Marley Natural. “I’ve had probably 10 meetings in the last three years and I always ended up saying no because it’s the same story every time: somebody wants to slap Hunter’s name on their strain,” she said.

Thompson, famed inventor of gonzo journalism, once said: “I have always loved marijuana. It has been a source of joy and comfort to me for many years. And I still think of it as a basic staple of life, along with beer and ice and grapefruits – and millions of Americans agree with me.”

He committed suicide in 2005 at age 67. According to the Aspen Times, a trust was established before his death that allowed Anita to live on his Owl Farm property in Colorado, though it would be owned by the Gonzo Trust, “a legal entity overseen by his appointed attorneys and trustees”.

Earlier this year, Anita purchased Owl Farm and also gained access to Thompson’s name and likeness. Profits from the sale of the Gonzo brand of marijuana would support renovations to the property as well as Anita’s plans to establish a private museum and writers’ retreat.

Anita said she had been trying to keep the focus on her late husband’s legacy as a writer in the years after his death. “I was always steering toward his work and away from his lifestyle, but now I feel like I can talk more openly about his lifestyle,” she told the newspaper. “I’m proud to do it now. Before, it was a little too risky.”
Title: Re: The Potfolio ---- Let The Buyouts Begin
Post by: Eddie on December 01, 2016, 01:59:53 PM
Canopy Growth is making an offer for Mettrum. It's a marriage made in heaven, and both companies are in the Potfolio.

Canopy Growth Corporation to acquire Mettrum for $430M — making a mega-company serving half Canada’s medical pot users
 

Canopy Growth Corp. has offered to acquire Toronto-based Mettrum Health Corp. for $430 million, forming a Canadian marijuana mega-company with a patient base that would dominate the Canadian market.

The all-stock definitive agreement announced early Thursday would see Canopy add two brands to its portfolio and increase its production capacity to six licensed facilities and 665,000 sq. ft. It also diversifies its offerings into hemp through Mettrum Originals. Smith Falls, Ont.,-based Canopy already owns the Tweed and Bedrocan Canada brands.

A combined company would have some 39,730 patients as of Sept. 30 — nearly half of Canada’s current medical marijuana patient base.

“From day one, Canopy Growth has viewed production capacity, brand diversity, and highly-skilled management as the foundational aspects of our business,” said Bruce Linton, Chairman and CEO of Canopy Growth.

“Their substantial production facilities will add to our growing production platform as we expand to meet the needs of patients, and their experienced personnel will help Canopy Growth drive our vision forward to the next level.”

http://business.financialpost.com/news/agriculture/canopy-grow-to-acquire-rival-mettrum-for-430-million-to-form-mega-company-serving-half-canadas-medical-pot-users (http://business.financialpost.com/news/agriculture/canopy-grow-to-acquire-rival-mettrum-for-430-million-to-form-mega-company-serving-half-canadas-medical-pot-users)



Canopy Growth off 3.81% for the day, but Mettrum up 28.83% on the news.


Pot stocks have been holding up fairly well this week, as the Nasdaq shows signs of rolling over.



Title: Legalization of marijuana will cause chaos
Post by: RE on December 05, 2016, 02:14:14 AM
Some folks not so upbeat on Ganga legalization...

RE

Legalization of marijuana will cause chaos
By Paul Chavez / Detention Warden, Pueblo Of Laguna Detention Center
Monday, December 5th, 2016 at 12:02am
If the trend continues, New Mexico and the rest of the nation will legalize marijuana within the next few years; and in the long run our children and our grandchildren will ultimately hate us for it.

While many people are characterizing pot legalization as a tax and justice panacea, we don’t know the long-term ramifications of marijuana legalization. Let me give you a prediction based on 31 years in law enforcement, drug intelligence and public safety as well as many years studying this issue.

We already know marijuana use in teenagers and young adults has an adverse effect on brain development. The research is abundant and unequivocal.

Research also shows that greater availability of any substance whether it is alcohol, marijuana, prescription opioids or heroin will result in more people using that substance.

Advertisement

And please do not give me the argument that legalized marijuana is only intended for people over 21. See how well that worked with alcohol? Marijuana is already rampant to our middle and high schools. Legalization would just make it worse.

No matter how much money marijuana legalization raises in taxes, pot makes our children less successful in school and, frankly, dumber. New Mexico is already at the bottom of the list of most social indicators. Recreational marijuana will only make those problems worse.

Looking a generation or two down the road is where we will see the greatest consequences of legalization. Marijuana legalization will create two phenomena that will lead to future problems we’re not even thinking about today.

The first is that, in time, our politicians and policymakers will divert public safety funds meant for the infrastructure to combat marijuana trafficking and use, to other priorities. This is the same infrastructure meant to keep out heroin, cocaine, methamphetamine and other illicit products. That infrastructure will break down and access to these substances will be greater.

The second phenomena is the drug cartel’s reaction to legalization.

Anyone that believes that the legalization of marijuana will break the back of the drug cartels doesn’t know anything about drug cartels. These are very adaptable criminal organizations that won’t let a change in laws get in their way. They will not simply throw up their hands and get legitimate jobs.

Yes marijuana has been their cash crop, but all legalization will do is force them to concentrate on other, more deadly, illicit substances.

Open source information is already coming out of Mexico reporting that traffickers are tearing up marijuana fields and replanting them with opium (for heroin). They will put more effort in getting methamphetamine, heroin and cocaine into the United States.

Advertisement

And with a reduced infrastructure in place, they will have a much easier time getting those products to our citizens – especially our kids.

The other thing that gets completely ignored in this discussion is that the pot of today is not your mom and dad’s marijuana. Back in the 1970s and 1980s, the THC content of marijuana was around 3 to 5 percent. Marijuana today can be bioengineered to produce THC contents in the 25 to 30 percent range and even higher.

It doesn’t matter how many laws are put in place to regulate THC content, marijuana that has the same effect as LSD will be all over streets and in our schools.

The situation looks rosy now, very similar to the rosy situation of 1933 when prohibition ended. Look how many billions of dollars and millions of lives that alcohol has cost American society.

We can all be giddy about the promise of marijuana now, but in one or two generations when we have double or triple the number of drug addicts and America loses its greatness and economic power because of addiction, our kids and our grandkids will detest the society we have given them.

Paul Chavez is a retired Albuquerque Police Department deputy chief and a former director of intelligence for the Southwest Border High Intensity Drug Trafficking Area Program.
Title: Re: The Potfolio
Post by: g on December 05, 2016, 02:59:44 AM
Quote
Some folks not so upbeat on Ganga legalization...

RE


Let me state at the outset that I have made a massive score on Cannabis stocks already, 5x and 10x my capital on some, so this is in no way an affront to Eddie and his desire to make a few bucks. Also I still have substantial positions. I believe in stock ownership, free market decisions, peoples choice to do with there own lives as they see fit.   

This article is completely true in my opinion.

Anyone who doesn't see this as another nail in the coffin of humanity, moral degradation, another dicking of the youth as bad as student loans and another hastening forward of Doomsday is a horse's ass IMHO.       
Title: Re: The Potfolio - Canopy Growth Corporation Announces $60 Million Bought Deal
Post by: g on December 05, 2016, 04:44:46 AM
Eddie, In case you haven't seen it. Story just broke in Canada a few minutes ago.

December 05, 2016 07:36 ET
Canopy Growth Corporation Announces $60 Million Bought Deal Financing

SMITHS FALLS, ONTARIO--(Marketwired - Dec. 5, 2016) -

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Canopy Growth Corporation (TSX:CGC) ("Canopy Growth" or the "Corporation") announced today that it has entered into an agreement with a syndicate of underwriters led by GMP Securities L.P. and Dundee Capital Partners (the "Co-Lead Underwriters" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, 5,662,000 common shares (the "Common Shares") of the Corporation at a price of $10.60 per Common Share (the "Offering Price") for aggregate gross proceeds to Canopy Growth of $60,017,200 (the "Offering").
http://www.marketwired.com/press-release/canopy-growth-corporation-announces-60-million-bought-deal-financing-2180574.htm (http://www.marketwired.com/press-release/canopy-growth-corporation-announces-60-million-bought-deal-financing-2180574.htm)  :icon_study:





Title: Re: Legalization of marijuana will cause chaos
Post by: Eddie on December 05, 2016, 02:57:12 PM
Some folks not so upbeat on Ganga legalization...

RE

Legalization of marijuana will cause chaos
By Paul Chavez / Detention Warden, Pueblo Of Laguna Detention Center
Monday, December 5th, 2016 at 12:02am
If the trend continues, New Mexico and the rest of the nation will legalize marijuana within the next few years; and in the long run our children and our grandchildren will ultimately hate us for it.

While many people are characterizing pot legalization as a tax and justice panacea, we don’t know the long-term ramifications of marijuana legalization. Let me give you a prediction based on 31 years in law enforcement, drug intelligence and public safety as well as many years studying this issue.

We already know marijuana use in teenagers and young adults has an adverse effect on brain development. The research is abundant and unequivocal.

Research also shows that greater availability of any substance whether it is alcohol, marijuana, prescription opioids or heroin will result in more people using that substance.

Advertisement

And please do not give me the argument that legalized marijuana is only intended for people over 21. See how well that worked with alcohol? Marijuana is already rampant to our middle and high schools. Legalization would just make it worse.

No matter how much money marijuana legalization raises in taxes, pot makes our children less successful in school and, frankly, dumber. New Mexico is already at the bottom of the list of most social indicators. Recreational marijuana will only make those problems worse.

Looking a generation or two down the road is where we will see the greatest consequences of legalization. Marijuana legalization will create two phenomena that will lead to future problems we’re not even thinking about today.

The first is that, in time, our politicians and policymakers will divert public safety funds meant for the infrastructure to combat marijuana trafficking and use, to other priorities. This is the same infrastructure meant to keep out heroin, cocaine, methamphetamine and other illicit products. That infrastructure will break down and access to these substances will be greater.

The second phenomena is the drug cartel’s reaction to legalization.

Anyone that believes that the legalization of marijuana will break the back of the drug cartels doesn’t know anything about drug cartels. These are very adaptable criminal organizations that won’t let a change in laws get in their way. They will not simply throw up their hands and get legitimate jobs.

Yes marijuana has been their cash crop, but all legalization will do is force them to concentrate on other, more deadly, illicit substances.

Open source information is already coming out of Mexico reporting that traffickers are tearing up marijuana fields and replanting them with opium (for heroin). They will put more effort in getting methamphetamine, heroin and cocaine into the United States.

Advertisement

And with a reduced infrastructure in place, they will have a much easier time getting those products to our citizens – especially our kids.

The other thing that gets completely ignored in this discussion is that the pot of today is not your mom and dad’s marijuana. Back in the 1970s and 1980s, the THC content of marijuana was around 3 to 5 percent. Marijuana today can be bioengineered to produce THC contents in the 25 to 30 percent range and even higher.

It doesn’t matter how many laws are put in place to regulate THC content, marijuana that has the same effect as LSD will be all over streets and in our schools.

The situation looks rosy now, very similar to the rosy situation of 1933 when prohibition ended. Look how many billions of dollars and millions of lives that alcohol has cost American society.

We can all be giddy about the promise of marijuana now, but in one or two generations when we have double or triple the number of drug addicts and America loses its greatness and economic power because of addiction, our kids and our grandkids will detest the society we have given them.

Paul Chavez is a retired Albuquerque Police Department deputy chief and a former director of intelligence for the Southwest Border High Intensity Drug Trafficking Area Program.


I happen to disagree with this tired, old, lame argument. Pot is available to anyone who wants it already. Including teenagers. Including pre-teenagers, probably, in many places. The decision to decriminalize pot and make it legal and tax it is the correct decision, beyond a shadow of a doubt. The medical benefits are nice too, but making pot legal shouldn't hinge on that.

This is the party line of all those who stand to benefit from continued prohibition. Nowadays that's mostly down to cops, ex-cops, FBI, DEA, and...Jeff Sessions. Maybe a few preachers on the religious right.
Title: Re: The Potfolio - Canopy Growth Corporation Announces $60 Million Bought Deal
Post by: Eddie on December 05, 2016, 03:01:10 PM
Eddie, In case you haven't seen it. Story just broke in Canada a few minutes ago.

December 05, 2016 07:36 ET
Canopy Growth Corporation Announces $60 Million Bought Deal Financing

SMITHS FALLS, ONTARIO--(Marketwired - Dec. 5, 2016) -

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Canopy Growth Corporation (TSX:CGC) ("Canopy Growth" or the "Corporation") announced today that it has entered into an agreement with a syndicate of underwriters led by GMP Securities L.P. and Dundee Capital Partners (the "Co-Lead Underwriters" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, 5,662,000 common shares (the "Common Shares") of the Corporation at a price of $10.60 per Common Share (the "Offering Price") for aggregate gross proceeds to Canopy Growth of $60,017,200 (the "Offering").
http://www.marketwired.com/press-release/canopy-growth-corporation-announces-60-million-bought-deal-financing-2180574.htm (http://www.marketwired.com/press-release/canopy-growth-corporation-announces-60-million-bought-deal-financing-2180574.htm)  :icon_study:

Missed it. thanks for posting. I've spent most of the last three days building a pig ark...outside, in the rain.
Title: Legalization of marijuana will cause chaos but only in the head of Paul Chavez
Post by: K-Dog on December 05, 2016, 07:07:40 PM
Some folks not so upbeat on Ganga legalization...

RE

Legalization of marijuana will cause chaos
By Paul Chavez / Detention Warden, Pueblo Of Laguna Detention Center
Monday, December 5th, 2016 at 12:02am
If the trend continues, New Mexico and the rest of the nation will legalize marijuana within the next few years; and in the long run our children and our grandchildren will ultimately hate us for it.

While many people are characterizing pot legalization as a tax and justice panacea, we don’t know the long-term ramifications of marijuana legalization. Let me give you a prediction based on 31 years in law enforcement, drug intelligence and public safety as well as many years studying this issue.


Actually we do know the long-term ramifications of marijuana legalization because some dogs have been heavy users of it for a very long time and their 'culture' has acted like it has been legal all along.  Some of these dogs have earned college degrees and have had very successful careers all while being heavy users.  In addition their health, both mental and physical is still excellent.  They are loved by their families and active with life and curiously, they want other people to be happy too!

Quote

We already know marijuana use in teenagers and young adults has an adverse effect on brain development. The research is abundant and unequivocal.


No we do not.  After fifty years of research studies still return the results which sponsors of studies desire.  Abundant and unequivocal research, as apposed to paid for studies says weed is essentially harmless.

Quote

Research also shows that greater availability of any substance whether it is alcohol, marijuana, prescription opioids or heroin will result in more people using that substance.



You needed research to tell you this why?

Quote

And please do not give me the argument that legalized marijuana is only intended for people over 21. See how well that worked with alcohol? Marijuana is already rampant to our middle and high schools. Legalization would just make it worse.


Ok, I won't, but the obvious conclusion from this statement is that alcohol needs to be made illegal again.  I have no problem with that. I prefer not to drink.

Quote

No matter how much money marijuana legalization raises in taxes, pot makes our children less successful in school and, frankly, dumber. New Mexico is already at the bottom of the list of most social indicators. Recreational marijuana will only make those problems worse.

 

People who want to learn can't be stopped and people who do not want to learn never start.  Seems to me if New Mexico is already at the bottom of the list of most social indicators marijuana might help.

Quote

Looking a generation or two down the road is where we will see the greatest consequences of legalization. Marijuana legalization will create two phenomena that will lead to future problems we’re not even thinking about today.


The evidence is all around us.  There are closet and not so closet tokers who are very successful at what they do.  The evidence is saying that the author of this idiotic argument is very afraid of loosing his job despite already being retired.

Quote

The first is that, in time, our politicians and policymakers will divert public safety funds meant for the infrastructure to combat marijuana trafficking and use, to other priorities. This is the same infrastructure meant to keep out heroin, cocaine, methamphetamine and other illicit products. That infrastructure will break down and access to these substances will be greater.


Not having law enforcement distracted by  marijuana will allow interdiction of dangerous drugs to intensify.

Quote

The second phenomena is the drug cartel’s reaction to legalization.

Anyone that believes that the legalization of marijuana will break the back of the drug cartels doesn’t know anything about drug cartels. These are very adaptable criminal organizations that won’t let a change in laws get in their way. They will not simply throw up their hands and get legitimate jobs.


I don't know much about drug cartels and neither does this author.

Quote

Yes marijuana has been their cash crop, but all legalization will do is force them to concentrate on other, more deadly, illicit substances.


Usually when cash flow is cut by an order of magnittude a buisness goes out of buisness.

Quote

Open source information is already coming out of Mexico reporting that traffickers are tearing up marijuana fields and replanting them with opium (for heroin). They will put more effort in getting methamphetamine, heroin and cocaine into the United States.


If the info is open source why do you give no details.  Perhaps because your open source is your own puckered asshole?

Quote

And with a reduced infrastructure in place, they will have a much easier time getting those products to our citizens – especially our kids.


With the reduced infrastructure cartels won't have an easy time smuggling the shit north like they do now.  Their criminal infrastructure will be reduced.  Throwing in 'the kids' is a really low blow.  Perhaps the author wishes to throw in that white women will be ravaged by black cock because they will be seduced by black men with evil weed.  A whole generation of mulattoes lies before us.

Quote

The other thing that gets completely ignored in this discussion is that the pot of today is not your mom and dad’s marijuana. Back in the 1970s and 1980s, the THC content of marijuana was around 3 to 5 percent. Marijuana today can be bioengineered to produce THC contents in the 25 to 30 percent range and even higher.


I'm impressed, this author turned a two to one difference at most into a ten to one difference by cherry picking his numbers.  FYI, people who go to pot stores in WA state already know that just because something is marked with a high THC percentage does not always mean it is good shit.

Quote

It doesn’t matter how many laws are put in place to regulate THC content, marijuana that has the same effect as LSD will be all over streets and in our schools.

 

The ignorance of this statement is astounding.  The effects of marijuana are nothing like the effects of LSD.  Someone who has tried both would say that the ignorance of this statement is astounding.

Quote

The situation looks rosy now, very similar to the rosy situation of 1933 when prohibition ended. Look how many billions of dollars and millions of lives that alcohol has cost American society.



That is because alcohol unlike marijuana is a very dangerous drug with a huge potential for abuse.

Quote

We can all be giddy about the promise of marijuana now, but in one or two generations when we have double or triple the number of drug addicts and America loses its greatness and economic power because of addiction, our kids and our grandkids will detest the society we have given them.



Something in my gut tells me this guy does not give two shits about children or grandchildren or he would not be a compulsive liar concerned only with keeping law enforcement budgets growing.  That is the only kind of green
Paul Chavez gives two shits about.  If we were at Standing Rock Paul would be on the wrong side of the fence.

Quote

Paul Chavez is a retired Albuquerque Police Department deputy chief and a former director of intelligence for the Southwest Border High Intensity Drug Trafficking Area Program.



And there you have it.  This whole rant has been like a mirror image of the CEO of BP or Shell Oil saying that fracking is kind and gentle to the planet.

Title: Re: The Potfolio -BRIEF-Canabo Medical raises $8.4 Million
Post by: g on December 07, 2016, 09:32:57 AM
Eddie, Breaking story.

BRIEF-Canabo Medical raises $8.4 mln in equity financing,announces intention to complete 7,500 patient observational study


Canabo Medical Inc says entered into an agreement with Aphria Inc for private placement of 6 million common shares at a price of $1.40 per share

* After offering, Aphria will own approximately 16.6% of total issued and outstanding common shares of company

http://uk.reuters.com/article/idUKFWN1E20VW (http://uk.reuters.com/article/idUKFWN1E20VW) :icon_study:
* Canabo Medical - Observational study to complete participant enrollment in 2017 Source text for Eikon: Further company coverage:

Title: Re: The Potfolio
Post by: Eddie on December 07, 2016, 09:38:07 AM
Aphria, in the Potfolio.

Thank you for posting, GO.
Title: Re: The Potfolio
Post by: g on December 07, 2016, 09:40:45 AM
Aphria, in the Potfolio.

Thank you for posting, GO.

Yes, That's why I posted, you mentioned way back it was one of your favorites.  My largest position as well in the group.
Title: Re: The Potfolio
Post by: Eddie on December 09, 2016, 12:45:19 PM
(https://chart.finance.yahoo.com/c/1y/MNTR?lang=en-US&region=US)

It's been a neutral week for pot stocks. After a good day on Tueday, the last couple of days have been, in the aggregate, down days for the Potfolio. The main thing that bothers me is that volume has fallen way off on most of these stocks...but there is one notable exception.

MNTR, the financial company that specializes in raising money for pot companies, is trading on decent volume, and looks (to me)  like it's trying to base now for a move higher.

I'm still having some difficulty copying decent detailed charts, but you can play around at this link, and see what I'm talking about.



Not a horrible day today. Ten up and eight down.

(Correction: Nine up and eleven down, at the close. The Potfolio is up to 20 stocks at the moment. I forgot I added a couple.)



Weekend update: The Potfolio overall is currently underwater by 20.6 percent. However, there are some winners. These are the gainers in the Potfolio since I bought in.

Cannabics Pharmaceuticals --- Up 7.9%

Canopy Growth --- Up 42.27%

Medical Marijuana Inc ---- Up 44.06%

Organigram --- Up 7.66%

The strategy of the Potfolio is to dollar cost average into the winners, and just hold on to the losers, for now.


Title: Re: The Potfolio ---- Clive Maund Pot Sector Update
Post by: Eddie on December 10, 2016, 10:43:10 AM
Maund says it's likely US pot stocks will correct . I tend to agree, mainly because the good trading volume we saw coming into the election has dried up. He is more bullish on the Canadian players (the Potfolio is weighted toward them, fortunately).

I read that 80% of retail (non-professional) stock market traders are bullish right now. That's a lot of people on one side of the boat. I do look for a stock market correction before too long. Pot stocks aren't likely to be immune to a general market correction, imho, at a time when the future of the nascent industry is so cloudy due to changing of the guard at the Imperial Palace on Pennsylvania Avenue.

I am in this for the long haul, so I'll be riding out any correction, no matter how severe. But if I weren't, I'd wait and see here before piling into this sector. If there is a general correction, and the markets are hit hard, then it would be a great time to pick these stocks up on the cheap. Long term, the outlook is stellar, imho


CANNABIS SECTOR GENERAL REVIEW...
originally published Monday, December 05, 2016

Marijuana U.S. Stocks

The cannabis sector has done pretty much as expected in recent weeks. After the huge gains into the multi-State vote on legalization on 8th November, this heavily overbought sector has started reacting back and may be forming a top. The votes on legalization went well (only Arizona voted no), which certainly augurs well for the sector over the longer-term, but this outcome was expected so the vote became a “sell on the news” event that triggered heavy profit taking, which even started to kick in several days before the vote.
The following charts, courtesy of the marijuanaindex.com are most interesting and make clear how the sector has topped out, at least for now, and the big question is whether the sideways pattern now forming is a top or a consolidation. Here it should be pointed out that we were long many stocks across the sector months ago, and sold out for massive profits around the time of the vote on November 8th.

The North American marijuana index shows a large top or consolidation pattern, which looks like a flat-topped broadening formation, which is normally bearish…

(https://www.clivemaund.com/charts/namerica.jpg)


The US marijuana index has fared somewhat worse, because of the effect of the Republican victory (the Republicans are not as well disposed towards marijuana as the Democrats) and latterly, the appointment of anti-cannabis firebrand Jeff Sessions as Attorney General…

(https://www.clivemaund.com/charts/us.jpg)


The Canadian marijuana index meanwhile, looks a lot better, because it is not blighted by US Federal law, or the likes of Jeff Sessions…

(https://www.clivemaund.com/charts/canada.jpg)


Charts above courtesy of the THE MARIJUANA INDEX.


Although the multi-State vote had a largely positive outcome, it’s not necessarily plain sailing for the sector from here on in the US. This is because the Republicans won the general election, not the Democrats, and they are not so favorably disposed towards the marijuana industry as the Republicans, and here we should remember that at the Federal level, the industry remains illegal, even if approved at State level. A particular setback was the nomination of anti-cannabis firebrand Jeff Sessions as Attorney General, who may have the power to impede the industry and even roll back some recent gains.

The criminalization of cannabis actually has strong parallels with the era of “prohibition” when alcohol was banned in the US, a big difference being that unlike alcohol, marijuana has a wide range of important medicinal uses. Just as, in modern times, the abuse of alcohol by many young people, and some older people, is no longer seen as grounds to ban it, the abuse of cannabis by some young people, which is inevitable, should not and probably will not be seen as grounds to ban it. Up until recently, an underlying reason for the criminalization of cannabis has been the threat that medical marijuana poses to the profits of Big Pharma as an alternative to their expensive pills and potions, but they are now yielding to public pressure to permit it, aided by the knowledge that they can proceed to buy up much of the industry using their massive war chest and then administer it on their own terms. This is a big reason why resistance to the decriminalization of cannabis by the likes of Jeff Sessions, although potentially a significant problem over the medium-term, is likely to ease with the passage of time.

This Ride with Larry video, assuming it was not in some way faked, shows the dramatic effect of marijuana on a man suffering from Parkinson’s.


Translating all these fundamental considerations into their impact on the marijuana sector as a whole, and individual stocks, is the challenge facing analysts trying to assess the potential of the sector for investors going forward. Our assessment that the sector was likely to react back or at the least go into a period of lengthy consolidation after the vote, even if it was favorable, was based on the fact that it had risen so sharply ahead of it, and attracted rampant speculative interest. Thus far, this assessment has proven to be correct, but what now?

Given the potential of people like the new Attorney General to invoke Federal law to create problems for the industry over the medium-term, which might lead to the still overbought sector reacting back further, a cautious and selective approach to the sector appears to be in order for now. There are still stocks within the sector that look well placed to advance further even if the sector as a whole corrects back, and these are the stocks that we will be focusing on at www.clivemaund.com (http://www.clivemaund.com) going forward.



Thanks to Clive Maund, for posting this free report.

https://www.clivemaund.com/free.php?id=4007 (https://www.clivemaund.com/free.php?id=4007)

Title: Re: The Potfolio --- Eleven MJ Stocks That Claim To Be Growing Weed
Post by: Eddie on December 10, 2016, 11:30:40 AM
Another article that confirms my stock picking genius.

11 Marijuana Stocks That Claim To Be Growing Weed
DECEMBER 9, 2016 BY NANALYZE LEAVE A COMMENT

While recreational and medical marijuana is not one of the 30 emerging technologies we cover here at Nanalyze, it’s a hot topic right now with our lovely readers. Our article on 57 marijuana stocks to invest in (or not) has topped 8,000 shares and our article on medical marijuana pharma stocks has been quite popular as well. We’ve done quite a bit of research around this topic now and our takeaway is that while the majority of over-the-counter (OTC) stocks about as desirable as a big bag of seedy Mexican brick weed, the big Canadian weed growers are where the investment opportunity lies for now. Here are the marijuana stocks that claim to be growing weed which we highlighted before:

 

11 Marijuana Stocks that Claim to Be Growing Weed


Company          Ticker                 Share Price             Cap (USD)                       Focus                       Country


Canopy Growth TSE:CGC                9.99                 1390                            Production                Canada

Aphria           CVE:APH                    4.67                  522                            Production                Canada
                                                       
Aurora Cannabis   CVE:ACB             1.95                  503                            Production                Canada

Mettrum Health  CVE:MT                5.04                  265                            Production                 Canada

OrganiGram       CVE:OGI                2.85                  243                            Production                 Canada

Surpreme Pha    CNSX:SL                1.22                  189                            Production                  Canada

Cronos Group     CVE:MJN                1.46                  167                            Production                  Canada

Emerald Health   CVE:EMH                0.86                    55                            Production                   Canada

Golden Leaf CNSX:GLH                0.31                    26                            Production                    Canada

CanadianCanOTCMKTS:CCAN           0.72                    23                            Production                    Canada

VodisPhaCNSX:VP                        0.09                      5                            Production                    Canada


With Canada moving to legalize recreational marijuana net year, the focus is on the people who grow a weed and then sell it for extremely high margins. We’ve already written about Canopy Growth and Aphria. In the news this past week, Canopy Growth moved to acquire Mettrum Health in a $430 million dollar deal so we’re already starting to see some consolidation in this space. What we’re interested in doing now is looking at the remainder of the growers listed above to see which ones are viable investment opportunities.

If you’ve ever grown weed, or knew a fella who had a grow operation, you’ll get a kick out of this:

(http://www.nanalyze.com/app/uploads/2016/12/Growing-Weed.jpg)

How funny is that? The cops came and snatched their crops because they didn’t take into account that their heat lamps generate well…. a lot of heat. Those same heat lamps require a lot of electricity too. When you’re growing weed, you should also pay attention to the spike in your electric bill. The business model any marijuana grower uses to grow skunk buds in their closet has not changed one bit. In order to get into the business of growing weed, you’ll need:

Space
A light source
Outdoors the sun is free
Indoors requires electricity
Soil or hydroponics
Fertilizer
Seeds
Patience

That’s it. The business model is simply how cheaply you can produce quality weed and how much you can sell it for. Aphria claims to be the cheapest grower of weed at the moment.

The single question you should be asking any one of these growing companies first is “how much weed are you growing and selling”? If the answer is not expressed in kilos, move on. None of this “well we’re going to grow when we get our license” crap. You’re either growing or you’re not. Using this measure, we can look at our 11 growers listed above to see how much weed they are growing. Vodis Pharmaceuticals and Canadian Cannabis aren’t realizing any revenues from growing nor do we see any mention of kilos grown per month. We’re dropping them off our list.

Weed Growers              Ticker          Kilos Last Quarter      Rev Last Quarter         Profit/Loss

Canopy Growth          TSE:CGC                     900 (est)                     7                         -4.68

Aphria                  CVE:APH                        585                             4.3                          0.787

Aurora Cannabis           CVE:ACB                     435                             3.1                           -5.6

Mettrum Health            CVE:MT                     553                             4.7                      -1.8

OrganiGram Holdings    CVE:OGI                     213                              1.8                     0.37

Surpreme Pharma    CNSX:SL                       0                                0                           -1 (est)

Emerald Health            CVE:EMH                    ???                              0.048                    -1

Golden Leaf Holdings    CNSX:GLH                ???                               2.5                        -1.4

Cronos Group            CVE:MJN                      ???                              0.123                      -0.227


If you’re one of the growers listed above that doesn’t have numbers on the “kilos sold” column, please make available information about how many kilos you are selling just like the big growers on the list. Take a page from grower Organigram and put together a slide that looks like this:

(http://www.nanalyze.com/app/uploads/2016/12/Organigram-Slide.jpg)

Investors shouldn’t have to go digging through your SEDAR filings to locate this stuff.

While doing research for this article, we came across an excellent chart from Canopy Growth that shows who the real players in the marijuana grower space:

(http://www.nanalyze.com/app/uploads/2016/12/Canopy-Growth-Revenues.jpg)

Firstly, the bar titled “PF Canopy” means “pro forma Canopy” which shows the revenues that Canopy Growth expects once their acquisition of Mettrum Health is finalized. Secondly, this pretty much matches the list we had of who is growing weed. We’re going to trust that Canopy, the world’s biggest grower of marijuana that trades on a public stock exchange, has a good grasp on who their competition is. If you are a “grower” and you’re name is not on the above chart it’s because you’re not a player. You’re only hoping to be a player. As investors, we’re not interested in buying stocks that promise hope, we’re interested in buying marijuana stocks that are growing weed and selling it.



http://www.nanalyze.com/2016/12/marijuana-stocks-growing-weed/ (http://www.nanalyze.com/2016/12/marijuana-stocks-growing-weed/)

I'm not big on making recommendations, but if I had to pick just one pot stock that I expect to outperform the rest, it would be Canopy Growth. They just continue to do all the right things, and they already grow more pot than anybody else.
Title: Re: The Potfolio EDDIE ALERT
Post by: g on December 13, 2016, 09:31:23 AM
Pot stocks erupting in rally, report out from Canada on regulations..

Back later Eddie, have to tend to mkt

http://markets.businessinsider.com/news/stocks/BRIEF-Canadian-marijuana-stocks-jump-after-govt-panel-APH-1001593463 (http://markets.businessinsider.com/news/stocks/BRIEF-Canadian-marijuana-stocks-jump-after-govt-panel-APH-1001593463)



Dec 13 (Reuters) - Shares In Canadian marijuana companies jump after gov`t panel issues recommendations to regulate cannabis industry;

* Canopy Growth Co rises 2.4 percent to C$10.24

* Aphria Inc adds 9.1 percent, Mettrum Health Corp up 6.2 percent, Emerald Health Therapeutics Inc jumps 9.6 percent Source text for Eikon: (Reporting by Alastair Sharp)
Title: Re: The Potfolio
Post by: Eddie on December 13, 2016, 09:35:57 AM
Thanks.

And I thought I had real time information. Not like GO.
Title: Re: The Potfolio
Post by: Eddie on December 13, 2016, 09:45:51 AM
Canadian marijuana stocks on a high after panel recommends widespread retail sale

Sunny Freeman | December 13, 2016 12:39 PM ET
More from Sunny Freeman


The recreational market for marijuana should allow for a “diversity” of companies to sell through storefronts and mail-orders, but limit advertising and marketing of brands, suggested a federal task force report released Tuesday.

Canadian marijuana stocks moved higher after the federal Task Force on Marijuana Legalization and Regulation released its 106- page report of 80 recommendations for the government’s planned end to cannabis prohibition.

Shares in Canopy Growth Corp. — the largest Canadian producer, considered the bellwether for the industry — gained four per cent to $10.39 apiece as investors digested the industry implications of the framework. Aphria Inc. rose nearly 5 per cent to $5.35 and Aurora Cannabis Inc. surged just over six per cent to $2.44.

“We are the largest developed country to ever move toward legalization,” said task force chair and former Liberal cabinet minister Anne McLellan in announcing the results of the 5-month long process, which included visits to legal markets including Colorado, Washington and Uruguay.

The recommendations offer opportunities for current licensed producers to play a major role of a new legal market, by stressing the need for a diversity of well- regulated producers of all sizes.


“The government needs to understand the value of a diverse market with growers of different sizes and, arguably, different expertise,” McLellan said.

It also advised allowing product to be sold at retail outlets in addition to through the mail, the only legal channel currently available.

However, the task force rejected the idea of allowing marijuana to be sold at outlets that also carry alcohol or tobacco. The Ontario government has suggested it would like to see cannabis sold through the LCBO.

The decision on how and where it is sold could ultimately rest on the provinces and territories themselves. The report suggested the federal government should be responsible for regulating production while the provinces and territories oversee retail distribution.


The framework also contained some disappointments for current licensed marijuana producers, including the effective ban on advertising and similar rates of taxation for recreational and medical pot.

Many companies were hoping to be able to openly brand their products to distinguish themselves from smaller and black market players.

The recommendation to tax medical product at the same rate as recreational could discourage producers from continuing to hone in on the research-intensive medical market, some companies have said. They believe medical marijuana should receive the same exemptions as pharmaceuticals.

The committee also suggests allowing individuals to grow up to four plants at home for personal use, which could also take a bite out of anticipated revenues in what could be a $5 to $11 billion market.

The report comes ahead of Canada’s plan to become only the second country in the world to legalize a recreational marijuana market.

The government has said it intends to table legislation for legalization in the spring. However, McLellan stressed the government is under no obligation to follow the recommendations of the task force.

The value of publicly traded marijuana stocks has ballooned in recent weeks in anticipation of the recreational market, which could be worth as much as $6 billion by 2021, according to Canaccord Genuity. However, projections vary widely—anywhere from $5 billion to $11 billion.

The report recommended upholding a separate medical marijuana market and suggested tax revenues from the recreational market should be funnelled partially into medical research of the drug’s therapeutic properties. The number of medical marijuana patients has tripled in the past year and now sits at 98,000 and is worth about $224 million today, according to an analysis by Beacon Securities.

Less than 40 licences have been doled out to companies looking to get into the production and sale of marijuana, but there are hundreds more in various stages of the stringent application process.

The task force focused on five major themes: minimizing harms of use; establishing a safe and responsible production system; designing an appropriate distribution system; enforcing public safety and protection; accessing marijuana for medical purposes.

It suggested a minimum age for use of 18 and also recommended upholding criminalization for activities such as impaired driving, selling to minors, sales outside the legal system and exporting marijuana.

http://business.financialpost.com/news/agriculture/canadian-marijuana-stocks-on-a-high-after-panel-recommends-widespread-retail-sale (http://business.financialpost.com/news/agriculture/canadian-marijuana-stocks-on-a-high-after-panel-recommends-widespread-retail-sale)



Title: Re: The Potfolio
Post by: g on December 13, 2016, 11:37:19 AM
Big run in Aphria to 4.20 Eddie and she gives most of it back.

They are having second thoughts on report. Everything the fucking government touches turns into a quagmire of nonsensical regulations hundreds of pages long.

While I can understand their idea advertising should be prohibited, the idea that a company cannot develop it's own brand or even packaging is just ridiculous. Imagine everyone having to package their products in the same plain paper wrapper with no brand recognition. There is just no end to control freaks and their fucking idiocy and hatred of uniqueness.

We would all drive the same black car and wear  black jump suits all the same left up to the dick heads that like to tell everyone how life should be.

Hopefully they won't kill everyone over and under 5' 10" tall in the future for being different.  :laugh:

My study of the action today leads me to believe Aphria is the big one that the looneys are going to fall in love with when the big crazy move comes. At least at the current time and judging by today's action only she is the big play and my current favorite.

You realize I'm sure she has set out way ahead of the others to be the LOW COST producer and already holds that title.

To my way of seeing things currently, this idea of no brand recognition is most advantageous to her particular business model.

Canopy of course is another go to, but all the acquisition and financing activity makes Aphria more understandable at this point in time.  :icon_scratch: :dontknow:

Of course Aphria being half the price helps me to be fonder of her as well.  ;D ;D
Title: Re: The Potfolio
Post by: g on December 14, 2016, 05:17:31 AM
Edward, a bit of reading material to go with your morning coffee. :coffee: :exp-grin:

Aphria continues expansion strategy

Aphria acquires additional 200 acres in Leamington, Ontario

LEAMINGTON, ONTARIO--(Marketwired - Dec. 14, 2016) - Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.

http://www.marketwired.com/press-release/aphria-continues-expansion-strategy-tsx-venture-aph-2183079.htm (http://www.marketwired.com/press-release/aphria-continues-expansion-strategy-tsx-venture-aph-2183079.htm)  :icon_study:
Title: Re: The Potfolio
Post by: Eddie on December 14, 2016, 05:28:34 AM
Mea culpa.

Went online to check my Aphria yesterday and realized that I hadn't actually bought any. That one and Mettrum were on the list, but I had decided to wait until after the election to see if they took a hit before I added them. I'm going to take a position today, unless they take off, in which case I won't chase them but wait for the right entry.

Part of the confusion was that I had discussed Aphria with one of my kids, and she had bought some...I really thought I had too. LOL. Taking corrective action immediately.
Title: Re: The Potfolio
Post by: Eddie on December 14, 2016, 05:34:10 AM
Probably better to wait until Friday, I guess, and see what happens with da Fed and the quad witching stuff.
Title: Re: The Potfolio
Post by: Eddie on December 14, 2016, 06:46:35 AM
Took a small position in Aphria but Mettrum gapped up and I'm going to wait on it.

Left my order for Mettrum open, and it eventually got filled at my price while I was working.
I will update the buy list on page 2 of the thread.
Title: Re: The Potfolio --- The Good, the Bad, and the Ugly
Post by: Eddie on December 16, 2016, 06:49:36 PM
The charts of most of the Potfolio look pretty decent. Lack of volume is a problem lately for most of them, though.


The Good.



(https://chart.finance.yahoo.com/c/1y/CGC.TO?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MT.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/APH.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/OGI.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/ACBFF?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CBDS?lang=en-US&region=US)


The Not-That-Bad


(https://chart.finance.yahoo.com/c/1y/AGTK?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNAB?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNBX?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MCOA?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CBIS?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/AMMJ?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/TRTC?lang=en-US&region=US)



The Bad



(https://chart.finance.yahoo.com/c/1y/CANN?lang=en-US&region=US)
Still holding some good gains, but trending down at the moment.

(https://chart.finance.yahoo.com/c/1y/GRNH?lang=en-US&region=US)
Not horrible.

(https://chart.finance.yahoo.com/c/1y/ERBB?lang=en-US&region=US)
Disappointing so far.

(https://chart.finance.yahoo.com/c/1y/MSRT?lang=en-US&region=US)
Stable and gaining but not yet making new highs.

(https://chart.finance.yahoo.com/c/1y/TRTC?lang=en-US&region=US)
Just marking time.


The Ugly


(https://chart.finance.yahoo.com/c/1y/CGRW?lang=en-US&region=US)
Also disappointing. May be a while before this one pops.

(https://chart.finance.yahoo.com/c/1y/MNTR?lang=en-US&region=US)
Mentor is a favorite of mine , but this looks like a possible head and shoulders top.

Title: Re: The Potfolio
Post by: Eddie on December 27, 2016, 08:04:32 AM
I expected there would be selling of pot stocks at year end, since they haven't blown out the way some people (me included) were hoping...but if I had to guess, a lot of long term investors are rotating out of other areas and IN to pot stocks this week. Today the Potfolio is having a yuge day so far.



Title: Re: The Potfolio
Post by: Eddie on December 30, 2016, 08:43:57 AM
I've spent the last few days watching my nascent stock portfolio, both miners and pot stocks, playing catch-up from some serious drawdowns....the miners from the huge hit on gold that happened starting at the end of August and lasted until a few days ago.....and the Potfolio, which had largely made the best gains of the year before I got onboard in the month or so before the election, and has been up and down on low volume since.

It's nice to see that standing pat seems to have been the correct decision. I'm in it for the long haul.

I've had one pot stock that has definitely outshown the rest, and that one is MJNA (Medical Marijuana Inc.) which is up a startling 137.46% since I bought it on 10/19/2016. This stock is volatile, but in general, has stayed in green territory for the last two months. One thing they're doing, that no one else is doing, is doing business in Mexico.

Mexico has legalized medical marijuana, and will probably soon legalize recreational marijuana too. This will be a great positive benefit to the country. So far, it is the medical product that MJNA is lined up to export, and they are way ahead of all the competition in going after market share south of the border.

Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations

Marketwired   MarketwiredDecember 29, 2016

SAN DIEGO, CA--(Marketwired - December 29, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its subsidiary HempMeds® Mexico and its products were featured in an L.A. Weekly article focused on the first-ever import permit granted by Mexico for the cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™).

The Dec. 23, 2016, article titled "Mexico Begins Importing Medical Marijuana As Views on Therapeutic Cannabis Evolve" states, "The California-based company's partnership with Mexico -- an ally of particular interest thanks to cultural and historical ties that date back centuries -- was solidified earlier this year when COFEPRIS, the Mexican health department, approved the country's first permit allowing the import of hemp-based CBD oil across its border." The article goes on to describe how the company worked with attorneys representing families -- who then worked with COFEPRIS to develop a "THC-free" version, called RSHO-X™.

The article continues: "But in Mexico, cannabis-based treatment is viewed with suspicion and remains highly taboo. So when the Maldonado family discovered that another Mexican family had a child with the same kind of affliction, the two families combined their efforts and participated in a series of congressional hearings in Mexico City in January. On February 1, 2016, they were rewarded when COFEPRIS granted permits for the little girls to receive CBD treatments from abroad."

"We are very humbled to have this opportunity," the L.A. Weekly article quoted Medical Marijuana, Inc. CEO Dr. Stuart Titus as saying. "Today, we remain the only legal cannabis-based products allowed into the country and remain the only Botanical CBD company with a COFEPRIS import permit."

The article also discussed Medical Marijuana, Inc. subsidiary HempMeds® Brasil receiving the first-ever import permit from the federal government of Brazil, stating: "Brazil has a similar arrangement with Medical Marijuana, Inc., whose hemp oil was first allowed in the country in 2014 on a case-by-case basis for the treatment of chronic pain, epilepsy and Parkinson's disease."

"We helped educate the government [in Brazil] and, going further, the government saw this product actually helped control these seizure disorders. Since there wasn't a good pharmaceutical medication, the regulatory officials declared it would be "inhumane" to keep these products from the patients," Titus was quoted as saying.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com (http://www.medicalmarijuanainc.com).

To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

About HempMeds® Mexico

HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx (http://www.hempmeds.mx).

About HempMeds® Brasil

HempMeds® Brasil currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds® Brasil is working on additional approvals for multiple indications.


http://finance.yahoo.com/news/medical-marijuana-inc-featured-l-140000149.html (http://finance.yahoo.com/news/medical-marijuana-inc-featured-l-140000149.html)

Title: Re: The Potfolio
Post by: Eddie on December 30, 2016, 09:05:04 AM
Looks like it's another green day for pot stocks, with 19 stocks in the Potfolio up today...and only one down.



So, in honor of a green day, here's a little Green Day. Billy Joe Armstrong is a master of the tasteful use of eyeliner, don't you think? I wonder if he does it to look like a zombie? That's my guess. Tapping into the unspoken zombie zeitgeist of his generation.


http://www.youtube.com/v/3NAFGZRBf1g&fs=1
Title: Re: The Potfolio - Medical Marijuana (MJNA)
Post by: g on January 03, 2017, 06:33:31 AM

Hi Eddie, in going through the pot stock list of our favorites I have spent some time doing more intensive research in the area after having used the shotgun approach.

MJNA was on of my first and major purchases due to it's extremely low price and the fact it was a going concern that showed promise, was established early, and had a bit of substance to it rather than just hype as most had.

Insider ownership of 47% of the shares was also a factor that caused me to jump in immediately, as that is a situation most compelling to me in my analysis of new stock purchases.

As usual however, when rushing headlong into a group major problems appear upon much closer study at a further date. The major problem with this corporation is the amount of stock it has issued and outstanding.  Three BILLION shares to be exact with about Two Billion outstanding. This of course is a totally absurd capitalization for a company of this size, the type you would expect in a GM, Apple, Microsoft etc., hardly a company with sales of 10 million.

Fortunately this does not reflect on the company or it's merits, merely on it's valuation which is excessive. Ergo, I would be a seller if it approached a dollar and move into something with a more reasonable capital structure.

Kindly remember that I am not giving investment advice, only relating my observations and analysis which is subject to change at anytime. Never forget that the markets are an area where the Dim run wild with hopes dreams and aspirations that only fools can have, and one never knows when a stampede begins. Getting in their way and telling them to calm down is an exercise in Futility.


                                               (https://etccreative.files.wordpress.com/2014/04/moneysandwich-321-v1-2.jpg)
Title: Re: The Potfolio
Post by: Eddie on January 03, 2017, 06:56:17 AM
Sounds like a candidate for a reverse split at some point. I appreciate your candid comments, as always.

As I remarked earlier, this has been my best gainer to date. Based on what you've said, I rate it a hold at the moment, but will be putting new funds into companies with less dilution.
Title: Re: The Potfolio
Post by: Eddie on January 03, 2017, 08:03:27 AM
Today is a mixed bag for pot stocks, but there are two stocks in the Potfolio worth mentioning in terms of technical charts, which are CGRW and CBDS.

See charts:


MSRT deserves an honorable mention, as well.


Title: Re:The Potfolio - Canopy Growth Corporation Comments on the Year that was 2016
Post by: g on January 03, 2017, 11:00:29 AM
Edward,  For our reading pleasure.  The Blue Chip Speaketh  :laugh: ;D ;D

              Canopy Growth Corporation Comments on the Year that was 2016
           

                       

   SMITHS FALLS, ON , Jan. 3, 2017 /CNW/ - As a leader in Canada's medical cannabis industry, Canopy Growth Corporation (Canopy Growth) (CGC.TO) wishes to offer the following commentary on the events of late 2016.

Transitioning Canadians into the legal cannabis system with the appropriate checks and balances has been very successful to date. The number of authorized medical cannabis users tripled in 2016 as healthcare professionals and individuals became increasingly aware of the emerging regulated system, and as the system itself evolved to better meet Canadians' needs.

Since May 2014 when Tweed shipped its first gram, its facilities have evolved and become more efficient. Each stage of production and processing has dozens of Standard Operating Procedures that make its products better and safer. Through hard work and a culture of improving every aspect of our operations as we grow, Canopy Growth has earned almost a quarter of the market share and developed a strong track record of compliance across multiple facilities.

Canada is ahead of the global curve with regards to cannabis regulation. The system in place today has successfully introduced over one hundred thousand Canadians to a legal source of cannabis for medical purposes. The success of the Access to Cannabis for Medical Purposes Regulations is evident in its growth, which has continued at a rate of approximately ten percent per month for more than two straight years. Quality of product is improving across the sector, while average prices have come down. Patients now have cannabis oils and capsules to choose from, in addition to a variety of dried cannabis options.

Late last year, our sector was met with two announced product recalls and some related negative media coverage. These instances were of course unfortunate. As neither recall was related to Canopy Growth or its subsidiaries, Canopy is in no position to comment on the details related to the product recalls. One of the companies, however, is set to join the Canopy family and we remain proud of the reputation Mettrum has built for its quality products, customer support, and physician outreach.

It is important to note that recalls are not the sign of a system in disarray, rather they are signs that the system is working to protect Canadian patients. This is true of all regulated industries, from food production to medical production, but it is especially important in a sector such as the cannabis industry, which remains in its infancy and subject to incredible scrutiny.

All licensed producers are highly regulated, tracking every plant from seed to sale, testing product for release, and maintaining samples in case further testing is required.  Additionally, and unique to our sector given the direct relationship we have with our patients, every licensed producer has procedures in place to contact every one of our clients if a recall or other customer notification needs to occur. Upon discovering anything warranting a recall, such as the presence of unapproved treatment products, a licensed producer will ensure that impacted customers are identified and advised of the recall and of any potential risks associated with product consumption. Furthermore, substantial testing and reviews of procedures will occur, to ensure that corrective actions are put in place and implemented.

In the case of Mettrum's disclosed recall, it was concluded by Health Canada and external experts that the recall constituted a Type 3 Recall, defined by Health Canada as a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences. All patients who are potentially impacted are notified, corrective actions are put in place, and existing product and procedures re-tested and examined.

Looking to the future, there are no signs of things slowing down for our sector or our Company. In spite of the fact that illegal sources exist, Canadians requiring cannabis for medical purposes increasingly place their trust in a system that delivers high quality products and has safeguards in place to recognize and react in the rare cases when that standard is not met.  We are not perfect, nor is the system in which we operate. There will be bumps along the road, but for a new sector we all have a lot to take pride in.     :icon_sunny:

http://sports.yahoo.com/news/canopy-growth-corporation-comments-2016-175000395.html (http://sports.yahoo.com/news/canopy-growth-corporation-comments-2016-175000395.html) :icon_study:
Title: Re: The Potfolio
Post by: Eddie on January 03, 2017, 11:46:48 AM
Canopy Growth is the number two gainer since October, in the Potfolio.

Mettrum, which Canopy Growth is in the process of buying, is also one of the more solid companies in the Potfolio.

Canadian pot stocks are safer, in general, than US pot stocks, due to the continued attempts by the Feds to criminalize marijuana and cannabinoid drugs. jmho.

Title: Re: The Potfolio --- The Solution Is Dilution
Post by: Eddie on January 06, 2017, 07:09:04 AM
I piled into pot stocks in a hurry, before the election in hopes that positive news (which we got) would drive the price up further. Instead it turned out to be a classic case of "buy on the rumor, sell on the news". The potfolio took a pretty good hit in Nov.-Dec., but now it looks like MOST  of the pot stocks we picked are coming back.

The majority of the 20 stocks I'm holding are still slightly in the red, and a couple are still in real trouble. Each week though, for the past few weeks, more of the symbols are lighting up green when I open my brokerage account and look at the list.

But...more information is coming in. Like a lot of  penny stocks, the problem with some of the Potfolio picks is that the companies have sold so much stock that their market cap is at a level that isn't justified by their earnings, or even by their sales (for brand new companies, there often are no earnings, but if there aren't any sales either, you got a real problem that won't get better.)

Since the tech boom of the 90's, the way stocks are evaluated has changed a lot. The strongest stock there is, is probably Amazon, and their earnings have always sucked. But it's because Bezos has put 99% of the money they've made into expanding the company. P/E ratios for tech stocks in general are way higher than what used to be considered healthy.

So...momentum is mostly what traders look at these days, and not fundamentals. This is true for the Potfolio stocks too. Also, from what I'm reading, investors are picking companies that have a name that sounds good, like MJNA, which looks like "marijuana", and CANN, and CNBS, which are symbols that invoke the word cannabis. Not necessarily a good metric, but it's branding, which is a proven marketing tool.

But fundamentals do matter, ultimately, in the success or failure of a business enterprise. Money has to be made to keep the employees paid and the doors open. So, as we go forward,, and try to pick and choose which stocks to hold and which ones to eliminate, and which one's to continue to dollar-cost average into over time, we'll be looking a little closer at market caps and earnings.

At present, the best performing stock in the the Potfolio (in the time I've held it) has been MJNA. However, it has come to my attention, thanks to GO, that this company has sold  more shares of stock than they should have, by maybe a factor of 100X. So...I will hold it as long as it climbs, but I won't add to it. And I wouldn't recommed it to you as a buy.

Another stock in the Potfolio, that made many watch lists last year and had a decent initial sniff test, was CANN. Now CANN has not performed well, even though the company has good news coming out. I finally figured out that the company sold 9 million warrants (in October, I think). A warrant is kinda like a call option. They are sold to big investors to raise money in a hurry, and they sell at a steep discount to the stock price, and allow the holder to convert the warrants to stock at a predetermined price. This dilutes the stock outstanding,  raising the P/E ratio ( a lot, if we're talking 9 million warrants)

If the stock goes up, the investors are likely to exercise (convert) large numbers of warrants and sell the stock for a big profit...which creates downward momentum for the stock price. If the stock doesn't go up, there isn't as much incentive to exercise the warrants en masse, but the fact that they are out there creates a real headwind...which is happening for CANN, right now.

Not to get too deep in all this shit, but warrants also create arbitrage opportunities, where traders can sometimes buy the warrants and short the stock, locking in a a small but guaranteed profit. Most retail investors don't have a clue how to do this, but traders love to do it, and it plays hell with the stock price. CANN is down about 33% from when I bought it, and probably should be sold soon.

There is one other stock in the Potfolio that looks pretty iffy, in spite of a lot of hype on the net, and that one is GRNH. The concerns there are not quite so straightforward, but have to do with certain activities of the major stockholders and board members that make one worry that they might not take their fiduciary responsibility to the stockholders as seriously as they should.

So...I will keep watching and updating. At some point some of these will probably be culled.








Title: Re: The Potfolio --- The Good, The Bad, and the Ugly
Post by: Eddie on January 07, 2017, 01:44:03 PM
Just did the numbers, and the Potfolio overall is down 3.6% below par. The individual stocks are all over the map. Half of them  are still showing double digit losses, but the winners are carrying the losers pretty well. After studying the charts, I have decided not to cull anything yet.

As I said, MJNA has a dilution problem, so I won't average into that one, even though it's up an astounding 120.99%. I am tempted to set a trailing stop on this one.

The other leaders are:

MNTR    +13.45%

MSRT     +15.51%

TWMJF   +41.67%

ACBFF    +5.51%

TWMJF (Canopy Growth) would still be my best recommendation (and I expect some others here would agree). I will be dollar cost averaging into this one, for sure.

Some of the stocks still underwater still have excellent potential. Just because they're drawn down a little doesn't bother me too much.

These are:

OGRMF    -6.50%

MQTRF    -9.02%

APHQF     -5.10%

ERBB       -2.38%

CBIS       -8.62%

AMMJ      -12.87

CGRW      -13.66

MCOA      -11.99

CNBX      -5.33


These are mostly companies that are very strong in the industry. The US companies are still suffering from fears of Trump Administration unknowns.

If I had to pick a cannabis industry lotto ticket stock, ERBB would be my choice. It's only down 2.38% from when I bought it on 11-14-2016, and it goes for a low premium at $.002/share. Lots of room to run. Think I might buy a million shares. I never owned a million shares of anything.

To round out my report, the stocks below are going on my wall of shame (not to mention my shit list). I am not ready to write them off, but I'm not encouraged, and I would NOT recommend any of them, at this time. Some of them do have potential. We'll see.

AGTK     -23.16%

CANN     -34.73%   (Diluted by sale of 9 million warrants)

CBDS     -22.82%

CNAB     -20.11%

GNRH     -37.99%   (Majority owners might be crooks)

TRTC      -27.98%

That's it, pot stock fans. At ease. Smoke 'em if you got 'em.






 
Title: Re: The Potfolio
Post by: Eddie on January 07, 2017, 03:04:25 PM
I found an excellent source for checking fundamentals on the pot stocks. I'm going to study the numbers and I'll try to get something up on this topic before long, too.

Check out MJNA.

Huge float , but MJNA has a rare thing going on, which might explain why it's doing so well. They have actual EARNINGS! LOL.

Their P/E is only 25, even with 3 billion shares outstanding. 11% ROI. 9.5% ROA. I might have to average into this one after all. Not horrible fundamentals. Not compared to most stocks in this sector.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNA






Title: Re: The Potfolio --- Cautious Optimism
Post by: Eddie on January 11, 2017, 06:04:48 PM
Jeff Sessions is taking one for the team on pot. That's what I get out of this.


Wonkblog
Sessions on enforcing federal marijuana laws: ‘It won’t be an easy decision’
By Christopher Ingraham January 10
 
Attorney General-designate, Sen. Jeff Sessions, R-Ala. testifies on Capitol Hill on Tuesday at his confirmation hearing before the Senate Judiciary Committee. (AP Photo/Alex Brandon)
In his Senate confirmation hearing on Tuesday, Sen. Jeff Sessions, President-elect Trump's nominee for attorney general, declined to say whether he'd adhere to the more lenient marijuana enforcement guidelines adopted by the Obama administration's Justice Department in states that have legalized medicinal or recreational marijuana use.

"Would you use our federal resources to investigate and prosecute sick people who are using marijuana in accordance with their state laws, even though it might violate federal laws?" Senator Patrick Leahy (D.-Vermont) asked.

"I won't commit to never enforcing federal law, Senator Leahy," Sessions replied. "I think some of [the Obama-era guidelines] are truly valuable in evaluating cases," he added. "Using good judgment about how to handle these cases will be a responsibility of mine. I know it won't be an easy decision, but I will try to do my duty in a fair and just way."

Under Obama, the Department of Justice largely adopted a hands-off approach to marijuana enforcement in states that legalized the drug for medical or recreational use, provided that certain criteria -- like keeping the drug out of the hands of children -- were met under state laws. That policy was outlined in a Justice Department document that came to be known as the Cole Memo, for former U.S. Deputy Attorney General James Cole, who drafted the memo.

[Sessions emphasizes the primacy of the law over his political views]

Drug policy experts have said that this tacit green light from the Obama administration was instrumental in Colorado and Washington's decisions to fully follow through on recreational marijuana laws passed by voters in 2012. In November 2016, four more states including California voted to make the recreational use of marijuana legal, bringing the total to eight states plus the District. Medicinal marijuana has been legalized in 28 states.

In prior public statements, Sessions was harshly critical of the Justice Department 's approach on the issue. In an April 2016 Senate drug hearing, Sessions said, "I think one of [Obama's] great failures, it's obvious to me, is his lax treatment in comments on marijuana. It reverses 20 years almost of hostility to drugs that began really when Nancy Reagan started 'Just Say No.'"

Sessions also said at the time that "the Department of Justice needs to be clearer" on marijuana legalization and enforcement.

Sessions didn't appear to commit to providing such clarity today. He neither voiced support for the Obama-era rules, nor signaled that he was eager to throw them away altogether. Marijuana legalization advocate Tom Angell called it a "good sign that Sen. Sessions seemed open to keeping the Obama guidelines, if maybe with a little stricter enforcement of their restrictions."

"It is notable that Sen. Sessions chose not to commit to vigorously enforcing federal prohibition laws in states that have reformed their marijuana laws," said Robert Capecchi of the Marijuana Policy Project in a statement. "He was given the opportunity to take an extreme prohibitionist approach and he passed on it."

[Trump’s pick for attorney general: ‘Good people don’t smoke marijuana’]

Wonkbook newsletter
Your daily policy cheat sheet from Wonkblog.
Sign up
Marijuana industry leaders voiced similar notes of cautious optimism. "Though it is possible that a slightly more restrictive 'Sessions Memo' will replace the existing Cole Memo," said Frank Lane, Vice President of financial services company CannabisFN, "we do not believe an AG Sessions will disrupt the long-term growth prospects of the U.S. cannabis industry."

Later in the hearing, Sessions noted that "the U.S. Congress has made the possession of marijuana in every state, and distribution of it, an illegal act. So if that's not desired any longer, Congress should pass a law to change the rule."

Those words echo remarks by President Obama, who has repeatedly rebuffed calls to reschedule marijuana by saying that it is properly Congress' job to change the nation's drug laws.

President-elect Trump has himself given mixed signals on marijuana laws. He has spoken out about the negative effects of making marijuana recreationally available, but has said that changes to marijuana law should be handled on a state-by-state basis.

In a reminder of the low salience of marijuana reform for many lawmakers and voters, the questions to Sessions on marijuana law came roughly six hours into his first day of hearings. By that time, many of the Senators had already left the room.

https://www.washingtonpost.com/news/wonk/wp/2017/01/10/sessions-on-enforcing-federal-marijuana-laws-it-wont-be-an-easy-decision/?utm_term=.e56d086a87b8 (https://www.washingtonpost.com/news/wonk/wp/2017/01/10/sessions-on-enforcing-federal-marijuana-laws-it-wont-be-an-easy-decision/?utm_term=.e56d086a87b8)
Title: Re: The Potfolio
Post by: Eddie on January 13, 2017, 07:54:14 AM
A better than average take on the Canadian stocks.

3 Stocks To Consider In Canada Pot Market
Jan. 9, 2017 3:52 PM

Michael Hooper   Michael HooperFollow(570 followers)


Canada moves faster than USA toward full legalization of marijuana.

Canopy Growth and Aphria have shown profits in recent quarters.

A look at the U.S. Market and Donald Trump.

While U.S. states have been passing medical and recreational marijuana laws, Canada is moving along faster toward legalization of cannabis than in the United States. The legal framework in Canada is much more supportive of the Canadian companies operating there, while those in the U.S. may operate legally in their state, but fear the mighty hand of the U.S. federal government, which still considers cannabis to be a Schedule 1 drug "With no currently accepted medical use and a high potential for abuse."

Twenty-eight U.S. states have legalized medical marijuana. Eight U.S. states -- Nevada, Maine, Colorado, Washington, California, Massachusetts, Alaska and Oregon -- have approved the sale of medical and recreational use of cannabis, but timetables for implementation vary.

Jeff Sessions, Donald Trump's pick for Attorney General, does not appear to be a big fan of cannabis, but I think the Trump Administration has already made it clear that its top priorities are corporate tax reform, job growth, immigration and health care. I expect Trump to work on tax reform and health care in the first year. When faced with a decision on cannabis, I imagine Trump will see that new pot laws in over half of U.S. states have created tens of thousands jobs, hundreds of millions of dollars in tax revenue, helped the sick, and taken the pot trade away from Mexico. He probably would leave good alone, while pursuing other things that matter to him.

Meanwhile, Canada is allowing licensed producers to sell cannabis to customers who obtain a medical cannabis prescription. Canada's federal laws support medicinal benefits of marijuana. Canada approved passage of the Marijuana for Medical Purposes Regulations (MMPR). The law authorized licensed producers to grow and sell cannabis to registered users who obtained a medical cannabis prescription.

Canada is the leader in the reform of cannabis regulation. The system in place today has successfully introduced about 100,000 Canadians to a legal source of cannabis for medical purposes.

Industry experts say the success of the Access to Cannabis for Medical Purposes Regulations is evident in its growth, which has continued at a rate of approximately 10% per month for more than two straight years. That means the industry is on track to more than double in size in a year.

Pot advocates say the quality of product is improving across Canada, while average prices have come down. Patients in Canada now have cannabis oils and capsules to choose from, in addition to a variety of dried cannabis options.

The next step for Canada is passing laws to handle recreational use of cannabis. The Liberal government announced that it would be introducing new legislation April 20, with target implementation January 2018. Legislation will likely follow findings in the work of The Task Force on Cannabis Legalization and Regulation for Health Canada. The Task Force recently published A Framework For The Legalization and Regulation of Cannabis in Canada.

Some highlights

--Set a national minimum age of purchase of 18.

--Apply restrictions to the advertising and promotion of cannabis -- similar to restrictions on promotions of tobacco products.

--Prohibit mixed products, such as cannabis-infused alcoholic beverages. No co-location of alcohol or tobacco with cannabis sales.

--The Task Force recommends allowing personal cultivation of cannabis for non-medical purposes a limit of four plants per residence, maximum height 100 cm.

--The Task Force also recommends using licensing and production controls to encourage a diverse, competitive market that also includes small producers.

Among the licensed producers are Canopy Growth (OTCPK:TWMJF), Aphria (OTCQB:APHQF) and Organigram Holdings (OTCQB:OGRMF).

Canopy Growth's Tweed Farms Inc. is a Licensed Producer for Cultivation and Sale since Aug. 8, 2014.

Canopy has achieved tremendous gains over the past two and a half years. Most notably, the company had over 24,400 registered patients on Sept. 30, 2016, compared to 16,600 in the previous quarter. That's 46% growth quarter to quarter.

When second quarter fiscal 2017 ended Sept. 30, Canopy's revenue of $8,498,000 Canadian dollars was up 22% over the previous quarter, and up 245% over the second quarter of fiscal 2016 when revenue totaled $2,466,000. Canapy sold 1,169,000 grams of cannabis in the quarter, representing an increase of 19% over the first quarter of Fiscal 2017 and an increase of 267% over the second quarter of last year. The company reported $5.4 million net income or $0.05 per share.

Canopy's Tweed Farms greenhouse grows a variety of high quality cannabis strains that sell, through Tweed, across multiple price points, from value strains, priced at $6 per gram, to premium strains, priced at $12 per gram.

In the quarter ended Sept. 30, Canopy sold 1,169 kilograms or 1,169,000 grams. At an average price of $7.01 per gram, that would generate $8.19 million in one quarter. I expect that number to double, triple in the next two years.

Tweed is housed in a former Hershey chocolate factory at 1 Hershey Drive, Smith Falls, Ontario. the campus comprises 40 acres of land with over 500,000 square feet of available space. Tweed occupies 168,000 square feet of licensed production space, plus office space where Canopy's head office drives the vision forward. It is a data-driven, automated and lean operation, housing an R&D facility, oil extraction infrastructure, and in-house lab. Precise climate controlled spaces for each stage of cannabis production, from clone to cured bud, allows for the highest quality and widest variety of product in the sector.

Canopy stock is up 278% in the past 12 months. Aphria stock is up 374% in the past 12 months. Aphria considers itself a low-cost producer, supplier and seller of medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. The company is committed to providing pharma grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. "We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters," Aphria says.

Because there is the legal framework for licensed cannabis businesses in Canada, companies like Canopy, Organigram and Aphria make their headquarters there, but also can operate in other markets like the United States, Germany and Brazil. Organigram Holdings has a market cap of $280 million and is operating in Canada and Colorado with plans to open other shops in Illinois, Oregon, Florida and Maryland. Organigram stock is up 249% in the past 12 months.

Stock markets tend to run in cycles. We had the tech sector run-up in the 1990s followed by the tech crash in 2000-01. We had real estate bubble in the mid 2000s, that blew up, followed by the big stock market crash in 2008-09. Then we entered the longest recovery, it was steady about 2% GDP growth annually during the Obama years, not bad, really. Biotech/drug stock sector is now the disenfranchised and unloved, some of these stocks, like Gilead Sciences (NASDAQ:GILD) are trading at 7 times earnings. If you are looking for deals, you might consider the biotech/drug sector.

By comparison, Canadian pot stocks are trading at very high valuations already. Canopy Growth's market capitalization of $1.2 billion is an extremely high valuation for a company that had about $8 million in revenue in its most recent quarter.

Aphria's market cap is $500 million; the company only had $4.3 million revenue, with $895,000 income, in quarter ended in August 2016.

The cannabis industry is creating thousands of jobs in Canada and the United States. This is a multi-billion dollar industry, with job growth at all levels, from production to processing to sales, plus so many jobs supporting the industry, like companies that make grow lights.

Canada has 36 million people. About 28 million are older than 19. About 12% of Canada's population aged 15-64 use marijuana. That's a pot market of about 3.3 million.

I think prospects for growth in cannabis sales look more attractive in Canada compared to Kansas. I plan to acquire shares in two or three Canadian companies in the cannabis business, and will be looking for opportunities in 2017. I recently purchased a few hundred shares in Canopy Growth and Aphria. I am buying these Canadian pot stocks at very high valuations, but they are making money, the pot industry in Canada will likely double this year in the medicinal arena and then triple when there is full legalization of recreational marijuana in 2018. The stocks may double with the growth in sales, but the stocks could also go down substantially, depending on what happens with federal regulation. The risk/reward ratio is high on this trade. Valuations are high. Since there is so little volume in pot stocks some days, the prices tend to swing widely. But what if this pot industry explodes into 10 times what it is today? Companies that supply legal weed to the masses will do well.

Disclosure: I am/we are long TWMJF, APHQF.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.


http://seekingalpha.com/article/4035365-3-stocks-consider-canada-pot-market (http://seekingalpha.com/article/4035365-3-stocks-consider-canada-pot-market)
Title: Re: The Potfolio
Post by: Eddie on January 13, 2017, 09:00:48 AM
A few take-aways for anyone considering buying into pot stocks. These are the things you won't read anywhere else.

1. All twenty stocks in the Potfolio, every one of them, is trading at a new, higher level than last summer, before the sector got so hot in the couple of months leading up to the election. Not even the sketchiest companies have fallen back anywhere near their previous levels. This is different action from the past (like 2014, when there was a huge run-up that subsequently fizzled completely). To me, this signifies that pot stocks are in a new, real bull market. I am down on some stocks I bought near the pre-election highs, but I am calling those timing mistakes. Bull markets always correct timing mistakes.

2.Looking at momentum, and looking at charts in general, I cannot see much difference between the action in the most profitable stocks in the Potfolio, with the best fundamentals, and those that have problems, fundamentally speaking. A couple of stocks with good fundamentals are doing very well, but those with fundamentals that stink don't look bad from a price action standpoint either. Not looking at a one year chart.

(https://chart.finance.yahoo.com/c/1y/AGTK?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MNTR?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNAB?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CNBX?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CGRW?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MCOA?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/AMMJ?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MSRT?lang=en-US&region=US)
Not really at a new higher level, not like the rest, but doing okay.Look at the volume spike.

(https://chart.finance.yahoo.com/c/1y/TRTC?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CBIS?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CANN?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CBDS?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/ACBFF?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/OGI.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/GRNH?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MJNA?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/APH.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/MT.V?lang=en-US&region=US)

(https://chart.finance.yahoo.com/c/1y/CGC.TO?lang=en-US&region=US)

3.Half the Potfolio stocks have reasonable fundamentals, considering the nature of this market. Half do not. Of the ones that do have good fundies (sales, earning, good financials, low float) there is a wide range. I rated them all on fundamentals, from +++  to --. I'll publish those results, but you can look for yourself too. Here's MJNA, for example. This is the site I'm using to evaluate them. MJNA gets a ++ by my rough estimate, in spite of a huge float.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNA

4. Here's my own personal quick and dirty assessment of fundamentals of the 20 stocks now held by yours truly in the Potfolio. The symbols I use here are the ones Ameritrade uses. On the Canadian exchanges the ticker symbols are different, fwiw.

Stock                                 Fundamentals

ACBFF                                         +

AGTK                                           -

AMMJ                                          +

APHQF                                       +++

CANN                                           -

CBDS                                          --

CBIS                                           --

CGRW                                          -

CNAB                                           +

CNBX                                           +

ERBB                                            -

GRNH                                           -

MCOA                                           --

MJNA                                           ++

MNTR                                           +

MQTRF                                         ++

MSRT                                            -

OGRMF                                         ++

TRTC                                            +

TWMJF                                          ++


*Once again, these are off-the-cuff, rough estimates. Many people consider Canopy Growth to be the best pot stock of all, but I had to rate Aphria higher on fundamentals, as of last weekend, when I ran the numbers here.

5 .Canadian pot stocks are a safer buy than American companies, due to the legal issues still hanging around due to stupid bureaucratic bungling by our government. Also, the fundamentals of Canadian pot stocks, on the whole, are better. The strongest four stocks are all Canadian. I don't think that means you should write off American companies, but the crystal ball is cloudy for them, at the  moment. I noticed one MSM article yesterday that had all kinds of negative headlines about the medical use of pot, and possible negative effects, like causing schizophrenia. If you read the whole article, you learned that the headlines were mostly bullshit. Still, we see this stuff, and I think it's part of a still-powerful anti-pot lobby that is able to persuade media to smear the industry. Who would do such a thing? (I mean, besides the private prison owners, the DEA, the FBI, and the billionaires that profit off alcohol sales (Sheldon Adelson)).

6. We live in troubled times, and there is about 100% odds of a major stock market correction on the horizon.This will drive down all stock prices, and could temporarily decimate pot stocks just like everything else. If that happens, it's a gift from God. I'll be adding to the better performers. Pot is not going away. I view it as the best contrarian play in recent history.

7. So as not to appear to be baiting anyone to follow some link to a pay site, I'll list the four best Canadian stocks in the Potfolio (my opinion). I'll also add a fifth, which might arguably be on the list. They are in order of best first (overall, not just fundies): TWMJF, APHQF,OGRMF, MQTRF, and ACBFF. My rating is based on fundamentals and recent price action. Of these five, since November 2016, TWMJF has outperformed the rest handily, as far as gains.

8. Of the American companies, the best overall stocks in the Potfolio are, in order: MJNA, MNTR, and MSRT. Of these, MJNA is off-the-charts ahead in gains. It might be worth mentioning that MNTR and MSRT are not actually pot growing companies. MNTR is a financial company that specializes in raising capital for pot companies, and MSRT is a social media platform for people interested in buying and discussing pot. Many of the American pot growing companies that came highly recommended are underwater (for me) at the moment.

9. Just to cover a couple of possible questions you might have, let me say that all the selections in the Potfolio were made by me, and I deliberately avoided a few highly rated stocks. I don't like breathalyzers, so I won't buy stocks of companies looking to sell them, and I avoid pot stocks that might be considered high-flying biotechs, ones that have already shot up to $50/share and beyond. I am continuing to look at possible new stocks to add to the Potfolio, but since 20 companies is nice round number( and since I don't have unlimited funds), any additions might necessitate paring back some of the ones I'm currently holding.


I think RE plans to run this on the blog. Any constructive criticism prior to publication is welcomed.












Title: Re: The Potfolio
Post by: RE on January 13, 2017, 09:27:13 AM
A few take-aways for anyone considering buying into pot stocks. These are the things you won't read anywhere else.

1. All twenty stocks in the Potfolio, every one of them, is trading at a new, higher level than last summer, before the sector got so hot in the couple of months leading up to the election. Not even the sketchiest companies have fallen back anywhere near their previous levels. This is different action from the past (like 2014, when there was a huge run-up that subsequently fizzled completely). To me, this signifies that pot stocks are in a new, real bull market. I am down on some stocks I bought near the pre-election highs, but I am calling those timing mistakes. Bull markets always correct timing mistakes.

2.Looking at momentum, and looking at charts in general, I can not see much difference between the action in the most profitable stocks, with the best fundamentals, and those that have problems, fundamentally speaking. A couple of stocks with good fundamentals are doing very well, but those with fundamentals that stink don't look bad from a price action standpoint either. Not looking a one year chart.

3.Half the Potfolio stocks have reasonable fundamentals, considering the nature of this market. Half do not. Of the ones that do have good fundies (sales, earning, good financials, low float) there is a wide range. I rated them all on fundamentals, from +++  to --. I'll publish those results, but you can look for yourself too. Here's MJNA, for example. This is the site I'm using to evaluate them. MJNA gets a ++ by my rough estimate, in spite of a huge float.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNA

4.Canadian pot stocks are a safer buy than American companies, due to the legal issues still hanging around due to stupid bureaucratic bungling by our government. Also, the fundamentals of Canadian pot stocks, on the whole, are better. The strongest four stocks are all Canadian. I don't think that means you should write off American companies, but the crystal ball is cloudy for them, at the  moment. I noticed one MSM article yesterday that had all kinds of negative headlines about the medical use of pot, and possible negative effects, like causing schizophrenia. If you read the whole article, you learned that the headlines were bullshit. Still, we see this stuff, and I think it's part of a still-powerful anti-pot lobby that is able to persuade media to smear the industry. Who would do such a thing? (I mean, besides the private prison owners, the DEA, the FBI, and billionaires that profit off alcohol sales (Sheldon Adelson)).

5. We live in troubled times, and there is about 100% odds of a major stock market correction on the horizon.This will drive down all stock prices, and could temporarily decimate pot stocks just like everything else. If that happens, it's a gift from God. I'll be adding to the better performers. Pot is not going away. I view it as the best contrarian play in recent history.


DING DING DING!

BLOG POST!

I'll also get John Lounsbury to publish it on Global Economic Intersection.

You can start  Pot Financial Newzletter and become the Guru of Pot Stocks!  :icon_mrgreen:

If there is more you want to add before I add it to the Blog, do it in the next couple of days.

RE
Title: Re: The Potfolio
Post by: Eddie on January 13, 2017, 10:17:27 AM
Gimme the weekend to figure it out. I need to make a new yahoo account so I can post links to the current charts and so forth in the article, without the link going to my personal yahoo page that is tied to my email.

Too many pot stock gurus out there already. Don't know if you noticed, but my newest competitor is Bill Bonner.

https://pro.agorafinancial.com/TEK_secretpot_1016/LTEKSC77/Full

Although this could be viewed as a sell signal, I am standing pat for the moment.
Title: Re: The Potfolio
Post by: RE on January 13, 2017, 10:43:14 AM
Gimme the weekend to figure it out. I need to make a new yahoo account so I can post links to the current charts and so forth in the article, without the link going to my personal yahoo page that is tied to my email.

Too many pot stock gurus out there already. Don't know if you noticed, but my newest competitor is Bill Bonner.

https://pro.agorafinancial.com/TEK_secretpot_1016/LTEKSC77/Full

Although this could be viewed as a sell signal, I am standing pat for the moment.

You got the weekend EZ.  I got an article in the queue up from Allan Stromfeldt Christiansen for tomorrow, and then my Sunday Brunch article for Sunday, which is another Inside the Diner compilation article.

Multiple email addys are an ESSENTIAL!  Palloy has got the Diner email domain pretty well set up, so you could make a Diner email instead of a yahoo one for this purpose.

RE
Title: Re: The Potfolio
Post by: Eddie on January 13, 2017, 12:56:18 PM
Okay, it's ready. I just went ahead and posted charts, which are not tied back to my email (I don't think). I have removed all the old links from the Potfolio thread to my personal watchlist, which, unfortunately provided a backdoor to my email mailbox. If anyone sees one I missed, please let me know, or just delete it if you're an admin.
Title: Marijuana research: Massive report details knowledge base with eye on future
Post by: RE on January 14, 2017, 04:10:55 AM
http://www.thecannabist.co/2017/01/12/marijuana-research-review-united-states-health-benefits-risks-future/71204/ (http://www.thecannabist.co/2017/01/12/marijuana-research-review-united-states-health-benefits-risks-future/71204/)

Marijuana research: Massive report details knowledge base with eye on future

(http://www.denverpost.com/wp-content/uploads/2017/01/dpo-slack_-com-c1urlhttp3a2f2fw-2f102fap16298782494891.jpg?w=525)
Connor Hellings, left and science director John Rudd, right, work on marijuana samples at CannTest, the first commercial marijuana testing laboratory to open in Alaska on Monday, Oct. 24, 2016, in Anchorage, Alaska. (Dan Joling, The Associated Press)

Comprehensive look at 10,000 studies since 1999 assesses what is known about health effects, calls for lowering barriers to study


Published: Jan 12, 2017, 11:55 am • Updated: about 20 hours ago Comments (37)

By Alicia Wallace, The Cannabist Staff

As marijuana legalization becomes entrenched across America, the plant’s health benefits and adverse effects are rapidly becoming better known.

In the first comprehensive review by American researchers in decades, their assessment of 10,000 studies conducted since 1999 quantified the weight of research evidence and found cannabis has legitimate medicinal benefits for a variety of ailments, but also has been shown as a contributor to certain mental health issues and, to some degree, has a role as a gateway drug, according to the report published Thursday by the National Academies of Sciences, Engineering, and Medicine.

Those are among nearly 100 conclusions reached by the U.S. scientific academy in a massive report on marijuana research to-date that includes directives for future study — notably that more robust exploration is needed across a wide array of public health-focused areas.

RELATED: Learn more about the study findings

In an interview with The Cannabist, key committee members said they hoped their report would serve as a resource for both medical professionals and public health officials.

“We know very little about the high-potency cannabis that people are smoking; we know very little about the different ways people are using (cannabis),” said Ziva Cooper, a committee member and assistant professor of clinical neurobiology at Columbia University Medical Center.

The review of more than 10,000 scientific abstracts is documented in a 400-page report: “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.” In cataloging and assessing research as a whole, the report provides clarity on the current knowledge base and also shines a spotlight on what’s lacking, particularly how cannabis is used in treating epilepsy and other conditions such as post-traumatic stress disorder.

Although there have been dramatic increases in both the availability and potency of marijuana products in recent years, there are no accepted standards for safe and appropriate use, the committee said.
More research news

Wrap-up: Year in weed: The five most important medical marijuana research studies of 2016

What’s the slow-down?: U.S. drug czar: The feds have dragged their feet on pot research

Gupta on the DEA: Will DEA’s new policy tweak foster more cannabis research? Sanjay Gupta doesn’t think so

Monroe on the NFL: I am worried about my NFL family. I am ready to talk cannabis. I am Eugene Monroe.

Split on stress: How PTSD became the most divisive medical pot issue of 2016

Weed news and interviews: Get podcasts of The Cannabist Show.

Subscribe to our newsletter here.

Watch The Cannabist Show.

Peruse our Cannabist-themed merchandise (T’s, hats, hoodies) at Cannabist Shop.

The committee found areas of study that had the most substantial scientific evidence included:

• cannabis or cannabinoids are effective in treating chronic pain in adults, quelling chemotherapy-induced nausea or vomiting and improving multiple sclerosis-related spasticity syndromes;

• long-term cannabis smoking triggers worse respiratory symptoms and more frequent bronchitis episodes;

• there is a statistical association between cannabis use and increased risk of motor vehicle crashes;

• a statistical association is evident between maternal cannabis smoking and lower birth weight of the offspring;

• being male and smoking cigarettes are risk factors for the progression of cannabis use into “problem cannabis use,” and starting use of cannabis at an earlier age is also a risk factor;

• stimulant treatment for attention deficit hyperactivity disorder in teens is not a risk factor for problem cannabis use.

The committee’s most significant conclusions, however, were what was not there. Researchers’ questions related to cannabis’ therapeutic or adverse health effects could not be answered because of limited or lacking evidence. Additionally, the studies did not address how other forms of cannabis — concentrates and edibles included — interacted with the human body.

“It was that lack of information that I think was most impressive,” said Dr. Marie McCormick, committee chair and the Sumner and Esther Feldberg Professor of Maternal and Child Health at Harvard Medical School.

The report comes amid a significant shift in public opinion and policies related to cannabis.

Favorable attitudes toward legalization have reached their highest-ever levels and a surge of states have adopted measures to legalize and regulate the sale of medical marijuana and — in the case of eight states and Washington, D.C. — the sale of marijuana for recreational use. However, even within the 28 states that allow medical marijuana, qualifying conditions for patients vary, and there is controversy about recommending cannabis for certain ailments because of a lack of research.

“This growing acceptance, accessibility and use of cannabis and its derivatives have raised important public health concerns,” McCormick said in a statement. “Moreover, the lack of any aggregated knowledge of cannabis-related health effects has led to uncertainty about what, if any, are the harms or benefits from its use.

“As laws and policies continue to change, research must also.”

Research advancements in cannabis have been impeded by regulatory barriers — including cannabis’ classification as a Schedule I substance, according to the report. Additionally, researchers have encountered difficulty in obtaining the quantity, quality and type of cannabis products needed to address specific research concerns, the study concluded.

The committee outlined four recommendations to further research:

• Address current research gaps, highlighting the need for a national cannabis research agenda that includes clinical and observational research, health policy and health economics research, and public health and public safety research.

• Identify actionable strategies to improve research quality and promote the development of research standards and benchmarks.

• Highlight the potential for improvements in data collection efforts and the enhancement of surveillance capacity.

• Propose strategies for addressing the current barriers to the advancement of the cannabis research agenda.

On the fourth recommendation, the National Academies called on the Centers for Disease Control and Prevention, the National Institutes of Health, the Food and Drug Administration, industry groups and other organizations to form a committee evaluating whether some of the barriers — scheduling, product quality and otherwise — should be removed.

For the committee to make a recommendation on whether to reschedule would be beyond the mandate of the report, said Sean Hennessy, a professor of biostatistics and epidemiology and a professor of pharmacology at the University of Pennsylvania’s Perelman School of Medicine.

In short, more research needs to happen and more funding — from a variety of public and private avenues — needs to be put toward that goal, according to the 16-member committee, comprised of health officials, academic leaders and prominent researchers.

As to whether they believe if it could lead to broader changes in policy, especially on the federal level?

“Yes, but it will depend on the federal landscape,” McCormick said.

Work for the peer-reviewed report was initiated in June 2016.

Sponsors of the report included the departments of public health in Arizona, California, Oregon and Washington; the Colorado Health Foundation; federal agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health, the U.S. Food and Drug Administration and the National Highway Traffic Safety Administration; and private nonprofits such as the anti-tobacco Truth Initiative and the Mat-Su Health Foundation in Alaska.
Title: Re: The Potfolio - The Problems With Meta-Analysis
Post by: Eddie on January 14, 2017, 09:39:51 AM
It isn't clear to me whether this is just a massive literature review, or whether it's a meta-analysis.

Both are subject to a lot of problems. Literature reviews just list all the research that's been done in a particular field, without evaluating the study designs or questioning the conclusions of the original authors. Metastudies try to use multiple studies in a particular area as a source of data to recrunch the numbers and draw additional conclusions.

Meta-analysis is popular now because the internet makes it easy to collect lots of data. There are a host of potential problems in trying to use this kind of study to draw real world conclusions. It can often be a "garbage in-garbage out" situation.

http://www.mv.helsinki.fi/home/hemila/metaanalysis/problems.htm (http://www.mv.helsinki.fi/home/hemila/metaanalysis/problems.htm)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868184/ (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868184/)

https://en.wikipedia.org/wiki/Meta-analysis (https://en.wikipedia.org/wiki/Meta-analysis)
Title: Re: The Potfolio --- The Problems With Meta-Analysis
Post by: Eddie on January 14, 2017, 09:59:18 AM
For instance, the article says:

• there is a statistical association between cannabis use and increased risk of motor vehicle crashes

It doesn't say what the statistical significance amounts to.

What about this study? It says cannabis reduces risk of traffic fatalities for drivers who tested positive for opioids. Driving under the influence of opioids is a much bigger problem for traffic fatalities than driving under the influence of cannabis, imho.

https://qz.com/870397/new-research-argues-that-legal-marijuana-is-the-answer-to-traffic-fatalities/

Title: What We Know And Don't Know About The Effects Of Marijuana
Post by: RE on January 14, 2017, 11:03:14 AM
http://www.forbes.com/sites/kevinmurnane/2017/01/14/what-we-know-and-dont-know-about-the-effects-of-marijuana/#5726d6d83ab7 (http://www.forbes.com/sites/kevinmurnane/2017/01/14/what-we-know-and-dont-know-about-the-effects-of-marijuana/#5726d6d83ab7)

What We Know And Don't Know About The Effects Of Marijuana

What We Know And Don't Know About The Effects Of Marijuana

I write about technology, science and video games

Credit: Angie3888/Pixabay

Credit: Angie3888/Pixabay

Marijuana is the most widely used illicit drug in the United States and both proponents and opponents of its use and legalization have had a lot to say about how it’s good or bad for you. Some of the claims made for or against marijuana are scientifically well-grounded and some are not. How can you tell which is which?

The National Academies of Sciences, Engineering, and Medicine (NASEM) have recently released a thorough, rigorous and weighty report that answers this question. From this point on, anyone who tells you how marijuana can help you, hurt you or not affect you that cannot support their claims with the research summarized in the NASEM report is blowing smoke.

The NASEM report is based on more than 10,700 abstracts of papers published in peer-reviewed journals since 1999. Emphasis was given to systematic review papers published since 2011 and high-quality primary research for topics that were not covered by the reviews. The NASEM committee responsible for the report was made up of experts in the fields of marijuana, addiction, oncology, cardiology, neurodevelopment, respiratory disease, pediatric and adolescent health, immunology, toxicology, preclinical research, epidemiology, systematic review, and public health.

The report summarizes research that addresses how ingestion of cannabis and cannabinoids affects health outcomes grouped in 11 categories. The scientific evidence supporting the report’s findings was evaluated as conclusive, substantial, moderate, limited, and no or insufficient evidence.

Recommended by Forbes

A complete summary of the findings detailed in the NASEM report is well beyond the scope of this article. Selected highlights are presented below. Interested readers are encouraged to examine the complete report which can be read or downloaded as a PDF for free.

The phrase "statistical association" has been shortened to "association" in the following selection of highlights from the NASEM report. It should be kept in mind that a statistical association may or may not provide evidence of a causal relationship. In other words, a statistical association between smoking marijuana and something else does not mean that smoking marijuana causes that something else. It means that the two things appear together more often than is likely to happen by chance. Smoking marijuana may be the cause and it may not.

Credit: Wikimedia Commons

Credit: Wikimedia Commons

Therapeutic effects of cannabis or cannabinoids

There is conclusive or substantial evidence that cannabis is effective for the treatment of chronic pain. There is also conclusive or substantial evidence that oral cannabinoids are effective for reducing the nausea and vomiting that can accompany chemotherapy, and for reducing patient reported spasticity stemming from multiple sclerosis. There is only limited evidence in support of clinician-measured reductions in this type of spasticity.

There is limited evidence that both cannabis and cannabinoids are ineffective for reducing symptoms associated with dementia, improving glaucoma-induced pressure in the eye, or reducing depression that is associated with chronic pain or multiple sclerosis.

No or insufficient evidence was found that supported or refuted claims that cannabis and cannabinoids are an effective treatment for a list of other physical and mental ailments.

Cancer

The report uncovered moderate evidence for no association between cannabis and lung, head or neck cancers.

No or insufficient evidence was found that supported or refuted an association between cannabis and a list of other types of cancer.

Cardiometabolic Risk

The report found limited evidence of an association between smoking marijuana and the triggering of an acute myocardial infarction. However, it found no evidence to support or refute an association between chronic marijuana smoking and having acute myocardial infarction in general.

There is limited evidence of an association between smoking marijuana and both a decreased risk of diabetes and an increased risk of prediabetes.

Credit: Wikimedia Commons

Credit: Wikimedia Commons

Respiratory disease

There is substantial evidence of an association between long-term marijuana smoking and an increase in the frequency of episodes of chronic bronchitis. There is also moderate evidence of an association between stopping marijuana smoking and improvements in respiratory symptoms.

Moderate evidence supports an association between acute (occasional, short-term) but not chronic marijuana smoking and improved airway dynamics.

There is no or insufficient evidence to support or refute an association between marijuana smoking and the development or exacerbation of asthma.

Immunity

The report found limited evidence of an association between smoking marijuana and decreased production of several inflammatory cytokines in healthy people. Inflammatory cytokines play an important role in regulating the immune response.

There is no or insufficient evidence to support or refute an association between marijuana smoking and other negative effects on the immune system in healthy people or in people with HIV.

Injury and death

There is substantial evidence of an association between smoking marijuana and an increased risk of motor vehicle crashes. There is also moderate evidence of an association between cannabis use and overdose injuries to children in states where smoking marijuana is legal.

There is no or insufficient evidence to support or refute an association between marijuana smoking and occupational accidents or injuries, nor between smoking marijuana and deaths due to cannabis overdose.

Photo credit: Jonathan Piccolo/flickr

Photo credit: Jonathan Piccolo/flickr

Prenatal, perinatal, and neonatal exposure

The report found substantial evidence of an association between maternal marijuana smoking and low birth weight. There is also limited evidence of an association between maternal marijuana smoking and pregnancy complications.

There is no or insufficient evidence to support or refute an association between marijuana smoking and later developments such as sudden infant death syndrome, depressed cognitive or academic achievement, or later substance abuse.

Psychosocial effects

There is moderate evidence of an association between impairments in learning, memory and attention immediately after smoking marijuana. There is limited evidence of no long-term effects on these cognitive functions following sustained abstinence after a smoking episode.

There is limited evidence of an association between smoking marijuana and impaired academic achievement, increased rates of unemployment and low wages, and impaired social functioning.

Mental health effects

The effects of marijuana smoking on mental health are complex. Readers concerned with issues related to mental health are encourage to read the relevant sections of the NASEM report for a more complete understanding.

There is substantial evidence of an association between smoking marijuana and developing schizophrenia and other psychoses. The most frequent users are at the highest risk. There is moderate evidence of no association between marijuana smoking and the worsening of symptoms for people who already suffer from a psychotic disorder. There is also moderate evidence of an association between smoking marijuana and improved cognitive performance among people with a psychotic disorder who also have a history of marijuana smoking.

The report found moderate evidence of an association between smoking marijuana and higher incidences of suicidal ideation and suicide attempts among heavy marijuana smokers along with a higher incidence of suicide completion among all marijuana smokers.

There is no or insufficient evidence to support or refute an association between marijuana smoking and the development of posttraumatic stress disorder (PTSD) but there is limited evidence of an association between smoking marijuana and an increase in the severity of PTSD symptoms among individuals who already have PTSD.

Photo credit: Jantaaa/Pixabay

Photo credit: Jantaaa/Pixabay

Development of problematic cannabis use

There is moderate evidence that adolescent ADHD is not a risk factor for the development of problematic cannabis use and there is substantial evidence that treatment of ADHD with stimulants is also not a risk factor.

There is moderate evidence that major depressive disorder is a risk factor for the development of problematic cannabis use while anxiety, personality and bipolar disorders are not risk factors.

The report found there is substantial evidence that being male and smoking cigarettes are risk factors for the progression from moderate to problematic cannabis use. In addition, there is an association between being male and the severity of problematic cannabis use. However, there is no difference between males and females in the recurrence of problematic cannabis use.

Does marijuana smoking lead to the use of other drugs?

There is moderate evidence of an association between smoking marijuana and the development of substance dependence or abuse for alcohol, tobacco and illicit drugs.

What do we know about marijuana use?

Perhaps the most striking feature of the NASEM report is how thoroughly it documents how little we know about the effects of marijuana use. Only 12 of the conclusions in the report are supported by conclusive or substantial evidence. Twenty-five are supported by moderate evidence and 27 are supported by limited evidence. There is no or insufficient evidence for an additional 27 conclusions.

The NASEM report details the barriers that stand in the way of conducting high-quality research on marijuana use and offers suggestions about what needs to be done to overcome these barriers. These issues are covered in more detail in an article by my fellow Forbes contributor Janet Burns.

Proponents and opponents of marijuana use and legalization have been known to make claims about marijuana that are not always. Sometimes this stems from jumping to conclusions based on the results of one study, or from an inability to differentiate between high and low-quality scientific research, or from a willingness to believe anything that supports the cause.

None of those factors apply to the NASEM report which is a painstaking summary of a vast body of research by a committee of scientific experts in a wide range of relevant fields. If you would rather have your opinions about marijuana be based on science than ideology, the NASEM report is the best source of information that is currently available.

Kevin Murnane covers science, technology and video games for Forbes. You can find more of his writing at The Info Monkey and Tuned In To Cycling. Follow on Twitter@TheInfoMonkey.

Title: Re: What We Know And Don't Know About The Effects Of Marijuana
Post by: Eddie on January 14, 2017, 11:19:37 AM
http://www.forbes.com/sites/kevinmurnane/2017/01/14/what-we-know-and-dont-know-about-the-effects-of-marijuana/#5726d6d83ab7 (http://www.forbes.com/sites/kevinmurnane/2017/01/14/what-we-know-and-dont-know-about-the-effects-of-marijuana/#5726d6d83ab7)

What We Know And Don't Know About The Effects Of Marijuana

What We Know And Don't Know About The Effects Of Marijuana

I write about technology, science and video games

Credit: Angie3888/Pixabay

Credit: Angie3888/Pixabay

Marijuana is the most widely used illicit drug in the United States and both proponents and opponents of its use and legalization have had a lot to say about how it’s good or bad for you. Some of the claims made for or against marijuana are scientifically well-grounded and some are not. How can you tell which is which?

The National Academies of Sciences, Engineering, and Medicine (NASEM) have recently released a thorough, rigorous and weighty report that answers this question. From this point on, anyone who tells you how marijuana can help you, hurt you or not affect you that cannot support their claims with the research summarized in the NASEM report is blowing smoke.

The NASEM report is based on more than 10,700 abstracts of papers published in peer-reviewed journals since 1999. Emphasis was given to systematic review papers published since 2011 and high-quality primary research for topics that were not covered by the reviews. The NASEM committee responsible for the report was made up of experts in the fields of marijuana, addiction, oncology, cardiology, neurodevelopment, respiratory disease, pediatric and adolescent health, immunology, toxicology, preclinical research, epidemiology, systematic review, and public health.

The report summarizes research that addresses how ingestion of cannabis and cannabinoids affects health outcomes grouped in 11 categories. The scientific evidence supporting the report’s findings was evaluated as conclusive, substantial, moderate, limited, and no or insufficient evidence.

Recommended by Forbes

A complete summary of the findings detailed in the NASEM report is well beyond the scope of this article. Selected highlights are presented below. Interested readers are encouraged to examine the complete report which can be read or downloaded as a PDF for free.

The phrase "statistical association" has been shortened to "association" in the following selection of highlights from the NASEM report. It should be kept in mind that a statistical association may or may not provide evidence of a causal relationship. In other words, a statistical association between smoking marijuana and something else does not mean that smoking marijuana causes that something else. It means that the two things appear together more often than is likely to happen by chance. Smoking marijuana may be the cause and it may not.

Credit: Wikimedia Commons

Credit: Wikimedia Commons

Therapeutic effects of cannabis or cannabinoids

There is conclusive or substantial evidence that cannabis is effective for the treatment of chronic pain. There is also conclusive or substantial evidence that oral cannabinoids are effective for reducing the nausea and vomiting that can accompany chemotherapy, and for reducing patient reported spasticity stemming from multiple sclerosis. There is only limited evidence in support of clinician-measured reductions in this type of spasticity.

There is limited evidence that both cannabis and cannabinoids are ineffective for reducing symptoms associated with dementia, improving glaucoma-induced pressure in the eye, or reducing depression that is associated with chronic pain or multiple sclerosis.

No or insufficient evidence was found that supported or refuted claims that cannabis and cannabinoids are an effective treatment for a list of other physical and mental ailments.

Cancer

The report uncovered moderate evidence for no association between cannabis and lung, head or neck cancers.

No or insufficient evidence was found that supported or refuted an association between cannabis and a list of other types of cancer.

Cardiometabolic Risk

The report found limited evidence of an association between smoking marijuana and the triggering of an acute myocardial infarction. However, it found no evidence to support or refute an association between chronic marijuana smoking and having acute myocardial infarction in general.

There is limited evidence of an association between smoking marijuana and both a decreased risk of diabetes and an increased risk of prediabetes.

Credit: Wikimedia Commons

Credit: Wikimedia Commons

Respiratory disease

There is substantial evidence of an association between long-term marijuana smoking and an increase in the frequency of episodes of chronic bronchitis. There is also moderate evidence of an association between stopping marijuana smoking and improvements in respiratory symptoms.

Moderate evidence supports an association between acute (occasional, short-term) but not chronic marijuana smoking and improved airway dynamics.

There is no or insufficient evidence to support or refute an association between marijuana smoking and the development or exacerbation of asthma.

Immunity

The report found limited evidence of an association between smoking marijuana and decreased production of several inflammatory cytokines in healthy people. Inflammatory cytokines play an important role in regulating the immune response.

There is no or insufficient evidence to support or refute an association between marijuana smoking and other negative effects on the immune system in healthy people or in people with HIV.

Injury and death

There is substantial evidence of an association between smoking marijuana and an increased risk of motor vehicle crashes. There is also moderate evidence of an association between cannabis use and overdose injuries to children in states where smoking marijuana is legal.

There is no or insufficient evidence to support or refute an association between marijuana smoking and occupational accidents or injuries, nor between smoking marijuana and deaths due to cannabis overdose.

Photo credit: Jonathan Piccolo/flickr

Photo credit: Jonathan Piccolo/flickr

Prenatal, perinatal, and neonatal exposure

The report found substantial evidence of an association between maternal marijuana smoking and low birth weight. There is also limited evidence of an association between maternal marijuana smoking and pregnancy complications.

There is no or insufficient evidence to support or refute an association between marijuana smoking and later developments such as sudden infant death syndrome, depressed cognitive or academic achievement, or later substance abuse.

Psychosocial effects

There is moderate evidence of an association between impairments in learning, memory and attention immediately after smoking marijuana. There is limited evidence of no long-term effects on these cognitive functions following sustained abstinence after a smoking episode.

There is limited evidence of an association between smoking marijuana and impaired academic achievement, increased rates of unemployment and low wages, and impaired social functioning.

Mental health effects

The effects of marijuana smoking on mental health are complex. Readers concerned with issues related to mental health are encourage to read the relevant sections of the NASEM report for a more complete understanding.

There is substantial evidence of an association between smoking marijuana and developing schizophrenia and other psychoses. The most frequent users are at the highest risk. There is moderate evidence of no association between marijuana smoking and the worsening of symptoms for people who already suffer from a psychotic disorder. There is also moderate evidence of an association between smoking marijuana and improved cognitive performance among people with a psychotic disorder who also have a history of marijuana smoking.

The report found moderate evidence of an association between smoking marijuana and higher incidences of suicidal ideation and suicide attempts among heavy marijuana smokers along with a higher incidence of suicide completion among all marijuana smokers.

There is no or insufficient evidence to support or refute an association between marijuana smoking and the development of posttraumatic stress disorder (PTSD) but there is limited evidence of an association between smoking marijuana and an increase in the severity of PTSD symptoms among individuals who already have PTSD.

Photo credit: Jantaaa/Pixabay

Photo credit: Jantaaa/Pixabay

Development of problematic cannabis use

There is moderate evidence that adolescent ADHD is not a risk factor for the development of problematic cannabis use and there is substantial evidence that treatment of ADHD with stimulants is also not a risk factor.

There is moderate evidence that major depressive disorder is a risk factor for the development of problematic cannabis use while anxiety, personality and bipolar disorders are not risk factors.

The report found there is substantial evidence that being male and smoking cigarettes are risk factors for the progression from moderate to problematic cannabis use. In addition, there is an association between being male and the severity of problematic cannabis use. However, there is no difference between males and females in the recurrence of problematic cannabis use.

Does marijuana smoking lead to the use of other drugs?

There is moderate evidence of an association between smoking marijuana and the development of substance dependence or abuse for alcohol, tobacco and illicit drugs.

What do we know about marijuana use?

Perhaps the most striking feature of the NASEM report is how thoroughly it documents how little we know about the effects of marijuana use. Only 12 of the conclusions in the report are supported by conclusive or substantial evidence. Twenty-five are supported by moderate evidence and 27 are supported by limited evidence. There is no or insufficient evidence for an additional 27 conclusions.

The NASEM report details the barriers that stand in the way of conducting high-quality research on marijuana use and offers suggestions about what needs to be done to overcome these barriers. These issues are covered in more detail in an article by my fellow Forbes contributor Janet Burns.

Proponents and opponents of marijuana use and legalization have been known to make claims about marijuana that are not always. Sometimes this stems from jumping to conclusions based on the results of one study, or from an inability to differentiate between high and low-quality scientific research, or from a willingness to believe anything that supports the cause.

None of those factors apply to the NASEM report which is a painstaking summary of a vast body of research by a committee of scientific experts in a wide range of relevant fields. If you would rather have your opinions about marijuana be based on science than ideology, the NASEM report is the best source of information that is currently available.

Kevin Murnane covers science, technology and video games for Forbes. You can find more of his writing at The Info Monkey and Tuned In To Cycling. Follow on Twitter@TheInfoMonkey.


The phrase "statistical association" has been shortened to "association" in the following selection of highlights from the NASEM report. It should be kept in mind that a statistical association may or may not provide evidence of a causal relationship. In other words, a statistical association between smoking marijuana and something else does not mean that smoking marijuana causes that something else.



The most important sentence in this article.
Title: Re: The Potfolio --- Stocks to Watch in 2017
Post by: Eddie on January 14, 2017, 12:35:54 PM
Some of these are in the Potfolio, but several are not. I will attempt to rate the ones that I have not been following. Stay tuned.

A List of Marijuana Stocks to Watch in 2017

By JACK DELANEY, Associate Editor, Money Morning • January 11, 2017

marijuana stocksMarijuana stocks continue to be on our radar after legal cannabis sales topped $6.7 billion in North America in 2016.

But as impressive as that sounds, we are even more excited now because of the future growth prospects of the industry.

According to Fortune, legal marijuana sales could reach $21.8 billion by 2020.

That's a 225% increase in just four years.

Now, it's true marijuana is still illegal under U.S. federal law. Plus, most marijuana stocks are penny stocks, and penny stocks are speculative investments.

But as more U.S. states and countries like Canada consider legalizing cannabis, investing in marijuana stocks will become less taboo for most investors. And with massive sales, marijuana stock prices will skyrocket.

That's why we're providing readers with a list of 50 marijuana stocks to watch.

These marijuana stocks are from every ecosystem – growers, edibles, dispensaries, and more. This list will also show the market cap of each company as well as the average 30-day trading volume (as of Jan. 11).

And as a service to Money Morning readers, we're also making available a 90-page cannabis investing guide called The Roadmap to Marijuana Millions.

You can learn more about that opportunity after the list.

(http://moneymorning.com/wp-content/blogs.dir/1/files/2017/01/weed-table-companies.png)



Title: Re: The Potfolio
Post by: Eddie on January 14, 2017, 02:04:47 PM
Some stocks being hyped that need to be evaluated.


A caveat:

I used Trade King's online research engine to evaluate the fundamentals of  39 stocks from the Money Morning article above. I ran through them quickly and did not double check the accuracy of the data from my source. As of now, (1-15-2016) I am reviewing some of these and have not been able to confirm some of the data. What I'm saying is that there appear to be some inaccuracies, but I'm still investigating. I would welcome feedback from anyone using this site (see link). The example linked, for instance shows GBHFP to have sales of 9 Billion dollars (Canadian) I don't think this is right, from what I've been able to get from the company's financials. If the data I sourced is all bad, then my evaluations might be too. Do your own due diligence.   -- Eddie

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GBHPF

MCIG  This company could be considered a "broadly diversified" pot company. It distributes vaporizers and ready-rolled doobies, and is into consulting and building growing facilities. I didn't buy this one in the beginning, because I really didn't understand their business model. The chart is parabolic. It makes me afraid when I look upon it.

(https://chart.finance.yahoo.com/c/1y/MCIG?lang=en-US&region=US)

I'd rate it +/- on fundamentals. Expensive looking for what it is, a company with sales of 1.4M. I say we watch for a better entry.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MCIG



CCAN  Abysmal chart. Fundamentals are a -- .Say no more.

(https://chart.finance.yahoo.com/c/1y/CCAN?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=CCAN



CVSI  Unimpressive chart, but decent fundamentals (I give it a +) and looks cheap for a stock with only 53M shares. Might be a sleeper. Deserves further study.
(https://chart.finance.yahoo.com/c/1y/CVSI?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=CVSI

HEMP  Unimpressive chart. Good fundamentals (+) Has a really serious dilution problem, though.
(https://chart.finance.yahoo.com/c/1y/HEMP?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=HEMP




DIGP  Unimpressive chart. Reasonable fundamentals. Very low float. Looks fairly cheap. But nothing says buy me.
(https://chart.finance.yahoo.com/c/1y/DIGP?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=DIGP



ETST  2 year chart sucks. Can't seem to get a 2 yr to post. Fundamentals are a -. Not for me.
(https://chart.finance.yahoo.com/c/1y/ETST?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=ETST



FUTL  Chart....Eewww, nasty!!! Fundamentals suck. (--) No way.
(https://chart.finance.yahoo.com/c/1y/FUTL?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=FUTL


GBHPF  Nice chart. Fundamentals ++ with 9 Billion in sales. Borderline dilution issues but not the worst out there. I don't think the TK numbers are correct on this one. Still investigating fundamentals)
I'd lean toward buying this one.
(https://chart.finance.yahoo.com/c/1y/GBHPF?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GBHPF


GRWC Unimpressive chart. Fundamentals are a -.  Only rates watching.
(https://chart.finance.yahoo.com/c/1y/GRWC?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GRWC


GBLX  So-so chart. Fundamentals --. Also a watch only.
(https://chart.finance.yahoo.com/c/1y/GBLX?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GBLX

GRSO  Chart is absolutely moribund. Fundamentals are okay. (+). Watch for signs of new life.
(https://chart.finance.yahoo.com/c/1y/GRSO?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GRSO


GWPH. The horse has left the barn. Fundamentals are a + but it's too expensive. Low float. I bet the shorts love this one.
(https://chart.finance.yahoo.com/c/1y/GWPH?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=GWPH

KAYS  Popped post-election.  Fundies are a -.  Too expensive at $.40. Wait for better entry point.
(https://chart.finance.yahoo.com/c/1y/KAYS?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=KAYS



















Title: Re: The Potfolio
Post by: RE on January 14, 2017, 02:23:20 PM
Do you want me to add these charts to the Potfolio article?

RE
Title: Re: The Potfolio
Post by: Eddie on January 14, 2017, 05:05:20 PM
Nope.
Title: Re: The Potfolio
Post by: RE on January 14, 2017, 05:11:30 PM
Nope.

OK.

RE
Title: Re: The Potfolio (Evaluations of More Pot Stocks Part Two)
Post by: Eddie on January 14, 2017, 06:11:31 PM
More evaluations. Had to link to a few charts or use grade B images. Sorry. Most of them are okay.

KSHB    Pretty typical Potfolio chart pattern, Yahoo refuses to print chart. Fundamentals rate a +. At 2.97 seems expensive. Here's a chart link.

http://bigcharts.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=KSHB&uf=0&type=2&size=2&sid=21410137&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=838508364&compidx=aaaaa%3a0&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1 (http://bigcharts.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=KSHB&uf=0&type=2&size=2&sid=21410137&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=838508364&compidx=aaaaa%3a0&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1)

Here's a link to fundamentals.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=KSHB (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=KSHB)




LAGBF   Unimpressive chart (see link below). ++ Fundamentals.

http://charting.nasdaq.com/ext/charts.dll?2-1-14-0-0-512-03NA000000LAGBF-&SF:1%7C5-BG=FFFFFF-BT=0-WD=635-HT=395- (http://charting.nasdaq.com/ext/charts.dll?2-1-14-0-0-512-03NA000000LAGBF-&SF:1%7C5-BG=FFFFFF-BT=0-WD=635-HT=395-)

Fundamentals link.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=LAGBF (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=LAGBF)


LXRP  Beautiful chart. Fundamentals are +/_ .
(https://chart.finance.yahoo.com/c/1y/LXRP?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=LXRP (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=LXRP)


MRPHF  Nice chart. Fundamentals are a -.
(https://chart.finance.yahoo.com/c/1y/MRPHF?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MRPHF (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MRPHF)



MQPXF   Crappy chart. Great fundamentals. ++
(http://ih.advfn.com/p.php?pid=staticchart&s=NO%5EMQPXF&t=37&p=5&dm=0&vol=0&width=280&height=200&min_pre=0&min_after=0)

http://ih.advfn.com/p.php?pid=staticchart&s=NO%5EMQPXF&t=37&p=5&dm=0&vol=0&width=280&height=200&min_pre=0&min_after=0 (http://ih.advfn.com/p.php?pid=staticchart&s=NO%5EMQPXF&t=37&p=5&dm=0&vol=0&width=280&height=200&min_pre=0&min_after=0)



MCPI    Decent chart. Great fundamentals (++). A possible buy.
(https://chart.finance.yahoo.com/c/1y/MCPI?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MCPI (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MCPI)


REFG  Great chart. Fundamentals are good (++) but theres a dilution problem, looks like 10X too many shares.
(https://chart.finance.yahoo.com/c/1y/REFG?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=REFG (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=REFG)




MJNE  Unimpressive chart. Fundamentals +.
(https://chart.finance.yahoo.com/c/1y/MJNE?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNE (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNE)



MYHI  Exciting chart. Fundamentals, got to rate this one +++. Looks like a buy here and now.I now think the TK numbers are not correct)
(https://chart.finance.yahoo.com/c/1y/MYHI?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MYHI (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MYHI)



NSPDF Bad chart. Fundamentals +.
(https://chart.finance.yahoo.com/c/1y/NSPDF?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NSPDF (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NSPDF)


NMUS  Bad chart. Bad fundamentals (--)
(https://chart.finance.yahoo.com/c/1y/NMUS?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NMUS (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NMUS)


NTRR  Chart sucks. Fundamentals suck.(--)
(https://chart.finance.yahoo.com/c/1y/NTRR?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NTRR (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NTRR)








Title: Re: The Potfolio
Post by: RE on January 14, 2017, 06:20:39 PM
I think we need a Weekly Update on the percentage value change of the Potfolio for followers of the thread.

A suggestion would be to tag say a $10,000 Total Investment to Ganga Stocks, and then track week-to-week what the Potfolio is worth.  $10K is more or less affordable as an investment, at least if you are upper middle class to lower level rich anyhow.

RE
Title: Re: The Potfolio
Post by: Eddie on January 14, 2017, 06:49:58 PM
I give reports periodically. No weekly updates. No model portfolios. Too much structure and it's just a non-paying job. Fuggedaboutit.
Title: Re: The Potfolio
Post by: RE on January 14, 2017, 07:07:28 PM
I give reports periodically. No weekly updates. No model portfolios. Too much structure and it's just a non-paying job. Fuggedaboutit.

Non-paying jobs is what the Diner is all about! lol.  In fact for me the fucking job COSTS me money!  ::)  The Diner is POTLATCH!  A Gift Economy!  No Ads, no Paywall, nada.  Diners GIFT to each other their Knowledge and their Napalm! lol.

I wanna know what my Potfolio is WORTH from week to week!  Today, I am handing you $10,000 of my WC settlement to invest in Pot Stocks (hypothetically, of course).  You are my Pot Investment Advisor and Guru.  Lemme know next week what my Potfolio is worth. ???

It in fact is even more complicated since it depends on when the Potvestor drops in on these stocks.  If you got in real early on some of them, you're doing quite well.  If you buy now on some overvalued ones, you might not do so well in the future.

RE
Title: The Potfolio 1
Post by: Guest on January 15, 2017, 04:00:19 AM


youtube-Logo-4gc2reddit-logoOff the keyboard of Eddie



Follow us on Twitter @doomstead666

Friend us on Facebook



Published on The Doomstead Diner on January 15, 2017



https://media.giphy.com/media/jy4kfeF7Taw48/giphy.gif



Discuss this article at the Marathon Man Newz Table inside the Diner



A few take-aways for anyone considering buying into pot stocks. These are the things you won't read anywhere else.



1. All twenty stocks in the Potfolio, every one of them, is trading at a new, higher level than last summer, before the sector got so hot in the couple of months leading up to the election. Not even the sketchiest companies have fallen back anywhere near their previous levels. This is different action from the past (like 2014, when there was a huge run-up that subsequently fizzled completely). To me, this signifies that pot stocks are in a new, real bull market. I am down on some stocks I bought near the pre-election highs, but I am calling those timing mistakes. Bull markets always correct timing mistakes.



2.Looking at momentum, and looking at charts in general, I cannot see much difference between the action in the most profitable stocks in the Potfolio, with the best fundamentals, and those that have problems, fundamentally speaking. A couple of stocks with good fundamentals are doing very well, but those with fundamentals that stink don't look bad from a price action standpoint either. Not looking at a one year chart.


























Not really at a new higher level, not like the rest, but doing okay.Look at the volume spike.




































3.Half the Potfolio stocks have reasonable fundamentals, considering the nature of this market. Half do not. Of the ones that do have good fundies (sales, earning, good financials, low float) there is a wide range. I rated them all on fundamentals, from +++  to –. I'll publish those results, but you can look for yourself too. Here's MJNA, for example. This is the site I'm using to evaluate them. MJNA gets a ++ by my rough estimate, in spite of a huge float.



https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MJNA



4. Here's my own personal quick and dirty assessment of fundamentals of the 20 stocks now held by yours truly in the Potfolio. The symbols I use here are the ones Ameritrade uses. On the Canadian exchanges the ticker symbols are different, fwiw.



Stock                                 Fundamentals



ACBFF                                         +



AGTK                                           –



AMMJ                                          +



APHQF                                       +++



CANN                                           –



CBDS                                          —



CBIS                                           —



CGRW                                          –



CNAB                                           +



CNBX                                           +



ERBB                                            –



GRNH                                           –



MCOA                                           —



MJNA                                           ++



MNTR                                           +



MQTRF                                         ++



MSRT                                            –



OGRMF                                         ++



TRTC                                            +



TWMJF                                          ++



*Once again, these are off-the-cuff, rough estimates. Many people consider Canopy Growth to be the best pot stock of all, but I had to rate Aphria higher on fundamentals, as of last weekend, when I ran the numbers here.



5 .Canadian pot stocks are a safer buy than American companies, due to the legal issues still hanging around due to stupid bureaucratic bungling by our government. Also, the fundamentals of Canadian pot stocks, on the whole, are better. The strongest four stocks are all Canadian. I don't think that means you should write off American companies, but the crystal ball is cloudy for them, at the  moment. I noticed one MSM article yesterday that had all kinds of negative headlines about the medical use of pot, and possible negative effects, like causing schizophrenia. If you read the whole article, you learned that the headlines were mostly bullshit. Still, we see this stuff, and I think it's part of a still-powerful anti-pot lobby that is able to persuade media to smear the industry. Who would do such a thing? (I mean, besides the private prison owners, the DEA, the FBI, and the billionaires that profit off alcohol sales (Sheldon Adelson)).



6. We live in troubled times, and there is about 100% odds of a major stock market correction on the horizon.This will drive down all stock prices, and could temporarily decimate pot stocks just like everything else. If that happens, it's a gift from God. I'll be adding to the better performers. Pot is not going away. I view it as the best contrarian play in recent history.



7. So as not to appear to be baiting anyone to follow some link to a pay site, I'll list the four best Canadian stocks in the Potfolio (my opinion). I'll also add a fifth, which might arguably be on the list. They are in order of best first (overall, not just fundies): TWMJF, APHQF,OGRMF, MQTRF, and ACBFF. My rating is based on fundamentals and recent price action. Of these five, since November 2016, TWMJF has outperformed the rest handily, as far as gains.



8. Of the American companies, the best overall stocks in the Potfolio are, in order: MJNA, MNTR, and MSRT. Of these, MJNA is off-the-charts ahead in gains. It might be worth mentioning that MNTR and MSRT are not actually pot growing companies. MNTR is a financial company that specializes in raising capital for pot companies, and MSRT is a social media platform for people interested in buying and discussing pot. Many of the American pot growing companies that came highly recommended are underwater (for me) at the moment.



9. Just to cover a couple of possible questions you might have, let me say that all the selections in the Potfolio were made by me, and I deliberately avoided a few highly rated stocks. I don't like breathalyzers, so I won't buy stocks of companies looking to sell them, and I avoid pot stocks that might be considered high-flying biotechs, ones that have already shot up to $50/share and beyond. I also didn't buy ECIG because it has a dismal looking chart. FYI.


Title: Re: The Potfolio (Evaluations of More Pot Stocks Part Three)
Post by: Eddie on January 15, 2017, 10:31:10 AM
More evaluations.

NGMC  Flatline 2 year chart. Fundamentals --.
(https://chart.finance.yahoo.com/c/1y/NGMC?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NGMC (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NGMC)


NHLE  Chart was flatlined, now looks like CPR being administered. Fundamentals --. Watch for signs of life.
(https://chart.finance.yahoo.com/c/1y/NHLE?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NHLE (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=NHLE)


SPLIF  Decent chart. Very good fundamentals. (++) Buy?
(http://ih.advfn.com/p.php?pid=staticchart&s=NO%5ESPLIF&t=37&p=5&dm=0&vol=0&width=280&height=200&min_pre=0&min_after=0)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SPLIF (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SPLIF)


OWCP Good chart. Fundamentals -.
(https://chart.finance.yahoo.com/c/1y/OWCP?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=OWCP (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=OWCP)




PZOO   Chart is a flatline, but recently volume is up. Hard to find a chart. Maybe showing signs of new life? Fundamentals are decent (+).
(https://chart.finance.yahoo.com/c/1y/PZOO?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=PZOO (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=PZOO)
(http://ih.advfn.com/p.php?pid=staticchart&s=NO%5EPZOO&t=37&p=5&dm=0&vol=0&width=280&height=200&min_pre=0&min_after=0)




PNPL  Horrid chart.  Good fundamentals. (+). Big mkt cap and sales.
(https://chart.finance.yahoo.com/c/1y/PNPL?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=PNPL (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=PNPL)




POTN  Chart sucks. Good fundamentals. (++)
(https://chart.finance.yahoo.com/c/1y/POTN?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=POTN (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=POTN)



RMHB  Scary chart. Fundamentals (+/_)
(https://chart.finance.yahoo.com/c/1y/RMHB?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=RMHB (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=RMHB)



SGBY  Decent chart. Fundamentals (+/_).
(https://chart.finance.yahoo.com/c/1y/SGBY?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SGBY (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SGBY)


SPRWF   Lovely chart. Fundamentals suck (--).
(https://chart.finance.yahoo.com/c/1y/SPRWF?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SPRWF (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=SPRWF)


BUDZ  Red hot chart.  Fundamentals nonexistent (--).
(https://chart.finance.yahoo.com/c/1y/BUDZ?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=BUDZ (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=BUDZ)



ZDPY   Chart sucks. Fundamentals (-).
(https://chart.finance.yahoo.com/c/1y/ZDPY?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=ZDPY (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=ZDPY)


ZYNE   Great chart. Fundamentals (-). Big mkt cap. Low float. Expensive biotech. 21% short interest.
(https://chart.finance.yahoo.com/c/1y/ZYNE?lang=en-US&region=US)

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=ZYNE (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=ZYNE)

Okay, that's a quick eval of all the stocks in the Money Morning article above. Proof that the author made his list by googling "marijuana stocks". LOL. Turned up a few prospects though.















Title: Re: The Potfolio (Evaluations Recap)
Post by: Eddie on January 15, 2017, 11:24:26 AM
From the Money Morning article of 50 pot stocks to watch in 2017, eleven of those listed are already in the Potfolio. They are AMMJ, ERBB, CBDS, TWMJF, CANN, MCOA, MSRT,  MJNA, MNTR, OGRMF, and TRTC.

I found four stocks (not already in the Potfolio) that I'd consider a possible buy right now.

GBHPF,MCPI, MYHI, and SPLIF.

I will do more DD on these four and consider adding them. Stay tuned.


Another dozen rate a watch. They are all possible winners, but have something going on that says wait. (Like.....some issue with  fundamentals, a parabolic chart screaming for a correction, or a high price.)

MCIG, CVSI, KAYS, KSHB, LXRP, MRPHF, REFG, OWCP, SGBY, SPRWF, BUDZ,  and ZYNE.


None of my ratings constitute financial advice. Do your own due diligence, always.


The Potfolio strategy is not aimed at making trades and and booking short term gains. The Potfolio strategy is a long term buy-and-hold strategy.  The idea is to buy as many decent performing pot stocks as I can identify, establishing a small base position in each of them, and then dollar cost average into the ones that continue to perform. The obvious culls will be sold once a year and the Potfolio rebalanced.

I am reviewing some of the data from Trade King I used to evaluate fundamentals. It appears to me that there might be some inaccuracies. I am trying to decide if I should trust TK or not, as a source. FYI.

Update:

At least three stocks, GBHPF, MYHI, and MCPI were given better ratings than they should have been on fundamentals, due to (what appears to me anyway)inaccuracies in the Trade King research reports. None of them looks like a real dog, but on review, I'm changing the fundamentals assessment of each of them to (-). I am looking for a better screener, since (imho)Trade King can't be trusted.
Title: Re: The Potfolio --- Pot Company Goes Into the Mining Business
Post by: Eddie on January 15, 2017, 11:51:38 AM
MCPI is a company that sells medical MJ in Arizona and elsewhere. They now own dispensaries in several pot-friendly states, from what i can glean.

I ran across this interesting recent 8-K, detailing their acquisition of some of the assets of a private Arizona mining company, Armada, which mines, among other things, silver. FYI



MCPI, INC. (OTCMKTS:MCPI) Files An 8-K Entry into a Material Definitive Agreement

Item 1.01 – Material Definitive Agreement

On November 28, 2016, MCPI, Inc. (the “Registrant”) entered into a Material Definitive Agreement. Under the terms of the Agreement, the Registrant will issue 284,580,000 shares of its common stock to Armada Mining, Inc., an Arizona corporation, in exchange for rights and interests in mining properties in the historic Tombstone Mining District. The Registrant will acquire rights and interests to approximately 3,800 acres of contiguous mineral leases, including some property acquired in fee simple, and ownership of 100% of Tombstone Development Company, which was formed in 1933, and is believed to be the oldest continually operating mining company in Arizona. A copy of the Agreement is furnished herewith. Subject to financing and various regulatory approvals, the Registrant intends to commence development of these properties by processing previously mined materials for silver, as well as precious and base metals; by reopening and developing existing mines using modern equipment and techniques; and by completing an existing drill/test grid to establish the boundary of producible ore bodies, in anticipation of a Bankable Feasibility Study and further development.
Item 2.01 – Completion of Acquisition or Disposition of Assets
See above. The mining rights and interests identified will be acquired from Armada. Although some of these rights and interests are nominally held in the names of Armont Mining Corp., Sandwich JV or John T. Bauska (who is also President and CEO, as well as a controlling shareholder of Armada), their ownership resides in Armada.
Item 5.01 – Changes in Control of Registrant
Under the terms of the Agreement, the Registrant will issue 284,580,000 shares of its common stock to Armada in exchange for certain of its assets, which will result in Armada owning approximately 85% of the Registrant post-transaction. Armada reports that it anticipates exchanging a portion of these shares with existing shareholders; using a portion to satisfy obligations to related parties and others; and using a portion to finance other operations. The Parties have agreed that Registrant’s current management will appoint new directors and resign upon completion of a brief transition period. The Registrant also contemplates a name change, pending approval by the Nevada Secretary of State.
Item 9.01 – Financial Statements and Exhibits
The Registrant expects this results of this transaction will be fully integrated and assumed into its financial statements prior to December 31, 2016, so that it will be reported upon as part of the normal year-end audit cycle, and the requirements of Form 8-K can be incorporated into the Registrant’s next Form 10-K. The Registrant understands that such plan will require its Form 10-K to be filed prior to the due date, and currently anticipates meeting this accelerated schedule. Because the rights and interests covered by the Agreement were acquired by Armada, its predecessors, or other related persons over an extended period, in both cash and non-cash transactions, the Parties anticipate requirement of a Fair Value Report as part of the audit process, and have agreed to work together in preparation thereof. Furthermore, because, among many reasons, Armada will continue to pursue its business and this is not a liquidating transaction for Armada, the Parties do not anticipate a requirement that Armada’s financial statements be audited under the Sale of Business standards. If such contingency develops, or the Fair Value Report cannot be obtained, the Registrant is uncertain as to whether an audit of Armada’s financial statements can be completed in a timely manner, which could have a negative impact on its ability to file the referenced reports in accordance with this accelerated schedule.

About MCPI, INC. (OTCMKTS:MCPI)

MCPI, Inc., formerly Med-Cannabis Pharma, Inc., intends to focus its sales and marketing efforts on qualifying patients within states that allow medical marijuana and/or states that allow for personal recreational use of marijuana. In states where vertical integration is not permitted, the Company plans to determine which of the permitted activities offer the potential for growth and value creation. It seeks to engage, sponsor or lead local advocacy and lobbying groups that have an impact on the evolution and character of laws and the regulations under which legal marijuana operations are implemented in select markets. Its products and services range from the sale of buds and edibles, oils, consumable supplies and other products complementary to the use of medical and/or personal use marijuana. It also has a protocol for providing management services to privately owned mom-and-pop dispensaries. The Company has not generated any revenue.




http://marketexclusive.com/mcpi-inc-otcmktsmcpi-files-an-8-k-entry-into-a-material-definitive-agreement/41104/ (http://marketexclusive.com/mcpi-inc-otcmktsmcpi-files-an-8-k-entry-into-a-material-definitive-agreement/41104/)

MCPI  HAS generated some revenue as of now, according to my previous DD. As in 2.1 Billion in sales, according to Trade King.

https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MCPI (https://research.tradeking.com/research/quotes/fundamentals.asp?mcsymbol=MCPI)

This company was going nowhere and getting bad press in 2015. They seem to have made a good decision to buy dispensaries in AZ, CO, and OR. The stock price was in the toilet until recently. Seems to be a turn-around.

Overall, I don't get overly excited on this one though. Might have to change it back to a watch.




Title: Re: The Potfolio
Post by: azozeo on January 15, 2017, 11:54:31 AM
Nice update, thanks.
I've not heard of Armada. I'll check into them.
Title: Re: The Potfolio
Post by: Eddie on January 15, 2017, 12:08:02 PM
Nice update, thanks.
I've not heard of Armada. I'll check into them.

Report back.
Title: Re: The Potfolio
Post by: azozeo on January 15, 2017, 12:11:17 PM
Nice update, thanks.
I've not heard of Armada. I'll check into them.

Report back.

Absotively , posilutely
Title: Re: The Potfolio
Post by: RE on January 15, 2017, 12:21:54 PM
John Lounsbury will cross post the Potfolio on Global Economic Intersection probably Monday night.

RE
Title: Re: The Potfolio
Post by: Eddie on January 15, 2017, 12:25:03 PM
A very recent article on MYHI. The author says they're way up for mysterious reasons.

Mountain High Acquisitions Corp (OTCMKTS:MYHI) Penny Stock Jumping Higher
By Jermaine Farmer -  January 5, 2017



Mountain High Acquisitions Corp (OTCMKTS:MYHI) is a tiny play in the cannabis space that has become the latest mysterious sudden explosion on the charts. There is likely some factor unknown to us at present – either an aggressive investor awareness campaign that slipped our attention, or something coming together in the form of an IPO of a subsidiary. But what we do know is this: the cannabis space continues to be red hot, and this stock has a tiny float. It doesn’t take much under those conditions to get a squeeze underway.

In all, the chart shows 550% tacked on to share pricing for the company in the past month. Market participants may want to pay attention to this stock. MYHI has evidenced sudden upward volatility on many prior occasions. What’s more, the name has benefitted from a jump in recent trading volume to the tune of a bit less than 410% over the long run average. Traders should note this as important with the stock trading on a float that is extremely small at just  shares. One is wise to respect the dynamic this may create — a restricted trading float and a jump in trading volume can crimp supply and push share prices higher.

Mountain High Acquisitions Corp (OTCMKTS:MYHI) trumpets itself as a company that focuses on the commercial hemp and CBD products industries.

A diversified holding company focused on the acquisition and development of businesses within the hemp and CBD nutraceutical sectors, the company’s wholly owned subsidiary, GreenLife BotaniX, Inc. (www.greenlifebotanix.com (http://www.greenlifebotanix.com)), is a California-based developer and marketer of the “SuperCBD” brand of CBD hemp oil infused nutraceutical products.

Freedom Seed and Feed, Inc., also a wholly-owned subsidiary of the Company, is an innovative Kentucky-based industrial hemp cultivation, processing, and marketing company. In 2014, Michael Lewis, COO of Freedom Seed and Feed, became the first federally permitted private citizen to farm hemp in the United States since 1937.

MYHI is based in Scottsdale, Arizona.


Speculation will no doubt run rampant about this stock until something hits the wires, either in the form of a management comment – “we don’t know why the stock is acting like this” – or something that explains to the rest of the world why a handful of people are charging into this stock right now.

But, whatever the story turns out to be, we know that the furious pace set by many stocks in the marijuana business last Fall looked similar to this action. And this stock did not really participate then.

The momentum in the space is built on solid footing for the most part.

The regulated cannabis market in the United States is projected to reach more than $7 billion for 2016, when all the books have been counted up. That’s according to a report by New Frontier and ArcView Market Research. That represents 26% growth over the previous year, driven largely by adult recreational sales of marijuana. Regulated adult recreational marijuana sales topped $998 million in 2015 compared to $351 million in 2014 — growing 184% year-over-year.

In addition, according to Cowen & Co., the fact that California legalized on a recreational basis in November will likely push the overall legal sales footprint of pot in America to over $20 billion.

Naturally, this is about more than just the US. In Canada, the story may be even more compelling. Legislation is likely to be on the table sometime this year to fully legalize pot on a national basis for all conceivable consumers, according to a promise made by the country’s PM Trudeau.

Hence, while we know something will likely break onto the scene for MYHI as a scapegoat for the recent extreme momentum, we should keep in mind that this type of monstrous sector tailwind, mixed with thin trading conditions and a tiny float, is an explosive combination.

At this time, carrying a capital value in the market of $11.5M, MYHI has virtually no reserve of cash on the books, which compares with a small mountain of debt ($416k). The company is pre-revenue at this point. Nonetheless, for traders, this may be a very interesting story and we will look forward to updating it again soon.



The author of this article beats on them for low operating capital.....but according to Trade King they had 2 Billion in sales with a 35% gross margin. That's very healthy revenue if what I read is correct. He also says they have a tiny float, which I calculated to be roughly 275 Million shares, which is more like "medium" for  pot companies, imho.

I have to wonder if my data from Trade King is accurate. It doesn't exactly match what this guy says. FYI
Title: Re: The Potfolio
Post by: Eddie on January 15, 2017, 12:26:54 PM
John Lounsbury will cross post the Potfolio on Global Economic Intersection probably Monday night.

RE

I hope it doesn't attract a bunch of trolls to the Potfolio thread here. We'll see. Might get some good feedback, you never know.
Title: Re: The Potfolio
Post by: azozeo on January 15, 2017, 12:29:37 PM
Nice update, thanks.
I've not heard of Armada. I'll check into them.

Report back.


Looks like these cats are out of O'Canada & Aussie land.

http://www.dmp.wa.gov.au/Documents/Wardens-Court/2014WAMW10.pdf (http://www.dmp.wa.gov.au/Documents/Wardens-Court/2014WAMW10.pdf)

Title: Re: The Potfolio
Post by: RE on January 15, 2017, 12:33:35 PM
John Lounsbury will cross post the Potfolio on Global Economic Intersection probably Monday night.

RE

I hope it doesn't attract a bunch of trolls to the Potfolio thread here. We'll see. Might get some good feedback, you never know.

Although we get referal hits when JL cross posts one of our articles on GEI, so far we never got a new Diner out of it, troll or otherwise.  They don't post up much on GEI either.  Mostly a Lurker crowd.

RE
Title: Re: The Potfolio
Post by: Eddie on January 15, 2017, 03:37:46 PM
A good article on MJNA. This is my best gainer to date. Good company, but the stock is very diluted. But as the oldest public pot stock, it has a certain cache, apparently.

Two-Pronged Approach for Medical Marijuana Inc (OTCMKTS:MJNA)
By Jermaine Farmer -  January 15, 2017

 
Medical Marijuana Inc (OTCMKTS:MJNA) is a penny stock player in the MMJ space that has become increasingly central in the zeitgeist for OTC traders. The stock has become a mainstay on the top of the “most traded” list on the daily basis for all OTC stocks so far in 2017, and a number of catalysts are serving to stoke the flames. Most recently, the company announced that its subsidiary, Kannaway LLC, “the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products”, is holding an exclusive Red Carpet Event in Atlanta, Ga., over the weekend.

That announcement piles on to the company’s recent notice that its CEO was featured in a series of interviews on Phoenix TV, one of China’s largest TV networks, outlining the history and the various benefits of the Company’s products. In both cases, we are talking about exposure. There are two prongs to the “great race to get ahead in the cannabis game” right now: investment and exposure. We like to see investment most, but exposure is branding, and the battle for public awareness is an institutionalization process, and cannot be overlooked.

Medical Marijuana Inc (OTCMKTS:MJNA) trumpets itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.

The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.

In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products.

Medical Marijuana Inc. is the first publicly held company vested in the medical marijuana and industrial hemp markets.

According to company materials, “The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.”

Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

(http://bigcharts.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MJNA&uf=0&type=2&size=2&sid=3742382&style=320&freq=7&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=18&rand=1495379210&compidx=aaaaa%3a0&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1)

(http://bigcharts.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MJNA&uf=0&type=2&size=2&sid=3742382&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=1191794607&compidx=aaaaa%3a0&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1)





In terms of recent action, the stock has seen 35% piled on for shareholders of the name during the trailing month. Market participants may want to pay attention to this stock. Furthermore, the listing has seen an influx in interest of late, with the stock’s recent average trading volume running exceeding 100% over what the stock has registered over the longer term. The float is huge in this name, so that added attention isn’t a major swing factor, but it does illustrate the point we made at the outset.

As far as the race for exposure, the company’s introduction to Chinese awareness is probably the more important point to consider. The interviews on Phoenix TV in China, which were broadcast on Dec. 23 and Dec. 30 of 2016, summarized the personal experiences of CEO Dr. Stuart Titus and also detailed the disruptive nature and enormous economic potential for Medical Marijuana, Inc.’s cannabidiol (CBD) products. The broadcast also showcased the Company’s major sales subsidiary HempMeds and flagship product Real Scientific Hemp Oil (RSHO).

According to the recent release, the Phoenix TV segments discussed developments such as athletes preferring cannabis to pharmaceutical treatments currently on the market – and also laid out the vast economic opportunities that CBD products have brought to the ever-expanding cannabis industry.

“If you extrapolate Colorado to California where we have a much larger population, we believe that this now-legal market is going to represent about $35 billion, so this will be the largest cannabis market in the world,” Phoenix TV quoted Titus as saying. “Not only will this add to our national GDP, it’s going to improve employment with tremendous job creation.”

At this time, carrying a capital value in the market of $103M, MJNA has a chunk ($406K) of cash on the books, which compares with about $3.9M in total current liabilities. One should also note that debt has been growing over recent quarters. MJNA is pulling in trailing 12-month revenues of $7M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 18.6%. This will almost certainly continue to be a very interesting story and we will look forward to updating it again soon.


http://oracledispatch.com/2017/01/15/two-pronged-approach-medical-marijuana-inc-otcmktsmjna/ (http://oracledispatch.com/2017/01/15/two-pronged-approach-medical-marijuana-inc-otcmktsmjna/)

Title: Re: The Potfolio - The Compleat List of Pot Stocks
Post by: Eddie on January 15, 2017, 03:47:11 PM
This is borrowed from Anthony Cataldo, who writes for Seeking Alpha. 230 Players, according to AC.



OPMZ, XXII, FTPM, ATTBF, ACCA, ACOL, RAMO, AERO, RSSFF, AGTK, ACGX, AFPW, AMMJ, ERBB, ACAN, AMFE, APHQF, ACBFF, AVTCQ, AXIM, BXNG, BAYP, BLDV, BLPG, BABL, CBNT, CAFS, CCAN, CNZCF, CBMJ, CNBX, CBDS, CBIS, BLOZF, LGBI, CBGI, CGRW, CPMD, MJTK, CANL, TWMJF, CARA, CRTL, CBSC, CGRA, CIIX, CHUM, CLSH, CRLRQ, FITX, CRWG, CBCA, CSAX, CVSI, DEWM, DPWW, DIGP, DIRV, DSCR, ETST, EAPH, ESSI, ESPH, EFFI, ECIG, VATE, EMMBF, TBQBF, EDXC, ENDO, ENRT, FFFC, FBEC, FNREF, HVST, FRLF, FSPM, FUTL, FWDG, GLAG, GEAR, CANN, GNBT, GBHL, GBHPF, GLDFF, GRCV, GRCU, GYOG, GTSO, GRNH, MJLB, GRWC, GRSO, GBLX, GRWG, PHOT, GWPH, HALB, HLSPY, HLIX, HMPQ, HEMP, HMKTF, ICNM, IJJP, ICBU, IGC, UPOT, INQD, NRTI, IMLFF, IIPR, INSY, IGPK, IGRW, INCC, IVITF, ITNS, KAYS, KSHB, LAGBF, LATF, LXRP, LCTC, LDSYF, LSCG, LVVV, MDEX, MGWFF, MRPHF, MCOA, MJMJ, MSRT, MQPXF, MCIG, MBOO, NGBL, MCPI, MEDT, REFG, MJNA, MDCN, MDCL, MJMD, MNTR, MQTRF, MMHC, MJNE, MDRM, BTFL, MYHI, MYDX, MYEC, VNTH, NSPDF, NMUS, NTRR, NEWC, NWWTF, NGMC, NXTTF, NHLE, USMJ, NCAP, NVGT, NDEV, SPLIF, OGRMF, OSLH, OWCP, OXIS, PZOO, PKPH, PTOG, PRMCF, PMCB, PNPL, PLPL, PNTV, POTN, PRRE, PMCM, PUFXF, QEDN, QASP, RFMK, REVI, RMHB, SMG, SNNC, SGBY, SING, SIPC, SLNX, SLTK, SAGD, STEV, STWC, SPRWF, SRNA, UNGS, TAUG, TECR, TRTC, GRPOF, THCBF, TASE, ENCC, TRPX, USEI, UAMM, UBQU, UMBBF, KGKG, CNAB, VAPE, VAPI, VPCO, VPOR, VHUB, VAPR, VRCI, VRTHF, WDRP, WTII, WCIG, BUDZ, ZDPY, ZYNE



http://seekingalpha.com/article/4035019-230-marijuana-stocks-testing-january-effect-building-portfolio-2017 (http://seekingalpha.com/article/4035019-230-marijuana-stocks-testing-january-effect-building-portfolio-2017)
Title: Re: The Potfolio
Post by: Eddie on January 16, 2017, 04:23:30 PM
The best of the Money Morning picks.

MCIG
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MCIG&uf=7168&type=2&size=2&sid=10085397&style=1013&freq=1&time=8&rand=202012556&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Looks overbought. Will wait for a better entry.



MYHI
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MYHI&uf=7168&type=2&size=2&sid=10725103&style=1013&freq=1&time=8&rand=1323790294&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Possible buy here.




BUDZ
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=BUDZ&uf=7168&type=2&size=2&sid=3854403&style=1013&freq=1&time=8&rand=1482640762&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Possible buy here.




KAYS
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=KAYS&uf=7168&type=2&size=2&sid=5542673&style=1013&freq=1&time=8&rand=1608633132&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Losing a little steam, but on an uptick.



SPLIF
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=SPLIF&uf=7168&type=2&size=2&sid=18936105&style=1013&freq=1&time=8&rand=742230619&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Losing a lot of steam. On a downtick.



LXRP
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=LXRP&uf=7168&type=2&size=2&sid=3815265&style=1013&freq=1&time=8&rand=1280517784&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Rolling over?



MCPI
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MCPI&uf=7168&type=2&size=2&sid=11132665&style=1013&freq=1&time=8&rand=333055396&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Possible buy here.



REFG
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=REFG&uf=7168&type=2&size=2&sid=4256047&style=1013&freq=1&time=8&rand=216905390&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Rolling over?



MRPHF
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=MRPHF&uf=7168&type=2&size=2&sid=20214494&style=1013&freq=1&time=8&rand=1142040007&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Possible buy here.



ZYNE
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=ZYNE&uf=7168&type=2&size=2&sid=19840125&style=1013&freq=1&time=8&rand=1802049818&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Rolling over. Expensive for a pot stock. Wait for better entry, or avoid due to price.

HEMP
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=HEMP&uf=7168&type=2&size=2&sid=5244582&style=1013&freq=1&time=8&rand=753244799&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Recent daily action and volume spike signals this one might pop tomorrow. Long term chart is not great. More of a trade than a buy and hold. See link below.

https://finance.yahoo.com/chart/HEMP?ltr=1#eyJtdWx0aUNvbG9yTGluZSI6ZmFsc2UsImJvbGxpbmdlclVwcGVyQ29sb3IiOiIjZTIwMDgxIiwiYm9sbGluZ2VyTG93ZXJDb2xvciI6IiM5NTUyZmYiLCJtZmlMaW5lQ29sb3IiOiIjNDVlM2ZmIiwibWFjZERpdmVyZ2VuY2VDb2xvciI6IiNmZjdiMTIiLCJtYWNkTWFjZENvbG9yIjoiIzc4N2Q4MiIsIm1hY2RTaWduYWxDb2xvciI6IiMwMDAwMDAiLCJyc2lMaW5lQ29sb3IiOiIjZmZiNzAwIiwic3RvY2hLTGluZUNvbG9yIjoiI2ZmYjcwMCIsInN0b2NoRExpbmVDb2xvciI6IiM0NWUzZmYiLCJyYW5nZSI6IjFtbyJ9 (https://finance.yahoo.com/chart/HEMP?ltr=1#eyJtdWx0aUNvbG9yTGluZSI6ZmFsc2UsImJvbGxpbmdlclVwcGVyQ29sb3IiOiIjZTIwMDgxIiwiYm9sbGluZ2VyTG93ZXJDb2xvciI6IiM5NTUyZmYiLCJtZmlMaW5lQ29sb3IiOiIjNDVlM2ZmIiwibWFjZERpdmVyZ2VuY2VDb2xvciI6IiNmZjdiMTIiLCJtYWNkTWFjZENvbG9yIjoiIzc4N2Q4MiIsIm1hY2RTaWduYWxDb2xvciI6IiMwMDAwMDAiLCJyc2lMaW5lQ29sb3IiOiIjZmZiNzAwIiwic3RvY2hLTGluZUNvbG9yIjoiI2ZmYjcwMCIsInN0b2NoRExpbmVDb2xvciI6IiM0NWUzZmYiLCJyYW5nZSI6IjFtbyJ9)




GBHPF
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=GBHPF&uf=7168&type=2&size=2&sid=15207348&style=1013&freq=1&time=8&rand=582281824&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Possible buy here.


Oops. Forgot one.


OWCP 
(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=OWCP&uf=7168&type=2&size=2&sid=3329643&style=1013&freq=1&time=8&rand=1405264734&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)

Also looks nosebleed overbought. Wait for a pull back,

Title: Re: The Potfolio ---An Outlier
Post by: Eddie on January 16, 2017, 04:43:06 PM
ABBV is really what I'd call a biotech company that happens to make cannabis drugs. It's expensive at $60 bucks a share. I avoided it like the plague when I was deciding what to put in the Potfolio, even though it's something of an industry darling.

Thing is...it pays a nice dividend, currently about 4%.  It's in a different category that just about any other pot stock. Might be a buy for the income, while it lasts.

(http://www.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=ABBV&uf=7168&type=2&size=2&sid=11543026&style=1013&freq=1&time=8&rand=42387939&ma=1&maval=50&lf=1&lf2=4&lf3=0&height=444&width=579&mocktick=1)
Title: The Investment Potfolio now UP on Global Economic Intersection~!
Post by: RE on January 16, 2017, 07:35:39 PM
Start working on your monthly Newzletter Eddie, this could be a great new income stream!  :icon_sunny:

http://econintersect.com/pages/investing/investing.php?post=201701162038 (http://econintersect.com/pages/investing/investing.php?post=201701162038)

What's my $10K Potfolio worth this week?  ???

RE
Title: Re: The Potfolio
Post by: JRM on January 16, 2017, 08:26:08 PM
I can read an eddy on a trout stream but I can't read a graph on an Eddie stream.  :icon_scratch:

--------------

Sections of a River

Riffle: A riffle is a rocky, shallow area in a stream where water cascading over rocks creates a noticeable surface disturbance. To identify a riffle, look for a choppy surface or whitewater spilling over shallow rocks into deeper water. A good riffle will fulfill all of the basic needs of a trout. The shallow, highly oxygenated water is a perfect environment for the aquatic insects trout eat. Boulders and rocks create plentiful hiding and resting spots. Deeper water downstream gives trout rest and security. All of these aspects make a riffle a great starting point when looking for trout.

Run: A run is an in-between zone directly below a riffle, where the water becomes deeper and the current is more uniform. Aside from a riffle, a run is one of the top places to look for trout in a stream. Trout like the shelter provided by deeper water and the proximity to an easy meal. Fish often suspend at the edge of the current or lie along the bottom eating insects that are carried downstream out of a riffle.

Pool: A pool is the deepest portion of any given section of river with the slowest current. Fish will often retreat to a pool on bright, sunny days or if they feel threatened. In shallow streams, pools might be the only areas that hold fish, but it is different for larger rivers. While most river trout – especially big ones – may spend a portion of their day in a pool, typically this is when they are least active.

Eddy: An eddy is an area of the river where structure such as an indent in the riverbank, a log, or a large boulder blocks the current flow and influences its direction. Directly downstream of the object, a pocket of swirling water will form opposite the main direction of current flow. Trout love eddies because they funnel and trap insects drifting by in the current. Look for foam or bubbles collecting on the surface where the main current meets up with the swirling water and place your casts there.

Tailout: A tailout is a shallow, flat section at the end of a pool before the water spills over into another riffle. Where the water becomes shallow, a natural funnel is formed that brings anything drifting downstream right to the fish. Trout will often wait in a tailout and sip hatching insects off the surface as they float by, so it is a good spot to look for rising fish.
Title: Re: The Potfolio
Post by: Eddie on January 18, 2017, 05:36:30 PM
Today most of the Potfolio stocks pulled back after a stellar day yesterday. I got busy and let the day go by without checking. MCIG and MYHI (two of the new possibles) both took expected corrections of close to 20%. I might take a position in those two tomorrow.

MCPI, one of the Money Morning article picks I evaluated a possible buy last weekend, went up 62.5% today, the largest single day gain I've ever seen. Not sure what that was about. I just noticed, I'll have to check to see if it was news driven. I expect some of that will be given back. Definitely not going to chase that one.
Title: Re: The Potfolio
Post by: Eddie on January 19, 2017, 06:55:10 AM
Options expiration tomorrow. Waiting and looking to find good entry for two or three of the new ones I've started watching. If I had to guess, I'd look for stocks to make one final post-inauguration rally, for maybe up to a month or two, and then for some stagnation leading to a significant correction in the major indices (and probably these highly volatile microcap pot stocks too).

I could wait for the real correction that almost everyone thinks is coming to get in any deeper, but that would risk losing a year or more of possible good gains for the pot stocks, which appear to be getting past the post election jitters that shook them up for a while. I don't look for the broad indices to really melt down until the fall, or even into next year. I think we'll reach the long awaited 20000 Dow (big fucking deal) and maybe a couple hundred more points too...but at some point in the not-too-distant future the puking will begin. Slow at first, and then faster, as Hemingway once said about going bankrupt.

BUDZ, MYHI, MCPI, AND MCIG  are the best candidates to add here, if they don't runaway. Best not to chase a penny stock on a tear to the upside though.  Chances are always good you'll get to take the express elevator back down.

Title: Re: The Potfolio
Post by: Eddie on January 19, 2017, 09:15:03 PM
With stocks really poised now to make at least a minor correction into a yearly cycle low, and options expiry tomorrow, and the inauguration follies, I expect the Potfolio to take another hit...probably not as much as the week of the election, but I don't know.

On minor pullbacks today I went ahead and took preliminary positions in 3 more pot stocks. MCIG, MCPI, and OWCP . BUDZ hasn't dropped off the nosebleed highs and MYHI was off to the races and I didn't chase it. It was up 44% just today. Crazy.

I am now convinced that the Potfolio strategy is valid. Risk is high in these companies, and can only be managed effectively by holding a fairly large stable of them. I'm now up to 23 stocks, and I think it would be wise to hold ten more. So far, I have some real underperformers (all of which were hyped by various pimps and touts).  I am currently holding seven stocks that are down more than 20% from when I bought in, but the high flyers are making up for it. I am roughly even at the moment.

At some point I will stop buying new companies and just add to the winners. As of now, my position size in any one stock is not large enough to hurt much if it tanks completely. If they ALL tank though, that's not the case. Still, there is more safety in numbers.

Some of the Money Morning picks I evaluated and gave bad marks are making good gains right now anyway. Apparently not many people are reading my reports.

MCPI has been acting very bullish. Even today, when it was falling, it wasn't easy to get my order filled at my bid prices.

OWCP is interesting because it's an Israeli company. Medical MJ has been legal in Israel for 7 years now, and there is some low talk about legalizing recreational pot, but it hasn't gotten off the ground as of yet.

If the Dow and S&P really tank, I will buy more, but primarily the winners, building up a bigger stake in my best gainers while they are on sale.
Title: You can become a Millionaire in 1 Year with $50 Investing in Pot Stocks!
Post by: RE on January 20, 2017, 06:09:49 AM
Goodle Ads KNOWS about the Potfolio thread!  This Ad showed up on my Reddit Channel.

https://pro.technologyprofitsconfidential.com/TEK_secretpot_1016/PTEKT102?h=true



Take Action Before February 1st and you could watch the...
Secret “$50 Marijuana
Stock Blueprint”...
… Turn a Single $50 Bill Into
a Massive Fortune

"Now is the right time to bet big on marijuana...
[as] the industry is poised to be gigantic.” —CNBC

RE
Title: Re: The Potfolio
Post by: Eddie on January 20, 2017, 06:31:45 AM
Pot stock pimps are multiplying like cockroaches.

The Money Morning ads are clearly done by the very same agency that does Porter Stansfield, Bill Bonner, and all those people. If you watch the come-ons, its nauseating.

Buy stocks, not newsletters. They are all masters of hindsight.
Title: Fla. senator offers road map for marijuana changes
Post by: RE on January 22, 2017, 07:35:26 AM
http://www.theledger.com/news/20170121/fla-senator-offers-road-map-for-marijuana-changes (http://www.theledger.com/news/20170121/fla-senator-offers-road-map-for-marijuana-changes)

Fla. senator offers road map for marijuana changes
Saturday
Posted at 7:03 PM Updated at 7:03 PM
Share
By Dara Kam, The News Service of Florida

TALLAHASSEE - A key senator Thursday released the Legislature's first attempt at carrying out a constitutional amendment that broadly legalized medical marijuana, with the proposal calling for a growing number of marijuana licenses and making it easier for doctors to order the treatment for patients.

The bill by Sen. Rob Bradley, who was instrumental in passage of medical-marijuana laws in 2014 and 2016, came days after health officials published proposed regulations to implement the constitutional amendment, which received more than 71 percent approval from voters in November.

Under Bradley's bill, the state could see another 20 marijuana operators - nearly triple the seven current licensed "dispensing organizations" - once the number of patients registered for the treatment reaches 500,000.

Christian Bax, director of the Florida Department of Health's Office of Compassionate Use, told lawmakers last week he expects that many patients to be registered in a state database by the end of the year.

Bradley's plan (SB 406) also would do away with a current requirement that doctors treat patients for at least 90 days before being allowed to order marijuana for them and would expand from 45 days to 90 days the amount of marijuana supplies patients can purchase. The legislation would also ban edible marijuana products "in a format designed to be attractive to children."

Ben Pollara, campaign manager of the political committee that backed Amendment 2 in November, called Bradley's effort "a stark contrast" to the rule proposed Tuesday by the Department of Health.

"It's a good start toward implementing both the letter and the spirit of the constitutional amendment," Pollara said in a telephone interview Thursday.

While the health department's proposed rule appears to overlay requirements now in the Constitution onto current Florida law, Bradley's legislation makes frequent references to the amendment, Pollara said.

"I appreciate the fact that Sen. Bradley's bill actually respects that we're implementing a constitutional amendment here," he said.

The constitutional amendment allows doctors to order marijuana as a treatment for patients with cancer, epilepsy, glaucoma, HIV, AIDS, post-traumatic stress disorder, amyotrophic lateral sclerosis (ALS), Crohn's disease, Parkinson's disease or multiple sclerosis. Doctors also have the power to order marijuana for "other debilitating medical conditions of the same kind or class as or comparable to those enumerated, and for which a physician believes that the medical use of marijuana would likely outweigh the potential health risks for a patient."

The rule floated by the health department would leave it up to the state Board of Medicine to decide which patients would qualify for treatment under the unspecified conditions, something Pollara objected to strenuously.
More Video: Ocoee senior and 2016 state champion Victoria Jefferson breaks her own st…

Bradley's proposal does not include any language that would restrict doctors' ability to decide for themselves if patients qualify for marijuana treatment. But his bill does include a definition of "chronic nonmalignant pain," something not addressed in the amendment, as "pain that is caused by a debilitating medical condition or that originates from a debilitating medical condition and persists beyond the usual course of that debilitating medical condition."

"There is a question about how we handle generalized chronic pain. This clarifies that," Bradley, R-Fleming Island, told The News Service of Florida on Thursday.

Under current law, doctors must complete eight hours of training before they can register patients for marijuana treatment. Bradley's plan would cut the required training from eight to four hours.

Bradley's bill would also allow the state's seven dispensing organizations - currently licensed to grow, process and dispense non-euphoric marijuana for patients with epilepsy or cancer, and full-strength marijuana for terminally ill patients - to operate as "medical marijuana treatment centers" defined in the Constitution.

Under current law, health officials must authorize three new marijuana operator licenses - including one license for a member of the Black Farmers and Agriculturalists Association - once 250,000 patients are registered in the state's "compassionate use" database.

Bradley's proposal also would require a member of the black farmers' association to receive one of the highly sought-after licenses.

Under his plan, health officials would have to grant five more "medical marijuana treatment center" licenses once 250,000 patients are registered in the database; five more when that number reaches 350,000; another five after 400,000 patients are registered; and five more when the number reaches 500,000. His plan also would require five more licenses each time 100,000 more patients are registered after that.

"I don't think it's a significant enough expansion of licenses, nor a quick enough one to serve what's going to be a quickly growing patient base," Pollara said. "It's not a perfect piece of legislation, but I think it's a good start considering it's the first bill released in either chamber."

The number of licenses has been a thorny issue for the marijuana industry, but operators who currently have licenses aren't complaining about the expansion included in Bradley's bill.

"It appears at first blush he's found a way to implement the will of the voters while balancing the needs of patient access and protecting patient safety," Steve Vancore, who represents several licensed medical marijuana operators, said.
Title: Re: The Potfolio
Post by: Eddie on February 01, 2017, 07:43:33 AM
Just a quick update. After a surge that lasted through most of January, pot stocks have been chopping sideways for the most part over the last week and a half.

The winners, that is to say the stocks that are in positive territory for me at present, are as follows:

MJNA   up 93%

CBIS    up 55%

TWMJF  up 48%

MCIG     up 32%

MNTR     up 15%

MCPI      up 4%

The red ink on most of the other Potfolio stocks has shrunk, too, and the Potfolio is currently slightly in positive territory, but not by much.

I think the greatest threat is a crash or correction of the broader markets, which will no doubt be brutal for pot stocks, if and when it comes.....although the Potfolio often goes up when the Dow has an off day.

Other than that, news is driving these stocks, and any negative waves out of DC and the Justice Department will hurt.

It might not be a bad time to add some of the ones that ran away from me, like MYHI and BUDZ, which have corrected slightly.

Title: Re: The Potfolio - Healthcare Technology Heavily Influencing the Legal Cannabis
Post by: g on February 07, 2017, 05:51:22 AM
Disclosure, Own a ton of a stock mentioned here MCIG. Have a major score in it already over 4 times. In no way is this a tout or recommendation, just an article out 10 minutes ago about the goings on in the industry, where it was mentioned.  GO

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry

ALM BEACH, Florida, February 7, 2017 /PRNewswire/ --

The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry. The synergy created between modern technology and the explosive cannabis industry is allowing leaders in marijuana to leverage consumer technology engagement for companies such as Reliq Health Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Acology Inc. (OTC: ACOL), Cannabis Science, Inc. (OTC: CBIS), Lifestyle Delivery Systems Inc (OTC: LDSYF) and mCig, Inc., (OTC: MCIG) 

Reliq Health Technologies Inc. (OTCQB: RQHTF) (RHT.V), is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Invictus MD Strategies Corp. (IMH.V on the CSE exchange and also trading on the OTC Markets under the symbol: IVITF;) ("Invictus MD") to develop a mobile application for cannabis patients and consumers and their clinical care teams. Reliq Health, a healthcare technology company focused on developing innovative mobile health and telemedicine solutions, has developed a novel SaaS (software as a service) solution for the community health care market. The solution provides automated remote patient monitoring in the home and secure cloud-based communication, care planning and collaboration for all members of the patient's circle of care. Reliq's secure platform allows clinicians to collect comprehensive data on patients' clinical conditions, medication usage, symptoms, side effects and behaviours - creating a wealth of population health data. Read this full release and recent news releases for Reliq Health Technologies at http://marketnewsupdates.com/news/rqhtf.html. (http://marketnewsupdates.com/news/rqhtf.html.)

"Studies consistently show that providing patients with the tools they need for self-management of their health conditions produces better health outcomes and reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress disorder. Our cannabis app allows patients to track usage and record symptoms specific to their clinical condition, allowing patients and their care providers to determine optimum strain, dosing and mode of administration. Our platform will improve access to care by connecting patients with physicians in their community who have experience with medical marijuana, and supports physician-approved automated prescription refills through participating producers," said Dr. Lisa Crossley, CEO of Reliq.

Invictus MD's Chairman and CEO, Dan Kriznic, said, "Our wholly owned subsidiary: Poda Technologies Ltd. ("Poda") is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective, reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers." The Poda Pod vaporizer product, made with medical-grade components, has been designed to connect to users' smartphones via Bluetooth to provide real-time information about dosage, product characteristics, track remaining contents, find vendors nearby, and customize their experience. Agreements are being negotiated to license the PODA products to the Access to Cannabis for Medical Purposes Regulations ("ACMPR") and licensed producers in Canada, helping those producers better reach and serve consumers with convenient, refillable devices.

In other cannabis and medical marijuana sector related performance and announcements in markets of note:

Acology Inc. (OTC: ACOL) closed up over 13% on Monday trading big volume of over 77.8 Million shares by the market close. Acology announced on Monday that January was the biggest sales month in company history, shattering previous marks achieved during the last quarter of 2016. Acology executives have expressed strong confidence that the first quarter of 2017 would continue this trend, basing their optimism on continued expansion in Canada and the addition of new, complimentary products and product lines. Company income rose 33% above the same period last year. Unit sales of all products, led by Acology's signature product, the MedTainer™, increased by 25% over last year.

Cannabis Science, Inc. (OTC: CBIS) closed up slightly on Monday trading over 21.8 Million shares by the market close. Cannabis Science, together with its subsidiaries, develops, produces, and commercializes phyto cannabinoid-based pharmaceutical products primarily in the United States. The company is involved in developing medicines for autism, blood pressure, cancer and cancer side effects, as well as for other illnesses comprising for general health maintenance.

Lifestyle Delivery Systems Inc (OTCQB: LDSYF) closed up over 12% at $0.5752 on Monday trading over 800,000 shares by the market close. Lifestyle Delivery Systems produces and sells cannabis infused strips. It develops and licenses a proprietary filmstrip technology that can be used to produce oral delivery systems for energy elixirs, herbal remedies, and a smokeless alternative option to medical and recreational users of cannabis

mCig, Inc., (OTCQB: MCIG), a diversified company servicing the legal cannabis, hemp, and CBD markets announced on Monday its preliminary earnings and financial results for its third quarter for FY 2017, ending January 31, 2017. MCIG generated $1.3M in revenue through its construction, CBD, and e-Cig divisions during the third quarter bringing its total revenue for the FY to $2.2M. The revenue generated represents a 546% increase from the same period last year, and a 204% increase from last quarter. MCIG's net income for the quarter was $898K (with a $118K adjusted net income) bringing its total net income YTD to $716K ($227K adjusted net income), a 32% net margin. The company generated $341K in cash from operations and has increased its cash, and cash equivalents, position by 311% this fiscal year to $420K. MCIG reports $1.26M in current assets with only $287K in current liabilities giving it an acid test ratio of 4.3:1, its highest rating in company history.

DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Reliq Health Technologies Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:
Media Contact email:
info@marketnewsupdates.com

http://www.prnewswire.com/news-releases/healthcare-technology-heavily-influencing-the-legal-cannabis-patient-industry-613014533.html# (http://www.prnewswire.com/news-releases/healthcare-technology-heavily-influencing-the-legal-cannabis-patient-industry-613014533.html#)  :icon_study:
Title: Re: The Potfolio
Post by: Eddie on February 09, 2017, 04:24:07 PM
Does Jeff Sessions Fear The Reefer?


Jeff Sessions’ Coming War on Legal Marijuana

There’s little to stop the attorney general nominee from ignoring the will of millions of pro-pot voters.
By JAMES HIGDON December 05, 2016

 

On Election Day, eight states voted to legalize recreational or medical marijuana, bringing the nationwide total of medical states to 29. In Florida, medical marijuana won nearly 2 million more votes than Donald Trump. Added up, 65 million people now live in states that authorize adult recreational use; more than half of all Americans have access to medical marijuana; and almost everyone else lives in a state that permits CBD, a non-psychoactive component of cannabis that helps treatment of juvenile epilepsy. It’s easier now to identify the six states that have done nothing to end the prohibition on marijuana than the ones that are breaking away from the federal law that treats marijuana the same as heroin.

There was another winner on November 8, however, and he has thrown up a serious challenge to the seemingly inexorable march of legal marijuana. By nominating Senator Jefferson Beauregard Sessions III for attorney general, President-elect Donald J. Trump is about to put into the nation’s top law enforcement job a man with a long and antagonistic attitude toward marijuana. As a U.S. Attorney in Alabama in the 1980s, Sessions said he thought the KKK "were OK until I found out they smoked pot.” In April, he said, “Good people don't smoke marijuana,” and that it was a "very real danger" that is “not the kind of thing that ought to be legalized.” Sessions, who turns 70 on Christmas Eve, has called marijuana reform a "tragic mistake" and criticized FBI Director James Comey and Attorneys General Eric Holder and Loretta Lynch for not vigorously enforcing a the federal prohibition that President Obama has called “untenable over the long term.” In a floor speech earlier this year, Senator Sessions said: "You can’t have the President of the United States of America talking about marijuana like it is no different than taking a drink… It is different….It is already causing a disturbance in the states that have made it legal.”


Sessions has not shared his plans on marijuana enforcement, but if he chooses, he will be able to act decisively and quickly—more so perhaps than with any other of his top agenda items such as re-doubling efforts to combat illegal immigration and relaxing oversight of local police forces and federal civil rights laws. With little more than the stroke of his own pen, the new attorney general will be able to arrest growers, retailers and users, defying the will of more than half the nation’s voters, including those in his own state where legislators approved the use of CBD. Aggressive enforcement could cause chaos in a $6.7 billion industry that is already attracting major investment from Wall Street hedge funds and expected to hit $21.8 billion by 2020.

And so far, Congress has shown no interest in trying to stop the Sessions nomination, at least on this issue. Even members who are in favor of protecting states from federal interference on the marijuana issue have said they support Sessions’ confirmation as attorney general: “I strongly support Jeff Sessions as Attorney General,” said Representative Tom McClintock, Republican from California. “He is a strict constitutionalist who believes in the rule of law. I would expect that he will respect the prerogative of individual states to determine their own laws involving strictly intra-state commerce.”

Meanwhile, proponents of legalization across the country are panicking as they reckon with how quickly a Reagan-era throwback in the attorney general’s office will be able to dismantle more than a decade of progress.

“If we don't take action and hold President-elect Trump accountable,” said Representative Jared Polis, Democrat from Colorado, “in one fell swoop, the federal government could damage state economies, and discourage entrepreneurship—placing some of our innovators behind bars, all while eroding states' rights.”

***

California was the first state to legalize medical marijuana in 1996, largely in response to the AIDS crisis. Over the next decade, other western states followed suit. Then during the Obama administration, medical marijuana spread to every corner and every region of the country, including Washington, D.C., Guam and Puerto Rico. Like other culture war issues such as gay marriage, marijuana found favor with the general population, seemingly overnight after decades of work.

In 2012, Colorado citizens voted to become the first state to legalize weed for purely recreational purposes, leaving the federal government in a bit of a pickle. Marijuana was still considered by the feds to be more dangerous than cocaine, so what was it going to do about the eruption of grow operations? One solution would have been to reclassify marijuana out of Schedule I—the list of drugs like heroin considered the most dangerous and addictive and which are deemed to lack any medicinal value—but that didn't happen because of entrenched opposition from the Drug Enforcement Administration and an apparent lack of will at the White House to go to war with its own DEA. Instead, the DOJ wrote a memo as a short-term work-around, drafted by a deputy attorney general named James Cole.


Published in August 2013, the four-page Cole Memo was addressed to all U.S. attorneys and said, “In jurisdictions that have enacted laws legalizing marijuana in some form... conduct in compliance with those laws and regulations is less likely to threaten the federal priorities…” Translation: Don’t go out of your way to prosecute marijuana cases. It was a half-hearted solution that had the effect of giving states some breathing room, but marijuana activists knew that it was just a memo, lacking the force of law.

Some lawmakers attempted to give states greater protection, but to little avail. In 2007, Representative Dana Rohrabacher, a Republican from California, offered an amendment to the appropriations bill that funds the Justice Department to restrict federal funds that might be used to go after state-legal medical marijuana programs. His original cosponsor was Maurice Hinchey, a New York Democrat. The measure failed in 2007, and six more times. Upon Hinchey's retirement, Sam Farr, Democrat from California, signed on as the cosponsor. In 2014, Rohrabacher-Farr finally passed. In 2015, McClintock and Polis tried to go further by proposing a similar measure that would protect state-legal recreational marijuana programs, but it failed narrowly.

When asked by POLITICO about his concerns for the future of marijuana policy reform, Rohrabacher focused on his past successes rather than the possibility that the reform that bear his name might not survive: “The Rohrabacher-Farr amendment has twice passed the House, most recently with a vote in 2015 of 242-186, and has twice been included in an omnibus spending package and signed into law, as well as being extended in a number of continuing resolutions,” he said. Sam Farr declined to comment.

But this strategy to limit the executive branch by using Congress' power of the purse has one significant downside: Those amendments must be renewed with each budget or they’ll expire. Like the Cole Memo, the Rohrabacher-Farr amendment is not yet the law of the land, and because of new rules implemented by Speaker of the House Paul Ryan, amendments related to guns, abortion, LGBT issues and marijuana will no longer be permitted—a change that Kentucky Representative Thomas Massie, sponsor of a bill to protect industrial hemp programs, considers “an affront to regular order” and “a travesty to our democracy.”

So, with the amendment process shut down in the House, advocates will have to rely on their allies in the Senate to stop the incoming attorney general or take matters into their own hands with a stand-alone bill, even though the chances of such a marijuana bill passing through committee has always been zero. However, Massie has hopes that his stand-alone hemp bill will get a hearing in the House Judiciary Committee, whose chairman, Bob Goodlatte, represents Virginia, which legalized industrial hemp in January 2016. Likewise, Polis plans to re-introduce his “Regulate Marijuana like Alcohol Act,” in the next Congress. “I urge my colleagues in Congress to immediately pass it,” Polis said.

It’s unlikely. His bill has failed twice before.

***

Without any protection from Congress, every marijuana grower and dispensary owner who came out of the shadows to become a taxpaying member of the legal recreational cannabis industry in Colorado, Oregon, Washington state and Alaska has exposed himself to potential criminal prosecution by a DOJ run by Sessions. A list of potential defendants would number in the hundreds (The National Cannabis Industry Association, a trade group, boasts more than 1,000 dues-paying members). The higher the profile of these cannabis businesspeople, the more at risk to federal prosecution—like when the Justice Department under George W. Bush went after Tommy Chong of "Cheech & Chong" fame for selling glass pipes across state lines. But beyond going after those engaged in legal recreational weed, what could Attorney General Sessions actually do to reverse the progress of legalizing marijuana?

Sessions won’t say, but Smart Approaches to Marijuana, an anti-marijuana group that spent about $2 million last year fighting legalization, has a wish list.

“At the very least, the incoming Attorney General should enforce the terms of the DOJ’s own memoranda,” said Jeffrey Zinsmeister, executive vice-president and director of government relations for SAM, referring to the Cole Memo and citing a GAO report that claimed “the DOJ was not even collecting the information necessary to follow-up on its own marijuana enforcement priorities, much less enforce federal law on marijuana. ”

His group, said Kevin Sabet, SAM's founder and president, "looks at marijuana use as a public health issue, not a moral issue. We don't think people should be in prison for using marijuana, and we don't want to see arrest records for young people caught smoking marijuana." But there are more aggressive steps the new attorney general could take, according to SAM officials, to crack down on purveyors of marijuana.

“The DOJ could write a letter to governors in legalized states stating that any state issued licenses regulating marijuana sales is a violation of the Controlled Substances Act, and say they have 90 days to revoke licenses. It could issue a new memo to the states that have not implemented marijuana sales yet and say that they advise those states not to allow them. DOJ could also say that in the next six months they will enforce the 2013 Cole Memo and determine if states have violated its terms. It would be hard to argue that they haven’t,” Zinsmeister said.

Without any restraint from Congress and being egged on by the likes of Project SAM, the only thing that could stand in Attorney General Sessions's way of launching a new front in the marijuana wars is the president-elect.


But Trump's exact views on the issue remain elusive and mixed at best. At the annual conservative CPAC gathering in February 2015, then-candidate Trump expressed support for medical marijuana, but drew the line at recreational adult use: “I say it's bad," he said, in answering a question about Colorado’s recreational marijuana law. "Medical marijuana is another thing, but I think [recreational marijuana is] bad. And I feel strongly about that." When the moderator, FOX News’s Sean Hannity, pressed Trump on the states’ rights aspect, Trump replied, "If they vote for it, they vote for it. But they've got a lot of problems going on right now in Colorado. Some big problems. But I think medical marijuana, 100 percent.”

It’s not clear what problems Trump is referring to in Colorado, though it could be the slight uptick in marijuana-related traffic fatalities and teen usage. But that lack of clarity could in itself be a green light for an attorney general predisposed to act aggressively. Trump also applauded the brutal anti-drug campaign conducted by Philippines president Rodrigo Duterte. Since June, police in the Philippines have killed more than 2,000 people in drug raids, which Trump applauded as doing things "the right way," according to Duterte.

“Part of the challenge here is that the wild card is the president,” Rep. Earl Blumenauer told POLITICO, referring to the president-elect. Blumenauer has been an advocate for marijuana policy reform since 1973 and represents Portland, Oregon, which has legalized medical and recreational marijuana. “I think it’s unlikely that a President Trump takes a stand and reverses this trend that would put him out of step with his constituents. He’s not likely to do anything to alienate himself with millions of his supporters.”

Then again, it might not be up to him.


James Higdon is a freelance writer based in Louisville. His book, Cornbread Mafia: The Story of the Biggest Marijuana Syndicate in American History was published in 2012.


http://www.politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501 (http://www.politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501)
Title: Re: The Potfolio
Post by: azozeo on February 09, 2017, 05:05:44 PM
Trump gets it...
Sessions is a pin head .
Title: Re: The Potfolio -- For GO, Recommended for Relief of Trauma
Post by: Eddie on February 16, 2017, 01:05:46 PM
(https://chart.finance.yahoo.com/instrument/1.0/CNBX/chart;range=5d/image;size=f1?region=US&lang=en-US&scheme=gsbeta)
CNBX

Up 44.06% today.

Potfolio and Miners.....Best. Day. Ever. I'm up 5.83% for the day. Not unusual for a good trader I know, but a fairly stellar one day performance for a little buy-and-hold portfolio.
Title: Re: The Potfolio -- For GO, Recommended for Relief of Trauma
Post by: g on February 16, 2017, 01:19:20 PM
(https://research.ameritrade.com/grid/wwws/research/uploadhandler/z28897c0azbce9b0f2814c4afbabca7637557fdd5f.png)
CNBX

Up 44.06% today.

Potfolio and Miners.....Best. Day. Ever. I'm up 5.83% for the day. Not unusual for a good trader I know, but a fairly stellar one day performance for a little buy-and-hold portfolio.

I've had quite a run the last few days as well Eddie. Aphria and Canopy came to life big time. Have a triple going with MCIG as well but it was quiet the last few days.  MJNA continues to languish, think it's the huge float.

Whatever I am on top of them and see what you see down the road a while. My fear is only of a market break before they really catch fire.   It looks to me currently that Canopy is the leader and one the mad men will be playing when the orgy starts, subject to change of course if a new one comes along, but appears to be the boss at this juncture.
Title: Re: The Potfolio - Marijuana Is Not Just About Getting High
Post by: g on February 17, 2017, 05:34:02 AM
Starting Edward's day with some pleasant reading material ;)
                                      (https://dweaay7e22a7h.cloudfront.net/wp-content_3/uploads/2017/02/medicalweedhero.png)

Marijuana Is Not Just About Getting High

A brand-new market created before our eyes isn’t something you see every day — but that’s exactly what happened in 2016.

On Nov. 8, eight states around the country voted to legalize, either recreationally or medicinally, marijuana.

Today, legalization movements have gained more traction than they’ve had in decades. Marijuana is now legal in more places than it has been since the first anti-marijuana laws started appearing in the early 1900s.

The potential for medical use has led a number of states to decriminalize or legalize marijuana for medical purposes — although marijuana is still illegal at the federal level. This remains a major impediment to the use of the substance or to the use of drugs derived from it.

But the changes that have already occurred will create the opportunity to earn massive profits for investors who “get in ahead” of the creation of this market. Its medical applications provide marijuana legalization compelling investment potential. More on that in a minute.

I don’t want to get into the morality of legalizing marijuana today. It’s a controversial subject with strong opinions on each side.

The main controversy surrounding marijuana is of course that cannabis contains psychoactive chemicals — essentially drugs that affect the brain in some way. The most prevalent is tetrahydrocannabinol (THC), but the plant can contain up to 65 similar chemicals, collectively known as cannabinoids.

Ingesting or inhaling these chemicals can cause feelings of euphoria, among other effects. This is what so many in opposition of the drug are hung up about. But as a passionate student of medical science, I want to focus on the potential uses for marijuana from a medicinal standpoint. And hence, an investment standpoint.

Over the past several years, it’s become impossible to ignore that marijuana has become a very hot topic in the biotech industry. As restrictions on medical marijuana ease from state to state, it opens the door to broader research and development of cannabinoid treatments in everything from cancer to Alzheimer’s.

Modern science has found the effects of cannabinoids goes far deeper than producing a little buzz…

Marijuana reacts with several biological systems, allowing vast possibilities in biotech research. Research into marijuana has already led to the discovery of a network inside the body called the endocannabinoid system, which controls both the central nervous and immune systems.

If researchers can figure out how the compounds in the cannabis plant function, they can either extract them from the plant or produce or synthesize them chemically for therapeutic use.

There is a whole range of diseases that we can treat with these compounds.

There’s been research in autism and many other conditions. Cannabis has also been studied in the treatment of multiple sclerosis, an autoimmune disease. Evidence is mounting that cannabinoids help control everything from multiple sclerosis’ pain to involuntary muscle movements. This could well be a future avenue for research.

Studies have also shown that marijuana can decrease side effects of chemotherapy, such as nausea. It may further offer health benefits to people suffering from migraines, anorexia and glaucoma.

We’ve already seen a lot of anecdotal and informal evidence that marijuana actually works on these different health conditions.

Marijuana also offers pain management without the addiction and abuse potential that opioids have. The pain management market is one of the largest pharmaceutical markets, if not the largest segments of the pharmaceutical market.

Some 15,000 people in the United States are dying annually from opiate-related overdoses. Even under careful care in the hospital, people die. That’s because the opiates we use now metabolize slowly. A patient can get out of surgery and be given an opiate, which can later result in respiratory depression. The patient simply stops breathing.

Unlike other drugs, cannabis is relatively safe. With some drugs, the difference between an effective dose and a deadly one isn’t great. But with cannabis, you’d have to consume thousands of times the effective dose to be in danger of death.   :Thinkingof_:

I think this is where marijuana or marijuana derived-drugs can make the biggest inroads.

And cannabis-based drugs can be carefully designed and targeted so they don’t have the psychoactive effects of creating euphoria or creating some sort of impediment for everyday tasks. People want to manage their pain, they don’t necessarily want to be high when they’re at work operating heavy machinery or any kind of work that demands normal functioning.

So while marijuana will become increasingly important for medical uses, it won’t be a case of “Take two bong hits and call me in the morning.”

We’re going to be seeing clinical trial news in all these areas soon and I expect it’s going to be positive. That’s going to create positive sentiment for marijuana. Before too long, we’re going to be seeing more and more cannabis-derived or cannabis science-based pharmaceuticals enter the market where they will be very successful.

Add it all up and it becomes clear that marijuana is a compelling story that investors cannot afford to ignore any longer. The profit potential is simply too vast.

The total market, including pharmas, could end up being as big as $100 billion per year. Biotech investors could easily see gains for some of these companies in the hundreds and thousands of percent.

Marijuana companies have already soared just because a couple of U.S. states legalized marijuana for recreational use. It created a wave of marijuana-minted millionaires.

And half a dozen or more states may legalize marijuana over the new year. If that news plays out it will affect the general valuation of many marijuana stocks., I’m betting marijuana stocks will see another incredible surge…

Consider Abbattis Bioceuticals, a Canadian company specializing in “natural health” products, including one containing cannabinoids. It also sold products to help people cultivate marijuana.

Before Jan. 1, 2014, shares traded for about 2.5 cents per share. By March 21, it was trading for $2.46.

In other words, if you bought 1,000 shares for just $25, you would have cashed out with $2,460.

The story was repeated in other companies, too like CV Sciences… Easton Pharmaceuticals… CannaBusiness Group…

There are lots of ways to play the field.

Publicly traded marijuana companies continue to ride a wave of optimism following the 2016 elections. When legalization expands to more states, the tiny pioneers of this market could balloon into industry giants — vastly rewarding anyone who was brave enough to invest at the start of the wave.

But you don’t have to wait for other state governments to get their acts together to benefit from the next marijuana investment surge. In fact, I predict the next big pop could happen in a matter of months, even weeks.

When it does, stocks that are trading today for just a few dollars, even pennies, could soar 773%… 1,120%… maybe even as high as 9,108%.

And I’ve discovered companies that are still flying under the radar of most investors. Of course, the only chance investors have to see these kinds of gains is to buy the stocks before they take off.

Whatever your personal take on marijuana, this is a story investors need to take very seriously.

To a bright future,

https://dailyreckoning.com/author/rayblanco/ :icon_study:
Title: Re: The Potfolio
Post by: Eddie on February 17, 2017, 01:17:59 PM
Thank you GO.

Today's winners:

(https://chart.finance.yahoo.com/c/1y/OWCP?lang=en-US&region=US)
OWCP ----- up 36.57% today

Chart is not updating properly, sorry.


(https://chart.finance.yahoo.com/c/1y/CNBX?lang=en-US&region=US)
CNBX ---- up 36.86% today, after a 40% pop yesterday.
Title: Re: The Potfolio
Post by: Eddie on February 17, 2017, 01:43:19 PM
Smokin'.........



Stock                            Shares   Purchased    Price       Cost           Last      Mkt Val         Gain$              Gain%

CANNABICS PHARMA       1,000   11/14/16      0.76     759.99        4.00        4,000.0        3,240.01          426.32
(CNBX)
Title: Re: The Potfolio
Post by: JRM on February 17, 2017, 04:06:41 PM
"I am the pie in the sky."

      - misheard lyric by Alan Parsons Project
Title: Re: The Potfolio
Post by: JRM on February 17, 2017, 04:13:46 PM
http://www.youtube.com/v/NNiie_zmSr8[/embed]
Title: Re: The Potfolio
Post by: JRM on February 17, 2017, 04:21:47 PM
(http://
pie in the sky
pie in the sky
)
Title: Re: The Potfolio
Post by: Eddie on February 18, 2017, 10:35:38 AM
At the moment the internet is chock full of various whores, pimps and touts writing in the pot stock space. The companies themselves are not above paying for fake news designed to pump their share prices, either. Let the investor beware. However, from above this sewer one clear voice emerges to bring some clarity. That is the voice of Anthony Cataldo, a stock analyst who is sincerely trying to track what's going on, using the regular tools of the trade. I highly recommend him for anyone wishing to put a little money into pot stocks.


207 Marijuana Stocks: Nevada Corporations Outperform Delaware, Canada And Other Over 1, 4 And 52-Week Periods

Feb. 13, 2017 1:13 PM ET (from Seeking Alpha)


| Includes: ACAN, ACBFF, ACOL, AERO, AFPW, AGTK, AMFE, AMMJ, APHQF, ATTBF, AXIM, BABL, BAYP, BLDV, BLOZF, BLPG, BTFL, BUDZ, BXNG, CAFS, CANL, CANN, CBCA, CBDS, CBGI, CBIS, CBMJ, CBNT, CBSC, CCAN, CGRA, CGRW, CHUM, CIIX, CLSH, CNAB, CNBX, CNZCF, CPMD, CRLRQ, CRTL, CRWG, CSAX, CVSI, DEWM, DIGP, DIRV, DPWW, DSCR, EAPH, EDXC, EFFI, EMMBF, ENCC, ENDO, ENRT, ERBB, ESPH, ESSI, ETST, FBEC, FFFC, FITX, FRLF, FSPM, FTPM, FUTL, FWDG, GBHL, GBHPF, GBLX, GEAR, GLDFF, GNBT, GRCU, GRCV, GRNH, GRPOF, GRSO, GRWC, GRWG, GTSO, GWPH, GYOG, HALB, HLIX, HLSPY, HMKTF, HMPQ, HVST, ICBU, ICNM, IGC, IGPK, IGRW, IIPR, IJJP, IMLFF, INCC, INQD, INSY, ITNS, IVITF, KAYS, KGKG, KSHB, LATF, LCTC, LDSYF, LGBI, LSCG, LVVV, MCIG, MCOA, MCPI, MDCL, MDEX, MDRM, MEDT, MGWFF, MJLB, MJMD, MJNA, MJNE, MJTK, MMHC, MNTR, MQPXF, MRPHF, MSRT, MYDX, MYEC, MYHI, NDEV, NEWC, NGBL, NGMC, NHLE, NMUS, NRTI, NSPDF, NTRR, NVGT, NWWTF, NXTTF, OGRMF, OPMZ, OSLH, OWCP, OXIS, PHOT, PKPH, PLPL, PMCB, PNPL, PNTV, POTN, PRMCF, PRRE, PTOG, PUFXF, PZOO, QEDN, REFG, REVI, RMHB, RSSFF, SAGD, SGBY, SING, SIPC, SLNX, SLTK, SMG, SNNC, SPLIF, SPRWF, SRNA, STEV, STWC, TAUG, TBQBF, TECR, THCBF, TRTC, TWMJF, UAMM, UBQU, UMBBF, UNGS, USEI, USMJ, VAPE, VAPI, VAPR, VATE, VHUB, VNTH, VPCO, VPOR, VRCI, VRTHF, WCIG, WDRP, WK, WTII, XXII, ZYNE


Anthony Cataldo   


This article provides returns measures based on a marijuana firm STATE OF INCORPORATION.

Generally, Nevada corporations are outperforming Delaware, Canada & Other marijuana sector jurisdictions.

This surprised me, as academic research, in the distant past, suggested that Delaware corporations provide higher returns when compared to all other jurisdictions.

Perhaps this is due to the fact that the sector has not matured and is in its infancy My hypothesis?

The marijuana sector is immature and inefficient and trading opportunities based on other than fundamental measures will maximize returns.

Warning: Some of these marijuana stocks engage in paid promotions.

Why Should Corporate Jurisdiction Matter?

There is something called "the Nevada Effect." Nevada firms, generally, produce lower returns when compared to Delaware. Here are 2 of my articles with links:

Nevada Continues to Lead Delaware and All Other States and Jurisdictions in 2014 Securities and Exchange Commission Trading Suspensions
The U.S. State of Nevada Consumes a Disproportionate Share of U.S. Securities and Exchange Commission Regulatory Resources
I already looked a comparable data through the end of 2015, and Nevada corporations continue to lead in SEC trading suspensions. Here is a YouTube video by Professor Barzuza, where she explains a little bit about Nevada corporate law.

Delaware corporate law is in the news, on a very different dimension. As a resident of Pennsylvania, I have seen advertising with respect to Delaware corporations in recent weeks.

The Marijuana Segment is Different from the Overall Market

Below is a table summarizing my findings with respect to marijuana stocks over the 1 week (NYSE:WK), 4 week, and 52 week periods ending February 5, 2017. The data is included in the APPENDIX.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/3646631_14869331225208_rId10.png)


First, the returns are just wonderful for the 52 week period for all jurisdictions. That is why you are reading this article. By all means, at least nibble in to the marijuana sector or segment of the economy.

Second, it is quite possible that the Canadian stocks, since more mature with respect to a nationwide legalization effort, are generating lower risk-adjusted rates of returns. I have not tested for this. If you can stand the risk, I would seek higher returns for firms outside of Canada. Having said that, I suspect the Canadian marijuana stocks are safer than non-Canadian, at least that is my hypothesis.

Third, I did attempt to run regressions against each and every single portfolio item available with respect to the Seeking Alpha "my portfolio" feature or toolbar item, and I could not find any correlation, causal or otherwise, between returns and any fundamental values. Therefore, as much as I hate to say this, fundamental measures on working capital, debt to equity, toxic convertible or death spiral financing, and any other variable available, was insignificant. Zero results. Fundamentals do not matter. I do not provide these results, because no one is interested in reading a "no results" paper or article. So, I thought I would run state of jurisdiction to see what resulted.

So, How Are Marijuana Stocks Doing AFTER the January Effect?

I am more than impressed to see that the full portfolio of N=229 marijuana stocks that I have listed and use for my Seeking Alpha portfolio continue to provide equal-weighted positive returns AFTER the January Effect. Below are some measures taken on February 12, 2017, where "1 WK PERF" represents returns for the week of February 6 through February 10, 2017:

1 WK PERF ---2.1%

4 WK PERF --- 19.7%

52 WK PERF --- 445%


Summary

The marijuana sector or segment of the economy continues to trade inefficiently. The market is not yet mature, particularly for U.S. firms. This is likely to continue. Therefore, those interested in trading these, largely, micro-cap and "penny" marijuana stocks must keep this first and foremost in their mind.

My recommendation is that "traders" continue to make buy and sell decisions based on "events" and not based on fundamental values, as the latter appear likely to lead to poor or unprofitable trades and decisions. The next big "event date" that will lead to an upside marijuana segment over-reaction is likely to be the formalization of recreational marijuana use procedures for Canada, anticipated in the next few months.

Disclosure: I am/we are long BLOZF.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.



Follow the link to Anthony's excellent appendix that summarizes the action for all 207 pot stocks he is following. As someone who is trying to follow 23 pot stocks at the moment, I'm blown away by his diligence, and I think you can use his research to good advantage. FYI

http://seekingalpha.com/article/4045410-207-marijuana-stocks-nevada-corporations-outperform-delaware-canada-1-4-52-week-periods (http://seekingalpha.com/article/4045410-207-marijuana-stocks-nevada-corporations-outperform-delaware-canada-1-4-52-week-periods)
Title: Re: The Potfolio
Post by: Eddie on February 18, 2017, 01:24:35 PM
Of possible interest. This is just a link to the current 8K for  Americann Inc. (ACAN). Not currently in the Potfolio.

The CEO is making a presentation at BU's Questrom School of Business on February 22nd. There is a synopsis here and a copy of the Power Point presentation he'll be making. This all has to do with ramping up the pot business in Massachusetts. Pretty exciting stuff.

ACAN is already showing some nice action, but I'd look for this kind of exposure to move the stock price over the medium term, like the next 3 months or so.

http://seekingalpha.com/filing/3414504 (http://seekingalpha.com/filing/3414504)
Title: Re: The Potfolio
Post by: Eddie on February 19, 2017, 01:32:13 PM
In an attempt to continue to identify pot stocks with better than average potential, it occurred to me to look at companies who might stand to profit from market share growth in particular states that have legalized medical or recreational pot use, or both.

These are a few that aren't currently in the Potfolio, but are showing strong momentum, and seem to fit the bill of being specific to a particular state:

ACAN

(https://chart.finance.yahoo.com/c/1y/ACAN?lang=en-US&region=US)

Supposedly breaking ground for a 1 million ft2 medical grow facility in MA. They are also presenting a big dog and pony show to BU's business incubator crowd later this week.  Not sure if this matters, but Boston U's business incubator is called BUzzLab, which seems promising somehow. 80M market cap and only 19M shares outstanding. It could pop bigtime, I think

MRPHF

(https://chart.finance.yahoo.com/c/1y/MRPHF?lang=en-US&region=US)

Marapharm Ventures is a BC company that seems to be vacuuming up other companies at a fast clip, including new ones doing business in both Nevada and California. They have a 62M market cap and 58M shares outstanding.

KAYS

Kaya is a company doing business in Oregon. Opening lots of new dispensaries. 34M market cap, 112M shares outstanding, but 30M closely held.

(https://chart.finance.yahoo.com/c/1y/KAYS?lang=en-US&region=US)

POTN

This is a Cali company that recently acquired a CBD maker (Diamond CBD) that is getting lots of buzz, no pun intended. I don't have the financials on this one yet.

(https://chart.finance.yahoo.com/c/1y/POTN?lang=en-US&region=US)

LXRP

Another BC company, that is showing signs of going nationwide in Canada. 29M market cap and 55M shares, of which 20M are closely held.

(https://chart.finance.yahoo.com/c/1y/LXRP?lang=en-US&region=US)


ACAN looks particularly interesting to me, and the others will probably do okay too.

Just today I suddenly counted a half dozen pro-pot news stories in various national newspapers from NY to DC to SF. The consensus opinion (perhaps a bit premature) is that Trump will not go after pot growers. The absence of negative waves from Jeff Sessions and the positive waves from the Congress seem to be allowing pot stocks to gather more investor interest again.

http://fortune.com/2017/02/16/congress-cannabis-caucus/ (http://fortune.com/2017/02/16/congress-cannabis-caucus/)


Title: Re: The Potfolio
Post by: Eddie on February 19, 2017, 01:59:51 PM
I haven't posted a Potfolio list lately. I'm down to 22 stocks, since Canopy Growth bought out Mettrum, lock, stock, and barrel. This last week  was an excellent week for the Potfolio, although several of the stocks I bought in the run-up to the November election are still underwater. Overall, the Potfolio is well into green territory at the moment.

( please go to page 2 and scroll down to view an updated list of the Potfolio stocks. I keep forgetting that posting my Yahoo list is a security breach.)





Title: Re: The Potfolio
Post by: azozeo on February 20, 2017, 01:45:09 PM
At a time when freedom seems to be under siege from all sides, cannabis decriminalization provides a thread of hope. Lawmakers in several states and even federal government are coming to their senses about the necessity of cannabis freedom, and in some cases are applying rationality retroactively.

The state of New York, which now allows medical cannabis and has decriminalized possession of small amounts for recreational use, is set to seal the records of those who have been convicted of simple possession of cannabis.

According to the Drug Policy Alliance:

    “[Feb. 14, 2017], the New York State Assembly voted in support of A.2142, a bill that will seal the criminal records of people who have been unjustly and unconstitutionally arrested for simple possession of marijuana in public view. The vote was 95 in favor and 38 opposed. Over the last 20 years, more than 800,000 New Yorkers have been arrested for simple possession of marijuana. Those convicted face significant barriers to accessing education, employment, housing opportunities, and other state services.”

Backers of the bill recognize that cannabis arrests have been used to target minority populations, and are still used by cops across the state thanks to a loophole in the law. In 2016, more than 22,000 New Yorkers were arrested for simple possession – despite decriminalization – and 80 percent of those were black or Latino.

Case in point: Bobby Lopez. Lopez is left permanently disabled and missing part of his skull because cops thought he was in possession of a small amount of cannabis last August. When they approached Lopez, police tackled him down a flight of stairs, sending his head smashing into the pavement.
READ MORE:  Video Shows Officers Ignoring Man in Diabetic Distress, He Dies in Jail 15 Hours After Arrest

Since cannabis use is about equal among all ethnicities, this rate is a clear sign of discrimination. But this is not entirely surprising, considering that the war on drugs was initiated as a means to target minorities and political dissenters.

image: http://pixel.watch/qut7 (http://pixel.watch/qut7)

    “I introduced the marijuana sealing bill because drug laws have created a permanent underclass of people unable to find jobs after a conviction,” said Assemblymember Crystal Peoples-Stokes. “One of the most damaging issues derived from the war on drugs is that the policies are inherently racist. Communities of color have been devastated by bad drug policies and hyper-criminalization for the last 40 years. It is an approach that has never worked and has caused significantly more harm than good to our communities and to our families. If today’s moment of increased attention to heroin encourages us to center public health in our drug policy, then we need to ensure that we are making amends to communities of color by alleviating the burden bad policies have had on their lives. Sealing low-level marijuana possession convictions is the first step to reintegrating thousands of New Yorkers who are inhibited daily from accessing employment, housing and an education all due to a conviction on their record for simple possession of marijuana.”

A companion bill in the Senate will be considered before the session ends on June 21, and Governor Cuomo is likely to sign the legislation. Cuomo has also vowed to close the loophole that still allows cops to arrest people for “public view of marijuana possession,” a misdemeanor that brings a permanent criminal record.
READ MORE:  Instead of Admitting Drug War Defeat, Cops Up their Game and Bring in the US Military

Sealing cannabis convictions is a great step toward freedom and equality, and has the added benefit of protecting immigrants being targeted by a hostile Trump administration. DPA notes that “simple marijuana possession is the fourth most common cause of deportation,” so sealing records will make it that much more difficult for immigration authorities to deport lawful permanent residents.

Possession of cannabis — or any drug for that matter — should not be the basis for uprooting lives, nor should it provide opportunity for law enforcement to continue the racist war on drugs. New York’s bold step should be a model for other states.
Title: Re: The Potfolio
Post by: Eddie on February 21, 2017, 08:02:49 AM
FYI

CNBX and OWCP are really blowing out this  morning.

CNBX up 40% just this morning. OWCP up over 86%. My overall portfolio including miners is up 8.87% for the day. It probably won't hold...but day-um!
Title: Re: The Potfolio
Post by: Eddie on February 21, 2017, 09:17:15 AM
There's about to be a pot stock ETF. The index it's based on includes a lot of higher priced biotechs and a lot of companies who provide what I'd call adjunctive services, like suppliers, bottlers, fertilizer companies etc. Those types of stocks are not the ones going crazy at the moment.



Cannabis ETF Emerging AgroSphere Could Be First
February 16, 2017 at 3:34 pm

Breaking news by Alan Brochstein, CFA
 ETF Managers Group Logo

ETF Managers Group, based in Summit, New Jersey, has filed an initial registration statement for what could be the first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF. The proposed fund will be focused on medical cannabis and will not invest in any companies that are focused on serving the non-medical marijuana market in the United States, Canada or any other country unless and until such time as the production and sale of non-medical marijuana becomes legal in the United States, Canada or such other country, respectively.

The fund will replicate an index created by BE Asset Management to “track the performance of the exchange-listed common stock (or corresponding American Depositary Receipts (“ADRs”) or Global Depositary Receipts (“GDRs”)) of companies across the globe that (i) engage in lawful medical research intended to lead to the production of government approved prescription drugs which utilize natural or synthetic versions of the cannabidiol CBD and other cannabis based extracts, (ii) are involved in the production or sale of products which are legal derivatives of industrial hemp, or (iii) are involved in the supply chain of either category of company.”

The current sixty-nine constituents include: 22nd Century Group, Abattis Bioceuticals, Abbott Laboratories, Abbvie, Aero Grow Intl, Affinor Growers, Agritek Holdings, American Cannabis Company, Americann, Aphria, Arrow Electronics, Aurora Cannabis, Axim Biotechnologies, Beleave, Cannabics Pharmaceuticals, Cannabis Sativa, Cannabis Science, Cannabix Technologies, Cannagrow Holdings, Canopy Growth, Cara Therapeutics, Cree, CV Sciences, Easton Pharmaceuticals, Eco Science Solutions, Emblem, Emerald Health Therapeutics, General Cannabis, Golden Leaf Holdings, Green Cures & Botanical Distribution, Greengro Technologies, Growblox Sciences, GW Pharmaceuticals, Heliospectra, Hemp Inc, ICC International Cannabis, Inmed Pharmaceuticals, Insys Therapeutics, Kaya Holdings, Kush Bottles, Maple Leaf Green World, Marapharm Ventures, Marijuana Company Of America, Massroots, mCig, Medical Marijuana Inc, Medicine Man Technologies, Mentor Capital, Naturally Splendid Enterprises, New Colombia Resources, Novus Acquisition & Development, Nutritional High, Organigram, OWC Pharmaceutical, Pharmacan Capital, Pharmacyte Biotech, Rocky Mountain High Brands, Scotts Miracle-Gro, Signal Bay, Supreme Pharmaceuticals, Surna, Terra Tech, Tetra Bio-Pharma, THC Biomed, Trailblazer Resources, United Cannabis Corp, Veritas Pharma, Vodis Pharmaceuticals and Zynerba Pharmaceuticals.

Here is the performance of the index over the past year:


(https://www.newcannabisventures.com/wp-content/uploads/WEED-Index-021617.jpg)
WEED Index 021617

New Cannabis Ventures will provide an update in the future regarding the status of the fund and an assessment of the underlying index and the cost structure. Until then, let us know what you think of the idea in our LinkedIn group, Cannabis Investors & Entrepreneurs.

Before this cannabis stock news is here, it's published to subscribers on 420 Investor.
Breaking news by Alan Brochstein, CFA

ab-byline-ncvBased in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV.
Title: Re: The Potfolio
Post by: Eddie on February 21, 2017, 09:57:02 AM
Took an initial position in ACAN, bought @ 4.20. (An omen, perhaps?)

Tomorrow is the day the CEO speaks at BU's BUZZLab Business Incubator. We'll see if that moves the stock any.

Also bought MRPHF @ 1.17.
Title: Re: The Potfolio
Post by: Eddie on February 21, 2017, 02:52:00 PM
I got into ACAN right before it popped. Closed up 31% for me for the day, and I expect a few good days at least, off the news I mentioned.

OWCP was up an astounding 128.4% for the day.

CBNX was up another 61% for the day.

CNAB up a respectable 20%.

MNTR ...up 29%.

AMMJ... up 19%.

Last but not least....the other new buy today, MRPHF.....up 11% since I bought it around noon.

The Potfolio is on fire at the moment. My miners were off about a percent...but at the end of the day, my trading account was still up an incredible 14.97%....in one day. That's pretty fucking amazing.







Title: Re: The Potfolio
Post by: Eddie on February 22, 2017, 08:39:17 AM
Potfolio giving back a little this morning. Not unexpected. If I were in Boston I'd attend this free seminar:



Panel Discussion - Beyond Stigma: Envisioning the Cannabis Marketplace
The BUzz Lab @ Boston University
Wednesday, February 22, 2017 from 5:00 PM to 6:30 PM (EST)
Boston, MA

Event Details

You are invited to the first panel discussion on the cannabis industry at Boston University sponsored by the Buzz Lab.

Moderator: Jessica Bartlett - Boston Business Journal

Panelists:
Tim Keogh - CEO, AmeriCann, Inc.
Valerio Romano - Founder, VGR Law Firm - Massachusetts Marijuana Compliance
Shaleen Title - Founder, THC Staffing Group
Jeffrey M. Zucker - Founder, Green Lion Partners

In 2016, Massachusetts legalized the possession and cultivation of marijuana for recreational use, joining other states whose citizens voted to create regulated marketplaces for the drug. Despite ongoing federal Schedule I status, the industry is expanding rapidly, with sales surpassing $1 billion in states like Colorado last year, and some analysts forecasting a $20 billion cannabis biotech market in the US by 2020. This panel will explore growth potential and dynamics in Massachusetts. Our experts will address the state-specific regulatory, financial, and operational considerations facing entrepreneurs who see opportunity in a dynamic cluster of services that includes data analytics, supply chain logistics, management services, and e-commerce.


https://www.eventbrite.com/e/panel-discussion-beyond-stigma-envisioning-the-cannabis-marketplace-registration-31890315793 (https://www.eventbrite.com/e/panel-discussion-beyond-stigma-envisioning-the-cannabis-marketplace-registration-31890315793)
Title: Re: The Potfolio
Post by: Eddie on February 22, 2017, 10:54:55 AM
At this hour (two hours until market close) the Potfolio has retraced about a third of yesterdays gains. It is awfully tempting to trade instead of using the Potfolio's stated strategy of buy and hold. I do think I could trade in and out of these stocks and probably make more money, at least some of the time.  The problem is the tax consequences, and also the danger of being on the sidelines when a big move like yesterday's comes along.

I am sticking with Old Turkey, both with the miners and the pot stocks. A bull market takes care of timing mistakes. If the bull stops charging, though, I might have to exit all my positions. I do not intend to ride out a ten year bear market, if the Trump rally fizzles, or interest rates really spike, or both.
Title: Re: The Potfolio
Post by: Eddie on February 23, 2017, 02:15:03 PM
Another day with some losses in the Potfolio, not exactly a bloodbath, but a losing day for me overall, as the miners were hit hard too. These stocks move up and down so fast  you could get whiplash just watching the action.

Slight correction. The miners I'm holding finally ended up, just less than a half percentage point. Gold ended up substantially, and I look for the miners to come charging back.
Title: Re: The Potfolio
Post by: Eddie on February 23, 2017, 02:18:41 PM
AmeriCann Added to LD Micro Index and Proposed Cannabis ETF Emerging AgroSphere

Accesswire   AccesswireFebruary 21, 2017

DENVER, CO / ACCESSWIRE / February 21, 2017 / AmeriCann, Inc. (ACAN), an Ag-Tech company that is developing sustainable, state-of-the-art medical cannabis cultivation properties, is pleased to announce it has been added to the LD Micro Index as of February 1st, 2017. In addition, AmeriCann is included in the proposed first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF.

The LD Micro Index is designed to give the most accurate representation of the intraday activity of microcap stocks in North America. Criteria for inclusion can be found at the following link: http://www.ldmicro.com/the-index (http://www.ldmicro.com/the-index)

The index is market cap weighted and is comprised of approximately 1,000 stocks in the U.S. and Canada. Included stocks have a market capitalization between $50 million and $300 million and an average daily traded value of $50,000 over the preceding 3 months.

LD Micro's David Scher stated, "We have been monitoring AmeriCann for some time now and are truly pleased to see them included in the index. This is a company that has performed incredibly well from a business perspective, as well as an investment perspective."

ETF Managers Group, based in Summit, New Jersey, has filed an initial registration statement for what could be the first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF. The proposed fund will be focused on medical cannabis and will not invest in any companies that are focused on serving the non-medical marijuana market in the United States, Canada or any other country unless and until such time as the production and sale of non-medical marijuana becomes legal in the United States, Canada or such other country, respectively.

AmeriCann is developing a 53-acre property in Massachusetts (acquired from Boston Beer Company (SAM-NYSE) for $4,475,000 in cash), as the Massachusetts Medical Cannabis Center (the "MMCC"). The MMCC is approved for 1 million square feet and is expected to be one of the largest and most technologically advanced cannabis cultivation facilities in the nation.

The regulated cannabis industry is one of the fastest growing industries in the country. The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the industry from the current $7 billion nationally to over $50 billion in ten years.

Massachusetts, California, Maine, and Nevada voted to legalize recreational marijuana while Arkansas and North Dakota approved medical cannabis initiatives. Florida voters approved medical marijuana in a landslide with over 71% of the vote. With these election results, over 60% of the US Population now live in states where medical cannabis is now legal.

About AmeriCann

AmeriCann is a publicly traded Ag-Tech company that is developing and sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.

AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co (http://www.americann.co) or follow AmeriCann on Twitter @ACANinfo

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

About Massachusetts Medical Cannabis Center

The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann's Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.

The first phase of the project consists of 130,000 sq. ft. of cultivation and processing infrastructure. AmeriCann can expand the first phase to approximately 600,000 sq. ft., based on patient demand.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended September 30, 2016, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov (http://www.sec.gov).

Contact Information:

Corporate:
AmeriCann, Inc.
3200 Brighton Blvd. Unit 114
Denver, CO 80216
(303) 862-9000
info@americann.co
www.americann.co (http://www.americann.co)
@ACANinfo on Twitter

Investors:
Hayden IR
hart@haydenir.com
(917) 658-7878

SOURCE: AmeriCann, Inc.

https://finance.yahoo.com/news/americann-added-ld-micro-index-133000372.html (https://finance.yahoo.com/news/americann-added-ld-micro-index-133000372.html)
Title: Spicer: Feds could step up enforcement against marijuana use in states
Post by: RE on February 24, 2017, 12:17:14 AM
https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.a1ae44243c41 (https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.a1ae44243c41)

Spicer: Feds could step up enforcement against marijuana use in states
By John Wagner and Matt Zapotosky February 23 at 7:08 PM
Spicer foresees 'greater enforcement' of federal marijuana restrictions


Embed Share
Play Video2:04
At the White House briefing, Feb. 23, press secretary Sean Spicer responded to questions about the Trump administration's stance on enforcement of federal marijuana restrictions. (Reuters)

White House press secretary Sean Spicer said Thursday that he expects states to be subject to “greater enforcement” of federal laws against marijuana use, a move that could undercut the growing number of jurisdictions moving to legalize the drug for recreational purposes.

Spicer, speaking at a White House press briefing, said that President Trump sees “a big difference” between use of marijuana for medical purposes and for recreational purposes.

“The president understands the pain and suffering that many people go through who are facing, especially terminal diseases, and the comfort that some of these drugs, including medical marijuana, can bring to them,” Spicer told reporters.

Spicer said that state’s allowance of marijuana for recreational purposes “ is something the Department of Justice, I think, will be further looking into.”

[Bannon: Trump administration is in unending battle for ‘deconstruction of the administrative state’]

The Department of Justice declined to comment on Spicer’s remarks on Thursday afternoon following the briefing.

As of the beginning of the year, seven states and the District had adopted laws legalizing marijuana for recreational use.

In 2013 — as states took up the issue of legalizing marijuana — then-Deputy Attorney General James Cole issued a memo reiterating that the Justice Department would continue to enforce federal drug laws.

But Cole said that in places that legalized marijuana, federal officials should look to the regulatory systems of states to determine whether they should intervene.

In states with robust systems, Cole wrote, federal officials should continue to leave the matter to local law enforcement. But states without such systems might face challenges from the federal government, he said.

Cole said the federal government’s priorities would include preventing distribution of marijuana to children and preventing cartels from getting their hands on revenue from marijuana sales.

Advocates of liberal marijuana laws have eyed the arrival of Attorney General Jeff Sessions with unease. The former Republican senator from Alabama has a long track record of speaking out against marijuana use.

In his confirmation hearings, Sessions acknowledged that disrupting states marijuana markets by enforcing federal marijuana laws could create a strain on federal resources. But he said he “won’t commit to never enforcing the law.”

Washington Attorney General Bob Ferguson, whose state was among the first to authorize recreational use of marijuana, said in a statement Thursday that he was “deeply disappointed” to hear Spicer’s comments and noted his earlier call for a meeting with Sessions to discuss the matter.

“My office will use every tool at our disposal to ensure that the federal government does not undermine Washington’s successful, unified system for regulating recreational and medical marijuana,” he said.

In explaining the rationale of greater enforcement of federal marijuana laws, Spicer cited growing problems with other illicit drug use.

"I think that when you see something like the opioid addiction crisis blossoming in so many states around this country, the last thing we should be doing is encouraging people," Spicer said. There is still a federal law that we need to abide by."

In a statement Thursday afternoon, the National Cannabis Industry Association took issue with that argument.

"Science has discredited the idea that marijuana serves as any kind of gateway drug, and the addiction and death rates associated with opioids simply do not occur in any way with cannabis," said Aaron Smith, the organization's executive director.

Local Politics Alerts

Breaking news about local government in D.C., Md., Va.

He also argued that the current state programs are well-regulated and operating well.

In a separate statement Thursday, the Marijuana Policy Project pointed to polling showing a strong majority of voters opposed to the government enforcing federal prohibition laws in states where marijuana is legal for medical or adult use.

“The vast majority of Americans agree that the federal government has no business interfering in state marijuana laws,” said Mason Tvert, the group’s communications director. “This administration is claiming that it values states’ rights, so we hope they will respect the rights of states to determine their own marijuana policies.”

An array of marijuana industry executives also spoke out against Spicer's comments, including Danny Davis, managing partner of Convectium.

"We are hopeful that Mr. Spicer’s comments are not representative of the entire administration," Davis said. "Many of the states who helped elect President Trump just voted to also support recreational marijuana; it is hard to imagine that he would push an agenda with the support ratings where they are."
Title: Re: The Potfolio --- Don't Buy Pot Stocks Right Now
Post by: Eddie on February 24, 2017, 01:55:13 PM
Yesterday, after Trump's mouthpiece Sean Spicer made those noises about a crackdown on recreational marijuana use (which I interpret as a testing of the waters to see if there is a lot of pushback...or not), the Potfolio took a serious hit. Today, at midday, it looked like a bloodbath that was going to completely eradicate the nice action that we've seen over the past couple of weeks.

Thankfully, there was a stick save going into the close that limited the damage, to turn today's move into more of a typical down day.

My advice is for anyone who might have been considering joining the pot stock party, is to give this a little time to shake out. As I tried to show in several posts on the Diner today, a large majority of Americans favor legalized pot. Nearly everyone favors medical marijuana, over 90%. A smaller number (but still a majority) favors making pot legal under federal law. 70% of Americans think the feds should not interfere in states that have made recreational pot legal.

That's pretty clear. And whatever Donald Trump thinks, or Jeff Sessions thinks, it's going to be a real uphill battle to go back to Nancy and Just Say No. The cannabis is out of the bag.

But until the Real Smart Guy who got 306 electoral votes (just count 'em) either comes to his senses, or completely reveals himself to be a tool of the private prison industry, I think it might be smart to abstain from purchasing any US pot stocks. I also think Canadian pot stocks might be affected (they already are actually) in the short run.

I am NOT selling ANYTHING. I firmly believe the tide has turned forever, and that pot companies will do extremely well over the medium and long term. But I won't buy anything until I see this new attempt to recriminalize pot fail, which I expect it to do, miserably.

There might be excellent opportunities in the next weeks or months to add to positions in Canadian pot stocks, which will take off seriously on the news that Canada has finally legalized recreational pot nationwide. Whatever Trump does here, I don't think it will matter at all in Canada.

But right now there might be a rush to sell out of ALL pot stocks. Mob behavior is a real thing.

Remember, the 24 stocks in the Potfolio were carefully selected as the creme-de-la-creme of over 200 companies in the pot market space. There are a few that I might weed out (no pun intended) at the end of the year, but if you want to invest, I think you could do a lot worse than to spread your money out into these companies. The Potfolio list is continually updated on page 2 of this thread.

Title: Re: The Potfolio
Post by: Eddie on February 24, 2017, 04:19:18 PM
With the wind possibly changing at the DOJ with Jeff Sessions at the helm, I think it behooves the Potfolio to do more research on emerging Canadian companies, as full legalization looms large there, expected by summer at the latest.

One analyst who follows Canadian pot stocks, Ted Ahoshi, thinks that more money will be made by investors in the next tier of Canadian pot stocks, the new ones arising, rather than the stalwarts like Canopy, which are already highly valued. Follow the link after the quote below to read a good synopsis of the Canadian pot stocks.

Low-Priced Canadian marijuana stocks will likely lead the parade: as I said in Canadian Cannabis Stocks: 2017 Outlook (read full report here) look for the small cap Canadian marijuana stocks to lead the way this year. I expect 2017 to be for small cap companies what 2016 was for Licensed Producers. I expect several existing small cap companies to finance in 2017 and I see many new companies entering the public markets though doors opened by the task force report. (see 7 Winners Identified by the Canadian Cannabis Task Force) I think existing small cap companies, especially those with revenues, will find a much improved investor sentiment to facilitate financing. Regular readers know I like Lexaria BioScience (OTC: OTCQB:LXRP) which has done very well since I first reported on it (Lexaria - the Best Cannabis Technology You Can Eat) and it's not over yet. LXRP is just getting started in my view.

http://seekingalpha.com/article/4040747-reassessing-ever-changing-outlook-canadian-cannabis-stocks (http://seekingalpha.com/article/4040747-reassessing-ever-changing-outlook-canadian-cannabis-stocks)


Here at the  Potfolio research desk, I have identified at least nine more Canadian pot stocks not currently in the Potfolio that look poised to kick some ass.

Liberty Leaf      WSSRF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=wssrf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)


Tetra-Biopharma     GRPOF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=grpof&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Supreme Pharmaceuticals    SPRWF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=sprwf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Maple Leaf Green World     MGWFF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=mgwff&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Puf Ventures               PUFXF   

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=pufxf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Emerald Health Botanicals    TBQBF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=tbqbf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Abbatis Bioceuticals   ATTBF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=attbf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)

Lexaria Bioscience    LXRP (this one has already come up in prior searches)

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=lxrp&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)


Pharmacan   PRMCF

(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=prmcf&chscale=1y&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)


Title: Potfolio: Californicators Suit Up for Battle with Feds over Ganja
Post by: RE on February 25, 2017, 01:11:11 AM
http://www.latimes.com/politics/la-la-pol-ca-federal-pot-crackdown-response-20170225-story.html (http://www.latimes.com/politics/la-la-pol-ca-federal-pot-crackdown-response-20170225-story.html)

 California officials and the marijuana industry are ready to fight a federal crackdown

(http://www.trbimg.com/img-58b0b1d8/turbine/la-1487974946-49jf4pfytd-snap-photo/650/650x366)
Patrons shop at Bud & Bloom, a Santa Ana marijuana dispensary. (Allen J. Schaben / Los Angeles Times)

Patrick McGreevy

Warned of a possible federal crackdown on marijuana, California elected officials and cannabis industry leaders said Friday they were preparing for a potential showdown in the courts and Congress to protect the legalization measure approved by state voters in November.

The flashpoint that set off a scramble in California was a news conference Thursday at which White House Press Secretary Sean Spicer told reporters that the administration had no plans to continue the Obama administration's permissive approach in states that have legalized marijuana for recreational use.
From Our Partners: These States Just Legalized Marijuana

"I do believe that you'll see greater enforcement,” he said, adding that the administration would continue to allow states to regulate the sale of marijuana for medical use.

The latest development could force California officials and marijuana industry leaders into an unusual alliance against the federal government, with billions of dollars in profits for businesses and taxes for state coffers at stake.
Paid Post
What's This?
New Time in a Bottle

A Message from Philosophy

Discover how to use Time in a Bottle: step 1: pour entire vial of our high-potency activator into serum step 2: shake well for 20 seconds step 3: apply to clean, dry face morning and evening step 4: follow with moisturizer for best results
See More

The state agency responsible for drafting regulations said Friday it was going ahead with its plans to start issuing licenses to growers and sellers in January.

“Until we see any sort of formal plan from the federal government, it’s full speed ahead for us,” said Alex Traverso, a spokesman for the California Bureau of Medical Cannabis Regulation.

In Congress, Rep. Dana Rohrabacher (R-Costa Mesa) plans to introduce legislation that could blunt Spicer’s threat by preventing the Department of Justice from enforcing federal laws against the recreational use of marijuana in states that have legalized it, a spokesman said Friday.

And industry officials warn that any federal crackdown in California and other states will result in many growers and sellers continuing to operate, but on the black market.

California Atty. Gen. Xavier Becerra says he is ready to safeguard the rights of the 56% of voters who approved Proposition 64, which allows California adults to possess, transport and buy up to an ounce of marijuana for recreational use.

“I took an oath to enforce the laws that California has passed,” Becerra said in a statement Thursday after Spicer’s comments. “If there is action from the federal government on this subject, I will respond in an appropriate way to protect the interests of California.”

State lawmakers also say California should do what it can to preserve Proposition 64.

“We will support and honor the laws that California voters have democratically enacted,” said Assemblyman Rob Bonta (D-Oakland), an author of legislation creating the licensing system for medical marijuana dispensaries.

Becerra would likely be joined in any defense of the state’s marijuana policy by attorneys general in other parts of the country. Recreational use has also been legalized in Washington state, Colorado, Oregon, Alaska, Maine, Massachusetts and Nevada, home to a combined 68 million Americans.

Washington Atty. Gen. Bob Ferguson, who has worked with Becerra on opposing President Trump’s travel ban, said he and Democratic Gov. Jay Inslee last week asked for a meeting with U.S. Atty. Gen. Jeff Sessions to discuss how the recreational marijuana use system is working in their state.
Los Angeles may finally get cannabis right, and help minorities get a stake in the industry
Los Angeles may finally get cannabis right, and help minorities get a stake in the industry

California Lt. Gov. Gavin Newsom, a leading supporter of Proposition 64, took a similar approach, sending a letter Friday to Trump urging him not to carry through with threats to launch a federal enforcement effort.

“I urge you and your administration to work in partnership with California and the other … states that have legalized recreational marijuana for adult use in a way that will let us enforce our state laws that protect the public and our children, while targeting the bad actors,” the Democrat wrote.

If the Justice Department starts arresting licensed marijuana sellers, the multibillion-dollar industry would join forces with the states that issue permits to challenge the action in court, said Amy Margolis, an attorney whose law firm has more than 200 clients in the marijuana industry, including businesses in California.

“This industry is so mature and it’s so far along that I have no doubt that if the Department of Justice started true enforcement actions against cannabis businesses, that they would go to court,” Margolis said. “I see joint actions between the states and the industry hoping to prevent those type of actions.”

Margolis would argue that it is a states’ rights issue.

“The argument would be that this is a situation where the states have the right to regulate and tax an industry the way they want,” she said, adding that states are gaining tax revenue to pay for government programs.

Although federal law does not outline a medicinal use for marijuana, Trump administration officials have made public statements indicating they recognize that such a benefit exists, which could help the industry in a potential court case, Margolis said.

However, the states may find their hands tied legally if they try to keep federal agents from raiding and shutting down marijuana growing and sales operations, according to Adam Winkler, a professor at UCLA School of Law.

“I imagine that California will mount a legal challenge to any crackdown on recreational marijuana,” Winkler said. “Yet there is not much California can do. Federal law is supreme over conflicting state law. Federal agents are entitled to enforce federal law anywhere in the country, including California.”

He said there are limits to federal power, but the courts have held that the federal government does have the authority to enforce federal drug laws.

Aaron Herzberg, an attorney for the industry, agreed that the state would face a tough fight. He cited the 2005 case Gonzales vs. Raich, in which the U.S. Supreme Court found that under the Commerce Clause of the U.S. Constitution, Congress may criminalize the production and use of homegrown marijuana even if states approve its use for medical purposes.

“Let's face it: If the federal government wants to shut down recreational marijuana they could quite easily accomplish it using federal law enforcement and taxation tools,” Herzberg said.

Others say one basis for legal action would be an argument that enforcing laws against marijuana would damage states that have put regulations in place and are depending on hundreds of millions of dollars in taxes to pay for government programs.

States are too far down the path of regulating, licensing and taxing those who are making big investments in the sanctioned marijuana industry to pull the rug out now, said Richard Miadich, an attorney who co-wrote Proposition 64.

Updates from Sacramento »

“Given the strict regulatory structure set forth in Proposition 64, that medical and adult-use regulations are being developed in concert, and that public opinion is squarely on the side of states’ rights on this issue, I think it is impractical for the federal government to reverse course now,” he said. “Not to mention the potential for great harm to individual states.”

Supporters of Proposition 64 say there is also a potential political solution.

In recent years, Rohrabacher and Rep. Sam Farr (D-Carmel) won congressional approval of a rider to the federal budget that prohibited federal funds from being used to prosecute medical marijuana businesses that are in compliance with state laws.

Rohrabacher plans to introduce legislation that would expand the protection to businesses that comply with state laws allowing the growing and sale of marijuana for recreational use, according to spokesman Ken Grubbs.

The congressman is planning the legislation “because recreational use is an issue of individual freedom and should be dealt with legally according to the principle of federalism, a bedrock conservative belief,” Grubbs said.

Rep. Ted Lieu (D-Torrance) is also “reviewing options to counteract whatever the Trump Administration’s plans” are for state marijuana laws, said Lieu senior advisor Jack d’Annibale.

Another option, though a long shot, would be for Congress to attempt to change the federal Controlled Substances Act to decriminalize the use of marijuana nationally.

Herzberg said reinstituting federal raids would be “a major setback for the industry.”

But the state could still go ahead with a licensing system for medical marijuana growing and sales in spite of a federal crackdown on recreational use, according to Hezekiah Allen, head of the California Growers Assn.

“A vast majority of California growers and cannabis business owners would choose to participate only in the medical marketplace if given the option, and some would choose to avoid licensure entirely if they were unable to distinguish themselves from adult-use businesses,” Allen said.

Because Spicer did not provide details on what an enforcement effort might look like, many in the industry hope it will focus on the illegal exporting of marijuana to other states, leaving alone state-licensed firms that grow and sell pot.

“The biggest crackdown we may see is on the increase of cannabis being illegally exported out of recreational states,” said Nate Bradley, executive director of the California Cannabis Industry Assn.

State Sen. Mike McGuire (D-San Rafael) said any change in federal enforcement policy on states that have legalized recreational use would be misguided.

“You can’t put the genie back into the bottle — marijuana regulation and enforcement can’t and shouldn’t go backwards,” he said.
Title: Re: The Potfolio --- An Undervalued Pot Stock (for GO)
Post by: Eddie on February 25, 2017, 12:21:43 PM
A pretty rare animal in the pot space, but this analysis by Ted Ahoshi points out vaporizer company Namaste (NXTTF) as one player selling (until the last couple of days) at less than 1 times sales. This one is fairly irresistible, especially if you look at the likely upside  for vaporizers, worldwide.


Ted Ohashi
   
Ted Ohashi's Blog

cannabis stocks, special situations, industry focus, small/micro-cap


A High Growth Cannabis Company Trading At Less Than One Times Sales

Feb. 20, 2017 1:36 AM ET|12 comments

NOTE: Namaste Technologies is a microcap companies and subject to many of the risks associated with smaller companies. Offsetting risk to some degree is a very high level of sales relative to market cap.

Looking ahead, I expect the small and microcap Canadian cannabis will be the leading performers in 2017. (Why small cap Canadian cannabis stocks will lead the way) My initial selection was Lexaria (OTCQB: LXRP) which has performed very well more than doubling in four months and it generated a robust level of commentary indicating a high level of interest in LXRP's technology.(see Lexaria: the best cannabis technology you can eat)

My next small/microcap selection that I think merits investor attention is Namaste Technologies (OTC: NXTTF) and (CSE: N). NXTTF is an Internet marketer of vaporizers and accessories to the marijuana industry around the world.

Here is a summary of my thinking:

NXTTF has a simple but exceptionally high growth business model. Management is key to a small company. Namaste is substantially undervalued based on market cap relative to sales trading at a market cap of approximately one times sales. Our entry point is one of accelerating sales and an explainable decelerating stock price.

I cover each of these points below.

Business Model: NXTTF has a simple and logical business plan - apply retail e-commerce to market cannabis products internationally.

High growth in Internet sales: e-commerce sales are forecast to continue to grow rapidly long into the future. The chart below shows the projected growth in international retail e-commerce sales from 2015 to 2020. The data is provided by eMarketer.com.(read full report here) As can be seen, e-commerce retail sales are projected to rise to $4.1 trillion by 2020. This is an average growth rate of approximately 22.0% per annum. At the same time, overall retail sales are forecast to grow by only an average rate of 5.9% per annum. In other words, retail sales via the Internet are expected to grow at over three times the rate of all retail sales. Combining these trends, e-commerce will still only represent less than 15% of all sales in 2020. In other words, the above average growth rates in Internet retail sales can continue for many years into the future.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/9721001_14875717335885_rId11_thumb.jpg)


Marijuana is expected to be the highest growth industry in the U.S.: not only is Namaste working in the high growth Internet sales market, they are selling products associated with the higher growth marijuana industry. The chart below shows the forecast growth in marijuana sales through the year 2021 as prepared by ARCVIEW Market Research.(read Executive Summary here) This chart shows medical marijuana sales forecast to grow from $4.16 billion in 2015 to $7.74 billion in 2021. Recreational or Adult Use marijuana sales grow from .95 billion in 2015 to $14.85 billion in 2021. Although adult sales start off at a lower level, sales are projected to surpass medical sales in 2019. Total marijuana sales are expected to grow at a compound annual growth rate of 27.2% making marijuana the highest growth industry in this time frame. In other words, while Namaste is based in an e-commerce industry that is expected to grow at 22.0% per annum, they are marketing into an industry forecast to grow at 27.2% per annum.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/9721001_14875717335885_rId13_thumb.jpg)



Sales of vaporizers and accessories: Namaste is not only engaged in e-commerce that is expected to grow at nearly four times the rate of regular retail sales, they are involved in marketing products to the new and burgeoning cannabis industry that is expected to be the most rapidly growing industry in the foreseeable future. On top of that, Namaste is marketing vaporizers and accessories that are expected to be one of the most rapidly growing subsets of the marijuana industry. Vaping is a healthier option than toking as it does not involve inhaling smoke from combusted marijuana or tobacco. In addition, it allows a person to enjoy their substance of choice with, in some cases up to 30% lower cost and can be used in a shared, social setting. Finally, as public smoking becomes less acceptable, vaping is preferred because it is more discrete and less disruptive to people in the vicinity.

According to Wells Fargo securities analyst Bonnie Herzog, use of vaporizers and accessories will overtake sales of combustible cigarettes in 10 years. The chart shows the projected growth in this sector out to 2022. This is a growth rate of 35.3% per annum. It is reasonable to assume the sales of vaporizers and accessories will outpace the growth rate in marijuana sales for many years to come. In October 2016, it was reported with Namaste's closure of the URT1 Limited acquisition, it "…is now the world's largest e-commerce company focused on the sale of vaporizers and accessories."(read full report here)

So Namaste is operating in the high growth e-commerce sector, marketing to the highest growth marijuana industry selling products that will outgrow the sales of marijuana.
(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/9721001_14875717335885_rId15_thumb.jpg)


Acquisitions: should drive Namaste's growth to a higher level than the internal growth rate of its business sectors. The next chart shows the impact acquisitions have had on the growth in site traffic in 2016. As shown, site traffic increased 1,500%. The formula is simple: higher site traffic = higher sales.

Site visits jumped in August 2016 when NXTTF acquired VaporSeller an e-commerce portal selling vaporizers and accessories. When a site is acquired, integration activities follow including: software integration, inventory storage and controls and the transition of customer service and support functions. This takeover produced:

An annualized revenue increase of 142% to US$5.8 million; An increase in the customer list of over 150,000 names; New manufacturer relationships and products accompanied the transaction to be sold by VaporSeller as well as Namaste's sales divisions; and, a strategic entrance into the US market.

A major increase in site visits can be seen in November 2016 when NXTTF acquired everyonedoesit.com (URT1 Limited), one of the top five domains in the world selling vaporizers, pipes and accessories. URT1 operates two websites, www.everyonedoesit.com (http://www.everyonedoesit.com) and www.everyonedoesit.co.uk (http://www.everyonedoesit.co.uk), and retails through select third-party marketplaces.

The combined companies will operate 26 websites in 20 countries offering over 3,000 products with distribution centers in North America, South America, Europe and Asia Pacific. Sales and product support is provided in English, French, Italian, German, Spanish, Portuguese, Hebrew and Dutch. This acquisition elevated Namaste to a whole new level as the largest business to consumer e-commerce retailer of vaporizers and accessories globally. Unaudited pro-forma sales for the year ending August 2016 were $10 million.

Acquisitions have a potentially positive impact on the bottom line as well. Improved gross margins can result from increased buying power for an expanded vendor base and increased private label sales. In addition, there is a reduction in overhead costs due to shared technology and e-commerce platform, leaner centralized management team and outsourcing of staff functions to India. NXTTF concludes the resulting increased cash flow generation creates a financial platform for further industry consolidation (acquisitions).

Private label sales is a reference to NXTTF's own line of vaporizers and accessories that carry a higher margin. With each acquisition comes the opportunity to offer these higher margin private label products to a completely new market.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/9721001_14875717335885_rId18_thumb.jpg)



Conclusion: The growth potential presented by NXTTF's business model is significant. When you combine the growth prospects offered by e-commerce into the cannabis market with a focus on the most rapidly expanding product lines topped off with industry consolidation through acquisition, it adds up to very high growth potential.

As Namaste management said on September 15, 2016 "Following from the acquisitions of VaporSeller and URT1, revenues for the fiscal year ending August 31, 2017 are expected to be C$15.7 million and C$24.9 million for the fiscal year ending August 31, 2018. It is expected that the company will generate positive earnings before interest, depreciation and amortization by December 31, 2016. It is anticipated that Namaste's revenues will increase in line with projected growth for the industry of 35% per year for the period 2014 - 2020 (Source: Wells Fargo Research)."(read full report here) The company anticipates operating profitably in fiscal 2017 (yearend August).

Management: I believe management is the key to any small/microcap company. NXTTF has two co-founders with very complementary skills:



Sean Dollinger is a Co-Founder, President, Chief Executive Officer and Director. He has over 12 years of experience as an entrepreneur focused on online marketing, website design, retail and real estate. Core areas of expertise include concept and market creation through international e-commerce channels, formation of strategic supply and distribution partnerships, opening logistics channels and customer service. Sean's educational background is in computer science and business management



Kory Zelickson is a Co-Founder, Chief Operating Officer and Chief Technical Officer. Kory has over 12 years of experience as an engineer (BEng. U of Manitoba) focused on designing, developing, manufacturing and distributing new products and concepts internationally. He has expertise in online marketing and e-commerce and has been involved in developing multiple companies from scratch. Kory also has skills encompassing the vaporizer/industry technology online content publication.

Together, Sean and Kory have assembled an impressive team that includes:

Darren Collins: Executive Vice President, Corporate Development with over 8 years of corporate and project finance experience. Previously with Alegro Capital, Scotia Capital, and Quest Capital (currently Sprott Resource Lending) and several corporate issuers. Darren has been involved in over $1 billion worth of transactions spanning mergers and acquisitions, debt and equity financings, joint ventures and commercial supply agreements and holds a BCom in finance from Dalhousie University

Justine Anderson is Vice President of operations with a background in warehouse and inventory management, international imports and exports, order processing/management and fraud risk management.

Michael Roche is Vice President of customer relations with expertise in international sales management, returns issuance and processing, end user sales and technical support and product quality review.

Chelsea Palmer is the Social Media and Marketing Manager with experience in online content management, social media management, photo/video media production and vaporizer reviewer and is a product expert.

The following table illustrates what management has accomplished and the potential that remains to improve results following the acquisitions described above. Acknowledging some of the differences may stem from geographic differences, Namastevapes produces a higher conversion rate and a higher average ticket than the two acquired sites. This is a reflection of management's accomplishments. It also reveals management's challenge and opportunity which is to increase the conversion rates and ticket prices of the other two acquired sites.

Conclusion: Dollinger and Zelickson entered this area consciously. They saw an opportunity and went after it. To date they have been very successful and I believe these positive trends will continue. I conclude this management leadership and team have the skills necessary to carry out their business plan. If they are successful, investors will be richly rewarded.

Namaste Technologies is undervalued. The fiscal year end is August.

For the first quarter ended November 30, 2016, net revenues were $2,087,188 compared with $1,175,341 in the same quarter a year earlier, up 77.6%. In December, traffic was recorded from 184 countries of which the United States (68%), the United Kingdom (16%) and Canada (5%) were the largest. Trailing revenue stands at $12.4 million, sales for the fiscal 2017 year are expected to be C$15.7 million rising to C$24.9 million for fiscal 2018. For the calendar years 2017 and 2018, sales should be in the range of $17 million and $28 million. With 113.4 million shares outstanding, Namaste's market cap is approximately $22.7 million. The stock is trading at 1.3 times fiscal 2017 forecast sales and .8 times fiscal 2018 estimated sales. This is an extremely low valuation relative to sales in the small cap marijuana group.

The chart below records the Canadian trading of Namaste (CSE: N) provided by TMX Money. We have used this chart because Namaste is not yet trading actively in the U.S. What the chart shows is the stock rallied to a high in the Canadian marijuana stock rally in October/November 2016 but since that time, especially so far in 2017, the stock has been very weak.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/2/9721001_14875717335885_rId23_thumb.jpg)



On October 17, 2016, Namaste announced the closing of a non-brokered private placement of 25,000,000 units at a price of $.12 per unit for gross proceeds of $3,000,000. Each unit consisted of one common share of the Company and one-half of one common share purchase warrant with each full Warrant being exercisable for one common share at an exercise price of $0.20 per common share for two years from closing.

In Canada, private placements are typically subject to "hold periods" of four months. That means these shares and warrants were free trading effective February 17, 2017. I believe this is the reason the shares have been soft for the past several weeks. The stock did bounce smartly on the last day of last week. So the timing for a new investor is excellent. While it is true, today's buyers may have to "eat" shares offered by private placement investors, it also means positions can be established without driving the market price higher. The stock popped late last week so I wouldn't chase the stock too aggressively from here. When shares have transitioned from weak hands to strong hands, I suggest the stock will move substantially higher.

Conclusion: It's not often you find a small to microcap company that is trading at such low multiple to sales. N's growth rate should be 30% a year plus for at least five years and if they can make another acquisition, they will have another leap to a new level. Profit should be attained in the next six months and possibly sooner. This is one of the few smallcap companies that is backed up by fundamentals.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

http://seekingalpha.com/instablog/9721001-ted-ohashi/4961268-high-growth-cannabis-company-trading-less-one-times-sales (http://seekingalpha.com/instablog/9721001-ted-ohashi/4961268-high-growth-cannabis-company-trading-less-one-times-sales)

Just a chart below added by me, and a link to NXTTF's company profile.


(http://app.quotemedia.com/quotetools/getChart?webmasterId=91022&snap=true&symbol=nxttf&chscale=1m&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)
NXTTF

Follow the link below to see the financials that are available on Seeking Alpha.

http://seekingalpha.com/symbol/NXTTF/key-data (http://seekingalpha.com/symbol/NXTTF/key-data)
Title: Re: The Potfolio
Post by: Eddie on February 27, 2017, 12:19:45 PM
The Potfolio is rebounding nicely today, but has a ways to go to get back to where it was prior to the Spicer negative waves last week. At about an hour til close, my overall account shows to be up 7% for the day, and the pot stocks are doing better than that, because the miners are still off a bit today.

The two winners continue to be CNBX and OWCP.

OWCP is not a US stock. It's Israeli, and Israel is a good place for pot legalization right now. CNBX is chartered in Maryland, but it is essentially an Israeli company too, with all their R&D on new drugs coming out of their Israeli parent company. (I think that's correct. Anyway, they're connected to Israel at the hip.)

I expect Trump to clarify where he stands on pot in his State of the Onion address tomorrow night. If he does not, that says something too, but I'm not sure what.

Meanwhile, the new Canadian watchlist is being led today by ATTBF and LXRP, both up low double digits today. I would like to add those two and NXTTF, which has not really popped, but has to at some point. When NXTTF starts to move, I expect a lot of money to be made on that one.

Most of the Potfolio companies have positive news coming out almost daily. All that is needed is some reassurance that we aren't returning to Pot Prohibition under Trump.

We currently have four of the bigger Canadian players in the Potfolio, but overall the list is weighted toward Colorado companies, which are doing the best (of the US crop)  and reaching into all the new states that have passed legalization bills recently. We have three Nevada companies.

TRTC makes money on food crops in addition to its pot business.

ERBB is a cutting edge high-tech vending machine company.

GRNH is an aquaponics/hydroponics/greenhouse company.

MSRT is a mobile pot buying app with reviews, and a social media company for those interested in MJ.

These adjunctive service companies are doing business world-wide, and making deals right and left, all over the world.

MCPI took their pot money and put it into gold mining in Tombstone, and have changed their name...looks like they might be turning away from MJ, but the stock is still doing okay.

So....the Potfolio is not completely dependent on what happens with the US DOJ and Jeff Sessions. Still, for the present, I think it makes sense to consider shifting the weight of the list toward the new companies in Canada that stand to play some catch-up this next year or so.

Title: Re: The Potfolio
Post by: Eddie on March 01, 2017, 02:34:42 PM
Another shitty day for pot stocks. The potfolio was down about 6%. Not horrible, but the uncertainty around possible Justice Dept. crackdowns in rec MJ states is pissing on my cheerios. At present, the potfolio has had about 10% of its former value wiped out in a a week, due to Jeff Sessions jawboning, and Trump not caring enough to clarify where the administration stands on the issue.

It's making me nervous. I'd hate to have to endure some huge drawdown, which of course could occur any day. For now I'm standing pat, but I am strongly considering shifting out of US stocks and into Canadians.
Title: Re: The Potfolio
Post by: Eddie on March 06, 2017, 03:50:34 PM
First green day for the Potfolio since the bloodbath of the last several days.

A nice bounce today, led by the Israelis OWCP  and CBNX, and GO's prior recommendation MCIG, which bled a lot of red last week, but gained 30% of it back today. I was up 2.5% even though the miners took it on the chin, losing about 3%.

Gold and silver looking weak. The dollar looking strong. Broader stock indices looking weak.

Most of the Trump Agenda these days is making big business nervous in spite of his constant jawboning. You can only jawbone markets so far, and the Fed is now Trump's enemy, pure and simple, as they rush to (barely) raise rates next week. Jobs report on Friday. I expect that to come in fairly strong, which will give Yellen more ammo to raise. Stocks will correct.

Cycle theory and conventional technical analysis both call for metals to keep correcting. For anyone who bought miners near the August highs last year, as I did, the bull market has not corrected your timing mistake so far. In general, the bull has remained pretty tame. Lame even.

I think decriminalization of pot in Israel is very bullish for OWCP and CBNX, but there won't be any great rallies in the Potfolio until the US federal government gives some real guidance on how the FBI and DEA are going to treat the states that have legalized recreational MJ. The potential still exists for more negative waves out of Nancy Jeff Sessions and his gang of thugs in the US Justice Dept.
Title: Re: The Potfolio
Post by: Eddie on March 07, 2017, 02:14:31 PM
Another red day for the Potfolio, I think mostly because of news from Canada about further delays in legalizing recreational pot. Down about 4% for the day, with the Canadians hit hardest.
Title: The Potfolio-Tulsi Gabbard Introduces Bill to End Federal Marijuana Prohibition
Post by: azozeo on March 10, 2017, 11:09:20 AM
Federal: Bill Introduced To End Federal Marijuana Prohibition

Representatives Tom Garrett (R-VA) and Tulsi Gabbard (D-HI) have introduced bipartisan legislation, HR 1227, to exclude marijuana from the Controlled Substances Act, thus leaving states the authority to regulate the plant how best they see fit.

The “Ending Marijuana Prohibition Act of 2017” eliminates federal criminal penalties for possessing and growing the plant. This legislation gives states the power and flexibility to establish their own marijuana policies free from federal interference.
Representative Garrett says that marijuana prohibition disproportionately impacts those residing in jurisdictions of lower socioeconomic status, and believes that state governments are plenty capable of setting their own marijuana policies.“Virginia is more than capable of handling its own marijuana policy, as are states such as Colorado or California,” he said in a prepared statement.
The intent of the “Ending Marijuana Prohibition Act of 2017 is consistent with the view of most voters. According to recent pollingby Quinnipiac University, 59 percent of Americans support full marijuana legalization and 71 percent believe that states, not the federal government, should set marijuana policy.
With the recent confirmation of militant marijuana prohibitionist Jeff Sessions to the position of US Attorney General, and with comments from the Trump administration warning of a coming federal crackdown in adult use states, passage of this Act is necessary to ensure that medical marijuana patients and others are protected from undue federal interference.
Title: Re: The Potfolio
Post by: Eddie on March 10, 2017, 11:19:15 AM
In the current mix of politics, I doubt it can pass. But good for her. The Potfolio needs some good news. Thanks for posting.
Title: Re: The Potfolio
Post by: azozeo on March 10, 2017, 11:25:35 AM
In the current mix of politics, I doubt it can pass. But good for her. The Potfolio needs some good news. Thanks for posting.

If we the people had more forward thinking public servants like Tulsi our future would be bright enough to wear shades  :icon_sunny:
Title: Re: The Potfolio
Post by: azozeo on March 13, 2017, 02:47:38 PM
North Carolina Officials Call For Farmers To Grow Industrial Hemp

Steemit

Officials in North Carolina are looking to start a new test program for industrial hemp and they’ve called on farmers in the state to start growing the crop. Interest in growing industrial hemp has blossomed in many different areas around the US, as more farmers begin to learn about and consider the possible benefits that it could provide.

Despite the activity remaining federally prohibited, many areas have embraced industrial hemp and exercised civil disobedience in growing it. Also, back in 2014 Congress passed a law that would allow for certain test projects to be considered which involved using industrial hemp. Following up on those changes, North Carolina is now looking to initiate a test program.

Industrial hemp has been used for thousands of years and provides a great variety of different uses, everything from clothing and rope, to animal feed and insulation, it really is a remarkable plant. For an economy that is drowning in debt and looking to boost productivity, it certainly wouldn’t hurt to embrace a lucrative market like industrial hemp.

For any farmers that are interested in taking part in the program in North Carolina, they are first going to need to apply for a license and that comes from the Industrial Hemp Commission that’s associated with that state. For any farmers that do want to engage in growing hemp, they will be strictly monitored and their crops will also be regularly tested in order to make sure that they don’t contain THC.

Farmers will also be required to report each acre of industrial hemp that they are growing to authorities. It’s urged that they give precise locations for their growing operation, by using GPS technology. At the moment there are estimated to be at least 17 different states that are engaged in permitting test industrial hemp programs, and Kentucky is credited with being a leader among them.

Sources:
https://www.usnews.com/news/best-states/north-carolina/articles/2017-03-13/north-carolina-starts-test-program-for-growing-hemp (https://www.usnews.com/news/best-states/north-carolina/articles/2017-03-13/north-carolina-starts-test-program-for-growing-hemp)
http://america.aljazeera.com/articles/2014/11/12/kentucky-s-greathemphope.html (http://america.aljazeera.com/articles/2014/11/12/kentucky-s-greathemphope.html)

Related Posts:
Progress For Industrial Hemp Legalization In Hawaii
https://steemit.com/news/@doitvoluntarily/progress-for-industrial-hemp-legalization-in-hawaii (https://steemit.com/news/@doitvoluntarily/progress-for-industrial-hemp-legalization-in-hawaii)
Officials In Hawaii Look To Make Way For Industrial Hemp Production
https://steemit.com/cannabis/@doitvoluntarily/officials-in-hawaii-look-to-make-way-for-industrial-hemp-production (https://steemit.com/cannabis/@doitvoluntarily/officials-in-hawaii-look-to-make-way-for-industrial-hemp-production)
Changes In New Mexico For Industrial Hemp Research
https://steemit.com/politics/@doitvoluntarily/changes-in-new-mexico-for-industrial-hemp-research (https://steemit.com/politics/@doitvoluntarily/changes-in-new-mexico-for-industrial-hemp-research)
Officials In Washington Vote Unanimously To Decriminalize Industrial Hemp
https://steemit.com/market/@doitvoluntarily/officials-in-washington-vote-unanimously-to-decriminalize-industrial-hemp (https://steemit.com/market/@doitvoluntarily/officials-in-washington-vote-unanimously-to-decriminalize-industrial-hemp)

Title: Re: The Potfolio
Post by: Eddie on March 18, 2017, 11:27:27 AM
An article on one of the Canadians on the watchlist. The Potfolio has been in a holding pattern with no big  ups or downs over the past week. Still about 25% off the tops of February, but looks like they're coiling for another up leg. In general, stocks are looking like they have one more blow-off run up before tanking. I decided to stand pat, and have not bought or sold anything.

I just read a story about a big Colorado bust on an illegal black market operation there. I think we'll see that the Feds are going to go after these guys (and there are a quite a few of them taking advantage of the liberal pot laws in CO to grow, but then illegally distribute pot to surrounding states for fun and profit without paying any pesky taxes). No sign yet they're going to fuck with legal operations, which is good.

This Canadian maker of edibles is a favorite of this guy Ted Ohashi, whose analysis is thorough and reasonable.


Before You Can Sell LXRP High, You Must First Buy It Low.

Mar. 17, 2017 3:02 AM ET|2 comments
Mark Twain's investment advice was, "Buy a stock and sell it when it goes up. If it doesn't go up, don't buy it."

I'm not Mark Twain so my approach is not foolproof but I do believe buying low helps investment returns in the long run. With this in mind, I've been watching Lexaria Bioscience (OTCQB: LXRP) very closely as it dropped from over $.60 per share in late January to as low as $.34 per share recently, last at $.35 per share.



My basic report on LXRP was posted here just four months ago and can be found here seekingalpha.com/instablog/9721001-ted-ohashi/4930543-lexaria-otc-lxrp-best-cannabis-technology-can-eat

Just so we're not buying blind, I touched base with management to ensure I wasn't overlooking anything. For people looking for those rare opportunities to buy a wonderful company at a bargain basement price, right now LXRP just might fit the bill.

For starters, management doesn't give me any information that is not generally available in the public domain but I received a complete update in general terms on the activities LXRP is engaged in. So as I asked about new licensees, testing being undertaken in collaboration with the National Research Council of Canada and other activities, their response was everything is proceeding as expected and there is nothing to explain the weakness in their share price.

There are two possible non-operating reasons for their stock being under such pressure at this time:

On March 6, 2017, the company announced a brokered, best efforts, private placement agreement to raise $2.5 million at US $.42 per unit with each unit comprised of one common share and one-half a two year warrant exercisable at $.60 per share.(Read press release here) The stock closed that day at $.49 per share. LXRP stated in the Press Release, this offering was expected to close on or about March 28, 2017. Announcements such as this can often depress a stock briefly and put a cap on the price as the new issue price is typically at a discount to the prevailing market price.

LXRP issued a press release dated March 13, 2017 (Read press release here) indicating shares had been issued pursuant to the exercise of warrants and options issued previously. Given the stock options were exercised at a price of US$0.2273 and the warrants were exercised at prices ranging from US $0.14 to US$.022.73, we can only assume with the stock price higher than these levels, this process continued. The exercising of options and warrants is often accompanied by selling some of the shares so acquired as the holder may not have the cash to cover the full amount of the exercise price. So although this process helps a company such as LXRP by putting money in the treasury, it can also depress the stock.

My conclusion is simple. This is an attractive level at which to acquire LXRP shares. The business activities of the company are in good shape and the stock is trading at low prices for reasons that can be explained. So here is my effort at replicating Mark Twain, "Before you can sell high, you must first buy low."

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

http://seekingalpha.com/instablog/9721001-ted-ohashi/4969685-can-sell-lxrp-high-must-first-buy-low (http://seekingalpha.com/instablog/9721001-ted-ohashi/4969685-can-sell-lxrp-high-must-first-buy-low)

Title: Re: The Potfolio
Post by: Eddie on March 20, 2017, 08:04:39 AM
Bought small positions in two of the stocks on the watchlist of new Canadians.  Got LXRP and NXTTF.  LXRP is an edibles company, and NXTTF is a company that sells vaporizers world-wide. NXTTF  is a stock I could get excited about. They have a great retail website and lots of traffic.

There are a couple of others on that list that are looking fairly good, but I'll have to wait on those.

To see all the stocks in the Potfolio, go to page two of this thread. The purchase dates and prices for all the Potfolio stocks are there, or will be as soon as I update the list there in a minute.
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 06:45:40 AM
A bell-weather, coming just around the corner, to take note of for clarification on this Administration's stance towards federal anti-marijuana enforcement is whether there will be a renewal of the Rohrabacher-Farr Bill when it expires April 28, 2017. This bill protects state-sanctioned marijuana business by limiting federal funding for enforcing laws (by means of raids and arrests, etc.) that are being subverted by medical and recreational marijuana growing and distribution. If this budget plan is not renewed, it is possible that raids on state sanctioned businesses will resume.



Sawsienowicz's Blog
Mar. 21, 2017 1:39 AM ET


Jeff Sessions and Sean Spicer made comments in February around enforcement of federal law against states that have allowed recreational use of marijuana. This has brought about the highest level of uncertainty since Trump took office around the seemingly unimpeded march toward nation-wide legalization.

Sean Spicer's Comment

https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.c4329222e1b6 (https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.c4329222e1b6)

"Well, I think that's a question for the Department of Justice. I do believe that you'll see greater enforcement of it. Because again, there's a big difference between the medical use which Congress has, through an appropriations rider in 2014, made very clear what their intent was in terms of how the Department of Justice would handle that issue. That's very different than the recreational use, which is something the Department of Justice I think will be further looking into."

Jeff Session's Comments

http://fortune.com/2017/01/10/jeff-sessions-marijuana-confirmation-hearing/ (http://fortune.com/2017/01/10/jeff-sessions-marijuana-confirmation-hearing/)

"Good people don't smoke marijuana."

"won't commit to never enforcing federal law."

Analysis
It is commonly reported that the final say on the topic of federal involvement in state marijuana legalization efforts will rest with Trump. This rings true due to the wide media coverage of stories around marijuana legalization and the nature of this issue's pop-culture appeal. Up until this point in his presidency, Trump has made it quite clear that he supports medical marijuana unequivocally, but he has a negative view of, and is somewhat unclear regarding his take on, state-backed recreational use. Comments he has made indicate that on the one hand he is a strong supporter of State's Rights and American Industry, while on the other hand he likens recreational marijuana use to opioid abuse. Before the comments of Sessions and Spicer it seemed certain that recreational marijuana use would advance wherever state lawmakers decided to embrace it. Uncertainty now comes around whether the federal government (by way of the DEA) will stifle state's interests on this matter.

Looking to anticipate Trump's future stance on this subject, it is important to note that there is a majority of the population in support of legal use in the United States (Figure 1). Also consider that Trump's voter base is fueled by populist sentiments, and that their support for Trump has cut across traditional party lines. This group is motivated by a set of issues relevant to them as working-class Americans and this, among the issues espoused by Trump's campaign, don't fall on either side of traditional Democrat/Republican divides (Figure 2).

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_1EHsWmfHWvnM479G2jf7Z93q9R0trnQuexD2kNAPHyLkpAL9PRvjE59FNunoQqZU8aqjJ-UVbmoFqMQE-GXSBRdNR9-ek8clN5LzeqXaiusr0siYuesHT3TOZMEcrh7C20UVoEo3_thumb1.png)



So will it be politically prudent for Trump's administration to take on an issue that may alienate his voter base in future elections? Since this populism is not defined by either the Democrat or Republican party, the populist approach to politics can also be leveraged by Democrats in future elections. If marijuana legalization is used by Democrats as a differentiator among candidates who will all likely support the broader populist agenda, this may take away from a large portion of those who would vote Trump in the next election (Compare Figure 2 and 3). Contrasting FIgure 2 and 3 shows that favorable views toward marijuana legalization are prevalent in areas where Trump received a lot of support from traditionally non-Republican voters. Considering that these individuals helped him secure a small margin of victory in the last election, It seems unlikely that Trump will take an unpopular stance on marijuana legalization issues.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_yL0d8StlLVLA-A6H4tO7zhl2Zw5B9i6KmWxau0xbGQ8L_PwbtRGO6sPr25OgPVTfrwwgphlfYGqnTRkb3bGYxT43nTetFy4oaFStp6I_4hdD7hWUjAtQa1I4eDmmxoebOHOpkST4_thumb1.png)



(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_Ee25l-uKax_EW8kxTBklu9XHSrpSOst_m4IIEEjdDS8y5cfzjhD2CZJImKq90ted_pxlm1PabrLTDyQ6Ic-oQqG_akgxw06BFQaRLdjRhdLgIzk20NEVRgi0P3s9pVRjkVmjL-1X_thumb1.png)



Moving beyond the leanings of the Trump Administration, it is important to understand that a continuing trend towards medical marijuana legalization is inherently supportive of its eventual legal recreational use. As the medical marijuana industry grows along with favorable popular sentiment, so to will the strength of its lobbyists. Legislatures will become increasingly pressured by more and more powerful marijuana lobbyists to expand a market that is increasingly in demand by the majority of their constituents.

These statements by Sessions, Spicer, along with a lack of clarification by Trump himself, may indicate that a slow in the advance of the recreational marijuana industry is around the corner, but that does not indicate an end to the overall trend of marijuana legalization and market development. In the worst case scenario, Trump's Administration will work hard to enforce federal laws against recreational-use supply chains. In this situation the recreational businesses will convert into medical ones, wait until an administration more closely aligned to popular sentiment is in power (most likely the next one, even if it is the incumbent due to influence of public opinion), and then convert products and distribution points to recreational paradigms once again. Even if all product development is converted into a strictly medical marijuana model, these products will develop in ways that will still be attractive to consumers in the future recreational markets.

Important Upcoming Events
A bell-weather, coming just around the corner, to take note of for clarification on this Administration's stance towards federal anti-marijuana enforcement is whether there will be a renewal of the Rohrabacher-Farr Bill when it expires April 28, 2017. This bill protects state-sanctioned marijuana business by limiting federal funding for enforcing laws (by means of raids and arrests, etc.) that are being subverted by medical and recreational marijuana growing and distribution. If this budget plan is not renewed, it is possible that raids on state sanctioned businesses will resume. If they resume they will likely target only recreational establishments and not medical ones. This will be due to an overall lack of federal resources as a result of an increased interest in enforcing immigration policy and existing counterterrorism efforts. If the budget rule is not renewed and recreational establishments are allowed to continue to operate without being raided, then you can take that as a sign that the administration is not intent on fighting trends in the marijuana industry even when they can. And finally, if it is renewed, then businesses will operate as they have, just with the same level of uneasiness they are feeling today after these comments.

There is also the March 3rd reintroduction of the Ending Federal Marijuana Prohibition Act of 2017 by Thomas Garrett (Republican, Virginia). This bill has been attempted to make it to congressional hearing since 2013 (by Bernie Sanders in 2015, without any co-sponsors) and always without any luck. It will again attempt to be considered this year, but it is unlikely to receive a hearing, and even if it did, is expected not to have the support of Trump.

Sources:

http://www.marketwatch.com/story/jeff-sessions-says-if-americans-dont-want-him-to-enforce-marijuana-laws-they-should-change-them-2017-01-11 (http://www.marketwatch.com/story/jeff-sessions-says-if-americans-dont-want-him-to-enforce-marijuana-laws-they-should-change-them-2017-01-11)

https://www.leafly.com/news/politics/watching-jeff-sessions-confirmation-hearings-dont (https://www.leafly.com/news/politics/watching-jeff-sessions-confirmation-hearings-dont)

http://www.politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501 (http://www.politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501)

http://time.com/4594445/legal-marijuana-trump-sessions-policy/ (http://time.com/4594445/legal-marijuana-trump-sessions-policy/)

http://www.businessinsider.com/trump-on-marijuana-legalization-2017-1 (http://www.businessinsider.com/trump-on-marijuana-legalization-2017-1)

http://www.oregonlive.com/marijuana/index.ssf/2017/02/trump_administration_takes_aim.html (http://www.oregonlive.com/marijuana/index.ssf/2017/02/trump_administration_takes_aim.html)

http://www.thecannabist.co/2017/03/15/jeff-sessions-medical-marijuana-trump/75622/ (http://www.thecannabist.co/2017/03/15/jeff-sessions-medical-marijuana-trump/75622/)

https://www.leafly.com/news/politics/what-states-are-most-likely-to-legalize-cannabis-next (https://www.leafly.com/news/politics/what-states-are-most-likely-to-legalize-cannabis-next)

http://www.huffingtonpost.com/2015/01/26/marijuana-industry-fastest-growing_n_6540166.html (http://www.huffingtonpost.com/2015/01/26/marijuana-industry-fastest-growing_n_6540166.html)


http://seekingalpha.com/instablog/46316636-sawsienowicz/4970728-reaction-recent-comments-made-jeff-sessions-sean-spicer-marijuana (http://seekingalpha.com/instablog/46316636-sawsienowicz/4970728-reaction-recent-comments-made-jeff-sessions-sean-spicer-marijuana)

Title: The Ganja Civil War
Post by: RE on March 21, 2017, 07:07:20 AM
A bell-weather, coming just around the corner, to take note of for clarification on this Administration's stance towards federal anti-marijuana enforcement is whether there will be a renewal of the Rohrabacher-Farr Bill when it expires April 28, 2017. This bill protects state-sanctioned marijuana business by limiting federal funding for enforcing laws (by means of raids and arrests, etc.) that are being subverted by medical and recreational marijuana growing and distribution. If this budget plan is not renewed, it is possible that raids on state sanctioned businesses will resume.



Sawsienowicz's Blog
Mar. 21, 2017 1:39 AM ET


Jeff Sessions and Sean Spicer made comments in February around enforcement of federal law against states that have allowed recreational use of marijuana. This has brought about the highest level of uncertainty since Trump took office around the seemingly unimpeded march toward nation-wide legalization.

Sean Spicer's Comment

https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.c4329222e1b6 (https://www.washingtonpost.com/news/post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-where-recreational-marijuana-is-legal/?utm_term=.c4329222e1b6)

"Well, I think that's a question for the Department of Justice. I do believe that you'll see greater enforcement of it. Because again, there's a big difference between the medical use which Congress has, through an appropriations rider in 2014, made very clear what their intent was in terms of how the Department of Justice would handle that issue. That's very different than the recreational use, which is something the Department of Justice I think will be further looking into."

Jeff Session's Comments

http://fortune.com/2017/01/10/jeff-sessions-marijuana-confirmation-hearing/ (http://fortune.com/2017/01/10/jeff-sessions-marijuana-confirmation-hearing/)

"Good people don't smoke marijuana."

"won't commit to never enforcing federal law."

Analysis
It is commonly reported that the final say on the topic of federal involvement in state marijuana legalization efforts will rest with Trump. This rings true due to the wide media coverage of stories around marijuana legalization and the nature of this issue's pop-culture appeal. Up until this point in his presidency, Trump has made it quite clear that he supports medical marijuana unequivocally, but he has a negative view of, and is somewhat unclear regarding his take on, state-backed recreational use. Comments he has made indicate that on the one hand he is a strong supporter of State's Rights and American Industry, while on the other hand he likens recreational marijuana use to opioid abuse. Before the comments of Sessions and Spicer it seemed certain that recreational marijuana use would advance wherever state lawmakers decided to embrace it. Uncertainty now comes around whether the federal government (by way of the DEA) will stifle state's interests on this matter.

Looking to anticipate Trump's future stance on this subject, it is important to note that there is a majority of the population in support of legal use in the United States (Figure 1). Also consider that Trump's voter base is fueled by populist sentiments, and that their support for Trump has cut across traditional party lines. This group is motivated by a set of issues relevant to them as working-class Americans and this, among the issues espoused by Trump's campaign, don't fall on either side of traditional Democrat/Republican divides (Figure 2).

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_1EHsWmfHWvnM479G2jf7Z93q9R0trnQuexD2kNAPHyLkpAL9PRvjE59FNunoQqZU8aqjJ-UVbmoFqMQE-GXSBRdNR9-ek8clN5LzeqXaiusr0siYuesHT3TOZMEcrh7C20UVoEo3_thumb1.png)



So will it be politically prudent for Trump's administration to take on an issue that may alienate his voter base in future elections? Since this populism is not defined by either the Democrat or Republican party, the populist approach to politics can also be leveraged by Democrats in future elections. If marijuana legalization is used by Democrats as a differentiator among candidates who will all likely support the broader populist agenda, this may take away from a large portion of those who would vote Trump in the next election (Compare Figure 2 and 3). Contrasting FIgure 2 and 3 shows that favorable views toward marijuana legalization are prevalent in areas where Trump received a lot of support from traditionally non-Republican voters. Considering that these individuals helped him secure a small margin of victory in the last election, It seems unlikely that Trump will take an unpopular stance on marijuana legalization issues.

(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_yL0d8StlLVLA-A6H4tO7zhl2Zw5B9i6KmWxau0xbGQ8L_PwbtRGO6sPr25OgPVTfrwwgphlfYGqnTRkb3bGYxT43nTetFy4oaFStp6I_4hdD7hWUjAtQa1I4eDmmxoebOHOpkST4_thumb1.png)



(https://staticseekingalpha.a.ssl.fastly.net/uploads/2017/3/21/saupload_Ee25l-uKax_EW8kxTBklu9XHSrpSOst_m4IIEEjdDS8y5cfzjhD2CZJImKq90ted_pxlm1PabrLTDyQ6Ic-oQqG_akgxw06BFQaRLdjRhdLgIzk20NEVRgi0P3s9pVRjkVmjL-1X_thumb1.png)



Moving beyond the leanings of the Trump Administration, it is important to understand that a continuing trend towards medical marijuana legalization is inherently supportive of its eventual legal recreational use. As the medical marijuana industry grows along with favorable popular sentiment, so to will the strength of its lobbyists. Legislatures will become increasingly pressured by more and more powerful marijuana lobbyists to expand a market that is increasingly in demand by the majority of their constituents.

These statements by Sessions, Spicer, along with a lack of clarification by Trump himself, may indicate that a slow in the advance of the recreational marijuana industry is around the corner, but that does not indicate an end to the overall trend of marijuana legalization and market development. In the worst case scenario, Trump's Administration will work hard to enforce federal laws against recreational-use supply chains. In this situation the recreational businesses will convert into medical ones, wait until an administration more closely aligned to popular sentiment is in power (most likely the next one, even if it is the incumbent due to influence of public opinion), and then convert products and distribution points to recreational paradigms once again. Even if all product development is converted into a strictly medical marijuana model, these products will develop in ways that will still be attractive to consumers in the future recreational markets.

Important Upcoming Events
A bell-weather, coming just around the corner, to take note of for clarification on this Administration's stance towards federal anti-marijuana enforcement is whether there will be a renewal of the Rohrabacher-Farr Bill when it expires April 28, 2017. This bill protects state-sanctioned marijuana business by limiting federal funding for enforcing laws (by means of raids and arrests, etc.) that are being subverted by medical and recreational marijuana growing and distribution. If this budget plan is not renewed, it is possible that raids on state sanctioned businesses will resume. If they resume they will likely target only recreational establishments and not medical ones. This will be due to an overall lack of federal resources as a result of an increased interest in enforcing immigration policy and existing counterterrorism efforts. If the budget rule is not renewed and recreational establishments are allowed to continue to operate without being raided, then you can take that as a sign that the administration is not intent on fighting trends in the marijuana industry even when they can. And finally, if it is renewed, then businesses will operate as they have, just with the same level of uneasiness they are feeling today after these comments.

I look forward to the Civil War beginning with State Troopers, Municipal Cops and local Gangs defending the local Ganja Growers vs the FBI, DEA and ATF trying to arrest them.

RE
Title: Re: The Potfolio
Post by: K-Dog on March 21, 2017, 01:19:33 PM
My preference is to have the commercial sale of marijuana continue to be illegal but have the personal possession and cultivation of it become legal.  This would allow the unemployed to earn money and there would be no advertising to offend those who do not want anything to do with what they consider to be an evil weed.  This would make everyone happy except for politicians who would be denied an income stream.  Those who want it will be able to find it just as it has always been.

I doubt many people are capable of putting this idea in their pipe and torching it up.
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 05:40:06 PM
I knew when I started picking pot stocks that not every one would be a winner, and I've held on to some stocks in the Potfolio even though they are seriously underwater. For the most part, the winners have made up for the losers, and right now some pretty decent companies are seriously down because of all the uncertainty about how Trump's DOJ will treat legalized recreational pot states.

But I have one that is showing every sign of being a total dog, and that is MCPI. I'm glad I kept my position small. I will hold on to this POS for the moment, but barring any amazing reversals to the upside, it will get weeded out at year end.

The company has taken their pot money and bought a bunch of mining claims, and changed the name of the company to reflect mining as the core business. Not sure, but maybe they'll get out of pot altogether. Maybe the failure of AZ to pass recreational weed impacted their business, dunno. Not much info out there, but the stock price is down 70% from when I bought it, and has had two straight weeks of selling on volume.



(http://app.quotemedia.com/quotetools/getChart?webmasterId=102684&snap=true&symbol=mcpi&chscale=6m&chtype=AreaChart&chwid=491&chhig=190&chfill=ffac6a&chfill2=febf8b&chln=fe9540&chmrg=0&chfrmon=false&chton=false&chbg=ffffff&chdon=false&chgrdon=true&chbdron=true&chbgch=ffffff&chcpy=ffffff&chtcol=ffffff)
MCPI  The ugliest stock in the Potfolio.
Title: Re: The Potfolio
Post by: RE on March 21, 2017, 05:56:01 PM
Not much info out there, but the stock price is down 70% from when I bought it, and has had two straight week of selling on volume.
[/color]

"The road to riches is littered with the corpses of stock investors" -RE Quote

"The Market can stay irrational longer than you can stay solvent" -Unknown Pundit

"I told you so." -RE Quote


RE
Title: Re: The Potfolio
Post by: azozeo on March 21, 2017, 05:56:10 PM
Looking at that national map of legal cannabis states really tells a tale.
Out west it's a bong fest except the 2 heavily Mormon populated states of Id. & Ut.
Shit, the Mormons own Coca-Cola now & caffeine used to be No-Bueno to them.
Once they do the math on revenue, they'll pony up.
Title: Re: The Potfolio
Post by: azozeo on March 21, 2017, 05:58:00 PM
Not much info out there, but the stock price is down 70% from when I bought it, and has had two straight week of selling on volume.
[/color]

"The road to riches is littered with the corpses of stock investors" -RE Quote

"The Market can stay irrational longer than you can stay solvent" -Unknown Pundit

"I told you so. -RE Quote


RE


Oh great one....
Please explain to the diners how in "F" you get hurt with penny frickin stocks.
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 06:14:43 PM
I'm actually still close to even on the Potfolio. And slowly, the fear factor about Jeff Sessions is going to die down. There was a federal bust in Colorado yesterday or the day before...and it involved illegal sales across state lines by a guy who was NOT a legal seller. No moves against any legal dispensary in any state, recreational or medical. Noticed that?

If the Rohrabacher-Farr Bill is renewed, that'll be a good sign, too.

The intent, when I started doing this, was to limit my losses by taking small positions and only averaging into the winners. That strategy is working fine, and will continue to work.

Within five years I expect medical pot to be legal in most of the known world, including the entire US. I also expect the feds to change pot from schedule 1 and for congress to legalize pot under federal law.
Title: Re: The Potfolio
Post by: luciddreams on March 21, 2017, 06:18:15 PM
I'm actually still close to even on the Potfolio. And slowly, the fear factor about Jeff Sessions is going to die down. There was a federal bust in Colorado yesterday or the day before...and it involved illegal sales across state lines by a guy who was NOT a legal seller. No moves against any legal dispensary in any state, recreational or medical. Noticed that?

If the Rohrabacher-Farr Bill is renewed, that'll be a good sign, too.

The intent, when I started doing this, was to limit my losses by taking small positions and only averaging into the winners. That strategy is working fine, and will continue to work.

Within five years I expect medical pot to be legal in most of the known world, including the entire US. I also expect the feds to change pot from schedule 1 and for congress to legalize pot under federal law.

You are doing us all a great service Eddie.  Keep up the good work :emthup:

And thank you.   :)
Title: Re: The Potfolio
Post by: RE on March 21, 2017, 06:23:37 PM
Not much info out there, but the stock price is down 70% from when I bought it, and has had two straight week of selling on volume.
[/color]

"The road to riches is littered with the corpses of stock investors" -RE Quote

"The Market can stay irrational longer than you can stay solvent" -Unknown Pundit

"I told you so. -RE Quote


RE


Oh great one....
Please explain to the diners how in "F" you get hurt with penny frickin stocks.

Depends how many pennies you invest in them.

If you invest 1,000,000 Pennies ($10K) and the companies go BK, you are out $10K.

Such companies go BK quite often.

RE

https://trendshare.org/how-to-invest/risks-of-penny-stock-trading

Risks of Penny Stock Trading

last updated December 03, 2016

The adage "buy low, sell high" is good advice, but there's nuance to it. "Buy low" doesn't mean "buy the cheapest stocks possible". Similarly "sell high" doesn't mean "wait for it to become the most expensive stock possible". In securities, low and high are relative terms which refer to the underlying value of the business itself: buy when it's undervalued and sell (if you must) when it's overvalued.

Novice investors commonly look for extremely cheap stocks, figuring that a stock selling for $1 has a lot more room to double or quadruple than a stick which sells for $10. Novices commonly fall into the trap of looking for penny stocks to buy. This is risky.
What is Penny Stock Trading?

Penny stock trading is a risky investment strategy that looks for very cheap stocks and tries to exploit big changes in their prices. For example, a stock that sells for $0.30 a share can make you a 25% profit if the price jumps suddenly to $0.40 a share.

Penny stocks generally sell for less than five dollars per share and trade outside of a major exchange. These stocks are cheap for a reason: they usually belong to companies in bankruptcy or other financial troubles. These stocks are popular in certain circles, but they're very risky. You might also hear them referred to as microcap stocks or pink sheet stocks. It's all the same thing. See the SEC's penny stock rules for more detail (warning; regulatory language).

You can't buy and sell them as easily as a "normal" stock; you won't find them on the NYSE or NASDAQ. You can buy or sell them through an online broker, however—if you're willing to take on the risk. In theory you can sell a penny stock at any time, but you have to find a willing buyer for the price. Hold that thought in your mind for a moment.

These cheapest stocks may seem like a good value for your money. If you have a thousand dollars, you can buy 7 shares of Boeing at $140 and 2000 shares of some random stock selling for $0.50. Which would you rather have, seven shares or two thousand? Psychologically speaking, it seems like it's easier for something selling for fifty cents to go up to a $1 (doubling your money) than it is for Boeing to go up to $280 (doubling your money).

The problem is that the value of a stock depends on two things. First, its value is whatever someone's willing to pay for it. With millions of shares changing hands every day, millions of people are judging what stocks are worth. Two, the value of a stock depends on the value of the business behind it. It's much better to own a company that's making money than it is a company that's losing money. People are willing to pay a little more for the privilege of owning part of a successful business than they are to own part of a failing business.

Most of the time, a stock price below a dollar means that people think the business is in trouble. Most of the time, they're right. Even if you've found likely candidates, penny stock trading is one of the riskiest types of investing. Ironically, sometimes the cheapest stock to buy may be the most expensive stock to own—when you can't sell it for what you paid for it.
Risky Companies Can Go Bankrupt

In November 2011, American Airlines filed for bankruptcy. Its stock shed value and dropped to pennies per share. "What a bargain," you might think. "For pennies per share you get an airline, airplanes, fuel options, flight plans, pilot contracts, and more!" Eventually American Airlines merged with US Airways and the resulting entity has a stock back on a major exchange.

Yet that's one success story out of countless failures. Keep in mind that one share of AAMRQ you bought at $0.25 doesn't necessarily equate to one share of the new AAL at $30. In bankruptcy, anyone with a claim on the assets of the bankrupt entity gets to negotiate on the terms of their payment. As the holder of a share of common stock (if you don't know what that means, you're definitely a holder of common stock) you're at the lowest place on the list. You have almost no say in what happens to the business's assets.

If the company is in so much financial trouble that there's no chance it'll be able to pay off its debts, it may have to be broken up and have all of its assets sold off to its creditors. You're not getting any money out of that. You're not making 900 percent returns. Those 400 shares you bought at $0.25 per share are worthless and you've lost all that money. That happens sometimes.
Struggling Companies and Buyouts May be Profitable

American Airlines didn't go out of business. Instead it merged with another company. Sometimes that happens, or sometimes a stock gets bought out entirely (as was the case with Orchard Hardware, which Lowe's bought in late 2013). In that case, the acquiring company will often make a bid for the troubled company, based on what they think the company is really worth. That's probably the value of the assets: real estate, inventory, existing contracts minus existing liabilities.

In the case of an acquisition, the acquiring company may either pay existing stockholders a fixed price per share or convert shares of the acquired stock into shares of the new parent company at some ratio. (In other words, you might get one share of AAL for every forty shares of American Airlines you held.)

Sometimes this is a good deal. Sometimes it's a fair deal. Any profit you make depends on the price you paid. If it's below the acquisition price, you might make a little profit. In this situation, timing is everything. You must buy the stock for less than what it will sell for.

How do you know what it'll sell for? You have to figure out what the company as a whole is worth—its inventory, any existing contracts, any investments, the value of real estate, and the opportunity costs of acquisition. That's a lot of financial analysis for a company that'll probably go bankrupt.
Selling Penny Stocks is Difficult

Of course, to buy a stock at the right price, you have to find someone to sell it to you at that price. That's not easy. Unlike a normal stock, where people buy and sell based on actual value of what the company can actually make, penny stock trading relies on speculation. Everyone who owns the stock is waiting for it to turn around somehow. Maybe you'll get lucky and someone who bought it for $0.20 a share is willing to unload a few thousand shares at $0.25 a share, but it's more likely that anyone who bought it wants to make 10 or 20 or 50 times profits.

The same goes for getting out of a stock. Sure, you bought it at $0.25 a share and good news has raised it to $0.50 a share, and you think you're as lucky as you're ever going to get, but are there enough buyers at $0.50 a share for you to sell all of your shares?

Penny stocks have very little liquidity. There aren't many buyers and sellers because they're so risky. Unlike a share of Coca-Cola stock you can buy or sell pretty much anytime near the asking price, there aren't enough buyers and sellers who agree on prices, so their prices have wild swings. You're going to have to have great timing and even better luck to sell at the price you had in mind. That's after you've gone through all of the hoops in buying these shares in the first place.

Sure, you can wait for the company to turn around—but most don't. Most don't get acquired. Most go out of business.

Day trading penny stocks will be frustrating when that lack of liquidity works against you. If you're at all ethical—if you're not defrauding other people with pump and dump scams—you're relying on luck, and luck is a poor investment strategy. As well, patience works against you. You have to race around the clock before these poor companies go out of business altogether. That "hot penny stock tip" you just saw in email? That's someone's desperation trying to trick you into buying what he really really wants to sell.

You can generally buy microcaps through any reputable stock broker, though you'll likely have to sign a disclaimer that you understand the risk of smallcap trading. In shadier corners of the Internet, you can find businesses which purport to specialize in these trades, but trust may be an issue. Any reputable stock broker will have to run you through several pieces of paperwork to ensure that you understand the risks of this type of investing.
Is Penny Stock Trading Worth It?

Before you hit the buy button on your penny stock trade, keep in mind several risks!

Their companies are often in bankruptcy. It's very difficult to find the fair valuation of a business in financial trouble, so you don't know the right price to pay. You're also a creditor probably last in line for liquidation, so if everything goes wrong and the stock goes out of business, you might lose all of your money (or get ten cents on the dollar).

Turning around a troubled company takes time. You have to be patient. Good returns are rare, and they're smaller than you might think. Turning a company losing millions of dollars a year into a company making millions is a lot of work!

It's difficult to buy and sell penny stocks for good prices. You don't even know what the right price is or the right price will be. You're competing with a lot of other people trying to outsmart each other.

Finally, many of the people promoting these stocks are really making money from convincing you to subscribe to a penny stocks newsletter. If there's a really great underpriced stock, would you want other people to swoop in and buy it and drive up the price? Maybe—if you want to sell it to them at inflated prices! It's especially insidious when you have to pay to subscribe to this hot penny stock newsletter. You're giving someone money to market their worthless stocks to you!
Characteristics of the Best Penny Stocks

If good penny stocks are out there for the taking, they'll all have several characteristics. The best penny stocks:

    ... represent companies with real assets, so there's business value in the companies themselves.
    ... have a well understood business plan, so there's a path to making money in the future.
    ... have a strong market liquidity, so you can buy and sell without too much hassle or time.
    ... have a turnaround plan, whether an acquisition, bailout, or improved business conditions.

The latter is the most important, as there's no point in buying a stock that's about to go out of business.

Don't fall for the hype. Making money by investing is a matter of time and patience and looking for true value—buying good businesses. You never need to pay anything besides discount broker commissions. No secretive broker will help you get wealthy with cheap stocks. Successful investors aren't day trading penny stocks. No hot cheap stock lets you make incredible money in a week; anyone who tells you otherwise is gambling.

Penny stocks
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 06:24:00 PM
I also have some real winners. CBNX is up 283% since I bought it.  OWCP up 128%. MNTR up 119%.

And that's after getting slammed hard by AG Sessions a couple of weeks back.  Overall, I'm happy with the action in pot stocks. Of 26 now owned in the Potfolio, only maybe 3 of them are not performing within expected limits.
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 06:24:45 PM
I'm actually still close to even on the Potfolio. And slowly, the fear factor about Jeff Sessions is going to die down. There was a federal bust in Colorado yesterday or the day before...and it involved illegal sales across state lines by a guy who was NOT a legal seller. No moves against any legal dispensary in any state, recreational or medical. Noticed that?

If the Rohrabacher-Farr Bill is renewed, that'll be a good sign, too.

The intent, when I started doing this, was to limit my losses by taking small positions and only averaging into the winners. That strategy is working fine, and will continue to work.

Within five years I expect medical pot to be legal in most of the known world, including the entire US. I also expect the feds to change pot from schedule 1 and for congress to legalize pot under federal law.

You are doing us all a great service Eddie.  Keep up the good work :emthup:

And thank you.   :)

You're welcome. 
Title: Re: The Potfolio
Post by: Eddie on March 21, 2017, 07:00:15 PM
Not much info out there, but the stock price is down 70% from when I bought it, and has had two straight week of selling on volume.
[/color]

"The road to riches is littered with the corpses of stock investors" -RE Quote

"The Market can stay irrational longer than you can stay solvent" -Unknown Pundit

"I told you so. -RE Quote


RE


Oh great one....
Please explain to the diners how in "F" you get hurt with penny frickin stocks.

Depends how many pennies you invest in them.

If you invest 1,000,000 Pennies ($10K) and the companies go BK, you are out $10K.

Such companies go BK quite often.

RE

https://trendshare.org/how-to-invest/risks-of-penny-stock-trading (https://trendshare.org/how-to-invest/risks-of-penny-stock-trading)

Risks of Penny Stock Trading

last updated December 03, 2016

The adage "buy low, sell high" is good advice, but there's nuance to it. "Buy low" doesn't mean "buy the cheapest stocks possible". Similarly "sell high" doesn't mean "wait for it to become the most expensive stock possible". In securities, low and high are relative terms which refer to the underlying value of the business itself: buy when it's undervalued and sell (if you must) when it's overvalued.

Novice investors commonly look for extremely cheap stocks, figuring that a stock selling for $1 has a lot more room to double or quadruple than a stick which sells for $10. Novices commonly fall into the trap of looking for penny stocks to buy. This is risky.
What is Penny Stock Trading?

Penny stock trading is a risky investment strategy that looks for very cheap stocks and tries to exploit big changes in their prices. For example, a stock that sells for $0.30 a share can make you a 25% profit if the price jumps suddenly to $0.40 a share.

Penny stocks generally sell for less than five dollars per share and trade outside of a major exchange. These stocks are cheap for a reason: they usually belong to companies in bankruptcy or other financial troubles. These stocks are popular in certain circles, but they're very risky. You might also hear them referred to as microcap stocks or pink sheet stocks. It's all the same thing. See the SEC's penny stock rules for more detail (warning; regulatory language).

You can't buy and sell them as easily as a "normal" stock; you won't find them on the NYSE or NASDAQ. You can buy or sell them through an online broker, however—if you're willing to take on the risk. In theory you can sell a penny stock at any time, but you have to find a willing buyer for the price. Hold that thought in your mind for a moment.

These cheapest stocks may seem like a good value for your money. If you have a thousand dollars, you can buy 7 shares of Boeing at $140 and 2000 shares of some random stock selling for $0.50. Which would you rather have, seven shares or two thousand? Psychologically speaking, it seems like it's easier for something selling for fifty cents to go up to a $1 (doubling your money) than it is for Boeing to go up to $280 (doubling your money).

The problem is that the value of a stock depends on two things. First, its value is whatever someone's willing to pay for it. With millions of shares changing hands every day, millions of people are judging what stocks are worth. Two, the value of a stock depends on the value of the business behind it. It's much better to own a company that's making money than it is a company that's losing money. People are willing to pay a little more for the privilege of owning part of a successful business than they are to own part of a failing business.

Most of the time, a stock price below a dollar means that people think the business is in trouble. Most of the time, they're right. Even if you've found likely candidates, penny stock trading is one of the riskiest types of investing. Ironically, sometimes the cheapest stock to buy may be the most expensive stock to own—when you can't sell it for what you paid for it.
Risky Companies Can Go Bankrupt

In November 2011, American Airlines filed for bankruptcy. Its stock shed value and dropped to pennies per share. "What a bargain," you might think. "For pennies per share you get an airline, airplanes, fuel options, flight plans, pilot contracts, and more!" Eventually American Airlines merged with US Airways and the resulting entity has a stock back on a major exchange.

Yet that's one success story out of countless failures. Keep in mind that one share of AAMRQ you bought at $0.25 doesn't necessarily equate to one share of the new AAL at $30. In bankruptcy, anyone with a claim on the assets of the bankrupt entity gets to negotiate on the terms of their payment. As the holder of a share of common stock (if you don't know what that means, you're definitely a holder of common stock) you're at the lowest place on the list. You have almost no say in what happens to the business's assets.

If the company is in so much financial trouble that there's no chance it'll be able to pay off its debts, it may have to be broken up and have all of its assets sold off to its creditors. You're not getting any money out of that. You're not making 900 percent returns. Those 400 shares you bought at $0.25 per share are worthless and you've lost all that money. That happens sometimes.
Struggling Companies and Buyouts May be Profitable

American Airlines didn't go out of business. Instead it merged with another company. Sometimes that happens, or sometimes a stock gets bought out entirely (as was the case with Orchard Hardware, which Lowe's bought in late 2013). In that case, the acquiring company will often make a bid for the troubled company, based on what they think the company is really worth. That's probably the value of the assets: real estate, inventory, existing contracts minus existing liabilities.

In the case of an acquisition, the acquiring company may either pay existing stockholders a fixed price per share or convert shares of the acquired stock into shares of the new parent company at some ratio. (In other words, you might get one share of AAL for every forty shares of American Airlines you held.)

Sometimes this is a good deal. Sometimes it's a fair deal. Any profit you make depends on the price you paid. If it's below the acquisition price, you might make a little profit. In this situation, timing is everything. You must buy the stock for less than what it will sell for.

How do you know what it'll sell for? You have to figure out what the company as a whole is worth—its inventory, any existing contracts, any investments, the value of real estate, and the opportunity costs of acquisition. That's a lot of financial analysis for a company that'll probably go bankrupt.
Selling Penny Stocks is Difficult

Of course, to buy a stock at the right price, you have to find someone to sell it to you at that price. That's not easy. Unlike a normal stock, where people buy and sell based on actual value of what the company can actually make, penny stock trading relies on speculation. Everyone who owns the stock is waiting for it to turn around somehow. Maybe you'll get lucky and someone who bought it for $0.20 a share is willing to unload a few thousand shares at $0.25 a share, but it's more likely that anyone who bought it wants to make 10 or 20 or 50 times profits.

The same goes for getting out of a stock. Sure, you bought it at $0.25 a share and good news has raised it to $0.50 a share, and you think you're as lucky as you're ever going to get, but are there enough buyers at $0.50 a share for you to sell all of your shares?

Penny stocks have very little liquidity. There aren't many buyers and sellers because they're so risky. Unlike a share of Coca-Cola stock you can buy or sell pretty much anytime near the asking price, there aren't enough buyers and sellers who agree on prices, so their prices have wild swings. You're going to have to have great timing and even better luck to sell at the price you had in mind. That's after you've gone through all of the hoops in buying these shares in the first place.

Sure, you can wait for the company to turn around—but most don't. Most don't get acquired. Most go out of business.

Day trading penny stocks will be frustrating when that lack of liquidity works against you. If you're at all ethical—if you're not defrauding other people with pump and dump scams—you're relying on luck, and luck is a poor investment strategy. As well, patience works against you. You have to race around the clock before these poor companies go out of business altogether. That "hot penny stock tip" you just saw in email? That's someone's desperation trying to trick you into buying what he really really wants to sell.

You can generally buy microcaps through any reputable stock broker, though you'll likely have to sign a disclaimer that you understand the risk of smallcap trading. In shadier corners of the Internet, you can find businesses which purport to specialize in these trades, but trust may be an issue. Any reputable stock broker will have to run you through several pieces of paperwork to ensure that you understand the risks of this type of investing.
Is Penny Stock Trading Worth It?

Before you hit the buy button on your penny stock trade, keep in mind several risks!

Their companies are often in bankruptcy. It's very difficult to find the fair valuation of a business in financial trouble, so you don't know the right price to pay. You're also a creditor probably last in line for liquidation, so if everything goes wrong and the stock goes out of business, you might lose all of your money (or get ten cents on the dollar).

Turning around a troubled company takes time. You have to be patient. Good returns are rare, and they're smaller than you might think. Turning a company losing millions of dollars a year into a company making millions is a lot of work!

It's difficult to buy and sell penny stocks for good prices. You don't even know what the right price is or the right price will be. You're competing with a lot of other people trying to outsmart each other.

Finally, many of the people promoting these stocks are really making money from convincing you to subscribe to a penny stocks newsletter. If there's a really great underpriced stock, would you want other people to swoop in and buy it and drive up the price? Maybe—if you want to sell it to them at inflated prices! It's especially insidious when you have to pay to subscribe to this hot penny stock newsletter. You're giving someone money to market their worthless stocks to you!
Characteristics of the Best Penny Stocks

If good penny stocks are out there for the taking, they'll all have several characteristics. The best penny stocks:

    ... represent companies with real assets, so there's business value in the companies themselves.
    ... have a well understood business plan, so there's a path to making money in the future.
    ... have a strong market liquidity, so you can buy and sell without too much hassle or time.
    ... have a turnaround plan, whether an acquisition, bailout, or improved business conditions.

The latter is the most important, as there's no point in buying a stock that's about to go out of business.

Don't fall for the hype. Making money by investing is a matter of time and patience and looking for true value—buying good businesses. You never need to pay anything besides discount broker commissions. No secretive broker will help you get wealthy with cheap stocks. Successful investors aren't day trading penny stocks. No hot cheap stock lets you make incredible money in a week; anyone who tells you otherwise is gambling.

Penny stocks

All those caveats about penny stocks are true, and I knew all that before I ever spent a nickel. And I know all about losing money. I've made and lost a lot of it. Been there, got the T-shirt. I used to trade options, back in the day. Talk about real gambling.

Pot stocks are a very special kind of penny stock. Because of the legal hassles, no really big money (other than cartel money) has gone into it.  But that's all about to change. This ride has just barely begun, and it'll be a long ride with a lot of money made along the way.

Almost ALL pot stocks are OTC stocks. If you want to invest in marijuana, you have to go there.

I own most of the the best companies. I bought 26 out of over 200 screened. I have a clearly stated strategy that makes sense, I haven't deviated from it, and it will work, unless Nancy Reagan comes back from the dead and gets elected President.

(http://images.scribblelive.com/2016/3/12/3dc1ce98-0159-4f4c-b2b3-e838db8134d4.jpg)
Title: Re: The Potfolio
Post by: azozeo on March 21, 2017, 07:01:12 PM
Thanks for posting RE.
Penny stocks don't pay dividends like Boeing or Coke for instance.
Title: Re: The Potfolio
Post by: RE on March 21, 2017, 07:19:15 PM
it will work, unless Nancy Reagan comes back from the dead and gets elected President.

Don't forget the Boys from Brazil

http://www.youtube.com/v/UJZiNhLnMzM

and Rosemary's Baby

http://www.youtube.com/v/mqcVAFheU_Q

They're BA-ACK....

http://www.youtube.com/v/TqSxQrDYsIc

RE
Title: Re: The Potfolio
Post by: Eddie on March 23, 2017, 06:16:53 PM
Picked up a tiny stake in Cronos Group (PRMCF), one of the Canadian licensed producers, yesterday. I wasn't able to get my entire order filled before the close, but today I bought a little more to round out the initial position. Part of my deliberate shift toward Canadian pot stocks in these uncertain times.

I broke a longstanding habit and actually bought a subscription to a pot newsletter, which was probably a good idea because the guy who writes the one I picked, Alan Brochstein, is a Texas guy who eats drinks and sleeps pot stocks and has his own "broad list" of over 400 pot related companies and his own "focus list" of 27 of the better stocks. He calls his site 420 Investor.

He has a model trading portfolio with five stocks in it, which, imho, is far too concentrated. One of the picks, TRTC is one of the poorer performing stocks in the Potfolio, and I also own 4 or 5 other stocks he really hates. I'm learning to hate a couple of them myself, but another couple of them have kept the Potfolio from getting completely wiped out by the recent fear factor selling....

In any case, I'm getting a lot of good info from Alan for the moment as he has done a lot of due diligence on the companies he follows, and tends (like most stock analysts) to be obsessed with fundamentals. ( TRTC has good fundamentals.)  Ultimately, I will probably assimilate the information I find useful and then  let the subscription go, but this week it's been fun to follow his live feed and get a feel for his approach.

As always, I am updating the post on page two of this thread to reflect the new additions to the Potfolio. I think we're up to 27 now, but I have three I'll be looking to cut, I think, including MCPI, GRNH, and CANN. I'd like to sell them during a rally, if we get another good one,
Title: Re: The Potfolio
Post by: Eddie on March 25, 2017, 01:02:39 PM
The Potfolio is now down 1.5% since inception. This is in spite of having 21 stocks red and only 6 green at the moment. 

This is confirmation of my strategy of holding as many companies as I can. A few big winners can really help keep you from being absolutely decimated in these drawdowns, like the one caused by Jeff Sessions' idiotic remarks a few weeks ago.

At the moment,  I am intending to add a couple more Canadians, and possibly ACNNF, a recent Aussie entry into the global pot market.

My impression of the action in pot stocks this last week is that the consolidation phase is coming to an end, and we'll either see another broad rally, or we'll see another big down leg. At this point, I can't rule that out.
Title: Why is Colorado risking hundreds of millions to protect its marijuana industry?
Post by: RE on March 26, 2017, 04:56:43 PM
http://www.csmonitor.com/USA/2017/0326/Why-is-Colorado-risking-hundreds-of-millions-to-protect-its-marijuana-industry (http://www.csmonitor.com/USA/2017/0326/Why-is-Colorado-risking-hundreds-of-millions-to-protect-its-marijuana-industry)

 Why is Colorado risking hundreds of millions to protect its marijuana industry?

(http://images.csmonitor.com/csm/2017/03/1033564_1_0326-Pot_standard.png?alias=standard_900x600nc)

A bill is being considered by the state Legislature to allow growers and sellers to reclassify their marijuana in the face of a federal crackdown. But opponents warn that the bill could be too costly, specifically for schools.


    Ben Rosen
    Staff   |   @Benji_Rosen   

March 26, 2017 —Colorado's state legislature is considering an unusual plan to defend the state's marijuana industry from a federal crackdown under the Trump administration.

The bill would allow growers and sellers to reclassify their recreational marijuana as medical “based on a business need due to a change in local, state, or federal law or enforcement policy.” The strategy is meant to keep marijuana businesses afloat if the federal government comes after them, even if it means the state losing hundreds of millions of dollars in taxes.

The bill represents a shift in how states might respond to what marijuana advocates say are an over-simplification of cannabis policy by the Trump administration. The Trump administration has indicated it is OK with medical marijuana, but not with the recreational use of the drug. Yet, most marijuana businesses cater to both the recreational and medical markets, meaning a crackdown would wipe out half of a store’s inventory while leaving the other half intact.

If federal authorities start seizing recreational pot, Colorado's recreational marijuana entrepreneurs "need to be able to convert that product into the medical side so they can sell it," state Sen. Tim Neville (R), who represents suburban Denver, told the Associated Press.

"If there is a change in federal law, then I think all of our businesses want to stay in business somehow. They've made major investments," Mr. Neville said.
How much do you know about marijuana? Take the quiz

The bill, which passed 4-1 last week in a committee in the Republican Senate, would allow Colorado’s 500 or so licensed recreational marijuana growers to instantly reclassify their pot. The measure says licensed growers could immediately become medical licensees “based on a business need due to a change in local, state or federal law or enforcement policy.”

According to the latest available data, the state had in June about 827,000 marijuana plants growing in the retail system. More than half were for the recreational market. The state industry also employs 25,000 people directly. Of these jobs, 18,000 were generated in 2015, according to a study conducted by the economic consulting firm Marijuana Policy Group.

The legislation being considered comes as the Trump administration threatens to crack down on the nascent marijuana industry in Colorado and the seven other states where its recreational use is legal. Ever since Jeff Sessions became US attorney general, marijuana advocates have worried the agency he oversees would come after these eight states’ industries. These fears grew in February, when White House Press Secretary Sean Spicer warned of “greater enforcement” of medical marijuana.

In a press briefing, Mr. Spicer suggested that President Trump views medical marijuana in a different light.

“That’s very different than recreational use, which is something the Department of Justice will be further looking into,” said Spicer. 

A few days later, Mr. Sessions indicated to a conference of attorneys general that he’d do away with the Obama administration’s hands-off strategy on state laws, in place since 2013 under a four-page directive known as the Cole memo, according to Bloomberg.

Although the Obama administration allowed states to determine their own marijuana laws, the drug remains classified as a Schedule 1 drug, alongside heroin. This means the federal government does not recognize it as having valid medicinal applications, and considers it as having a high potential for abuse.

Marijuana policy experts have said the Trump administration’s attitudes about marijuana over-simplify states’ regulatory frameworks.

“Mr. Spicer’s comments really signaled a deep misunderstanding within the administration about how marijuana policy is regulated and implemented at the state level,” John Hudak, a senior fellow at Brookings Institution, told Bloomberg. “There are dramatic regulatory differences from state to state. The comments from the podium were overly simplistic.”

States where both recreational and medical marijuana are legal have parallel regulatory frameworks, according to Bloomberg. While businesses must acquire separate licenses for the two uses, many have both.

The Colorado bill aims to prevent dispensaries from having a portion of their inventory declared illegal. But lawmakers opposed to it warn of the effects it could have on the state’s tax revenues.

"It's a big deal for our taxation system because this money has been coming in and has been set aside for this, that and the other," said Sen. Lois Court, a Denver Democrat who voted against the bill.

Colorado taxes recreational marijuana much more than medical marijuana — 17.9 percent compared to 2.9 percent – so businesses’ reclassification would cost the state more than $100 million a year. This loss would specifically affect schools, which depend on $40 million a year in these taxes for a construction fund, as well police training and public education campaigns related to marijuana use.
Follow Stories Like This

Get the Monitor stories you care about delivered to your inbox.
Sign Up

But Colorado isn’t the only state pursuing legislation of this order. Oregon's legislature is considering a bill that hides the names and other personal information of cannabis buyers, a practice that is already banned or discouraged in Colorado, Alaska, and Washington state. Other states such as California are considering proposals that would prohibit local and state law enforcement from cooperating with federal authorities on investigations into cannabis operations that are legal in their jurisdictions.

This report contains material from the Associated Press.
Title: Re: The Potfolio
Post by: Eddie on March 26, 2017, 06:15:27 PM
Several states scrambling to do this kind of thing to protect their new star tax revenue source. Oregon for one. Other states too, trying to head problems off a the pass.

All I can say is that the DEA is still busting people for drugs each and every day, all over, but if your read the news stories, it's almost all meth, heroin, or illegal pot sales across a state line by an unlicensed black market seller.

No dispensaries or growers in any legal state have been hassled or raided. I think the fear factor about Jeff Sessions is overblown. Could change, I guess.
Title: Re: The Potfolio
Post by: jdwheeler42 on March 27, 2017, 03:10:03 AM
Several states scrambling to do this kind of thing to protect their new star tax revenue source. Oregon for one. Other states too, trying to head problems off a the pass.

All I can say is that the DEA is still busting people for drugs each and every day, all over, but if your read the news stories, it's almost all meth, heroin, or illegal pot sales across a state line by an unlicensed black market seller.

No dispensaries or growers in any legal state have been hassled or raided. I think the fear factor about Jeff Sessions is overblown. Could change, I guess.
I don't think the state-sanctioned drug dealers are going to get prosecuted, as long as they pay their taxes.  It has nothing to do with individual rights and everything to do with the Federal government respecting the state governments sources of protection money.  If they didn't, I think you could see some serious secessionist movements develop.
Title: Canada is reportedly set to legalize recreational marijuana
Post by: RE on March 27, 2017, 06:29:48 PM
This should give a nice bump to the Hoser Pot Stocks.  :icon_sunny:

RE

http://wtkr.com/2017/03/27/canada-will-legalize-recreational-pot-report-tmwsp/ (http://wtkr.com/2017/03/27/canada-will-legalize-recreational-pot-report-tmwsp/)

Canada is reportedly set to legalize recreational marijuana
Posted 8:15 pm, March 27, 2017, by Tribune Media Wire

(http://wire.tribunemediahosting.com/wp-content/uploads/sites/7/2017/03/GettyImages-633229560.jpg)
A member of the Italian Military’s Cannabis Project Team enters a marijuana growing room. (FILIPPO MONTEFORTE/AFP/Getty Images)

By Ese Olumhense

Legal status will reportedly go into effect by July 1, 2018

Recreational marijuana will soon be legal nationwide in Canada, a recent report from the Canadian Broadcasting Corporation (CBC) stated.

The new legislation — which is in line with both Prime Minister Justin Trudeau’s pledge to legalize and regulate marijuana and with the November recommendations of a federally appointed task force on the drug — is expected to be introduced the week of April 10, the Sunday report said.

Under the proposed plan, the country’s federal government will oversee supply and licensing, while provinces would reportedly have the right to decide how marijuana will be distributed and sold, as well its prices. Canada’s minimum age for sale will be set at 18, but provincial governments can set higher limits.

Canadians hoping to grow their own plants will also be able to own four plants per household.

Though legalization looms, ‘current laws apply’

Trudeau’s controversial plan for legalization made him extremely popular with younger voters in Canada’s 2015 federal election. Forty-five percent of Canadians aged 18 to 25 voted for Trudeau and his Liberal Party; in that demographic, it was the highest share cast for any other party in the race, a survey showed.

“Young people affected the last election in a way they haven’t in the past,” David Coletto, who runs the company that conducted the survey, told The Huffington Post Canada in 2016. “We see much higher evidence of a higher turnout among those under 34, and, really for the first time since 1997, young people coalesced around one option.”

Despite Trudeau’s promises, the law did not change overnight. A federal Task Force on Cannabis Legalization and Regulation was convened in December 2015, and underwent a year of “extensive public consultations and expert advice” in its development of marijuana policy. The finished report, published in December 2016, had more than 80 recommendations on age and access restrictions, marijuana marketing, and safety and distribution guidelines.

Though legalization appears likely, Trudeau recently warned that “current laws apply,” and marijuana should not be assumed cleared for recreational use just yet. Sunday’s report comes weeks after police in some Canadian cities raided dispensaries, charging five with possession and trafficking.

What could the U.S. learn from Canada?

Just south of the Canadian border, in the United States, the conversation around recreational marijuana is quite different. Though it’s legal in seven states — California, Oregon, Washington, Alaska, Colorado, Nevada, and Maine — cannabis is still a Schedule I drug. That doesn’t seem like it will change any time soon.

Though Attorney General Jeff Sessions has said (to the relief of marijuana enthusiasts everywhere) that he will respect the Obama-era memo allowing states to implement their own rules around marijuana use and enforcement, he personally remains vehemently opposed to marijuana use — which he recently deemed “a life-wrecking dependency” that is “slightly less awful than heroin.” (In 2015, the head of the U.S. Drug Enforcement Agency disagreed, saying heroin was “clearly” more dangerous than marijuana.)

Judging from the task force’s report, Canada’s recreational marijuana policy will probably bear close resemblance to policies passed in some U.S. states, like Colorado, the first in the U.S. to legalize recreational marijuana.

Colorado policy establishes age limits, like Canada’s likely will, but the state established its age limit at 21. Regulations as to how many storefronts selling marijuana in a particular location exist in Colorado, and Canada’s proposal will probably include them as well. Retail sales are also regulated as they would be in Canada, though in Colorado they’re regulated by the state and not by the federal government.

U.S. lawmakers might want to consider Canada’s countrywide legalization drive. If it’s successful — as in Colorado, which made $53 million after its first year of legalization — it might be worth adopting in America. Canada’s model could show the United States how best to implement marijuana legalization at the federal level.
Title: Re: The Potfolio
Post by: Nearingsfault on March 27, 2017, 06:56:59 PM
Not a pot head but I'm cautiously optimistic that maybe the crazy war on a weed will finally end ; in Canada at least.
Best regards, David B.
Title: Re: The Potfolio- O' Canada legalizes pot in '18
Post by: azozeo on March 29, 2017, 01:46:58 PM
2017-03-27 - Canada to legalize cannabis for recreational use in 2018:
http://www.rt.com/news/382432-canada-legalize-weed-2018/ (http://www.rt.com/news/382432-canada-legalize-weed-2018/)
http://www.sott.net/article/346446-Canada-to-legalize-cannabis-for-recreational-use (http://www.sott.net/article/346446-Canada-to-legalize-cannabis-for-recreational-use)
Title: Re: The Potfolio
Post by: Eddie on March 29, 2017, 01:58:34 PM
The Potfolio is slowly going green again. That news is a couple of days old now. Canadian pot stocks had a good day Monday, but now tapering off.

In general, Canadians are off their highs. Good time to buy at slightly reduced prices. Prices are still high for the amount of revenue, but likely to stay high and go higher. Aphria and Canopy Growth are the favorites, but there are maybe 15 or so pretty good Canadian pot stocks, and they are all doing better than US stocks right now.

Australia now has a couple of speculative plays that might do well. Don't know much about them, but traders are driving up the Aussies this week. Companies in Oz would be ACNNF, MMJ.AX and ZLDAF.
Title: Re: The Potfolio
Post by: azozeo on March 29, 2017, 02:58:47 PM
The Potfolio is slowly going green again. That news is a couple of days old now. Canadian pot stocks had a good day Monday, but now tapering off.

In general, Canadians are off their highs. Good time to buy at slightly reduced prices. Prices are still high for the amount of revenue, but likely to stay high and go higher. Aphria and Canopy Growth are the favorites, but there are maybe 15 or so pretty good Canadian pot stocks, and they are all doing better than US stocks right now.

Australia now has a couple of speculative plays that might do well. Don't know much about them, but traders are driving up the Aussies this week. Companies in Oz would be ACNNF, MMJ.AX and ZLDAF.

I thought I'd seen the article posted somewhere.
If were all still vertical in their term I'd lay vegas-baby odds that cannabis bars will be next.
They'd have to be private clubs however because of non-smoking ordinances in public.

http://www.youtube.com/v/neUaSTSKFZc&fs=1
Title: Re: The Potfolio
Post by: Eddie on March 29, 2017, 05:47:48 PM
Also....Nevada seems to be moving faster toward getting their recreational market going than any other new state.

Pot stocks that might be a play in that direction would be GBLX and DIGP. GBLX is a cannabis producer (or soon will be) and DIGP is a cannabis lab, something that is required to do business in the world of regulated pot.
Title: Re: The Potfolio
Post by: azozeo on March 29, 2017, 06:45:40 PM
The AMA should/could have put up more of a battle against legalization.
With the rise of cure by THC, their screwed....
Next gen folks will be cancer free, glaucoma free, & etc. free because of this change.
Title: The Potfolio: Today's Headlines
Post by: RE on March 30, 2017, 05:08:44 PM
Ganja Stories Hot Off the Press! (https://paper.li/f-1490836599#/)

(https://thumbs.dreamstime.com/x/newspaper-icon-10559428.jpg)

RE
Title: Re: The Potfolio: Today's Headlines
Post by: Eddie on March 30, 2017, 06:14:54 PM
Ganja Stories Hot Off the Press! (https://paper.li/f-1490836599#/)

(https://thumbs.dreamstime.com/x/newspaper-icon-10559428.jpg)

RE

Cool.
Title: Re: The Potfolio: Today's Headlines
Post by: RE on March 30, 2017, 06:38:36 PM
Ganja Stories Hot Off the Press! (https://paper.li/f-1490836599#/)

(https://thumbs.dreamstime.com/x/newspaper-icon-10559428.jpg)

RE

Cool.

Indeed.  And that is just a really rudimentary job (took around 1 minute to set up).  You should curate this paper.li, not me.  You know more about the topic.  If you set it up right, you'll have your own custom source of information for deciding on investment opportunities.  Only takes around an hour or two to really customize and pick your bots.  Once done, it's Set it and Forget it!

http://www.youtube.com/v/tLq27iOW0R0

RE
Title: Re: The Potfolio
Post by: Eddie on March 30, 2017, 07:03:37 PM
I'll think about it. Not sure the internet needs another news aggregator.
Title: Re: The Potfolio
Post by: RE on March 30, 2017, 07:14:53 PM
I'll think about it. Not sure the internet needs another news aggregator.

It's not for the "internet" really in this case.  It's for YOU.  You harness the bots to give you your own source of daily information on ganja specific stories to assist in your investment decisions in the Potfolio.

RE
Title: Re: The Potfolio
Post by: Eddie on March 31, 2017, 07:28:55 AM
Added SPRWF at 1.1517. This is Supreme Pharmaceuticals, one of the Canadian licensed growers. I am deliberately changing the weight of the Potfolio to reduce exposure to US companies for the next little while.

Added SRNA, the maker of the best grow lights. This company has been ignored by the pot stock traders, but the company is making money and gonna make a lot of money as more growers come online. Paid .184 for this one.

As usual, I will add these to the complete Potfolio list on page 2 before the day is over.

I have some stocks I want to cut, but I'm waiting for a rally to lift all boats, hopefully. But put these on the No Buy List....CANN, MCPI,GRNH, and MCOA.

Update: As of now, the Potfolio is up .94% over cost. Not encouraging at the moment, although any good news out of Washington would start a rally, I'm pretty sure. The thing is we AREN'T getting anything, except elapsed time with no Federal pot busts of state licensed growers. Even that is better than Jeff Sessions opening his mouth in any public venue.

Update: Adding TRTC to the No Buy list, as their quarterly today revealed they have booked 72 million bucks in accumulated losses. Many people think this company will succeed. They are growing their revenue rapidly, but Geez Louise, 72 mil is a lot.

Title: Re: The Potfolio
Post by: Eddie on April 03, 2017, 12:26:58 PM
I finally decided to take profits today on several positions that had substantial gains. These are all companies that ran up after I bought them, but since then have shown themselves to be undesirable for one reason or another.

Overall, the pot stock market is going through a quiet low volume spell, and I decided locking in profits was wise. I really did not want to do much trading, but a buy-and-hold approach with these stocks is risky right now.

I took most of the money and doubled down on the highest quality Canadian licensed producers and a couple of hydroponics companies that are doing well, and a company that makes containers for dispensaries.

Sold today: MSRT (sold at a very slight loss, but it was close to par, and it looked like time to bail). Also sold MJNA, CBIS, OWCP, MNTR, and CNBX, all for substantial profit.

Bought today: More Organigram, more Canopy Growth, more Aurora, more Aphria. Also took small initial positions in KSHB and GRWG.

Today's changes reflect my desire to weed out some of the trashier stocks from the Potfolio.  Fortunately, several of those were profitable, even though they're starting to lose steam now. I am still holding a half dozen losers that need to be sold, but hopefully at some point we'll have a good rally, and I can sell them on more strength.

This is a flight to safety and and a flight to quality. Over the past week I have absorbed a great deal of due diligence from Alan Brochstein's site, and I'm trying to use the information wisely.

Later today I'll update the bought/sold list on page 2 of this thread.

Update: Added to the position in NXTTF too.

Title: Re: The Potfolio
Post by: Eddie on April 04, 2017, 07:00:53 AM
Put the last of my cash into Aphria, which is the lowest cost cannabis producer among the licensed Canadians. It also has the prettiest chart.

I do expect a rally in Canadians related to news about legislation for the upcoming rec market, which is widely believed to hit the Parliament next Monday. Also, some people expect some market action around the 4/20 date, due to lots of festivals and promotions at that time.

The Potfolio is locked and loaded now. I'm not planning to change much for a while. I have done as much as I can to protect my gains and shift mostly into Canadians, until some good news on federal US legalization comes out. Four governors just wrote a letter to Jeff Sessions requesting to be left alone. Might be good, might be like poking a rattlesnake.

Title: Re: The Potfolio
Post by: Eddie on April 06, 2017, 05:16:18 PM
So far, overweighting the Canadians has payed off. Generally it's been a shitty week for pot stocks, but some of the Canadians have done well, and today I had a very good day. The overall Potfolio was up 4.36% for the day. Days like that, if you can string a few together......it becomes very exciting.

At the same time, some few (about 6 really) of the older picks are really in the toilet. However, I expect some of them to recover on any good news out of Washington. The strategy of taking a very small starting position is paying off there, though, by limiting my losses.

Germany is an interesting market. They have national health insurance that pays for medical MJ, but they have no domestic cannabis production. Canada is going to fill that market, and its a big one, much bigger than the Canadian market.

The potfolio is down to 25 stocks now, and I'd definitely sell 6 of them on a good rally. Maybe I can get it down to 20 or so. It'd be easier to keep up.
Title: Re: The Potfolio
Post by: Eddie on April 07, 2017, 08:40:36 AM
It's been said for a couple of days, and now it's confirmed, that Jeff Sessions and Co. are studying how DOJ should deal with the legal pot states. Since the existing Obama policies were very liberal, my guess is that something will somehow be made worse instead of better, and that whatever policies that dufus comes up with will hurt US post stock prices more than help them.

On that rationale, I decided to cut losses on several of my losing US cannabis stocks while the getting is good, and instead of watching them go down more, put the money into the Canadians, which are now coming back, with tons of positive news about the companies themselves, and also about what a large market exists in other countries, that Canadian pot growers will be first in line to service.

I will update the list on page 2 later for anyone wanting to see where the Potfolio is going.

Title: Re: The Potfolio -Mark July 27th on Your Calendar
Post by: Eddie on April 08, 2017, 02:57:37 PM
Jeff Sessions task force on DOJ pot enforcement policies is due to report on July 27th, so anyone invested pot stocks (especially US companies) should mark that date on their calendar. My view is that since Obama era enforcement was quite liberal, that the most likely changes are going to be to the negative side rather than positive. Almost all US pot stocks are painting a similar chart right now.....substantially off the pre-election and February highs, and currently in a near-flatline basing pattern. If Sessions does decide to let the rec states alone for the most part, US stocks could really rally off this base, though.

I don't expect much to happen price-wise for the US stocks until that report comes out or it's leaked, whichever comes first. Meanwhile, Canadian pot stocks had a good week this last week, and Monday the parliament is set to bring rec legalization debate forward. Hard to say if this will be much of an upside catalyst. Might be more of a 'sell on the news" event, especially since most of these stocks have gotten a little overbought.

The Trudeau government has changed the date for rec pot legality from July1, 2018, now to "on or before" that date. I don't look for much before though. I think some people just objected to it being announced on the national holiday.

I expect after 420 day 2017, the entire sector will snooze for a while. I might try to lock in some profits, especially if Canada does rally all the way to 4-20-2017.

I still haven't updated page 2 as to Friday's changes, but I'll get it done before Monday. I've been dealing with a major time-waster for 2 days. A camper I had in long term storage got towed to one of those places where they nail you for a towing fee and then charge $20/day. Long story, but it's dealt with, and I didn't pay.
Title: Re: The Potfolio
Post by: Eddie on April 10, 2017, 09:06:08 AM
A decent rally in pot stocks in response to Canada moving forward with rec, and also Nevada moving quickly to allow rec sales by July.

At noon Eastern time the Potfolio is up about 3% for the day. I expect to see this rally fade pretty fast, but maybe there will be some waves of buying between now and 4-20.

I got the Friday changes updated on page 2, for anyone who wants to see them. The Potfolio is down to 20 stocks currently.

Update: Canadians rallied right into the close and I ended up 6% for the day. I will have to consider selling all the rest ofthe US companies and going 100% Canadian, other than the ancillary companies like GRWG, SRNA, And KSHB which are American companies that sell products to dispensaries and growers. The US companies are languishing, and it looks like I'll come out ahead to switch.
Title: A group of governors wrote a letter urging Jeff Sessions to keep marijuana legal
Post by: RE on April 12, 2017, 06:33:04 PM
Top Headline story in today's edition of The Potfolio Newzpaper (https://paper.li/f-1490836599#/).

RE

http://www.businessinsider.com/governors-wrote-a-letter-to-sessions-and-mnuchin-to-keep-weed-legal-trump-2017-4?r=UK&IR=T (http://www.businessinsider.com/governors-wrote-a-letter-to-sessions-and-mnuchin-to-keep-weed-legal-trump-2017-4?r=UK&IR=T)

A group of governors wrote a letter urging Jeff Sessions to keep marijuana legal

    Jeremy Berke

    Apr. 4, 2017, 5:13 PM 4,221

(http://static4.businessinsider.com/image/58e401a277bb7050008b64c6-2000/ap16321026231629.jpg)
marijuana Farmworkers transport newly-harvested marijuana plants, at Los Suenos Farms, America's largest legal open air marijuana farm, in Avondale, southern Colorado. AP Photo/Brennan Linsley

The governors of Colorado, Washington, Oregon, and Alaska wrote a letter to Attorney General Jeff Sessions, and Treasury Secretary Steven Mnuchin, urging the federal government to keep marijuana legal.

"As governors, we have committed to implementing the will of our citizens and have worked cooperatively with our legislatures to establish robust regulatory structures that prioritize public health and public safety, reduce inequitable incarceration and expand our economies," the governors wrote.

Marijuana is illegal at the federal level, though a number of states have voted to legalize and regulate the recreational market in recent years.

President Donald Trump's administration, led by Sessions, has vowed to "step up enforcement" of marijuana laws.

The heart of the issue is a 2013 Obama Administration directive — known as the Cole Memorandum — which stipulates that the Justice Department place "low priority" on enforcing marijuana laws against businesses and organizations that comply with state law.

Sessions has indicated a willingness to re-write the Cole Memo, in order to direct the Justice Department to crack down on marijuana businesses that comply with state laws but are still illegal at the federal level. The Justice Department contacted Colorado officials in March regarding marijuana cases, International Business Times reported, saying they hope it will lead to "positive changes" for the "new administration."

"As governors of states that have legalized marijuana in some form, we ask the Trump Administration to engage with us before embarking on any changes to regulatory and enforcement systems," the governors wrote.

Steven Mnuchin Jeff Sessions Jeff Sessions (R) and Steven Mnuchin (L). REUTERS/Lucas Jackson

Jesse Alderman,  an attorney at the Boston-based Foley Hoag LLP who works with marijuana-industry clients, previously told Business Insider that while Sessions may want to overturn the Cole Memo, "the regulated sale and decriminalization of cannabis is uniquely popular across the political spectrum."

Recent polls show that around 60% of adults support legalizing marijuana, across the political spectrum.

The governors assert that overturning the Cole Memo would "divert" existing marijuana inventory to the black market, which would cause an uptick in crime and states to forgo the much-needed tax windfall legalized marijuana provides.

Further, the governors called the Financial Crimes Enforcement Network (FinCEN) — which provides guidance for banks and other institutional investors to provide services to marijuana companies — "critical" to the success of a regulated market.

"We look forward to working with you and your administration. We stand ready to have further discussion on how these important federal policies work in our states," the governors wrote.

Marijuana activists applauded the governors' letter for upholding the "principles of federalism."

"The states are the laboratories of democracy. The people have spoken and clearly agree that regulating cannabis on the state level is working far better than prohibition has," Neal Levine, the chairman of the New Federalism Fund, a 501(c)4 group that advocates for marijuana reform said in a statement.

"We applaud the Governors of the first four states to opt out of federal cannabis prohibition for standing up for both the citizens of their states, and for the principles of Federalism," Levine said.
Read the full letter here.
Title: Re: The Potfolio
Post by: Eddie on April 17, 2017, 08:03:34 AM
I got last weeks trades updated on page 2, for anyone who actually reads this thread. The weeks was very volatile, with good gains up to the Thursday announcement from the Canadian Parliament, but then the Canadians all sold off on the news, and the selling is continuing today. Not capitulation selling, but traders taking profits and some short action driving the sector down a bit more.

Lots of these stocks have fairly small floats, and it might get interesting if the new ETF decides to buy more shares, and the shorts need to cover at the same time. The Canadian ETF has the ticker HMMJ, and I don't think you can buy it yet from most American online trading platforms. There has been a lot of money going into the ETF, and I'm holding most of the good stocks they're buying, and only staying out of the "biotech" pot stocks and out of Scott's Miracle Gro, which seems to me to be a bad pick. The ETF has 10% in  Scott's and 10% in INSYS, which is a nasty biotech that spent a half million dollars to help defeat rec legalization in Arizona. I won't buy INSYS for that reason alone.
Title: New Poll Finds Majority of Americans Have Smoked Marijuana
Post by: RE on April 18, 2017, 12:23:54 AM
http://www.nbcnews.com/news/us-news/new-poll-finds-majority-americans-have-smoked-pot-n747476 (http://www.nbcnews.com/news/us-news/new-poll-finds-majority-americans-have-smoked-pot-n747476)

Apr 17 2017, 6:57 pm ET
New Poll Finds Majority of Americans Have Smoked Marijuana

(https://media3.s-nbcnews.com/j/newscms/2017_07/1900876/170213-colorado-marijuana-farm-206p_e1eee79b1fb1742420fd34701d8d774f.nbcnews-ux-2880-1000.jpg)
Farmworkers process newly-harvested marijuana plants, at Los Suenos Farms, America's largest legal open air marijuana farm, in Avondale, southern Colo. on Oct. 4, 2016. Brennan Linsley / AP, file

by Mary Emily O'Hara

Planning on celebrating 4/20 this Thursday? You aren't alone.

According to a new poll released Monday, 52 percent of Americans over 18 have tried marijuana at some point in their lives. The survey conducted by Yahoo News and Marist Poll found that not only have most adults in the U.S. smoked pot, 44 percent of those who tried it once still use it today.

The poll, titled Weed and the American Family, looks at everything from family views on marijuana use to regulation, entertainment, social acceptability, and more. And of course it comes just in time for the unofficial holiday of cannabis culture that falls on April 20th each year.

Despite marijuana still being federally classified as a dangerous Schedule I drug, on par with heroin, American attitudes toward the drug have changed over time. The Yahoo-Marist poll found that, out of the respondents who have tried pot at some point, 65 percent are parents. In fact, people who are current marijuana users are slightly more likely to be parents, at 51 percent.

The poll also found that American parents aren't that worried about their kids smoking weed. Out of all parents surveyed (not just those who had tried marijuana), the leading concern is a fear that their kids will smoke cigarettes. It was true in reverse, too: those surveyed said they thought their own parents would be more upset if they smoked tobacco rather than marijuana.
Image: Farmworkers process newly-harvested marijuana plants
Farmworkers process newly-harvested marijuana plants, at Los Suenos Farms, America's largest legal open air marijuana farm, in Avondale, southern Colo. on Oct. 4, 2016. Brennan Linsley / AP, file

Responses to legalization were varied. While more than 8 in 10 Americans (83 percent) support legalizing medical marijuana, people are evenly split on recreational policy — 49 percent of Americans support legalizing marijuana for recreational use while 47 percent oppose it, according to the poll.

And most (62 percent) respondents said they wouldn't use marijuana as a self-prescribed pain reliever even if it were legal.

Recreational marijuana use is now legal in eight states and the District of Columbia — with a majority of U.S. states offering legal cannabis products to patients for medical use.

According to both Snopes and Time magazine, the use of the number 420 to signify marijuana use stems from 1971, when a group of high school students in California's Bay Area met regularly at 4:20 p.m. to smoke pot. One of the teens reportedly knew a member of the Grateful Dead and passed on the tradition, and the rest is hemp history.
Title: Happy Weed Day!
Post by: RE on April 20, 2017, 05:51:09 AM
 :multiplespotting: :ernaehrung004: :spacecraft: :circle:

RE

http://www.cnn.com/2017/04/20/health/420-origin-trnd/ (http://www.cnn.com/2017/04/20/health/420-origin-trnd/)

It's time you learned how 4/20 became 'Weed Day'

(https://s-media-cache-ak0.pinimg.com/736x/09/b6/8d/09b68d19a717aa9b324b18051c4b0e4e.jpg)

By Madeline Holcombe, CNN

Updated 6:58 AM ET, Thu April 20, 2017

marijuana edibles high profits_00000130.jpg
Is eating marijuana riskier than smoking it?
history medical marijuana orig nws_00003424.jpg
The quick hit history of medical marijuana
compare marijuana and alcohol_00002510.jpg
What's worse -- pot or booze?
pkg marijuana walmart toy_00002214.jpg
You won't believe what mom finds inside Easter present
393517 01: The prescription medicine OxyContin is displayed August 21, 2001 at a Walgreens drugstore in Brookline, MA. The powerful painkiller, manufactured to relieve the pain of seriously ill people, is being used by some addicts to achieve a high similar to a heroin rush. Its popularity among abusers of the drug has resulted in a string of pharmacy robberies nationwide. Armed robbers raid the pharmacies for the painkiller which has a street value of $40 for a 40mg pill. (Photo by Darren McCollester/Getty Images)
Study: Pot may reduce painkiller deaths
Now Playing
Your brain on weed
california weed vs whiskey sidner pkg _00001109.jpg
Will weed be bigger than whiskey?
Designer marijuana boost THC potency
Dave Warden, a bud tender at Private Organic Therapy (P.O.T.), a non-profit co-operative medical marijuana dispensary, displays various types of marijuana available to patients on October 19, 2009 in Los Angeles, California.
Banned pesticide found in marijuana in Colorado
marijuana edibles high profits_00000130.jpg
Is eating marijuana riskier than smoking it?
history medical marijuana orig nws_00003424.jpg
The quick hit history of medical marijuana
compare marijuana and alcohol_00002510.jpg
What's worse -- pot or booze?
pkg marijuana walmart toy_00002214.jpg
You won't believe what mom finds inside Easter present
393517 01: The prescription medicine OxyContin is displayed August 21, 2001 at a Walgreens drugstore in Brookline, MA. The powerful painkiller, manufactured to relieve the pain of seriously ill people, is being used by some addicts to achieve a high similar to a heroin rush. Its popularity among abusers of the drug has resulted in a string of pharmacy robberies nationwide. Armed robbers raid the pharmacies for the painkiller which has a street value of $40 for a 40mg pill. (Photo by Darren McCollester/Getty Images)
Study: Pot may reduce painkiller deaths
Your brain on weed
california weed vs whiskey sidner pkg _00001109.jpg
Will weed be bigger than whiskey?
Designer marijuana boost THC potency
Dave Warden, a bud tender at Private Organic Therapy (P.O.T.), a non-profit co-operative medical marijuana dispensary, displays various types of marijuana available to patients on October 19, 2009 in Los Angeles, California.
Banned pesticide found in marijuana in Colorado
marijuana edibles high profits_00000130.jpg
Is eating marijuana riskier than smoking it?
Story highlights

    The number 420 has long been shorthand for smoking marijuana
    Why? Let's sort out the myths and theories

(CNN)There is something in the air today. Maybe you've noticed.
April 20, or 4/20, is known as "Weed Day" in some circles because the date corresponds with a numerical code for marijuana.
Yes, it seems arbitrary. So how did the number 420 come to represent smoking pot?

First, let's get the myths and rumors out of the way:
The legend of the California penal code
Some claim the number is drawn from the California criminal codes used to punish the use or distribution of marijuana. But the state's 420 code actually applies to obstructing entry on public land. So, not quite.
But the rumor sounds a lot like ...
The legend of the police radio code
Neither LAPD nor NYPD even have a code 420. San Francisco Police have one, but it's for a "juvenile disturbance."
So never mind that theory.
Then there's ...
The legend of the Dylan song
This one is a nod to Bob Dylan's song, "Rainy Day Women #12 & 35" and its lyric, "Everybody must get stoned."
Multiply 12 by 35 and you get 420.
Seems a bit of a stretch. And Dylan himself has never confirmed any link.
The story that appears to hold the most water is ...
The legend of the Waldos
According to Chris Conrad, curator of the Oaksterdam Cannabis Museum in Oakland, California, 420 started as a secret code among high schoolers in the early 1970s.
A group of friends at San Rafael High School in Marin County, California, who called themselves "the Waldos," would often meet at 4:20 p.m. to get high.
For them, it was an ideal time: They were out of school but their parents still weren't home, giving them a window of unsupervised freedom. They met at that time every day near a statue of Louis Pasteur, the scientist who pioneered pasteurization.
CNN Money: 10 things to know about legal pot
The 4:20 time became a code for them to use in front of their unsuspecting parents, and 420 gradually spread from there -- possibly via Grateful Dead followers -- across California and beyond. It's even the number of a California Senate bill that established the state's medial marijuana program.
What was shorthand for a group of friends can now be seen on T-shirts, in Tinder bios (420 friendly) and throughout pop culture.
And of course, on the calendar every April.
Title: The Potfolio: Etymology of 420
Post by: RE on April 20, 2017, 06:18:04 AM
https://www.marijuana.com/news/2017/04/the-etymology-of-420-by-fred-gardner/ (https://www.marijuana.com/news/2017/04/the-etymology-of-420-by-fred-gardner/)

the real 420 story   
The Etymology of 420
by Fred Gardner

(https://www.marijuana.com/wp-content/uploads/2017/04/etymology-of-420-fred-gardner-702x336.jpg)

By Guest Post on April 19th, 2017 at 1:37 pm | Updated: April 20th, 2017 at 5:23 am 420, Marijuana News


Last year I got invited to an “Eve-of-420” party at a club in San Rafael called Terrapin Crossroads, launched by Phil Lesh of Grateful Dead fame. There was valet parking, a rare treat for my 1986 Volvo. I told the attendant, “It’s not a jalopy, it’s a classic.”

As I approached the entrance a tall, longhaired person named Tree was giving away thin squares of chocolate laced with cannabis oil. Maybe more than I wanted to ingest. The dark confection started melting on my fingertip so I headed in to the bar to get a plastic cup, figuring I’d bring it home for future investigation.

A man was giving me a puzzled look as I guided the melting sliver of chocolate into the cup. “It’s an edible,” I explained. “I never got into edibles,” he said. I asked if he’d had an early bad experience with a brownie and he said yes. “I’m a Waldo,” he added, introducing himself as Larry. “The Waldos are real. We’ve decided to tell our story — how we started using ‘420’ as code for smoking marijuana.”  Tell me more, said I.

Although the five friends all remained cannabis aficionados, they have kept their distance from the burgeoning industry — until very recently.

In the fall of 1971 Larry Schwartz, Steve Capper, Dave Reddix, Jeffrey Noel, and Mark Gravich, marijuana smoking students at San Rafael High School, had a designated meeting place: a wall near the statue of Louis Pasteur in front of the Science Department. As teenage boys are wont to do, the five friends shared a certain comic sensibility. They were all big fans of Johnny Carson (the Stephen Colbert of his day). Their usual meeting time was twenty minutes after four, and that became their secret word for getting together and getting high. “Like we might say ‘Four twenty at three thirty today,” Larry explained.

Other students dubbed them the Waldos in reference to their hang-out of choice.

The first of many exploits through which the friends bonded was a search for a small patch of marijuana plants near the Point Reyes lighthouse. They had been given a map with the location of the patch.  Asked who gave it to them, Larry consulted Jeffrey Noel about how much the Waldos were now planning to reveal. “We’re not holding back anything,” said Noel. We went outside where it was quieter.

As Noel tells it, “The term we used was originally ‘420 Louie.’ It was our code term for ‘this is when we’re gonna meet at the statue.’ The synonym so we could communicate without saying ‘Let’s go get high together.’

“I had to be somewhat secretive because my father was a state narcotics agent for 32 years.  I couldn’t be as open as the others in verbally expressing myself. This was back in the days of landlines and everyone listening to one another. ‘Four twenty’ was our way to get under the radar.

The friends would jive amicably with students passing by — the jocks, the academics, the stoners, the hot-rod aficionados — and they would go off and smoke joints together. Steve Capper was a senior and had a big 1966 four-door Chevy sedan. The others were juniors and sophomores. Noel says, “We would sit on the wall and make comments as everyone went by. We were self-deprecating as well as comical. We had a wry but vibrant humor that we thrived on. We still do. That was part of getting high, too — verbal play and banter. We all loved comedy. We all loved travel and seeing new places and exploration — all of that kept re-enforcing itself.”

Larry Schwartz credits the school administration with maximizing the Waldos’ 420 time: “The teachers thought they came up with this brilliant thing called ‘modular scheduling.’ It gave us big breaks in time between classes. We would have 30 minutes to drive around smoking joints.”

After high school the five Waldos stayed in touch with one another. They and their families socialize to this day. All still live in Marin except Noel, who moved to Calistoga and worked for a company that made candles (and for 11 years grew cannabis behind trellised grapevines). He now lives in Santa Rosa.

Steve Capper runs a successful lending company in San Francisco. Dave Reddix works with him and is an independent filmmaker. Mark Gravich is a professional photographer specializing in real estate (pictures for listings and sales). Larry Schwartz is a project manager for a company in San Rafael, married for 23 years, two kids in college. “We’ve all done all right,” he observes.

I asked if the Waldos had heard the urban legend that 420 was police code for a pot bust in Connecticut. Noel said, “Yes, but not in Connecticut.” I also laid out my own private theory: some stoned hipster, probably in the 1950s, thought the hands of a clock at 4:20 looked like a face smoking a joint.

Noel said, “We’ve heard all the theories of how 420 started — which is part of the reason we’ve decided to explain how it really happened.  Another was the number of compounds in the cannabis plant.”

Some of the first 420 get-togethers involved driving to Pt. Reyes in search of the pot patch. According to Steve Caper, “My friend Bill McNulty (and his brother Pat McNulty) had a brother in law named Gary Newman, who was in the U.S. Coast Guard and stationed at the Pt.Reyes Peninsula. They would go out to visit with him often.  Gary planted his plants in the spring while an Active, and then got out of the active military and went into the Coast Guard Reserve. During his time in the Reserve he took a job as a ranch hand just a mile or so down the road from the lighthouse. By fall when the crop was ready to harvest, he became fearful that he would be busted and decided not to harvest. One day when Bill and Patrick were up there visiting with him, Gary drew the map of the growing location and personally handed it over to them with a permission for them, and anybody they truly trusted, to harvest. Bill McNulty brought the map to the Waldos — trusted friends — and 420 was born.”

Was the map like the one in Treasure Island with “X marks the spot?” According to Noel, “There was a power box marked, a generator, a rock, and the patch was supposed to be behind the box where the generator was. We still have a copy of it. We recently interviewed Gary and got that information. It took years to find him. Steven hired a PI who searched records and came up with his location. (Newman is down on his luck in the South Bay.)

“So we all would meet at the Louis Pasteur statue at 4:20 and jump in Steven’s Chevy Impala and go out to Point Reyes. Of course on the drive we would smoke and get high, which really wrecked our ability to find the patch. We would walk around the fields — acres and acres of cow pastures and woods — and eventually we’d give up. We did this I don’t know how many times.” Clapper thinks there were five or six search attempts over the course of a month.

The Waldos were not desperately in need. “It was the early ’70s and Marin County was rife with avenues to access,” notes Noel. “And Marin was rich, so it drew people who had it and wanted to gain the best profits. I had come from San Francisco. Marin seemed kind of soft at first, not the same diversity, but then I made good friends. My older brother and his friends were going to the Fillmore, the Avalon Ballroom, Winterland — all those places.  We knew people who were bringing it into the country,  driving to Mexico, going to Hawaii. Guys in the military bringing it in from Southeast Asia.

(https://www.marijuana.com/wp-content/uploads/2017/04/Jeffrey-Noel-768x461.jpg)
Jeffrey Noel being interviewed by Fred Gardner 4/19/16. Photo by Big Mike Barnes of 420 Limo fame.

“My dad was in the Bureau of Narcotics Enforcement in San Francisco. He had a different car every few months. One time he came home — I was shooting hoops in our driveway with two of my friends and he said, ‘Hey guys, come over here and look at this.’ He threw open the trunk and he threw an aluminum-foil-rapped kilo brick to one of my friends — 2.2 pounds of pot. He showed a Thompson submachine gun to another guy. Me, I’m looking in the trunk and there’s all sorts of other confiscated drugs. Back in the day agents used to bring that stuff home. It was awesome. A block of hash as big as my head … I must admit I was a bit of a thief.”

Noel’s father died a few years ago. His disapproval of his children’s marijuana use had been tempered, Noel recalls, by a document published by the state of California in the mid-1970s. “It was heavy on the technical side but it demystified the bullshit put out by the federal government.” His father gave it to him to read, saying, ‘I’m not going to stop you from doing this, but I want you to be aware of the facts.’ And that’s when we kind of met at a common point.”

As I was interviewing the Waldos, Big Mike Barnes, who operates the 420 Limo service, took some photos and joined the conversation. He explained how he used to chauffeur Elvy Musikka, a glaucoma patient who had won the right to receive cannabis from the federal government, grown at the University of Mississippi under contract with the National Institute on Drug Abuse. This was all news to the Waldos, who had for all these years kept their distance from the movement that has now become an industry (except as footsoldiers, i.e., users).  The Waldos are bemused by their status as icons and justly proud of their unique accomplishment: adding a word/number/symbol to the international vocabulary. What a legacy!

“It’s not something we tried to do,” says Noel. “We were just a bunch of goofs.  It’s mind-boggling that something this personal — what we thought was code used by a tight group of people — just expanded and expanded. Friends outside our inner circle  picked up on ‘420’ and started using it. We have a letter from a friend who went to Israel in 1972. He wrote, ‘Oh, wow, having a wonderful time. There are some hot chicks here at the kibbutz but no 420.” One of our friends in ’74 went into the military and was stationed in Germany. He wrote us ‘No green 420 here, it’s all Lebanese kief.’ Dave Reddix’s brother was good friends with Grateful Dead. He used the terminology and it spread through them. There were a number of circuitous connections.

Noel added in an email,  “We want to and will get out the much larger Waldos backstory, which includes many other adventures we had, and continue to have.  All of it, and the  Waldos ‘identity,’ has to do with a mindset of finding, seeking, and curiosity — all with a sense of fun, wry humor, and friendship.”  The Waldos have created  a website, well worth checking out today — 4/20 — or any of the other 364.

(https://www.marijuana.com/wp-content/uploads/2017/04/the-waldos-420-351x185@2x.jpg)
Impresario/writer/organizer Steve Hager honoring the Waldos on the eve of 4/20/16. From left: Steve, Dave, Mark, Hagar, Larry, and Jeff. Back in the 1970s, Hager in High Times had identified the five friends as the originators of 420 as a code word for marijuana. This year Hager’s tribute to the Waldos will be at Strawberry Fields, Central Park, NYC. Graphic from videographer Chad Rea.

Fred Gardner is the managing editor of O’Shaughnessy’s and a songwriter. Musicians are invited to add “The Waldos” to their repertoire.
Title: Cutting Through the Haze - A Frank Talk about Cannabis in Canada
Post by: RE on April 22, 2017, 01:24:09 AM
http://www.huffingtonpost.com/entry/cutting-through-the-haze-a-frank-talk-about-cannabis_us_58fa8bf0e4b0f420ad99c77a (http://www.huffingtonpost.com/entry/cutting-through-the-haze-a-frank-talk-about-cannabis_us_58fa8bf0e4b0f420ad99c77a)

Lynn Posluns, Contributor Founder & President, Women’s Brain Health Initiative
Cutting Through the Haze - A Frank Talk about Cannabis in Canada
04/21/2017 06:57 pm ET

(http://i.dailymail.co.uk/i/pix/2012/03/03/article-2109731-11E5C4A9000005DC-385_468x329.jpg)

It was the kind of conversation that would have been unimaginable only five years ago. On the 16th floor of a gleaming office tower in the heart of Toronto’s financial district, in a meeting room at one of Canada’s most respected public affairs firms, a mixture of millennials and grey haired boomers gathered over wine and canapés to listen to a thoughtful discussion about smoking marijuana.

The event, Up in Smoke-Marijuana: The Good, the Bad and the Uncertain, could not have been more topical. It came only days after the federal government unveiled its legislation to legalize cannabis. The changing landscape is sparking the growth of a new industry, one that Deloitte estimates could be worth $22 billion. But it is also raising a multitude of questions about how Canadian society will adapt.

Up in Smoke was part of a series of events sponsored by Women’s Brain Health Initiative (WBHI) under our Millennial Minds™ program. The goal is to send a message that brain health is not only something that older people should be thinking about—it is just as important for millennials to consider as well.

The discussion was hosted by public affairs firm Navigator, which has been at the forefront of the debate, offering both counsel and analysis on the marijuana file to a variety of clients. Managing Partner Will Stewart acted as MC, noting that he is getting calls all the time asking whether the folks at Navigator are smoking up in the office. And he is regularly teased.

“Willy’s the weed guy,” he said, to titters from the audience.

But it was a serious and enlightening evening, featuring commentary from experts in medicine, the law and the emerging cannabis industry.

Dr. Mark Ware of McGill University is a renowned researcher in medical marijuana and was the co-chair of the recent task force on cannabis, whose report was influential in the drafting of the new legislation. He told the audience that he believes that legalization will make it easier for researchers to explore new therapeutic uses for cannabinoids—the chemicals that are unique to cannabis.

The best-known use for medical marijuana is pain relief, for which it has been legally prescribed for years, but Dr. Ware said we are only beginning to understand other possible benefits, such as the treatment of some of the most disturbing symptoms of dementia.

“Pain is the way in but there are a huge number of potential therapies,” he said.

He also pointed out that marijuana seems to affect men and women differently—women have been shown to be more susceptible to the effects whereas men are more likely to develop dependencies

Dr. Ware expressed the hope that amid the many millions of dollars currently being invested in the commercial exploitation of cannabis that some money might be set aside to support research.

Although cannabis is an ancient product that has already been studied extensively, there was a consensus on the panel that the Canadian public needs to know much more about it—in effect to become more knowledgeable consumers.

That is the role that a new firm called Lift hopes to play. It describes itself as “the meeting place for cannabis in Canada.”

Lift CEO Matei Olaru was an Up in Smoke panelist, saying: “there’s not a lack of information (about marijuana) but an overabundance of misinformation.”

He said there is a huge need for education for the new, legal “recreation market”.

“Lift hopes to fill the gap…we are all about empowering consumers.”

In fact, as I learned during the discussion, there are dozens of different forms of cannabis, which can have wildly varying effects on the user. Here is where the product differs from beer, wine or spirits.

But Alison Gordon, VP of Marketing and Communications for Delshen Therapeutics (which is in the medical marijuana sphere), said that the government’s proposed restrictions on advertising will make it harder for buyers to educate themselves.

“Marketing and branding is how people can make informed decisions. If we don’t allow licensed producers to create brands and market themselves, it’ll be harder to eliminate the black market because people want to know what they’re buying,” she said.

During the question and answer portion of the event, a mother raised concerns about potential harmful effects, having seen one of her children experience a psychotic episode after using marijuana.

Dr. Ware responded that he has heard many of these kinds of stories and warned that the cannabis industry ignores them at its peril. He believes legalization can help.

“The problem is that you have the black market waiting to prey on 18-25 year olds (the largest group of users). If we make it illegal, they’ll get it anyway. But if we can educate them to use lower THC products, then at least they’ll know what they’re using,” he said.

Up in Smoke covered a vast amount of ground over the evening. Employment lawyer Shelley Brown predicted that employers will need to develop policies to cover cannabis-related issues in the workplace. Aaron Salz, the CEO of the Stoic Advisory, a consultancy that specializes in financial issues for the new industry, observed that where once it was difficult for marijuana startups to raise money, investment is now pouring in.

We heard about the retail experience from Alan Gertner, the CEO of Tokyo Smoke, which already has two outlets in Toronto and plans to open more across the country.

He said customers come from out of town to his store “so they can buy from someone they can trust, in a safe place.”

I must thank both Navigator and Brain Canada for their generous sponsorship of Up in Smoke. A central element of WBHI’s mandate is knowledge dissemination and I believe we all learned a great deal. It was so encouraging to see so many millennials in attendance—clearly this is a subject of great relevance for them, as it is for those of us from an older generation.
AdChoices

The legalization of cannabis is already sparking an important national conversation. I hope WBHI and our partners in staging Up in Smoke played a small role in shedding light on the many and varied implications of this new era.
Title: Re: The Potfolio Weed sales will soon clobber beer sales
Post by: azozeo on April 22, 2017, 02:25:04 PM
2017-04-20 - Weed sales will soon clobber beer sales:
http://ca.finance.yahoo.com/video/weed-soon-clobber-beer-sales-130500309.html (http://ca.finance.yahoo.com/video/weed-soon-clobber-beer-sales-130500309.html)
http://www.cnbc.com/2017/04/20/beer-sales-are-going-to-fall-because-marijuana-is-getting-so-popular-wall-street-says.html (http://www.cnbc.com/2017/04/20/beer-sales-are-going-to-fall-because-marijuana-is-getting-so-popular-wall-street-says.html)
http://www.msn.com/en-us/money/smallbusiness/weed-will-soon-clobber-beer-sales-according-to-a-wall-street-firm/vi-BBA7MPa (http://www.msn.com/en-us/money/smallbusiness/weed-will-soon-clobber-beer-sales-according-to-a-wall-street-firm/vi-BBA7MPa)
Title: Re: The Potfolio
Post by: azozeo on April 25, 2017, 04:22:56 AM
2017-04-23 - Legalized marijuana could help pay teachers in South Dakota:
http://www.usatoday.com/story/news/politics/2017/04/03/could-recreational-marijuana-help-pay-sd-teachers/99976022/ (http://www.usatoday.com/story/news/politics/2017/04/03/could-recreational-marijuana-help-pay-sd-teachers/99976022/)
http://www.argusleader.com/story/news/politics/2017/04/03/could-recreational-marijuana-help-pay-sd-teachers/99976022/ (http://www.argusleader.com/story/news/politics/2017/04/03/could-recreational-marijuana-help-pay-sd-teachers/99976022/)
http://www.democraticunderground.com/1238247 (http://www.democraticunderground.com/1238247)
Title: Re: The Potfolio
Post by: Eddie on April 25, 2017, 06:04:10 AM
Pot stocks are looking weak these days, and I would not recommend buying in at this point. Traditionally, OTC stocks suffer in the summertime. The trading volume tends to be light, and prices can drift down as weaker hands give up their positions. This affects pot stocks, even though it has nothing to do with the individual companies and their prospects.

The best companies are still the Canadians. It is thought that parliament will likely pass rec in its final form (even though a lot of details still have to be worked out) before their summer break, which happens on June 24th. That might be a good catalyst for some upside.

If I were a potential buyer of these stocks, I would try to establish a good low buy-in price for any stock I was interested in at this point, and wait to see if it gets hit, or just set a buy order at that level. I would be happy to help anyone trying to figure out fair prices, or levels likely to be hit on the down side.

I am holding mostly the best of the best, with a huge emphasis on Canada. I can tell you that those betting on Nevada, which is the most positive US pot legalization story at the moment, are losing their bets right now. The stocks that benefit from Nevada rec are perceived to be DIGP, GBLX, and TRTC, and they have not done well this last month or so. That could change, it does bear watching.

I read somewhere about a bust in DC (where pot is legal) of some MJ legalization activists who were handing out free joints in public. The police decided they could arrest them under federal statutes. It certainly doesn't pay to be too blatant and confront law enforcement directly. Remember that law enforcement groups benefit from continued prohibition, and they have raised a lot of money to fight legalization.
Title: Re: The Potfolio
Post by: Eddie on May 02, 2017, 06:13:49 AM
Last week was tough on the Potfolio, although Friday we had a good bounce. Yesterday I did buy a half position in a new Canadian, MariCann (MRRCF).

The current pot stock situation in Canada is that a number of formerly private companies are now going public, and a few of them look pretty good. MRRCF is such a comapny. I am going to scale into MRRCF and also Harvest One Cannabis (HRVOF) which is also new, and is trading at a discount to some of its peers. The best one of the new ones looks to be MedReleaf, which has had great revenue as a private entity and will be an instant competitor to leaders like Aphria and Canopy Growth as soon as it goes public (I'm not sure on the date, as of yet, but pretty soon).

I will update the Potfolio changes on page 2 of this thread. All the history of Potfolio buys and sells is archived there.
Title: Re: The Potfolio
Post by: Eddie on May 05, 2017, 11:38:48 AM
The pressure in pot stocks was mostly down this week, although not as bad as last week. Today I bought a little more Maple Leaf (MGWFF), a little more MariCann (MRRCF), and I bought a small initial position in the recent IPO Harvest1 (HRVOF).  My intention is to continue to add small amounts of the Canadian LP's (licensed producers) over the summer, which is apt to be a time of low volume and more selling pressure.

I am still waiting for the announcement on the MedReleaf IPO, which will be the new hot stock the next time pot stocks heat up, most likely. It has a much bigger market share than any of the other private pot growers currently going public, and has the potential to compete with the leaders like Canopy Growth, Aphria, and Aurora.

I will update page 2 sometime today or tomorrow to reflect the new purchases. Right now the Potfolio is down significantly, although I haven't computed exactly how far underwater I am. Maybe 10% at the moment. Pot stocks, fwiw, still look positively stellar compared to mining stocks, which are continuing to get beat down, as the Masters of the Universe continue to short the hell out of gold and sliver with the blessing of the Powers That Be.
Title: Re: The Potfolio
Post by: RE on May 05, 2017, 12:17:17 PM
Right now the Potfolio is down significantly, although I haven't computed exactly how far underwater I am. Maybe 10% at the moment.

Looks like a long slog up to Billionaire Ganja Magnate.

RE
Title: Re: The Potfolio
Post by: Eddie on May 05, 2017, 12:35:21 PM
There will be some good times ahead. It isn't shaping up that badly. Until now, the only people making money in pot stocks have been traders, riding the volatility. There have been very few real investors. Insiders with stock have been quick to sell and take profits. Why not? It's a risky business.

Now, there is already one Canadian pot index ETF, which looks to be growing like gangbusters, and there will soon be others. As financial houses start to buy into the sector, things will change pretty quick.

I have made a conscious choice to average into the best stocks, over time. I have now eliminated almost all of the weak companies I bought before I had good intel. The Potfolio has almost all high quality companies with real revenue being generated. I have very little exposure to US companies (except the ones my Canadian companies are buying up with their cash).

A 10% drawdown is nothing in this space, where individual stocks sometimes move 30% or more in a day.
Title: Re: The Potfolio
Post by: azozeo on May 05, 2017, 01:37:51 PM
Right now the Potfolio is down significantly, although I haven't computed exactly how far underwater I am. Maybe 10% at the moment.

Looks like a long slog up to Billionaire Ganja Magnate.

RE

Sounds like a good time to load the boat Ed.

No guts, no glory  :icon_mrgreen:
Title: Re: The Potfolio
Post by: Eddie on May 11, 2017, 06:06:07 PM
After a brutal week or so, the Potfolio made a very nice bounce today while I wasn't looking. I'm treading water, but I still intend to add to some of my positions during the summer doldrums in the OTC market, which is always a factor according to people I talk to who play the penny stocks.
Title: The Potfolio-VT Becomes First State to Pass Legislation Legalizing All Pot Use
Post by: azozeo on May 14, 2017, 01:20:47 PM
I love how these authors use derogatory terms towards cannabis. "Illicit drug", indeed.
The description could have had been termed, "Plant from nature that cures cancer".


Alternet

According to the Burlington Free Press, Vermont became the first state to pass legislation legalizing the recreational use of marijuana through its legislature Wednesday. Colorado and eight other states have similarly moved to decriminalize the drug, but always through state referenda or other maneuvers. This marks the first true legislative victory for marijuana advocates in the U.S.

The bill, which passed through the Vermont House of Representatives with a 79-to-66 vote, would legalize small amounts of cannabis possession starting in 2018 and establish a taxed and regulated market for the illicit drug. Having already passed the state’s Senate, the bill is now headed for the desk of Republican Governor Phil Scott, a marijuana skeptic.

A recent poll found that 57 percent of Vermonters asked would approve of legalizing marijuana for recreational use.Lt. Gov. David Zuckerman said that the fact the state legislature was able to push the bill through shows how in touch the governing body is with Vermont’s people. “I think it reflects that Vermont elected officials are more in touch with our constituents than a lot of elected officials in other states,” he told the Free Press. Zuckerman added, “I think the public is ahead of us, but elected officials tend to be cautious when it comes to change. ”

The Vermont legislature had previously legalized medical marijuana in 2004 with a further expansion in 2007. In 2013, the state made minor possession a misdemeanor offense.

As the Free Press reports Wednesday’s developments:

    Wednesday’s vote closed a divisive debate over legalization, particularly in the House, that once prompted Senate President Pro Tempore Tim Ashe to predict that legalization would take a “miracle” to pass this year. Advocates hugged and shared high-fives outside the two chambers after the vote.

    Earlier in the day, the House Judiciary Committee voted 8-3 to support the limited bill, which was pitched as a compromise between the House and Senate approaches on marijuana.

    Wednesday’s vote closed a divisive debate over legalization, particularly in the House, that once prompted Senate President Pro Tempore Tim Ashe to predict that legalization would take a “miracle” to pass this year. Advocates hugged and shared high-fives outside the two chambers after the vote.

    Earlier in the day, the House Judiciary Committee voted 8-3 to support the limited bill, which was pitched as a compromise between the House and Senate approaches on marijuana.

The bill ties in a measure titled H.170 that was supported by the House and would allow individuals 21 years and older to possess up to one ounce of weed and also to grow two mature cannabis plants or four immature cannabis plants. If signed by the Governor, the law would go into effect on July 1, 2018 and nine-member commission will also be set up to study the regulation of marijuana in the future.

For his part, Governor Scott did not say if he would use his veto power prior to the passing of the bill in the House. Still in his first term, Scott noted that he doesn’t consider decriminalization a “priority.”

“I believe that what we should be doing is trying to find ways to protect those on our highways, deliver a level of impairment that is consistent throughout the Northeast, as well as to address the edibles for our kids, before we move forward with legalization,” Scott told the Free Press. “Having said that, I’m going to review the bill as it’s passed.”
Title: Re: The Potfolio
Post by: Eddie on May 17, 2017, 09:14:11 AM
Just a short new watch list of cannabis stocks that look to perform better than the rest, based on fundies like revenue and capital raised to date.. Revenue is as good as it gets for most pot stocks. Even the top companies are not showing much in the way of earnings, because they are all plowing their profits into new deals.

MDCL --- A Colorado company that's making more money every quarter. Seems to be well run. Still suffering from Jeff Sessions Syndrome. I am waiting for an obvious entry point to buy any new US companies, but this one is tops on the wish list currently. Probably a decent buy at the current beat down level....but it might go lower with more bad DOJ news.


CBICF --- A Canadian company building lots of deals in the US. Today they announced new deals in Maryland and Arizona.
Title: Re: The Potfolio
Post by: Eddie on May 22, 2017, 11:30:22 AM
Just a brief update. Today is an up day for the potfolio, but prices overall are still pretty beat down. I took a small position in CBICF last week and added a bit of OGRMF today, which I've been holding for a while. The price looks very good compared to the other licensed Canadian LP's.

Prices are looking pretty attractive on some of the stocks I'm holding long term, and I will continue to add a bit here and there to existing positions.

The upcoming Medreleaf IPO is interesting because as a private company they have had more revenue than all but a couple of the currently traded public pot stocks, and they will likely be a hot item at some point. However, the intel I'm getting  leads me to believe that the IPO is way overpriced and that insiders are looking to sell into it. I expect it to really tank, right off the mark....so wait and let it trade for a while before taking a position.
Title: Vermont Governor Blows Smoke With Legal Marijuana Veto
Post by: RE on May 30, 2017, 01:22:56 AM
http://dissidentvoice.org/2017/05/vermont-governor-blows-smoke-with-legal-marijuana-veto/ (http://dissidentvoice.org/2017/05/vermont-governor-blows-smoke-with-legal-marijuana-veto/)

Vermont Governor Blows Smoke With Legal Marijuana Veto

“Libertarian” Phil Scott enforces nanny state values — wtf?

(http://cdn8.openculture.com/wp-content/uploads/2012/11/13133115/reefermadness.jpg)

by William Boardman / May 30th, 2017

Vermont, of all places, offers the latest example of how marijuana makes people crazy, the people in this case being the Republican governor and most of the Republican Party. For all the “Reefer Madness” propaganda from governments over the past century, the real madness comes from opponents of marijuana, not its users or proponents.

Vermont governor Phil Scott waited until the last possible moment on May 24 to issue his veto of the  24-page bill (Senate bill S.22) passed by both houses of the legislature (Senate 20-9, House 79-66): An Act Relating to Eliminating Penalties for Possession of Limited Amounts of Marijuana by Adults 21 Years of Age and Older. The bill stops way short of full legalization, treating marijuana like aspirin, but it represents a major shift toward sanity and scientific reality that American populations seem to be slowly insisting that their governments address.

Gov. Scott, albeit in a slippery, mealy-mouthed way, is firmly in the rearguard reactionary camp, saying “reasonable” things while still defending the “values” of J. Edgar Hoover and drug fascists everywhere. To be fair, Gov. Scott has not yet encouraged a police and vigilante murder spree against “drug dealers” such as we’re now seeing in the Philippines, but he’s on the same spectrum of state control and intolerance.

The essence of S.22 is clearly stated in the bill (as approved, page 10):

    Sec. 1. LEGISLATIVE INTENT; CIVIL AND CRIMINAL PENALTIES It is the intent of the General Assembly to eliminate all penalties for possession of one ounce or less of marijuana and two mature and four immature marijuana plants for a person who is 21 years of age or older while retaining criminal penalties for possession, dispensing and sale of larger amounts of marijuana. This act also retains civil penalties for possession of marijuana by a person under 21 years of age, which are the same as for possession of alcohol by a person under 21 years of age.

This is only a baby step toward marijuana sanity. It is a measure of our cultural myopia that even this minimal, largely symbolic measure still provokes a reefer madness response. Read the legislative intent carefully: all it really does is remove the criminal threat from limited activity a good many people already engage in covertly.

Gov. Scott tries to sound reasonable in his veto message:

    With a libertarian streak in me, I believe that what adults do behind closed doors and on private property is their choice, so long as it does not negatively impact the health and safety of others, especially children…. I have supported, and continue to support, medical marijuana laws and decriminalization.

Even his “reasonableness” has nasty hooks. Decriminalization isn’t limited to “behind closed doors and on private property,” that’s a dishonest, self-contradictory concept. To focus on “especially children” in a bill aimed at adults over 21 is an equally deceitful bit of demagoguery.

Gov. Scott’s performance with regard to S.22 is an exercise in blatant bad faith. He did not engage in the legislative process to attempt to shape a bill he would sign, he did not engage in the legislative process meaningfully at all. Everything he’s done is consistent with delaying tactics, with the possible goal of preventing any change while amiably seeming reasonable about his behavioral rigidity. Gov. Scott is saying we should go slow (the familiar mantra that usually means “never”) and he has made no good faith effort to go at all.

“We must get this right,” Scott writes, adding that that “means letting the science inform any policy….” Then he proceeds to stand with the anti-science tradition that classifies marijuana with heroin. He cites no science in support of his views, perhaps because there is none and has been none for a long, long time. Even though marijuana science is politicized and selectively under-funded, scientists keep finding less and less danger from marijuana. The governor doesn’t even try to engage in an honest risk/benefit analysis of marijuana safety. To be in favor of a ban on marijuana without trying to ban tobacco is as stupid as it is irrational.

Perhaps because he has no compelling, rational argument, Gov. Scott uses his three-page veto message to raise the specter of mostly unnamed and undefined public and safety issues (referred to at least sixteen times). The desperation of his demagoguery is his single, specific “scientific” example: “Secondhand marijuana smoke can negatively impact a child’s brain development. Therefore, if an adult is smoking marijuana in a car or a confined space with a child this should be severely penalized.” And other secondhand smoke is OK?

“We can all work together on this issue in a comprehensive and responsible way,” Gov. Scott writes near the end of his veto message. This is true. Gov. Scott could have done as much when the legislation was introduced. He did not. He shows no sign now of being comprehensive (whatever that might mean), much less responsible.

The governor’s official state page declares:

    Governor Phil Scott became the 82nd Governor of Vermont on January 5, 2017. He previously served three terms as Vermont’s Lieutenant Governor, and as a Senator for Washington County. As Governor, he has committed to making a difference in the lives of Vermonters by growing the state’s economy, making Vermont more affordable, and restoring faith and trust in government.

This is a mountebank’s creed. Believe it at your peril. As Nixon’s campaign manager turned attorney general so long ago warned: pay no attention to what we say, watch what we do. For all his smarmy “recommendations,” Gov. Scott stands squarely in defense of an insane criminal system that fills prisons with nonviolent drug “offenders” for the sake of sanctimonious hypocrisy, racial discrimination, and private prison profits.

William M. Boardman has over 40 years experience in theatre, radio, TV, print journalism, and non-fiction, including 20 years in the Vermont judiciary. He has received honors from Writers Guild of America, Corporation for Public Broadcasting, Vermont Life magazine, and an Emmy Award nomination from the Academy of Television Arts and Sciences. This article was first published in Reader Supported News. Read other articles by William.
Title: Re: The Potfolio
Post by: Eddie on June 11, 2017, 12:26:33 PM
I haven't kept up with this thread very well lately. Today I updated recent buys on page 2. It is now up-to-date with regards to what's in the Potfolio.

In general, I'd say my knowledge base on this market is continuing to expand rapidly. Right now is a decent time, imho, for anyone with a few bucks to gamble to put a little money on the table. Share prices have been beaten down, especially the Canadian LP's, which are still the safest and best companies to own in the pot space. Anyone wanting specifics on which ones are best can pm me or just post a comment here.

The take-away, right now:

Nevada will go legal for rec, probably by July 1, 2017, but possibly slightly delayed. They are way ahead of Cali and MA.

There are only a few American companies I think are worth putting money into, so I'll make a brief mention.

(Remember we are expecting the DOJ to issue some new guidelines on July 27th or shortly thereafter, and that might be a negative for American pot companies, which are already beat down, mostly over the failure of Sessions/Trump to make any kind of statement on how the federal government is going to treat state-legal rec pot companies.)

TRTC is a Cali company that is going to make bank. The problem with TRTC is that the company insiders have a history of enriching themselves and screwing their shareholders during these difficult time we've been having. Going forward, there should be so much money being made they won't have to do that to live large, but they might do it anyway. Leopards seldom change their spots. The stock is beaten down a lot, and if the company insiders don't dilute the stock into infinity (like many pot companies have done already) then it's a good buy. But caveat emptor.

ACAN is a start-up in MA that looks to do very well, but so far they are just breaking ground on their giant-ass facility. They are a low float company with what looks like a great story, but they will have to raise a lot more money to get to the point where revenues are coming in. Their stock is much cheaper than it was a few months ago, and I'd buy some here.

MDCL is a Colorado company that is well run and making money and making decent acquisitions, but they are not a company that pays penny stock journals to pump their stock (many high-flying pot companies are proven pump-and-dumps). So they have not done well on stock price. The stock has been driven down by early stage private investors taking money off the table, and their stock is trading at 52 week lows. I think it's an excellent buy here, but the trend is still down, and it might take a while before it takes off. I think it's a buy, and I'm starting to buy it. I expect it will make me a great deal of money if I can accumulate shares near the current prices.

GBLX is a Nevada play (an actual grower) , and they will do well. The stock is beaten down, but basing for what might be a good run.

DIGP is a Nevada lab biz, and legal pot requires lots of lab samples. They are poised to do well, but the stock has been moribund for a while. At some point when Nevada revenues start rolling in, that will change. Management is a little spotty, but the numbers look good for this one.

That's all for the US. That's five somewhat decent plays out of a few hundred I've weeded out for you. No pun intended.

Canada keeps having formerly private companies go public, and some new ones are actually later stage companies with good revenue.

Medrealeaf is the biggest one. It went public last week, and it's selling right now for 6.77, which is a discount to it's fundamental value. It dropped some out of the gate, but is now recovering. Time to buy a little, for sure. I'm not sure we won't have one more wave of selling later in the summer, but long term I think the company (symbol MEDFF) is selling at a very attractive price here.

The potfolio is back up to 24 stocks, and they are all good ones, although I paid a little too much for some of my starting positions. But, the Potfolio strategy is to buy good companies in small increments and then average into the winners. Almost all the stocks I'm holding now will be winners over the next 2-5 years, with the possible exception of MCIG, which I might sell off on strength, which has been lacking lately.

Canada is very close to passing the rec legislation, but parliament goes on summer break in a few weeks and it's down to the wire. The announced date for national  rec legalization, July1, 2018, won't be marked by instant big money being made. It'll be baby steps at first, but then it'll take off like gangbusters. Most Canadian LP's are making deals to sell pot all over the globe. It won't just be Canucks smoking Canadian weed.






Title: Re: The Potfolio
Post by: Eddie on June 11, 2017, 01:01:14 PM
One more thing. Canadian pot stocks have a good long term possibility of a positive currency arbitrage. If the current bunch of earth rapers in DC keep improving the chances for resource companies to make money in the short term (and I'd say they are, in a big way, with the pipelines and other legislation to continue to subsidize coal and big oil) then we might see the Loonie make a comeback.

As recently as early 2013 the USD and the CAD were at parity. Now the Loonie is at .74 USD, and has recently been even lower. Long term, the USD is going down, way down, anyway. I expect ALL Canadian stocks to add 25% in value as the two currencies realign. Another reason to buy the Frozen North.
Title: Re: The Potfolio
Post by: RE on June 11, 2017, 02:35:25 PM
Long term, the USD is going down, way down, anyway.

Indeed.  All the way down to ZERO.  The Loonie will be at -0.25

RE
Title: The Potfolio MONSANTO AND BAYER ARE MANEUVERING TO TAKE OVER THE CANNABIS INDUST
Post by: azozeo on June 29, 2017, 03:44:37 PM
Waking Times

Phillip Schneider, Staff Writer
Waking Times

It has been rumored for years that Monsanto plans to take over the cannabis industry with genetic engineering just as they’ve taken over the corn and soy industries. Although they have always denied having any intentions to do so, at this point it is unlikely that anybody really believes them. In contrast, many in the cannabis sphere are prepared to resist any kind of GMO takeover of marijuana by Monsanto or any of their cohorts.

Evidence is mounting, though, which points strongly to the notion that Monsanto does indeed plan to take control of the cannabis plant, and it doesn’t look good for medical users, or anyone planning on getting into the industry.
Former Nazi Collaborator Bayer Buys Out Monsanto for $66 Billion

You may remember hearing back in September that Bayer, the largest pharmaceutical company in the world, made a deal to buy out Monsanto for $66 billion. Although Monsanto was voted the most evil company in the world in 2013 and its reputation has continued to fall since, Bayer still went ahead with the buyout.

A merger between these two companies is unsurprising, as though they both have long histories of involvement with Nazism and chemical weapons like agent orange which have devastated Vietnam since the war. In fact, Bayer began as a break-off company of the infamous IG Farben, which produced the chemical weapons used on the Jews during the Nazi reign. After the war, Farben was forced to break up into several companies, including BASF, Hoeschst, and Bayer.

Soon after at the Nuremberg trials, 24 Farben executives were sent to prison for crimes against humanity. However, in a matter of just 7 years each of them was released and began filling high positions in each of the former Farben companies, and many of them began working for the Russian, British, and American governments through a joint intelligence venture called “Operation Paperclip”.

    “IG (Interessengemeinschaft) stands for “Association of Common Interests”: The IG Farben cartel included BASF, Bayer, Hoechst, and other German chemical and pharmaceutical companies. As documents show, IG Farben was intimately involved with the human experimental atrocities committed by Mengele at Auschwitz. A German watchdog organization, the GBG Network, maintains copious documents and tracks Bayer Pharmaceutical activities.” – Alliance for Human Research Protection

After all these years, Bayer is now richer and more powerful than their predecessor company I.G. Farben ever was.
Monsanto And Miracle-Gro Have Intimate Business Ties

According to Big Buds Magazine, Monsanto and Scotts Miracle-Gro have a “deep business partnership” and plan on taking over the cannabis industry. Hawthorne, a front group for Scotts, has already purchased three of the major cannabis growing companies: General Hydroponics, Botanicare, and Gavita. Many other hydroponics companies have also reported attempted buyouts by Hawthorne.

    “They want to bypass hydroponics retail stores…When we said we won’t get in bed with them they said, ‘Well, we could just buy your whole company like we did with Gavita and do whatever we want.’” – Hydroponics Lighting Representative

Jim Hagedorn, CEO of Scotts Miracle-Gro, has even said that he plans to “invest, like, half a billion in [taking over] the pot business… It is the biggest thing I’ve ever seen in lawn and garden.”

He has also invested in companies such as Leaf, which grows cannabis in an electronically regulated indoor terrarium accessible via smartphone.
Bayer and Monsanto Trade Industry Secrets On Producing GMO Marijuana

It is logical that Bayer, being the parent company, would work together with Monsanto in order to share secrets which would advance mutual business. Many people in the cannabis industry have been warning about this, including Michael Straumietis, founder and owner of Advanced Nutrients.

    “Monsanto and Bayer share information about genetically modifying crops,” Straumietis notes. “Bayer partners with GW Pharmaceuticals, which grows its own proprietary marijuana genetics. It’s logical to conclude that Monsanto and Bayer want to create GMO marijuana.” – Michael Straumietis

Conclusion

It is possible that Bayer and Monsanto could create a monopoly on marijuana seeds in the same way that they have created a monopoly on corn and soy. Through immense corporate power and the enforcement of international patent law, these corporations could place themselves in a position of total control over cannabis as a medicine as well as for recreational use by using the same model as they do with the food crops they control.

But not all hope is lost. There is still a chance to fight back against the Bayer-Monsanto monopoly by boycotting genetically engineered products, Miracle-Gro and other Scotts brand products, Bayer pharmaceuticals, and companies that do business with any of these. You could even store seeds if you live in an area where it is legal and grow your own, while supporting hydroponics and nutrient companies that don’t do business with these corporate behemoths.

    “Corporations and people with hundreds of billions of dollars know marijuana is a miracle plant. They want to come in and steal our plants, seeds, and industry from us, [and] we must stop them.” – Straumietis

Read more articles from Phillip Schneider.
About the Author

Phillip Schneider is a student and a staff writer for Waking Times.

This article (Monsanto and Bayer are Maneuvering to Take Over the Cannabis Industry) was originally created and published by Waking Times and is published here under a Creative Commons license with attribution to Phillip Schneider and WakingTimes.com. It may be re-posted freely with proper attribution, author bio, and this copyright statement.
Title: Re: The Potfolio
Post by: Eddie on June 29, 2017, 03:50:35 PM
Second article I've seen in two days on this. I expect it's true. I read they are experimenting with it in Uruguay, where it's easier to get away with that kind of thing. I don't think it'll fly in Canada or the US, but I could be wrong. Basically, pot is not like soybeans or corn. Each grower and and each strain is a little different, and pot growers have their own well-developed proprietary genetics already. I hope Monsanto loses on this one. Who wants to get cancer from eating or otherwise using pot sprayed with Roundup, a known carcinogen? Not me.

Good to hear from you AZ. Been a little worried about you.
Title: Re: The Potfolio --- Okay Nevada, Smoke 'Em If You Got 'Em
Post by: Eddie on July 01, 2017, 11:39:30 AM
People were lined up around the block at midnight in Reno and Vegas to purchase legal marijuana for recreational use. Significant problems still exist due to legal challenges from the alcohol people, but the deadilne was met, and pot will be for sale until the unresolved issues make the dispensaries run out, which is a certainty, due to the way the government is handling things.


Nevada pot shops see green as sales of legal recreational marijuana begin

LAS VEGAS -- Nevada became the fifth state in the U.S. with stores selling marijuana for recreational purposes, opening a market early Saturday that is eventually expected to outpace any other in the nation thanks to the millions of tourists who flock to Las Vegas.

People began purchasing marijuana shortly after midnight, just months after voters approved legalization in November and marking the fastest turnaround from the ballot box to retail sales in the country.

Many pot shops have been gearing up for the extra business, and feeling the pressure, CBS News correspondent Jamie Yuccas reports.

"You have an influx of people trying to pick up and get and secure product for the influx of people that are going to be able to purchase now," said Dyran Stalling at the shop Nature's Kindest. "It's not a bad thing, but it's going to be interesting to see how it plays out."

Hundreds of people lined up at Essence Cannabis Dispensary on the Las Vegas Strip. People were excited and well-behaved as a lone security guard looked on. A valet was available to park the cars of customers.


A cheer erupted when the doors opened.

Those 21 and older with a valid ID can buy up to an ounce of pot. Tourists are expected to make nearly two of every three recreational pot purchases in Nevada, but people can only use the drug in a private home.

It remains illegal to light up in public areas, including the Las Vegas Strip, casinos, bars, restaurants, parks, convention centers and concert halls -- places frequently visited by tourists. Violators face a $600 fine.

And driving under the influence of marijuana is still illegal.

Despite the limits on where people can get high and restrictions on where the industry can advertise, dispensaries worked furiously to prepare for the launch. They stamped labels on pot products, stocked up their shelves, added security and checkout stations, and announced specials.

Desert Grown Farms hired about 60 additional employees. Workers in scrubs, hair nets and surgical masks slapped stickers on sealed jars this week as others checked on marijuana plants or carefully weighed buds.

"It would be a good problem to have if I couldn't meet my demand," said CEO Armen Yemenidjian, whose Desert Grown Farms owns the only dispensary that is selling recreational pot on the Las Vegas Strip, across the street from the Stratosphere hotel.

Some dispensaries took to social media to spread the word or tried to draw in buyers with special events. Some planned to give away free marijuana to their first 100 customers or throw parties with barbecues and food trucks later in the afternoon.

Some facilities are in strip malls, while others, in stereotypical Las Vegas fashion, are in neighborhoods shared by strip clubs.

Nevada joins Colorado, Oregon, Washington and Alaska in allowing adults to buy the drug that's still banned by the federal government.

http://www.cbsnews.com/news/nevada-pot-shops-see-green-as-sales-of-legal-recreational-marijuana-begin/ (http://www.cbsnews.com/news/nevada-pot-shops-see-green-as-sales-of-legal-recreational-marijuana-begin/)
Title: Re: The Potfolio --- Where do you Smoke it?
Post by: RE on July 01, 2017, 12:19:18 PM
People were lined up around the block at midnight in Reno and Vegas to purchase legal marijuana for recreational use. Significant problems still exist due to legal challenges from the alcohol people, but the deadilne was met, and pot will be for sale until the unresolved issues make the dispensaries run out, which is a certainty, due to the way the government is handling things.

Those 21 and older with a valid ID can buy up to an ounce of pot. Tourists are expected to make nearly two of every three recreational pot purchases in Nevada, but people can only use the drug in a private home.

According to the article, most people buying will be tourists.  But tourists don't live in Private McMansions in Vegas, they live in Hotel Rooms.  You can't smoke cigarettes anymore in most hotels, so I doubt they will allow ganja smoking.  Can't smoke it in the Casino, and can't smoke it in the Public Parks.  Definitely can't smoke it in your car.

The Nevada Goobermint may rack up more income in Fines than the Mary Jane vendors make in sales.

RE
Title: Re: The Potfolio --- Where do you Smoke it?
Post by: azozeo on July 01, 2017, 02:20:22 PM
People were lined up around the block at midnight in Reno and Vegas to purchase legal marijuana for recreational use. Significant problems still exist due to legal challenges from the alcohol people, but the deadilne was met, and pot will be for sale until the unresolved issues make the dispensaries run out, which is a certainty, due to the way the government is handling things.

Those 21 and older with a valid ID can buy up to an ounce of pot. Tourists are expected to make nearly two of every three recreational pot purchases in Nevada, but people can only use the drug in a private home.

According to the article, most people buying will be tourists.  But tourists don't live in Private McMansions in Vegas, they live in Hotel Rooms.  You can't smoke cigarettes anymore in most hotels, so I doubt they will allow ganja smoking.  Can't smoke it in the Casino, and can't smoke it in the Public Parks.  Definitely can't smoke it in your car.

The Nevada Goobermint may rack up more income in Fines than the Mary Jane vendors make in sales.

RE


That's why you stay off strip near the airport in a flop house El Cheapo roach motel.
Knowing Vegas, they'll invent some kind of Amsterdam type of controlled environment, if they can turn a buck.
Put butts in seats & make em' pay to play.

Hookers n' blo baby ...... :evil4:
Title: Re: The Potfolio
Post by: Eddie on July 14, 2017, 05:48:17 PM
After drifting lower for the last couple of months, pot stocks started to rally this last week.

It remains to be seen if it will be sustained, but after a couple of shaky weeks, it looks like NV will get the problems worked out between the alcohol distributors and the real pot sellers. This appears to be a market mover, at this point. It was a delayed reaction, if indeed that's the driver.

I haven't updated the potfolio holdings in several weeks, but most of my positions are the same. Good time to get some exposure, for those inclined to play at the Wheel of Mammon. The big risk is Jeff Sessions. Whatever they do, at Dept. of Justice, hopefully we'll know by the last week of this month or shortly thereafter.
Title: Re: The Potfolio
Post by: Eddie on July 17, 2017, 11:56:30 AM
A good interview with Nevada state legislator Tick Segerblom on The Takeaway, regarding pot legalization.

http://www.wnyc.org/story/more-states-legalize-marijuana-concerns-over-federal-crackdown-build (http://www.wnyc.org/story/more-states-legalize-marijuana-concerns-over-federal-crackdown-build)
Title: Re: The Potfolio --- Alert, Bumps Ahead
Post by: Eddie on July 23, 2017, 11:47:53 AM
The DOJ Subcommittee on MJ, which has been meeting since March, will be due to deliver their findings to Genius Boy Jeff Sessions on the 27th, which is this coming Thursday. As much as I'd like to believe the report will be in favor of states rights and have some sensible guidelines for federal prosecutors to follow in deciding whether to go after legal pot companies, both medical and rec, I really don't believe that will be the case.

Little bits of info have been leaking that point to some kind of fanciful heavily lawyered interpretation of the US Constitution that puts the DOJ firmly back in the drivers seat, makes the states clearly the submissive, less important part of government, and gives the feds lots of leeway to harass and dismantle the nascent legal pot industry in America. I even read something about how they might use possible UN treaty violations (there are claims that US pot is sneaking into Mexico, oh how horrible) to claim federal oversight everywhere.

It's all about money and power, and what the corporations and billionaires want.

As a result, share prices on pot stocks, which have been recovering nicely as of late, are due for another beat down. I am largely holding Canadians, but I don't think they're immune in the very short run. I expect a lot of red, probably starting before the announcement, as savvy retail investors go to the sidelines.

So are pot stocks dead? No, Canada is going well, and Germany is going to be THE place to be, since the Eurotrash medical insurance covers pot as a legit drug.

What it  means is that there will be this great, once in a generation buying opportunity, a chance to buy the best companies very cheap, and watch them rebound and double and triple over the next 2-3 years.

To anyone reading, I recommend the leading Canadian companies as the safest way to go. Most US companies have had to over dilute their stock to survive the recent hard times, and they don't have the good fundamentals the Canadians do. At this juncture, I am buying Canopy Growth, Aphria, Medreleaf, and Aurora, the 4 biggest, most developed pot companies in the world, at the moment. I am also buying Emblem, another Canadian not as far along, but looking good.

Title: Re: The Potfolio --- Understanding Jeff Sessions
Post by: Eddie on July 26, 2017, 06:40:24 AM
I was wondering about how somebody as stupid and lame as Jeff Sessions gets elected to the Senate, so I did some research.
 My conclusion is that if Jeff Sessions didn't exist, the people of Alabama would have had to invent him. He got elected because he's exactly what those ignorant crackers desire in a politician. Idiocracy in action.


It doesn't matter to Jeff Sessions that the American people overwhelmingly support the complete legalization of medical marijuana and a majority favor legalization for recreational use. When DOJ quietly classified the most innocuous and useful of all the cannabis drugs, CBD oil, as a schedule I narcotic, that was the first clue that a new wave of backlash against decriminalization and full legalization was underway.

Now it appears that he has spent the last few months trying to find ways to re-demonize pot use and figure out a convoluted legal path toward cracking down on the recent decriminalization and regulation being pursued by state governments in a majority of states in the US. Why is this man so stubbornly against what is clearly the will of the people? It's simple really. He knows which side his bread is buttered on.

 He was elected to the US Senate by the people of Alabama in 2014, running unopposed, and garnering 97.25% of the vote. (The same voters went for Trump in 2016 by 62.9% of the vote.) They are 72% white, 85% Christian (37% Baptist). Less than 25% are college educated, although 84% of them managed to complete high school. They are not financially well-off, with an average per capita income of only 24 thousand dollars a year. These are not people with great critical thinking skills. They follow leaders, especially the leadership in their conservative Christian churches, who have been happy to play along with the meme that gets people like Sessions elected.

Be tough on crime (regardless of whether crime is much of a problem). Be tough on illegal drugs. Be in favor of school prayer. Be opposed to abortion and a woman's right to choose. Be in favor of low taxes , but more military spending. Be anti-immigration and tough on Islamic terrorism. Be in favor of states rights (unless the states want to do something bad, like legalize pot). Make a lot of noise about the murder rate in places like Chicago, while being in favor of concealed carry, open carry, and every other kind of carry you can possibly think of. Oppose gay marriage. Keep TG women out to the Ladies Room. That's all it takes to win in Alabama (and Texas,and in several other southern states). It's that simple.

People like Sessions (and many others like him who hold office in the south), once elected, are free to peddle their influence at will, and collect money from Big Pharma (we know how they feel about putting MJ in the hands of the people), private prison corporations, Christian conservative billionaires, sellers of alcohol, both retail and wholesale, and a long list of rich lobbies that fear that legal pot will negatively affect their bottom line. It's about money and power. And....the facts really don't matter much, at least not in the short run.

We know that medical pot has a lot of benefits. We know that as recreational drugs go, alcohol is way, way worse than MJ. We know that legalizing pot doesn't cause a sudden rise in traffic deaths. We know that pot is not a gateway drug to heroin, but Vicodin, Oxycontin, Percocet (all Schedule II btw) are. But none of that matters, unless enough educated, savvy people show up on election day to vote. People who vote for the Sessions of the world don't vote the facts. They vote their emotions, which can be easily swayed by catering to their particular set of beliefs. For them to accept something as a fact, they just need to hear somebody they respect as an authority figure repeat it enough times for them to remember it. That's it. period.

 Right now I hear many people in our community taking hope on the possibility that Sessions might be fired by Trump. The problem with that is that there are at least three others just like him lined up to take his place. I'm writing this because I want you to understand the real basis for the weird political climate that is running our country off the rails. It is isn't just Jeff Sessions. It is that we have become an Idiocracy, run by people who know how to get elected and stay elected, but have no clue about how to run a country, nor do they even care about what is best for their constituents. It's about money (for them and theirs) and power, to control other people.

I'm not sure when the results of the MJ Subcommittee will be made public. Late this week, maybe, or maybe it'll be kept under wraps for a few more days. But soon we'll see what the demagogue Sessions has under his hat. I am not hopeful that it will be anything that makes any kind of sense. I fully expect it will be a heavily lawyered dense set of rules aimed at putting the Feds back in charge, reversing the positive gains of recent years, and making a long list of moneyed special interests happy.
Title: The Potfolio- Bill introduced to legalize pot nationwide
Post by: azozeo on August 03, 2017, 04:43:16 PM
http://www.youtube.com/v/IJqA5KT9j0I&fs=1

Published on Aug 2, 2017

U.S. Senator Cory Booker (D-NJ) today introduced a landmark bill to reverse decades of failed drug policy that has disproportionately impacted communities of color. Booker announced the bill earlier today on Facebook Live.

The Marijuana Justice Act would remove marijuana from the list of controlled substances, making it legal at the federal level. The bill would also incentivize states through federal funds to change their marijuana laws if those laws were shown to have a disproportionate effect on low-income individuals and/or people of color.

The bill is retroactive and would apply to those already serving time behind bars for marijuana-related offenses, providing for a judge’s review of marijuana sentences.

“Our country’s drug laws are badly broken and need to be fixed,” Senator Booker said. “They don’t make our communities any safer – instead they divert critical resources from fighting violent crimes, tear families apart, unfairly impact low-income communities and communities of color, and waste billions in taxpayer dollars each year.
Title: The Potfolio-Sessions vs. Congress over Cannabis
Post by: azozeo on August 06, 2017, 01:26:24 PM
https://www.bloomberg.com/news/articles/2017-08-03/marijuana-fight-puts-congress-on-collision-course-with-sessions (https://www.bloomberg.com/news/articles/2017-08-03/marijuana-fight-puts-congress-on-collision-course-with-sessions)



    Lawmakers consider measures relaxing federal marijuana ban
    Attorney general says his ‘best view’ is against legalization

Congress is heading for a confrontation with Attorney General Jeff Sessions over pot.

Sessions is seeking to crack down on marijuana use while lawmakers from both parties are pushing legislation that would do the opposite.

Measures have been attached to must-pass bills in the Senate that would allow Veterans Affairs doctors to counsel patients on the use of medical marijuana, and to continue blocking the Justice Department from pursuing cases against people who use medical marijuana in states that have legalized it.

Some lawmakers are pushing to go even further. Senator Cory Booker, a New Jersey Democrat, this week unveiled legislation that would legalize marijuana at the federal level. In the House, Republican Matt Gaetz of Florida proposed legislation that would change the federal classification of marijuana to allow research and a range of medical uses.

Booker said the law needs to be changed because minorities and the poor are disproportionately arrested for what amounts to a minor offense.

“It disturbs me right now that Attorney General Jeff Sessions is not moving as the states are — moving as public opinion is — but actually saying that we should be doubling down and enforcing federal marijuana laws even in states that have made marijuana legal,” he said in a video posted Tuesday on Facebook.

Eight states have fully legalized marijuana for adult use and 21 more have legalized it for medical use only. Federal law continues to ban the use and sale of cannabis. During the Obama administration, the Justice Department didn’t actively prosecute marijuana offenders, an approach Sessions has said needs to change.

“I’m not sure we’re going to be a better, healthier nation,” he said in February, “if we have marijuana being sold at every corner grocery store.” He later added, “My best view is that we don’t need to be legalizing marijuana.”

In April, Sessions put out a memo to U.S. attorneys about his crime-reduction efforts and said one of his subcommittees will “undertake a review of existing policies in the areas of charging, sentencing, and marijuana to ensure consistency with the department’s overall strategy on reducing violent crime and with administration goals and priorities.”

Sarah Flores, a Justice Department spokeswoman, declined to comment on the matter.

The president has repeatedly expressed his dissatisfaction with Sessions, a former senator from Alabama, for recusing himself from a federal investigation into whether there was collusion between Trump’s presidential campaign and Russia. The new White House chief of staff, John Kelly, told Sessions in a phone call over the weekend that Trump doesn’t intend to fire him, according to a person familiar with the conversation.

The Veterans Administration measure, sponsored by Republican Senator Steve Daines of Montana and Democratic Senator Jeff Merkley of Oregon, was added to a bill approved by the Appropriations Committee on July 13. The measure preventing funds from being used to crack down on medical marijuana was sponsored by Senator Patrick Leahy, a Vermont Democrat, and was approved by the Appropriations Committee on July 27.

The Republican-controlled Congress is already on record supporting medical marijuana. Since 2014, the Justice Department spending bill has included language that blocks funds from being used to enforce federal law relating to medical marijuana in states where the drug is legal.

Gaetz, the Florida lawmaker who introduced his marijuana legislation in April, said at the time that pot shouldn’t be classified by the federal government the same way as heroin or LSD.

“We do not need to continue with a policy that turns thousands of young people into felons every year,” he said in a statement. “Nor do we need to punish the millions of people who are sick and seeking medical help — from pain, from muscle wasting, from chemotherapy-induced nausea.”

Republican Senator Cory Gardner of Colorado said Sessions told him before being confirmed as attorney general earlier this year that he planned to take a hands-off approach toward states that legalize marijuana. Gardner, whose state is among them, said he’ll hold Sessions to his comments.

“The founders of our country intended states to be laboratories of democracy and Colorado is now deep in the heart of laboratory, along with many other states now,” Gardner said in an interview.
Title: The Potfolio Cannabis company buys town to create 'marijuana mecca'
Post by: azozeo on August 06, 2017, 06:08:39 PM
http://www.upi.com/Odd_News/2017/08/04/Cannabis-company-buys-town-to-create-marijuana-mecca/3581501856892/ (http://www.upi.com/Odd_News/2017/08/04/Cannabis-company-buys-town-to-create-marijuana-mecca/3581501856892/)


A 100-year-old ghost town founded during the California Gold Rush is being modernized for the "green rush" after a cannabis company purchased all the land, buildings and businesses for $5 million.

On Thursday, American Green, a marijuana technology company, announced they purchased a small town in San Bernardino County with the intention of turning it into the "the country's first energy-independent, cannabis-friendly hospitality destination."

"The Cannabis Revolution that's going on here in the US, has the power to completely revitalize communities in the same way gold did during the 19th century," David Gwyther, chairman and president of American Green, said in the announcement.

Located on the border of Nevada and California, the desert town of Nipton has a population of around 20 people, according to the Los Angeles Times. The town also comes with its own water supply, a general store, an RV park, a campground and a five-room hotel from 1904.

Last year, the previous owner, Gerald Freeman, placed the entire town on the market for $5.2 million dollars because he was too old to maintain it anymore. He told the Las Vegas Journal-Review that he wanted to sell it to "someone who's committed to sustainability of the human race."

American Green, the largest and second oldest publicly traded cannabis company in the US, said they bought the town as part of a 120-acre land purchase. The company plans to keep the existing structures intact and build new ones that they hope will attract tourists and boost the local economy.

"This acquisition allows us to channel the myriad interests in cannabis production and consumption for an immediate positive impact to this community's members and to cannabis consumers across the country," Gwyther said in a statement.

The company said it will start by bottling and distributing water infused with Cannabidiol (CBD), a cannabis compound that is believed to have medical benefits without making people feel "stoned." Then, the company plans to spend $2.5 million over the next 18 months to revitalize the town, according to Bloomberg.

The company wants to develop the nearby aquifer system and expand the town's existing solar farm to create a completely energy-independent town.

Tony Castrignano, who is the owner of the realty company making the sale, told the Las Vegas Journal Review that the current photovoltaic system provides up to 45 percent of the energy the town needs.

Ultimately, the company plans to host other marijuana-friendly businesses and events in town, including CBD and mineral baths, cannabis-product retail outposts, artists-in-residence programs, culinary events and Bed-and-Breakfast lodging.

Project manager Stephen Shearin said he hopes the work they are doing in Nipton will inspire other companies.

"We thought that showing that there was a viable means of having a cannabis-friendly municipality and further making it energy independent could be a way of really inspiring folks to say, 'Why can't we do that here?'" Shearin told Bloomberg.

Shearin said he wants to "create a community that is accepting and understanding" of marijuana use.

"The [idea] here isn't to create 'Woodstock 2017,'" Shearin said. "It's about creating an environment where people come to work and share in a community."

Both Nevada and California are among the four US states to have legalized marijuana. The drug is still illegal under federal law.


Title: Re: The Potfolio Cannabis company buys town to create 'marijuana mecca'
Post by: Eddie on August 07, 2017, 09:45:28 AM
http://www.upi.com/Odd_News/2017/08/04/Cannabis-company-buys-town-to-create-marijuana-mecca/3581501856892/ (http://www.upi.com/Odd_News/2017/08/04/Cannabis-company-buys-town-to-create-marijuana-mecca/3581501856892/)


A 100-year-old ghost town founded during the California Gold Rush is being modernized for the "green rush" after a cannabis company purchased all the land, buildings and businesses for $5 million.

On Thursday, American Green, a marijuana technology company, announced they purchased a small town in San Bernardino County with the intention of turning it into the "the country's first energy-independent, cannabis-friendly hospitality destination."

"The Cannabis Revolution that's going on here in the US, has the power to completely revitalize communities in the same way gold did during the 19th century," David Gwyther, chairman and president of American Green, said in the announcement.

Located on the border of Nevada and California, the desert town of Nipton has a population of around 20 people, according to the Los Angeles Times. The town also comes with its own water supply, a general store, an RV park, a campground and a five-room hotel from 1904.

Last year, the previous owner, Gerald Freeman, placed the entire town on the market for $5.2 million dollars because he was too old to maintain it anymore. He told the Las Vegas Journal-Review that he wanted to sell it to "someone who's committed to sustainability of the human race."

American Green, the largest and second oldest publicly traded cannabis company in the US, said they bought the town as part of a 120-acre land purchase. The company plans to keep the existing structures intact and build new ones that they hope will attract tourists and boost the local economy.

"This acquisition allows us to channel the myriad interests in cannabis production and consumption for an immediate positive impact to this community's members and to cannabis consumers across the country," Gwyther said in a statement.

The company said it will start by bottling and distributing water infused with Cannabidiol (CBD), a cannabis compound that is believed to have medical benefits without making people feel "stoned." Then, the company plans to spend $2.5 million over the next 18 months to revitalize the town, according to Bloomberg.

The company wants to develop the nearby aquifer system and expand the town's existing solar farm to create a completely energy-independent town.

Tony Castrignano, who is the owner of the realty company making the sale, told the Las Vegas Journal Review that the current photovoltaic system provides up to 45 percent of the energy the town needs.

Ultimately, the company plans to host other marijuana-friendly businesses and events in town, including CBD and mineral baths, cannabis-product retail outposts, artists-in-residence programs, culinary events and Bed-and-Breakfast lodging.

Project manager Stephen Shearin said he hopes the work they are doing in Nipton will inspire other companies.

"We thought that showing that there was a viable means of having a cannabis-friendly municipality and further making it energy independent could be a way of really inspiring folks to say, 'Why can't we do that here?'" Shearin told Bloomberg.

Shearin said he wants to "create a community that is accepting and understanding" of marijuana use.

"The [idea] here isn't to create 'Woodstock 2017,'" Shearin said. "It's about creating an environment where people come to work and share in a community."

Both Nevada and California are among the four US states to have legalized marijuana. The drug is still illegal under federal law.

I did own ERRB at one point, but I don't think they're a good bet at this point, town or no town. The only US company that interests me at the moment is TRTC, and I don't trust them for a long term hold. However, they stand to clean up in Nevada and California.

There are a bunch of Canadian companies that are doing business in the US. I like them better. Better capital structure and less stock dilution.
Title: Re: The Potfolio
Post by: azozeo on August 07, 2017, 09:55:29 AM
Nipton Calif. is an old mining town from the 1800's....

It was a town that saw action until I-40 turned Rt. 66 into a off the beaten path trail.

Perfect spot for an Amsterdam, Hedonistic mecca.

The place should be hoppin'.

If LD were to open a pizza joint there, he'd been a millionaire in no time.

Smoke dope, eat pizza & screw your brains out, in the middle of frickin' nowhere.
Title: Potfolio - Hempcrete Could Change The Way We Build Everything
Post by: azozeo on August 09, 2017, 03:59:18 AM
http://www.collective-evolution.com/2017/08/03/hempcrete-could-change-the-way-we-build-everything/ (http://www.collective-evolution.com/2017/08/03/hempcrete-could-change-the-way-we-build-everything/)


Collective Evolution

First off, what is Hempcrete? As the name suggests, hempcrete is a building material that incorporates hemp into its mixture. Versatile and hardy, it can be used for wall insulation, flooring, walls, roofing, and more, and is fireproof, waterproof, and rot-proof, provided it’s used aboveground. Derived from the shiv or inside stem of the hemp plant, it’s then mixed with a lime base binder to create the final, negative carbon footprint product. Hempcrete is much more versatile and pliable than concrete, making it an easier material to work with. In fact, earthquakes cannot crack these structures, as they are three times more resistant to damage than regular concrete.

Hempcrete also requires less energy to produce, since lime doesn’t need to be heated to the same degree as industrial concrete. What’s more, because it contains cellulose, Hempcrete also sequesters carbon. Through its growing life cycle, it takes in large amounts of carbon, which are then built into the home or building being constructed. Carbon is thus stored rather than released into the atmosphere, and as a result, a home can save about 20,000lbs of carbon when being built out of Hempcrete.

Strong, lightweight, and breathable, Hempcrete is inarguably a superior building material. When used in exterior walls, it lets water in without accruing rot or other damage. What’s more, rather than needing to build homes with space between exterior walls, which must then be filled with insulation, you can simply use a Hempcrete wall. As humidity is taken in from the external environment, the Hempcrete holds that humidity until it is ready to be released again when air becomes dry once again.

While lime takes longer to harden than concrete, since it’s wrapped in cellulose, it  is incredibly strong. Over time, the lime essentially turns back to rock, so the material becomes harder and harder until it petrifies completely. This means the wall will last thousands of years compared to the 40–100 years of today’s standard building materials.

Hempcrete is versatile in other ways, too. If too much is mixed in during building, you can simply return the mixture to the soil as a great fertilizer. And since hemp grows to maturity in just 14 weeks, it is a very powerful, cheap, and sustainable solution.

Hemp also requires no fertilizer, weed killer pesticide, or fungicide to grow, and can be used in nearly limitless capacities. The hemp seed can be harvested as a nutritious food rich in Omega-3 oil, amino acids, protein, and fiber, while the outer fibers can be used for clothing, paper, and many other everyday items. This truly is a remarkable plant, and its use in the mainstream should be a no-brainer.
Title: Re: Potfolio - Hempcrete Could Change The Way We Build Everything
Post by: K-Dog on August 09, 2017, 07:53:13 AM
http://www.collective-evolution.com/2017/08/03/hempcrete-could-change-the-way-we-build-everything/ (http://www.collective-evolution.com/2017/08/03/hempcrete-could-change-the-way-we-build-everything/)


Collective Evolution

First off, what is Hempcrete? As the name suggests, hempcrete is a building material that incorporates hemp into its mixture. Versatile and hardy, it can be used for wall insulation, flooring, walls, roofing, and more, and is fireproof, waterproof, and rot-proof, provided it’s used aboveground. Derived from the shiv or inside stem of the hemp plant, it’s then mixed with a lime base binder to create the final, negative carbon footprint product. Hempcrete is much more versatile and pliable than concrete, making it an easier material to work with. In fact, earthquakes cannot crack these structures, as they are three times more resistant to damage than regular concrete.

Hempcrete also requires less energy to produce, since lime doesn’t need to be heated to the same degree as industrial concrete. What’s more, because it contains cellulose, Hempcrete also sequesters carbon. Through its growing life cycle, it takes in large amounts of carbon, which are then built into the home or building being constructed. Carbon is thus stored rather than released into the atmosphere, and as a result, a home can save about 20,000lbs of carbon when being built out of Hempcrete.

Strong, lightweight, and breathable, Hempcrete is inarguably a superior building material. When used in exterior walls, it lets water in without accruing rot or other damage. What’s more, rather than needing to build homes with space between exterior walls, which must then be filled with insulation, you can simply use a Hempcrete wall. As humidity is taken in from the external environment, the Hempcrete holds that humidity until it is ready to be released again when air becomes dry once again.

While lime takes longer to harden than concrete, since it’s wrapped in cellulose, it  is incredibly strong. Over time, the lime essentially turns back to rock, so the material becomes harder and harder until it petrifies completely. This means the wall will last thousands of years compared to the 40–100 years of today’s standard building materials.

Hempcrete is versatile in other ways, too. If too much is mixed in during building, you can simply return the mixture to the soil as a great fertilizer. And since hemp grows to maturity in just 14 weeks, it is a very powerful, cheap, and sustainable solution.

Hemp also requires no fertilizer, weed killer pesticide, or fungicide to grow, and can be used in nearly limitless capacities. The hemp seed can be harvested as a nutritious food rich in Omega-3 oil, amino acids, protein, and fiber, while the outer fibers can be used for clothing, paper, and many other everyday items. This truly is a remarkable plant, and its use in the mainstream should be a no-brainer.

Fascinating !

http://www.americanlimetechnology.com/what-is-hempcrete/ (http://www.americanlimetechnology.com/what-is-hempcrete/)

This site has videos.  Which I have no time to  watch right now.



Title: Potfolio-GLOBAL BANKS SABOTAGE URUGUAY’S EFFORTS TO LEGALIZE MARIJUANA
Post by: azozeo on September 04, 2017, 11:22:41 AM
http://www.blacklistednews.com/Global_Banks_Sabotage_Uruguay%E2%80%99s_Efforts_to_Legalize_Marijuana/60675/0/38/38/Y/M.html (http://www.blacklistednews.com/Global_Banks_Sabotage_Uruguay%E2%80%99s_Efforts_to_Legalize_Marijuana/60675/0/38/38/Y/M.html)


Blacklisted News

By Don Quijones, Spain & Mexico, editor at Wolf Street. Originally published at Wolf Street.

The first country to fully legalize the recreational use of marijuana, Uruguay, has suddenly found itself facing an unexpected obstacle: the international banking industry.

It all began a few weeks ago when one of the 15 pharmacies that had agreed to sell the two varieties of cannabis distributed by the Uruguayan State announced that it was withdrawing from the scheme after its bank, Santander, had threatened to close its account unless it stopped providing services for the state-controlled sales. Shortly afterwards it was revealed that other banks, including Brazil’s Itaú, had canceled the accounts of the private companies that had been granted a license to produce marijuana as well as some cannabis clubs.

To fill the funding void, the state-owned lender Banco República (BROU) stepped up to provide financing to the 15 pharmacies involved in the scheme as well as producers and clubs. But within days it, too, was given a stark ultimatum, this time from two of Wall Street’s biggest hitters, Bank of America and Citi: Either it stops providing financing for Uruguay’s licensed marijuana producers and vendors or it’s dollar operations could be at risk — a very serious threat in a country where US dollars are used so widely that they can even be withdrawn from ATMs.

Under the US Patriot Act, handling money from marijuana is illegal and violates measures to control money laundering and terrorist acts. However, US regulators have made it clear that banks will not be prosecuted for providing services to businesses that are lawfully selling cannabis in states where pot has been legalized for recreational use. Some cannabis businesses have been able to set up accounts at credit unions, but major banks have shied away from the expanding industry, deciding that the burdens and risks of doing business with marijuana sellers are not worth the bother.

But that may not be their only motive. There are also the huge profits that can be reaped from laundering the proceeds of the global narcotics trade. According to Antonio María Costa, the former Under-Secretary of the United Nations Office on Drugs and Crime, over $350 billion of funds from organized crime were processed by European and US banks in the wake of the global financial crisis.

“Inter-bank loans were funded by money that originated from the drugs trade and other illegal activities… There were signs that some banks were rescued that way,” Costa said. To date, no European government or bank has publicly denied Costa’s charges. Meanwhile, numerous big banks on both sides of the Atlantic have been caught and fined, some repeatedly, for laundering billions of dollars of illicit drugs money — in direct contravention of the US anti-drugs legislation.

Whatever the banks’ real motives in denying funds to the Uruguayan pharmacies, the perverse irony, as the NY Times points out, is that applying US regulations intended to crack down on banks laundering the proceeds from the illegal sale of drugs to the current context in Uruguay is likely to encourage, not prevent, illicit drug sales:

    Fighting drug trafficking was one of the main reasons the Uruguayan government gave for legalizing recreational marijuana. Officials spent years developing a complex regulatory framework that permits people to grow a limited supply of cannabis themselves or buy it at pharmacies for less than the black market rate. Lawmakers hoped that these legal structures would undercut illicit marijuana cultivation and sales.

    “There probably isn’t a trade in Uruguay today that is more controlled than cannabis sale,” said Pablo Durán (a legal expert at the Center of Pharmacies in Uruguay, a trade group).

Despite that fact, the pressure continues to be brought to bear on Uruguay’s legal cannabis businesses. Banco República has already announced that it will close the accounts of the pharmacies that sell cannabis in order to safeguard its much more valuable dollar operations.

In other words, a state-owned bank of a sovereign nation just decided to put draconian US legislation before a law adopted by the Uruguayan parliament authorizing the sale and production of marijuana. The law’s prime sponsor, Uruguay’s former president, José Mujica, is furious. During a session of the country’s Senate, he accused the banks of directly attacking democracy. His successor, President Tabaré Vázquez, is far less enthused about the plans to legalize pot.

The potential implications of this issue extend far beyond Uruguay’s borders. For years opposition to the US-backed war on drugs has been building across Latin America. At the 2013 UN General Assembly Latin American leaders of all political stripes rose to the podium to take a stand against the war. They included Bolivia’s Evo Morales, Costa Rica’s Laura Chinchilla, Guatemalan president Otto Perez Molina, Mexico’s then foreign minister (and now finance minister) José Antonio Meade.

Even Juan Manuel Santos, the president of Colombia, the United States’ staunchest ally in South America and third largest recipient of US military aid after Israel and Egypt, bemoaned that that his country, which received more than $3.5 billion in counter-narcotics aid between 2002 and 2011 and was frequently cited as a model by the Obama administration, “has suffered more deaths, more bloodshed, and more sacrifices in this war” than almost any other, with the obvious exception of Mexico.

By now it is painfully obvious, to all but those who financially benefit from it, that the US government’s heavily militarized War on Drugs has been a dismal failure. Despite the slaughter of over 150,000 people in Mexico in a war that no one is winning and just about everyone is losing, the drugs keep crossing the border, and in many cases in greater numbers than ever before.

Uruguay’s efforts to legalize marijuana could represent a sea change in drugs policy in a region that is being ripped asunder by the global narcotics trade. If successful, it could go viral as other countries, including Canada, set out to legalize marijuana. But if big global banks like Santander, Citi and Bank of America get their way, the scheme will be snuffed out before it even has a chance to make a difference. By Don Quijones.

One reason stands out, and it’s not the price of oil. Read… How Did Things Get This Bad This Fast for Oil Giant, Pemex?
Title: Re: The Potfolio
Post by: K-Dog on September 04, 2017, 11:26:51 AM
It would be nice to have the names of those responsible for the policy.
Title: Re: The Potfolio
Post by: Eddie on September 04, 2017, 01:12:55 PM
I sold my one Uruguyan pot stock play IMMLF, primarily because the retail price per gram there is about a buck. They can't make money at those prices.

The banking issue is just one more difficult hurdle. Everything about legal pot in Uruguay is weird.
Title: Re: The Potfolio
Post by: Eddie on September 15, 2017, 12:14:08 PM
I completely gave up on trying to keep up with my trades on the Potfolio. I spent the summer trying to keep my head above water, and just in the past few days have started to make a little money.

The reason I'm posting this is that this week the Canadian Parliament and the provinces have been deciding how to split the recreational pot pie between the government and the various players. As a result, some of the bigger Canadian pot stocks are starting to do well.

I am making some money on Canopy Grow, Medreleaf, Canntrust, Organigram and Aurora. These are the industry leaders. The riskier smaller companies aren't moving much, as of yet. FYI.
Title: The Potfolio - Cannabis vs. Cancer
Post by: azozeo on September 18, 2017, 12:48:45 PM
How Cannabis Kills Cancer Cells Explained By A Molecular Biologist

https://healthfoodsoul.com/molecular-biologist/ (https://healthfoodsoul.com/molecular-biologist/)

Health Food Soul

Below is a video of Dr. Christina Sanchez, a molecular biologist at Compultense University in Madrid, Spain, clearly explaining how THC (the main psychoactive constitute of the cannabis plant) completely kills cancer cells.

Cannabinoids refer to any of group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. I think it’s also important to note that cannabis has been shown to treat cancer without any psychoactive effects.

Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. Although not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis. Contrary to popular belief, smoking cannabis does not assist a great deal in treating disease within the body as therapeutic levels cannot be reached through smoking. Creating oil from the plant or eating the plant is the best way to go about getting the necessary ingredients, the cannabinoids.

The world has come a long way with with regards to accepting this plant as a medicine rather than a harmful substance. It’s a plant that could benefit the planet in more ways than one. Cannabis is not something offered in the same regard as chemotherapy, but more people are becoming aware if it, which is why it’s so important to continue to spread information like this. Nobody can really deny the tremendous healing power of this plant.

http://www.youtube.com/v/1miGzTwK28U&fs=1
Title: Re: The Potfolio - Cannabis vs. Cancer
Post by: Eddie on September 18, 2017, 04:23:25 PM
How Cannabis Kills Cancer Cells Explained By A Molecular Biologist

https://healthfoodsoul.com/molecular-biologist/ (https://healthfoodsoul.com/molecular-biologist/)

Health Food Soul

Below is a video of Dr. Christina Sanchez, a molecular biologist at Compultense University in Madrid, Spain, clearly explaining how THC (the main psychoactive constitute of the cannabis plant) completely kills cancer cells.

Cannabinoids refer to any of group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. I think it’s also important to note that cannabis has been shown to treat cancer without any psychoactive effects.

Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. Although not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis. Contrary to popular belief, smoking cannabis does not assist a great deal in treating disease within the body as therapeutic levels cannot be reached through smoking. Creating oil from the plant or eating the plant is the best way to go about getting the necessary ingredients, the cannabinoids.

The world has come a long way with with regards to accepting this plant as a medicine rather than a harmful substance. It’s a plant that could benefit the planet in more ways than one. Cannabis is not something offered in the same regard as chemotherapy, but more people are becoming aware if it, which is why it’s so important to continue to spread information like this. Nobody can really deny the tremendous healing power of this plant.

http://www.youtube.com/v/1miGzTwK28U&fs=1

There appears to be something to this anti-cancer claim, especially the CBD oil products. Lots of anecdotal evidence that CBD oil shrinks tumors. It will be studied properly now and we'll find out for sure. It just won't be American scientists making the discoveries because our government is so fucked-up, and so many entities profit here still from the idiotic "War on Drugs".
Title: Re: The Potfolio
Post by: azozeo on September 19, 2017, 10:10:02 AM
I'll be curious to see how Monsanto deals with this plant.
I wonder if they can create Franken-Pot  :icon_scratch:
Title: Re: The Potfolio
Post by: Eddie on September 19, 2017, 11:57:59 AM
There is a rumor that they are experimenting with GMO pot in Uruguay. I suspect that's true. Uruguay recently legalized recreational pot, and it's very poor country...so a good place to carry out clandestine research.
Title: Potfolio - FrankenPot- IT LIVES !
Post by: azozeo on September 26, 2017, 03:23:04 PM
http://bloomsmag.com/dea-approves-synthetic-marijuana-for-big-pharma-company-against-legalization/ (http://bloomsmag.com/dea-approves-synthetic-marijuana-for-big-pharma-company-against-legalization/)


Blooms Mag

A synthetic marijuana product could be available for commercialization after the DEA gave a newly approved drug a schedule II classification.

On Thursday, Insys Therapeutics announced that the Drug Enforcement Administration (DEA) issued an interim final rule that would put Syndros, their synthetic marijuana drug, on Schedule II of the Controlled Substances Act (CSA).

“Insys is looking forward to bringing this new drug product to chemotherapy patients to help alleviate their nausea and vomiting and AIDS patients with anorexia associated weight loss, respectively,” Dr. Santosh Vetticaden, interim CEO, said in the announcement.

“We look forward to interacting with the FDA to finalize the labeling and subsequent launch of Syndros in the second half of 2017,” Vetticaden said.

Syndros is a synthetic version of tetrahydrocannabinol (THC), the main psychoactive component in the plant. In July 206, the company announced the FDA approved their liquid form of synthetic THC to treat anorexia associated AIDS patients, and nausea and vomiting induced by cancer patients going through chemotherapy.

The DEA approval placed Syndros and its generic formulations in schedule II of the CSA, which is reserved for drugs that have “a high potential for abuse, with use potentially leading to severe psychological or physical dependence.”

While some Schedule II drugs can be used for medical purposes, like Vicodin, oxycodone, Adderall, and many prescription painkillers, Schedule I drugs are all federally illegal. Non-synthetic marijuana is a Schedule I drug, which is reserved for drugs that have “no currently accepted medical use and a high potential for abuse.”

In 2011, Insys wrote a letter to the DEA, urging them to maintain the Schedule I status for non-synthetic marijuana, citing “a longstanding policy of the United States to disfavor domestic cultivation of narcotic raw materials because of concerns about the abuse potential from farming of this material.”

Insys also opposed legalization in Arizona, donating $500,000 to Arizonans for Responsible Drug Policy, a group opposing Proposition 205, an initiative to legalize and regulate marijuana like alcohol in Arizona.

In a statement, Insys said it opposed Prop 205, “because it fails to protect the safety of Arizona’s citizens, and particularly its children,” according to the Arizona Republic.

The proposition was narrowly defeated in the state, meaning users in Arizona could face felony charges for possessing even small amounts of the plant.

 

JP Holyoak, chairman of the Campaign to Regulate Marijuana Like Alcohol in Arizona, says Insys funded the opposition “to kill a non-pharmaceutical market for marijuana in order to line their own pockets,” according to the Washington Post.

In 2007, Insys filed a disclosure statement with the Securities and Exchange Commission, directly stating that marijuana legalization would threaten their products.

“If marijuana or non-synthetic cannabinoids were legalized in the United States, the market for dronabinol product sales would likely be significantly reduced and our ability to generate revenue and our business prospects would be materially adversely affected,” the company said.

The company is currently under investigation for illegally marketing Fentanyl, an opioid that is 50 times stronger than heroin, which has been linked to the death of Prince last year.

In December, several executives at the company were arrested and the CEO was forced to step down after they were charged with using speakers fees to entice doctors to prescribe Subsys, a medication for cancer patients that contains Fentanyl.
Title: Potfolio-12 Different Studies Exploring The Anti-Cancer Properties Of CBD Oil
Post by: azozeo on September 26, 2017, 03:28:41 PM
https://www.naturalblaze.com/2017/09/12-different-studies-exploring-anti-cancer-properties-cbd-oil.html (https://www.naturalblaze.com/2017/09/12-different-studies-exploring-anti-cancer-properties-cbd-oil.html)

Natural Blaze

In 2016, the cannabis industry grew by 30 percent. But its relaxing properties are not the only reason for the interest in medical marijuana dispensary outlets across the US.

Research across the globe is all pointing to CBD oil as having high potential for fighting cancer on various levels. CBD is short for cannabidiol. CBD is a compound found in the cannabis plant, but without the psychoactive element that the THC strain has. This means CBD does not give you the high that most people think of when they hear of cannabis. But what does CBD do and why is it being heralded as the new miracle cure?

Here are 12 studies that show why CBD oil could be the best discovery to happen during our generation.
1. CBD restrains angiogenesis by various mechanisms.

In this study, researchers found that CBD inhibits the growth of various tumors. Its effect on both tumor and endothelial cells supports the speculation that CBD is an effective agent for treating cancer.
2. CBD generated anti-tumor activity in human breast carcinoma.

Researchers tested strains of cannabis to find what was the most effective in limiting cancer in breast carcinoma. CBD was found to be the most powerful inhibitor of cancer cells’ growth.
3. CBD causes cancer cell death in breast cancer cells.

In another study focusing on breast cancer, it was found that CBD induced the death of breast cancer cells. Researchers concluded that continued investigation was needed to benefit from CBD’s potential antineoplastic possibilities.
4. CBD inhibits cancer cell growth in the brain.

The British Journal of Cancer reported a study that showed how strains of cannabis inhibit brain tumor growth. The cannabis strains were found to decrease cancerous tumor cells in 2 of 9 patients.
5. CBD effective in treating pancreatic cancer.

A study was conducted to evaluate CBD’s effect on human pancreatic tumor cells. Researchers found that CBD induced apoptosis, reduced growth, and inhibited further spread of pancreatic tumor cells.
6. CBD toxic to malignant oral cancer.

CBD has been successfully tested on oral tumors that are considered malignant. Research concluded that CBD is a potent inhibiting agent of cellular respiration of malignant oral tumors.
7. CBD inhibits growth of blood cancer cells.

In a study published in Molecular Pharmacology, researchers found that CBD inhibited cancer cell growth. As well as caused blood cancer cell death in mantle cell lymphoma.
8. CBD causes cell death in leukemia cells.

The US National Library of Medicine published a study where it was determined that CBD induced cell death in leukemia cells.
9. CBD receptors cause a decrease in prostate cancer cells.

Cannabinoid receptors are found throughout our bodies and play a large and wide reaching role. They are delicately connected to the functioning of all our other bodily processes. Including sensory, neuroendocrine, and sensory systems. In this study, a decrease in prostate cancer cells was due to the body’s cannabinoid receptors.
10. CBD inhibits invasiveness of lung cancer cells.

In research conducted by the Institute of Toxicology and Pharmacology in Germany, they found that CBD inhibits lung cancer cells. Tests were conducted on tumor cells taken from a lung cancer patient.
11. Cannabis strains effective in halting neurodegeneration.

The Journal of Neuroscience examined the progression of degenerative diseases of the brain. They found that cannabis strains reduced brain injury in rats. Which suggests that the human cannabinoid system is effective at protecting the brain from neural injury.
12. CBD effective in relieving pain in cancer patients.

A double blind, randomized, and placebo-controlled study was conducted to research the effectiveness of CBD on cancer pain. It was found that CBD was more effective than the THC extract at lessening strong pains that could not be relieved by prescription opioids.

Across all the studies mentioned above and many more, positive conclusions on the effectiveness and safety of CBD are being drawn by medical professionals. The needed qualities of an effective anti cancer remedy lie in its ability to halt the growth of cancer cells. Which is one of the reasons CBD has generated the interest it has.

What is also becoming clear is that the human endocannabinoid system plays a vital role in regulating tumor progression. Testing in lab settings has shown that CBD and other cannabis strains induce death in cancer cells and inhibit spread and growth of tumors. CBD also seems to enhance the anticancer activity in animal models. And it is being tested for its anticancer properties in phase 1 and 2 clinical studies.
Title: Cancer-Causing Compounds Found in Cannabis Oil
Post by: RE on September 27, 2017, 09:42:50 AM
http://www.genengnews.com/gen-news-highlights/cancer-causing-compounds-found-in-cannabis-oil/81254980 (http://www.genengnews.com/gen-news-highlights/cancer-causing-compounds-found-in-cannabis-oil/81254980)

 September 27, 2017
Cancer-Causing Compounds Found in Cannabis Oil

(http://www.genengnews.com/media/images/genhighlight/ao201701130a_00019324890681.jpeg)
Researchers are trying to better understand the effects of inhalable, noncombustible cannabis products, which are playing a central role in the expansion of the medical and recreational use of cannabis. [ACS Omega, 2017, 2 (9), pp 6112–6117]

    As the legalization of marijuana continues to spread among various states within the U.S., researchers, and physicians are trying to fully grasp the potential health hazards of the recreational use of the drug. Since marijuana can be consumed through a variety of methods—e.g., eating, smoking, or vaporizing—it is important to understand if and how drug delivery methods affect users. With that in mind, a recent study from investigators at Portland State University found benzene and other potentially cancer-causing chemicals in the vapor produced by butane hash oil, a cannabis extract.

    Findings from the new study—published recently in ACS Omega in an article entitled “Toxicant Formation in Dabbing: The Terpene Story”—raises health concerns about dabbing, or vaporizing hash oil—a practice that is growing in popularity, especially in states that have legalized medical or recreational marijuana. Dabbing is already controversial. The practice consists of placing a small amount of cannabis extract (a dab) on a heated surface and inhaling the resulting vapor. The practice has raised concerns because it produces extremely elevated levels of cannabinoids—the active ingredients in marijuana.

    "Given the widespread legalization of marijuana in the U.S., it is imperative to study the full toxicology of its consumption to guide future policy," noted senior study author Robert Strongin, Ph.D., professor of organic chemistry at Portland State University. "The results of these studies clearly indicate that dabbing, while considered a form of vaporization, may, in fact, deliver significant amounts of toxins."

    Dr. Strongin and his colleagues analyzed the chemical profile of terpenes—the fragrant oils in marijuana and other plants—by vaporizing them in much the same way as a user would vaporize hash oil.

    “The practice of 'dabbing' with butane hash oil has emerged with great popularity in states that have legalized cannabis,” the authors wrote. “Despite their growing popularity, the degradation product profiles of these new products have not been extensively investigated.”

    The authors continued, stating that the current study focused on the “chemistry of myrcene and other common terpenes found in cannabis extracts. Methacrolein, benzene, and several other products of concern to human health were formed under the conditions that simulated real-world dabbing. The terpene degradation products observed are consistent with those reported in the atmospheric chemistry literature.”

    Many of the terpenes that the researchers discovered in the vaporized hash oil are also used in e-cigarette liquids. Moreover, previous experiments by Dr. Strongin and his colleagues found similar toxic chemicals in e-cigarette vapor when the devices were used at high-temperature settings. The dabbing experiments in the current study produced benzene—a known carcinogen—at levels many times higher than the ambient air, the researchers noted. It also produced high levels of methacrolein, a chemical similar to acrolein, another carcinogen.

    “The results of these studies clearly indicate that dabbing, although considered a form of vaporization, may, in fact, deliver significant amounts of toxic degradation products,” the authors concluded. “The difficulty users find in controlling the nail temperature puts users at risk of exposing themselves to not only methacrolein but also benzene. Additionally, the heavy focus on terpenes as additives seen as of late in the cannabis industry is of great concern due to the oxidative liability of these compounds when heated. This research also has significant implications for flavored e-cigarette products due to the extensive use of terpenes as flavorings.”

To enjoy more articles like this from GEN, click here to subscribe now!

Related content

    Cannabidiol Does Not Convert to THC In Vivo
    Although CBD Can Be Transformed to THC Under Acidic Conditions, the Conversion of Oral CBD Doesn’t Occur In Vivo
    Marijuana Compound Alters Seizure Medication Levels
    Dendreon’s $70M Investment in Production Capabilities Could Woo Firms without Similar Expertise
    If cell-based immune therapy Provenge receives FDA sanction, it may corner a large market share and expand the company’s prospects.
Title: Dabbing with cancer
Post by: K-Dog on September 27, 2017, 12:44:21 PM
That goes to show.


'A little dab will do yah'

Seriously a finding of something inconsequentialy more concentrated than ambient of anything means nothing.  An empty scare article by the anti-cannabis lobby.  They were careful not to quantify the results.
Title: Re: The Potfolio
Post by: Eddie on September 27, 2017, 01:22:54 PM
It's the heat, not the dabs, that create toxicity, most likely.

Another reason to vape, or better yet use edibles. It's the tar and the intense heat that need to be avoided.
Title: Colorado: No edible pot shaped as people, animals or fruit
Post by: RE on October 02, 2017, 12:24:00 AM
http://www.coloradoan.com/story/news/local/colorado/2017/10/01/colorado-no-edible-pot-shaped-people-animals-fruit/721964001/ (http://www.coloradoan.com/story/news/local/colorado/2017/10/01/colorado-no-edible-pot-shaped-people-animals-fruit/721964001/)

Colorado: No edible pot shaped as people, animals or fruit
KATHLEEN FOODY, Associated Press Published 7:43 p.m. MT Oct. 1, 2017

(https://www.gannett-cdn.com/-mm-/a2f59ff1d76723d91a572c7a25b391e512e14e48/c=0-0-534-400&r=x404&c=534x401/local/-/media/FortCollins/2014/10/20/ediblepot.jpg)
(Photo: Coloradoan file photo)

DENVER — A ban on gummy bears and other edible marijuana products shaped like animals, people and fruit takes effect this month in Colorado — a change aimed at decreasing the likelihood small children will mistake them for a favorite treat.

The switch is less dramatic for Colorado’s cannabis companies than adapting to last fall’s rollout of exhaustive requirements for labeling, packaging and stamps on individual edible marijuana products.

But it’s motivated by the same concerns about children popping tasty-looking products into their mouths and getting sick, or adults accidentally overdoing it when they consume edible pot.

The marijuana industry isn’t alone in trying to anticipate what will catch a grabby toddler’s eye. People call Colorado’s poison control hotline thousands of times each year when kids swallow household cleaners and prescription medications — far more often than they call about marijuana products, said Larry Wolk, the state health agency’s executive director.

“Anything that can look like candy is more enticing to kids,” Wolk said.

But as part of an ongoing effort to avoid a federal crackdown on its marijuana experiment, Colorado has made cutting the number of accidental ingestion reports a priority. In an August letter responding to Attorney General Jeff Sessions’ request for information on marijuana legalization, Colorado’s governor highlighted the state’s progressively stricter packaging and labeling requirements as a key part of its efforts to minimize retail pot’s appeal to kids.
Story from Hyatt
7 ways to cultivate a #WhySettle spirit

Colorado lawmakers approved the ban on some edible shapes in 2016. At one hearing on the issue, lawmakers shown packages of gummy candies that contained pot and typical gummy bears couldn’t tell the difference, said Mike Hartman, director of Colorado’s Department of Revenue.

“That really highlighted that we need to take some action here and make sure these products are not to be mistaken, particularly anyone under the age of 21,” Hartman said.

Other states where marijuana is legal have similar restrictions, including Washington. California also may join in; lawmakers approved shape restrictions this year.

In Colorado, retailers aren’t allowed to sell the banned shapes after Oct. 1, but manufacturers had more than a year to prepare and say it wasn’t a difficult switch.

At Colorado Harvest Company, a Denver dispensary, CEO Tim Cullen displays the result: a chocolate bar wrapped in a paper sleeve that’s difficult for even an adult to slide off; cookies stamped with “T-H-C” in edible dye; and colorful gem-shaped lozenges sold in a white vial capped with a childproof top.

“The same rules that apply to alcohol or prescription medication have to apply to marijuana,” Cullen said. “Realizing that you have an adult product in your house and making sure your children can’t get it is the ultimate line of defense.”

Customers in Colorado pot shops also will notice a bolder disclosure on product labels for the amount of THC — the compound in marijuana that creates users’ “high” feeling.

Researchers don’t know much about the impact higher potency products have on consumers, but one study at the University of Mississippi found the potency of marijuana confiscated by federal authorities has steadily increased since the 1990s.

A team at the University of Colorado Boulder is several months into a study on what that means for users.

The team assigns people products ranging from 65 to 90 percent THC, said Cinnamon Bidwell, assistant research professor at the school’s Institute of Cognitive Science.

Federal law prevents researchers from providing cannabis, so study participants buy the products themselves. After they consume the products, Bidwell’s team monitors them in driving simulators and takes blood tests.

Right now, Bidwell said, marijuana users have to figure out what level of THC they can handle “with little science to base that on.”

“Is it comparable to drinking vodka versus a beer, or something totally different?” she said. “Adults in our state are able to purchase this product, so there are a lot of questions about how it affects them.”
Title: Re: The Potfolio
Post by: Eddie on October 05, 2017, 11:01:08 AM
I've pared the Potfolio way down, to only nine stocks at the moment. Six are Canadian licensed producers (LP's), two are plays on an anticipated coming rally in the US when Cali legalization becomes official in January, and one is Namaste, the very successful (so far) vaporizer online seller.

Aurora, Aphria, Canopy Growth, Supreme, HarvestOne, and Medreleaf are the LP's. I have been buying and selling some other LP's too, but they are mostly way up and I'm trying to wait until a better entry point appears to get back in. I buy and sell the ones above, but never get out completely, in case there is a sudden upside move, (like today, on Canopy).

The US plays (which are not currently moving yet) are CBICF (Chartered in Canada but mostly doing business in the US) and KSHB (Kush Bottles, the main supplier of pot containers for dispensaries). I'm looking for Kush to pop on their next earnings report (next month), which is expected to be a stellar upside surprise, and US pot stocks in general are likely to rally toward the end of the year.

The first tier of Canadian licensed producers is on a tear over the last week or so. I'm actually hoping for a correction so I can reload  a bunch of trades.

I'm currently up about 8.5% for the year, but I had to come back from being down 10% as recently as August, so the Canadians have done and continue to do very well as of late. US companies, not so much.
Title: Re: The Potfolio
Post by: RE on October 08, 2017, 12:50:07 AM
http://money.cnn.com/2017/10/07/news/marijuana-california-massachusetts-maine/index.html (http://money.cnn.com/2017/10/07/news/marijuana-california-massachusetts-maine/index.html)

Retail marijuana is spreading to California, Massachusetts and Maine
by Aaron Smith   @AaronSmithCNN October 7, 2017: 2:12 PM ET

(https://i0.wp.com/stuffstonerslike.com/wp-content/uploads/2012/12/is-smoking-weed-bad-2.jpg?resize=852%2C480)

Will recreational marijuana soon be legal nationwide?
The mainstreaming of marijuana is about to get huge boost.

Recreational marijuana sales will launch in three states next year, including the biggest one of all: California.

It's already for sale in five states, but the addition of a legal retail marijuana market in California, with its massive economy and population, will dramatically change the landscape.

California is aiming to open retail marijuana stores by January 1, Massachusetts and Maine plan to open stores next summer.

"We obviously still have a lot to do, but yes, we're going to be ready to go on January 1," said Alex Traverso, spokesman for the Bureau of Cannabis Control in California. "We will be issuing new regulations in November, so we're hard at work on those at the present time."

Among the checklist of expected regulations is new oversight on water usage -- like drip irrigation and reusing waste water -- that could prove expensive for marijuana businesses. Other rules will require licensing and background checks for distributors and safety and education training for consumers.

Dispensaries like Green Alternative, which has 10,000 patients in San Diego, are getting ready to add non-medical customers to their clientele.

"We are in the process of stockpiling cannabis in order to fulfill the market needs," said Zach Lazarus, COO of the Green Alternative. "We believe there will be a huge rush. We go through two to four pounds [per day] on average, and we anticipate going through three to four times as much when we open the doors for recreational."

This requires not only stockpiling pot, but negotiating hurdles on the state and local level, for licensing, zoning, taxation and other issues.

Erik Altieri, executive director of the pro-legalization group NORML, said it might take longer than January "to set up the regulation process and to work out how the new recreational market will exist alongside its already quite large medical market."

Related: Marijuana businesses worry about Trump, but expect to prevail

The Bureau of Cannabis Control in California put its proposed regulations up for public review and began holding community workshop meetings in Long Beach, Fresno and Sacramento in September.

Massachusetts will implement retail marijuana sales on July 1, once state officials finalize whether certain localities will be able to maintain a marijuana ban in their respective towns, said Altieri.

"We are committed to make that deadline," said Steven Hoffman, chairman of the Cannabis Control Commission in Boston, which held its first meeting on September 12 on developing and implementing regulations.

Maine would have the smallest market, and it's unclear when they'll get it off the ground. Dan Tartakoff, clerk for the Marijuana Legalization Implementation Committee of state lawmakers, said draft regulations were released in September proposing a 20% tax rate.

Related: Nevada issues first marijuana delivery licenses

These states already have medical marijuana programs and dispensaries, but soon they'll also have stores that can sell recreational marijuana to anyone 21 and older. Recreational marijuana dispensaries already exist in Colorado, which was the first to legalize adult-use pot in 2014, and also Washington, Oregon, Alaska and Nevada, which started in July this year.

Voters in California, Massachusetts and Maine approved legalization of recreational marijuana in referendum votes in November 2016, on the same day that Donald Trump was elected president. It typically takes at least a year for state officials to set up regulations for the industry.

The addition of California could grow nationwide sales to $24.1 billion by 2025, according to New Frontier Data, which tracks the cannabis industry. That's compared to $6.6 billion in 2016.

California was the first state to legalize medical marijuana, in 1996, and sales for that market are expected to total $2.76 billion this year. Opening the retail market will expand sales dramatically, to $3.8 billion in 2018, and to $6.6 billion in 2025, according to projections from New Frontier Data.

Related: Startups race to develop a Breathalyzer for pot

It also means the entire West Coast will be a free zone for retail marijuana as the industry gains its first legal markets on the East Coast. North America is going to grow even greener next year, because Canada is getting ready to legalize recreational marijuana nationwide.

In Massachusetts, sales are expected to increase from $106 million in 2017 to $457 million in 2018, and eventually to $1.4 billion in 2025, according to New Frontier Data. The market is smaller in Maine, which is expected to increase from $83 million this year to $175 million next year, and to $434 million by 2025.

Recreational marijuana is also legal in Washington, D.C., but there is no legal retail market for it. Residents are allowed to possess, grow and consume marijuana on their own property, but not buy or sell it.

Marijuana is actually illegal according to the federal government, which equates it to heroin. Attorney General Jeff Sessions has said he opposes legalization, but he hasn't done anything to crack down on the industry.
Title: Re: The Potfolio
Post by: Eddie on October 08, 2017, 08:29:05 AM
http://money.cnn.com/2017/10/07/news/marijuana-california-massachusetts-maine/index.html (http://money.cnn.com/2017/10/07/news/marijuana-california-massachusetts-maine/index.html)

Retail marijuana is spreading to California, Massachusetts and Maine
by Aaron Smith   @AaronSmithCNN October 7, 2017: 2:12 PM ET

(https://i0.wp.com/stuffstonerslike.com/wp-content/uploads/2012/12/is-smoking-weed-bad-2.jpg?resize=852%2C480)

Will recreational marijuana soon be legal nationwide?
The mainstreaming of marijuana is about to get huge boost.

Recreational marijuana sales will launch in three states next year, including the biggest one of all: California.

It's already for sale in five states, but the addition of a legal retail marijuana market in California, with its massive economy and population, will dramatically change the landscape.

California is aiming to open retail marijuana stores by January 1, Massachusetts and Maine plan to open stores next summer.

"We obviously still have a lot to do, but yes, we're going to be ready to go on January 1," said Alex Traverso, spokesman for the Bureau of Cannabis Control in California. "We will be issuing new regulations in November, so we're hard at work on those at the present time."

Among the checklist of expected regulations is new oversight on water usage -- like drip irrigation and reusing waste water -- that could prove expensive for marijuana businesses. Other rules will require licensing and background checks for distributors and safety and education training for consumers.

Dispensaries like Green Alternative, which has 10,000 patients in San Diego, are getting ready to add non-medical customers to their clientele.

"We are in the process of stockpiling cannabis in order to fulfill the market needs," said Zach Lazarus, COO of the Green Alternative. "We believe there will be a huge rush. We go through two to four pounds [per day] on average, and we anticipate going through three to four times as much when we open the doors for recreational."

This requires not only stockpiling pot, but negotiating hurdles on the state and local level, for licensing, zoning, taxation and other issues.

Erik Altieri, executive director of the pro-legalization group NORML, said it might take longer than January "to set up the regulation process and to work out how the new recreational market will exist alongside its already quite large medical market."

Related: Marijuana businesses worry about Trump, but expect to prevail

The Bureau of Cannabis Control in California put its proposed regulations up for public review and began holding community workshop meetings in Long Beach, Fresno and Sacramento in September.

Massachusetts will implement retail marijuana sales on July 1, once state officials finalize whether certain localities will be able to maintain a marijuana ban in their respective towns, said Altieri.

"We are committed to make that deadline," said Steven Hoffman, chairman of the Cannabis Control Commission in Boston, which held its first meeting on September 12 on developing and implementing regulations.

Maine would have the smallest market, and it's unclear when they'll get it off the ground. Dan Tartakoff, clerk for the Marijuana Legalization Implementation Committee of state lawmakers, said draft regulations were released in September proposing a 20% tax rate.

Related: Nevada issues first marijuana delivery licenses

These states already have medical marijuana programs and dispensaries, but soon they'll also have stores that can sell recreational marijuana to anyone 21 and older. Recreational marijuana dispensaries already exist in Colorado, which was the first to legalize adult-use pot in 2014, and also Washington, Oregon, Alaska and Nevada, which started in July this year.

Voters in California, Massachusetts and Maine approved legalization of recreational marijuana in referendum votes in November 2016, on the same day that Donald Trump was elected president. It typically takes at least a year for state officials to set up regulations for the industry.

The addition of California could grow nationwide sales to $24.1 billion by 2025, according to New Frontier Data, which tracks the cannabis industry. That's compared to $6.6 billion in 2016.

California was the first state to legalize medical marijuana, in 1996, and sales for that market are expected to total $2.76 billion this year. Opening the retail market will expand sales dramatically, to $3.8 billion in 2018, and to $6.6 billion in 2025, according to projections from New Frontier Data.

Related: Startups race to develop a Breathalyzer for pot

It also means the entire West Coast will be a free zone for retail marijuana as the industry gains its first legal markets on the East Coast. North America is going to grow even greener next year, because Canada is getting ready to legalize recreational marijuana nationwide.

In Massachusetts, sales are expected to increase from $106 million in 2017 to $457 million in 2018, and eventually to $1.4 billion in 2025, according to New Frontier Data. The market is smaller in Maine, which is expected to increase from $83 million this year to $175 million next year, and to $434 million by 2025.

Recreational marijuana is also legal in Washington, D.C., but there is no legal retail market for it. Residents are allowed to possess, grow and consume marijuana on their own property, but not buy or sell it.

Marijuana is actually illegal according to the federal government, which equates it to heroin. Attorney General Jeff Sessions has said he opposes legalization, but he hasn't done anything to crack down on the industry.

Look for a lot more articles like this popping up everywhere you look. I count 8 new articles in the past couple of days just on Canopy Growth when I google it.  The real US run probably won't kick off until December. I will post a list of my favorite US companies at that time for anyone who might want to roll the dice. It's a good bet.

This week the eye is on Canopy Growth, the undisputed world leader in cannabis, as the stock is technically very close to a break-out. Last week it popped bigtime and then retraced Friday. I traded that move successfully and I reloaded on the correction. It might consolidate or it might run right away. Not sure. But downside risk now is much less than a month ago. I think there will be mania buying in this area within the next few months.

Many very poor companies with cool sounding names will run up too. Okay to profit from those on a trade, but many of them are NOT healthy companies (some are outright scams) and these should not be held long term.
Title: Re: The Potfolio
Post by: Eddie on October 11, 2017, 11:46:52 AM
Canopy Growth Corporation, the premier pot stock of them all, drifted up on modest volume today to take out its all-time high from last year. It might consolidate a bit here, But I added to my position this morning, going all in. It wasn't really a true break-out, by my reckoning. Just a portent of what will be coming.

At some point in the next few days or weeks, I expect to see today's high of $11.01 taken out on big volume as institutional buyers come in to take positions ahead of full Canadian legalization and announcement that are expected concerning German medical cannabis deals that are in the works.

I expect this stock to double from here, although it is no doubt already overvalued on fundamentals. I don't think that will matter though.

Addendum: After checking the Canadian ticker volume, I have to make a slight correction. The volume was actually much better than I thought. That should mean more likely we have some follow-through over the next few days, I think.

Also, although the stock did break above the previous all time closing high, there is still one previous crazy intraday spike from the fall 2016 peak that has yet to be taken out. I don't think that's a big deal either, just wanted to be correct in my reporting.
Title: The Potfolio California wildfires threatening the weed industry
Post by: azozeo on October 12, 2017, 05:12:25 AM
2017-10-10 - California wildfires threatening the weed industry:
http://www.msn.com/en-us/money/markets/wildfires-are-endangering-parts-of-californias-dollar2-billion-weed-industry/ar-AAtgQIm (http://www.msn.com/en-us/money/markets/wildfires-are-endangering-parts-of-californias-dollar2-billion-weed-industry/ar-AAtgQIm)

Note: Protecting the weed makes sensimillion ways!
Title: Re: The Potfolio
Post by: azozeo on October 12, 2017, 05:24:33 AM
2017-10-10 - Fentanyl maker donates big to campaign opposing pot legalization:
http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization (http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization)
Title: Re: The Potfolio
Post by: Surly1 on October 12, 2017, 06:31:53 AM
2017-10-10 - Fentanyl maker donates big to campaign opposing pot legalization:
http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization (http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization)

If you ever needed proof of the beneficial effects of cannabis, there it is.
Title: Re: The Potfolio
Post by: azozeo on October 12, 2017, 07:03:04 AM
2017-10-10 - Fentanyl maker donates big to campaign opposing pot legalization:
http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization (http://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization)

If you ever needed proof of the beneficial effects of cannabis, there it is.

FKN-A
Title: Re: The Potfolio
Post by: Eddie on October 12, 2017, 07:21:46 AM
They even fight among themselves.

Biotech company INSYS, which makes some kind of synthetic cannabinoid drug, spent 500,000 to (successfully) lobby against legal rec in Arizona.
Title: Re: The Potfolio
Post by: azozeo on October 12, 2017, 03:58:18 PM
They even fight among themselves.

Biotech company INSYS, which makes some kind of synthetic cannabinoid drug, spent 500,000 to (successfully) lobby against legal rec in Arizona.


That must be the "Tell" for the dark side, no poker face what so ever.
Just wave those hole cards around like Kleenex ......

Buncha' Fucktards at best !
Title: Re: The Potfolio - Calling Edward Caling Edward
Post by: g on October 13, 2017, 09:35:49 AM

You capitalist Pigman  ;D


bizjournals.com
Aphria reports strong performance in Q1 2018, including record revenue and grams sold


Lowered cash costs for the quarter, furthering commitment to being a low-cost producer
Four-part greenhouse expansion on track for completion in 2018, poised to meet expected recreational demand

LEAMINGTON, ON, Oct. 13, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB:  APHQF) today reported its results, for the first quarter ended August 31, 2017.  All amounts are expressed in Canadian dollars.

   
   

Q1 - 2018
   
   

Q1-2017

$  6,120,359
   

Revenue
   

$  4,375,512

7,904,441
   

Gross profit
   

3,782,145

4,774,197
   

Adjusted gross profit1
   

3,331,596

78.0%
   

Adjusted gross margin1
   

76.1%

15,040,168
   

Net income (loss)
   

895,269

1,548,149
   

EBITDA from operations1
   

1,054,269

   
   

   
   

Q1-2018
   
   

Q4-2017

852.0
   

Kilograms (or kilogram equivalents) sold
   

738.3

$  6,120,359
   

Revenue
   

$  5,717,866

$  1,548,149
   

EBITDA from operations1
   

$  2,826,667

$  0.95
   

Cash cost to produce dried cannabis / gram – using Aphria's definition1
   

$  1.11

$  1.61
   

"All-in" cost of goods sold / gram1
   

$  1.67

$  118,731,275
   

Cash and cash equivalents & marketable securities
   

$  167,257,202

$  135,127,644
   

Working capital
   

$  169,051,562

$  23,704,138
   

Investment in capital and intangible assets
   

$  31,955,214

$  20,131,330
   

Strategic investments1
   

$  33,561,864

Operating highlights

    Eighth consecutive quarter of positive EBITDA. $1.5 million in EBITDA from operations in the quarter, a 47% increase from the prior year.
    First harvest and first sale of product flowered exclusively in the new facility expansion.
    Construction on Part III and Part IV expansion progressing as scheduled with first sale from Part III expected in late May 2018 and from Part IV in mid-to-late January 2019. Economies of scale achieved as a result of the completion of these expansion projects will further promote Aphria's commitment to being one of the lowest cost producers in the industry.
    Improved "all-in" costs to produce dried cannabis per gram from $1.67 to $1.61 in the quarter, a decrease of 3.5%.
    Lowered cash costs to produce dried cannabis per gram from $1.11 to $0.95 in the quarter, a decrease of 14.4%.
    Made the step change in the quarter from a company reporting cumulative losses greater than cumulative net income (deficit) to cumulative net income exceeding cumulative losses (retained earnings). Aphria becomes one of only a few publicly listed Licensed Producers in this position.
    Deployed approximately $20.1 million of capital in the form of strategic investments including additional investments in Copperstate Farms Investors, LLC, Green Acre Capital Fund I and investments in TS BrandCo Holdings Inc., HydRX Farms Inc. (d/b/a Scientus Pharma) and Nuuvera Corp.
    Deployed approximately $23.7 million of capital in the form of capital expenditures related to our Part II, Part III and Part IV expansion projects.

"In the first quarter of 2018, Aphria increased revenue and grams sold, and lowered cash costs, in addition to recording our eighth consecutive quarter of positive EBITDA," said Vic Neufeld, Chief Executive Officer, Aphria. "A key driver of our continued performance has been our ability to maintain leadership as one of the lowest-cost producers in the industry. As legal recreational cannabis comes into market in 2018, low costs per gram will be a critical factor for the entire supply chain. Our proven ability to grow to scale while keeping costs low is an important competitive advantage; it positions Aphria to profitably meet projected demand for cannabis and deliver sustainable value to our shareholders."

"Looking ahead, we are on track to meet critical short- and long-term goals: Our fully-funded facility expansion is well underway, and we expect to achieve further economies of scale once the expansion projects are completed in 2018. Additionally, we continue to develop new product innovations and invest in our recreational infrastructure and brand. This will enable us to serve growing demand from medical cannabis patients in the near term and will eventually support Aphria's position as a leader in Canada's recreational market, once federal and provincial regulatory frameworks are in place," said Mr. Neufeld.

Financial highlights

For the eighth consecutive quarter, the Company reported positive EBITDA.  In the quarter, the Company reported $1.5 million in EBITDA from operations, a 47% increase over the prior year.  The Company remains committed to the responsible use of our shareholders' investment in Aphria.  The Company continues to invest in its recreational brand, continues to proceed diligently on its capital investment plans and continues to explore other opportunities to increase shareholder value, including strategic investments, while ensuring appropriate liquidity risk mitigation strategies are in place.

Revenue for the three months ended August 31, 2017 was approximately $6.1 million, representing a 7% increase over the prior quarter's revenue of approximately $5.7 million, in a quarter in which the Company was effectively capacity constrained as the first sale from the Part II expansion did not occur until late in August. Further, on a kilogram and kilogram equivalent basis, the Company increased its sales by 15%, from 738.3 kgs to 852.0 kgs.  Cannabis oil sales, as a percentage of all revenue, remained constant in the quarter at 32% of revenue.

Gross profit before fair value adjustments for the first quarter was approximately $4.8 million with a gross margin before fair value adjustments of 78%, generated from both retail and wholesale shipments of medical cannabis.  The decrease in the gross margin before fair value adjustments from the prior quarter was a function of replacing sales to veterans, once their three gram per day limit became effective, with a combination of retail sales to patients and wholesale sales to other Licensed Producers.

During the quarter, our "all-in" costs of dried cannabis per gram decreased from $1.67 to $1.60. The decrease was largely related to economies of scale achieved as a result of the completion of our Part II expansion.  Similarly, our cash costs of dried cannabis per gram decreased from $1.11 to $0.95, for the same reason.

During the quarter, the Company reported significant activity as it relates to its strategic investment portfolio, as follows:

   
   

   

Q1-2018
   

Q4-2017

Foreign exchange (loss) gain
   

$  (150,702)
   

417,165

(Loss) gain on marketable securities
   

(1,746,367)
   

194,633

Gain on dilution of ownership in equity accounted investee
   

7,551,158
   

--

(Loss) gain from equity accounted investee
   

(8,840,264)
   

210,400

Finance income, net
   

479,719
   

29,765

Unrealized gain on embedded derivatives
   

532,750
   

--

Unrealized gain (loss) on long-term investments
   

19,081,556
   

(5,572,278)

Total
   

16,428,131
   

(4,720,315)

The largest increases in the strategic investment portfolio relate to the increase in fair value of the Company's investment in Copperstate Farms Investors, LLC and the increase in the value of the Company investment in its equity accounted investee, Liberty Health Sciences, Ltd. ("Liberty").  The largest offsetting decrease in the strategic investment portfolio was the Company's share of its equity accounted investee's, Liberty's, net loss for the quarter.  The Company's share was $8.8 million, with the vast majority of the loss ($8.4 million) relating to Liberty's listing fees as part of its reverse takeover, go public, transaction.

Net income for the three months ended August 31, 2017 was approximately $15 million or $0.11 per share as opposed to a net income of approximately $0.9 million or $0.01 per share in the same quarter in the previous year and a loss of approximately $2.6 million or $0.02 per share in the previous quarter.  The increase in net income for Aphria in the quarter is directly related to the net gains on the Company's strategic investment portfolio in the quarter.

EBITDA from operations for the first quarter was approximately $1.5 million, compared to an EBITDA from operations of $1 million in the same period of the prior year and EBITDA from operations of $2.8 million in the previous quarter.

We have A Good Thing Growing.

About Aphria

Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.

For more information, visit www.Aphria.ca (http://www.Aphria.ca).

                                 
Aphria Shareholder Auric Goldfinger
Aphria Shareholder Auric Goldfinger

                                     (https://screenshots.firefoxusercontent.com/images/ad868a3a-2cd0-44dc-989b-a90d5c8be6aa.png)

Title: Re: The Potfolio
Post by: g on October 13, 2017, 09:40:08 AM


                                             (https://screenshots.firefoxusercontent.com/images/6193b8bf-3c60-463f-8109-322886e8a519.png)
Title: Re: The Potfolio
Post by: Eddie on October 15, 2017, 04:35:01 PM
The Aphria report was stellar, but the stock barely moved. I was overweight Aphria, and chose to sell some Friday. I view the action there as short term bearish for the share price, although I still think the company is checking  the right boxes. I've recently been holding a core position in the top three 1st tier LP's, while adding on dips and selling on rips. It's been a good month for a trading style approach, with nice volatility without any of those gut-wrenching summer drawdowns.

Canopy Growth is currently 39% of my potfolio. I thought it might run this last week. I sort of expect it to take a breather, but it could still have some new upside. Wednesday was the all-time closing high for the stock. I will reduce and raise cash this next week whether it bounces or not, so I can enter a few new trades, but it remains the anchor, no matter what.
Title: The High Price of Cheap Weed
Post by: RE on October 17, 2017, 12:33:52 AM
http://grist.org/article/california-emerald-triangle-cheap-marijuana-economics-prop-64/ (http://grist.org/article/california-emerald-triangle-cheap-marijuana-economics-prop-64/)

 The High Price of Cheap Weed

(https://grist.files.wordpress.com/2017/10/highpricecheapweed.jpg)

The Napa Valley of pot faces an unlikely challenge: legalization.

By Stett Holbrook   on Oct 9, 2017

In collaboration with

Fern

The drive to Casey and Amber O’Neill’s HappyDay Farms winds up a dirt track off Highway 101, three hours north of San Francisco. The road climbs to 3,000 feet along a ridge with stunning views of pine-covered mountains and the blue band of the Pacific Ocean, 25 miles to the west.

As I turn down the O’Neill’s pitched driveway, a barking Great Dane–Catahoula named Emma rushes me, hackles raised. Casey and Amber insist she’s friendly, but it be would difficult to approach the O’Neill homestead undetected. And that’s by design.

The O’Neills grow cannabis in northwestern California’s infamous Emerald Triangle, a densely forested region of labyrinthine back roads, secret valleys, and perennial creeks. For more than 40 years, it’s been a great place to hide out and grow a prohibited but highly desired product — not just for the O’Neills, but for scores of other off-the-books growers, many of whom have been farming here for generations.

Casey O’Neill was born 35 years ago on this hilly, 20-acre spread. One acre of his property is flat enough to produce vegetables and strawberries, which he sells to nearby restaurants and members of a CSA. But it’s the rows of cannabis that bring in most of his income. His brother and father grow the same lucrative product on adjacent properties: a well-known hybrid strain called The Great Success, which took 11th place out of more than 650 entries at last year’s Emerald Cup, the state’s premier pot competition.
Grist / Google Earth

The Emerald Triangle is the Napa Valley of cannabis. Blanketing more than 10,000 square miles in Trinity, Humboldt, and Mendocino Counties, the region produces about 60 percent of the nation’s pot, most of which heads out of state on the black market.

And just as winegrowing and tourism dominate Napa County’s economy, so does cannabis dominate here, helping to fill the void created by the collapse of the once-robust fishing and timber industries. In Humboldt County, the region’s heart, researchers estimate that cannabis provides a third of private-industry revenue; in the triangle at large, the California Growers Association, a cannabis trade group, says every dollar spent on the cannabis industry leads to at least two dollars spent elsewhere.

A message from The Wilderness Society:

Senate is voting on a bill this week that would allow drilling in the Arctic Refuge. Help stop it!

But change is coming, thanks to voters’ passage last year of Prop 64. Starting in 2018, Californians will be able to legally grow and possess recreational cannabis. That’s in addition to medical weed, which the state legalized in 1996.

From an environmental standpoint, ending prohibition should be a boon. Illegal cultivation creates a raft of environmental problems — erosion, clear-cutting, garbage dumping, poisoned watersheds, and water diversions from creeks that support imperiled salmon and steelhead trout. The state will also begin collecting fees and taxes from growers who go legit; about $1 billion is expected next year, of which 20 percent will go toward watershed protection and remediation of state lands that were damaged by growers.

But for the O’Neills and other small-scale growers in the Emerald Triangle, legalization looks a lot less appealing. Many are either unable or unwilling to pay state or county fees, and even for those who can, legalization will increase competition from large-scale, cut-rate growers.

Fred Krissman, a Humboldt State University anthropologist conducting field studies of cannabis growers in the region, predicts “massive increases in unemployment, poverty, child hunger — a disaster.” The transformation might also offer a cautionary tale to other states embarking down the path of legalization.

In 2016, California’s legal medical cannabis industry — which fills the shelves of regulated dispensaries throughout the state — generated $1.8 billion in revenue. Meanwhile, the illicit markets pulled in $5.1 billion, according to the Arcview Group, a cannabis investment and research firm in Oakland.

Once legal recreational cannabis hits the market, Arcview forecasts its value will hit $5.8 billion in the next four years.

But how much of that pot will come from the Emerald Triangle? So far, only about 3,000 of the region’s operators, out of roughly 50,000 farms or “grows,” have applied for permits and licenses, but that number is growing as more growers come forward. For some operators, the cost of legalization – tens of thousands of dollars for even a modest-size operation, not including attorney and consultant fees — is simply too high.

Compounding the financial hit is competition from the south, where well-capitalized operators are planting cannabis in giant Salinas and Central Valley greenhouses and urban industrial parks. Economies of scale, plus easy access to labor and highways near lucrative markets, lower those operators’ price point to about $1,300 a pound. Just a few years ago, Emerald Triangle growers could get more than triple that.

As if that weren’t bad enough, the Emerald Triangle’s growers who have chosen to go legit, including the O’Neills, face further competition close to home. With lower overhead and no sales tax or permit fees, growers who choose to stay illegal can easily undercut legal operators’ prices.

As the industry emerges from the underground economy and blinks in the bright light of regulation, no one is quite sure what success will look like. The cannabis industry has existed outside the law for decades, but also well outside of mainstream agriculture. That has allowed small-scale growers to maintain financially and environmentally sound family-owned plots — a rarity in the rest of the ag industry, which has grown dependent on chemical companies and squeezed by low crop prices.
Casey and Amber O’Neill stand on a hillside at HappyDay Farms. Stett Holbrook

“We’ve seen how 20th century agriculture can be really bad for community, and really hard on the land, hard on workers and families,” Casey O’Neill says. “If we don’t build a different 21st century agriculture, we’re fucked.”

Done right, he adds, cannabis legalization offers a way to keep small, diversified pot-and-produce farms like his afloat. “It’s much bigger than growing some weed. We’re trying to put a face on small farms and communicate what we do, and why it’s valuable to society.”

When I first met Humboldt State’s Fred Krissman at a California Bureau of Medical Cannabis Regulation meeting in Santa Rosa last year, I thought he was a grower. He looked the part, sitting in the back of the room wearing a beanie pulled low and a cannabis farm T-shirt.

As an anthropologist studying cannabis growers, he cultivates the look to better mix with his research subjects, with whom he lives for days at a time.

Krissman works at Humboldt’s five-year-old Institute for Interdisciplinary Marijuana Research, the first academic research group to focus on cannabis — the role it plays in the regional economy and its impacts on community relations, the environment, and human health.

He hopes a majority of cannabis farmers can find the environmental and economic balance that Casey O’Neill exemplifies, but as an academic, Krissman is skeptical.

The industry’s shift into the legal sphere, he says, may pressure all cannabis growers — legal and illegal — to operate more like modern agriculture, with its “get big or get out” ethos of debt, larger investments in equipment, labor and facilities, and offsite corporate ownership.

In 2014, after Colorado legalized recreational and medical cannabis, prices plummeted as scores of new growers flooded the market, many of them large-scale operations that hold licenses for cultivation, distribution, sales, and other business activities.

According to Cannabase, a Colorado-based online retail site, the wholesale price for a pound of recreational pot dropped 38 percent in 2016, while medical marijuana fell by 24 percent. A similar phenomenon is happening in Washington State, which legalized recreational cannabis in 2012.

As an example of how industrial pot could affect California growers, Krissman points to Harborside, an Oakland-based cannabis dispensary that’s developing a 47-acre farm with 360,000 square feet of greenhouses in the Salinas Valley. Jeff Brothers, that company’s chief executive officer, told a reporter this past April: “If we want cannabis to be widely accepted, we need it to be cheap.”

That’s an imperative with which Krissman vehemently disagrees.

“If we force the cannabis industry into the capitalist mode of agribusiness,” he says, “this is the logical transition that’s going to occur — the one that our politicians and many people say they don’t want.”

To help protect Northern California’s traditional growers, Krissman suggests limiting farms to one acre, as well as imposing a government-subsidized floor price of $1,000 per pound at the farm gate — a proposal he realizes has little chance of passing muster in the current regulatory climate.

The growing glut of cannabis is already pushing prices to that floor, with no sign it will hold. But if public policy makers really do want rural communities to thrive, Krissman says, then they have to enact laws protecting them.

State lawmakers have created a tiered-fee structure, based on the number of plants and size of operation, to help cottage-scale growers survive in the post-legalization landscape. But even that, many say, isn’t enough to help Emerald Triangle growers match the economies of scale enjoyed by larger operations to the south.

Susan and Paul, partners in a small medical cannabis company called Lovingly and Legally Grown, are among those who fear the legalization juggernaut. They asked that their last names not be used because of ongoing raids in their region by authorities, even on legal growers.

They belie the cliché that all pot growers are raking in the money. Last year, they grossed $35,000, producing and distributing a line of tinctures, oils, and balms, working with doctors to create custom blends of cannabinoid (CBD) — a non-psychoactive compound that treats anxiety, epilepsy, arthritis, and other ailments.

Under the new regulatory framework, they estimate their annual fees and permits will top $30,000 next year.

“This is what is presenting us with this terrible quandary right now,” says Susan over a table filled with her homemade cheese, almonds, and gluten-free crackers. “We don’t know if we can continue.”

She and Paul now travel the state, attending hearings on cannabis regulation and explaining how legalization threatens to annihilate those who choose to stay small.

“Everybody wants to get their beak wet,” Paul adds. “All they know is this is a billion-dollar industry, and they want their piece of the pie.”

Indeed, 250 miles south of the Emerald Triangle, in California’s Salinas Valley, a 21st century cannabis industry is rising amid the region’s traditional crops of lettuce, strawberries, artichokes, broccoli, and wine grapes.

To protect Salinas Valley’s existing $5 billion agricultural industry, Monterey County officials have restricted cannabis cultivation to existing greenhouses, a land-use decision that has kicked off a real estate frenzy for tumbledown buildings that used to grow cut flowers until NAFTA opened the door to cheaper Colombian imports in the 1990s.

“Greenhouses are the most efficient way to grow,” says Omar Bitar, co-founder of Grupo Flor, a Salinas-based cannabis business consortium. “We have the ag infrastructure and, most importantly, we have the labor pool.”

Today, Grupo Flor leases or owns about 2.6 million square feet of greenhouse and indoor growing space in Monterey County. Eight-foot-tall chain-link fences, topped with razor wire, encircle the properties, which are dotted with security cameras and large “no trespassing” signs.

Inside the greenhouses, computer programs manipulate light exposure, spurring plants to flower early and produce multiple crops a year, instead of the single crop that outdoor growers, reliant on the sun, raise.

At Grupo Flor’s Salinas office, a whiteboard lists revenue projections for each of the company’s five business ventures: real estate, cultivation, manufacturing, investment, and retail. This year, the company will gross $5 million from its leases, says Gavin Kogan, a Grupo Flor cofounder. Next year, if all goes well, he projects gross earnings, from all Grupo Flor ventures, of $30 million and more than $80 million in 2019.

A former cannabis business attorney who favors checkered Van’s skateboard shoes, Kogan claims not to be motivated by riches. Instead, he touts the ability of cannabis to create economic opportunity for the majority-Latino population in an area riven by crime and lack of economic opportunity. Salinas has the highest youth homicide rate in the state and a total gun murder rate more than seven times the national average.

“The goal is to make the Salinas Valley the central plumbing for the California cannabis industry and generate jobs and completely reconstitute the economic infrastructure of this valley,” Kogan says.

And what of the Emerald Triangle growers? Kogan says he understands their plight and doesn’t want to take their business.

“I’ve faced open hostility from North Coast folks with what we’re doing here,” he admits. “But we’ve got multi-generation growers down here as well, and we’re doing what’s available to us.”

What’s available to northern growers, he adds, is appellations: identifying and marketing products with distinct geographical place names — a strategy employed by winemakers around the globe. (The California Growers Association is already pursuing this avenue.)

Emerald Triangle growers could also distinguish their product as sun-grown buds, distinct from anything cultivated under a roof in Monterey County.

But there’s another hitch: flower power may be on the decline. To appeal to new consumers, Kogan says the industry is moving away from smokable bud toward salves and candies made with cannabis oil — a commodity in the making. That’s where much of Grupo Flor’s business lies. It remains to be seen if customers will continue to seek out Emerald Triangle flower over more versatile oil.

Can big pot and little pot coexist, as Kogan imagines? Alicia Rose consulted for the Napa Valley wine industry before she opened a virtual cannabis dispensary called HerbaBuena, which specializes in sun-grown, biodynamic cannabis from heritage Emerald County growers.

She sees an opportunity for branded “farm-to-table” cannabis that comes with a story – for example, flowers grown outdoors by organic farmers on a small family plot in an ocean-cooled valley in Mendocino County — as the best hope for Northern California’s cottage growers.

For the Napa Valley of pot to survive, in other words, it might have to learn and adopt the marketing lessons of the actual Napa Valley.

“It gives me a little glimmer of hope we’ll be able to stay above the fray,” she says. Her hesitation? Backwoods growers who have long operated under the radar lack a certain business savvy. After all, they’ve succeeded in large part thanks to their ability to lay low. And that doesn’t usually translate into Napa-like promotional and sales skills.

Casey O’Neill, however, may have the adaptive qualities to make it in California’s new cannabis economy. Over the decades, he has played many roles: black market grower, plant breeder, cannabis consumer, and felon (he spent two months in the Mendocino County jail for cultivation). Now he’s a tax-paying cannabis farmer and policy activist.

Through it all, he has argued for the value of cannabis as a medicine, and for the benefits of small-scale, environmentally sound cultivation. Today, laminated cultivation permits hang on posts at the entrance to his farm. He relishes the security, predictability, and peace of mind that comes from running an above-board business.

Serving on the board of directors for the California Growers Association, O’Neill has become a strong advocate for small-scale cannabis cultivation. Perhaps hedging his bets, he also recently accepted a position in business and policy development at Flow Kana, a cannabis distributor building a 85,000 square-foot “cannabis campus” in nearby Redwood Valley.

The facility, which also houses a retreat center, will process, test, and distribute co-branded cannabis from some 80 boutique Mendocino and Humboldt county growers, operations not unlike the O’Neills’ HappyDay Farms.

So far, Emerald County growers don’t consider the San Francisco–based Flow Kana a threat. Rather, it’s a lifeline that, if all goes well, will help them stay afloat. Casey and Amber trust that the co-op will help them reach “discerning customers” — people who will seek Mendocino County sun-grown weed the way wine drinkers seek biodynamic-certified Napa cabernet.

“The strength of the story is what we’re counting on to keep us in the game against bigger, more capitalized operations,” O’Neill says. “Grown in a greenhouse has only so much story to it.”

Produced in collaboration with the Food & Environment Reporting Network, a nonprofit, investigative news organization.
Title: Re: The Potfolio
Post by: g on October 17, 2017, 04:16:26 AM
The Aphria report was stellar, but the stock barely moved. I was overweight Aphria, and chose to sell some Friday. I view the action there as short term bearish for the share price, although I still think the company is checking  the right boxes. I've recently been holding a core position in the top three 1st tier LP's, while adding on dips and selling on rips. It's been a good month for a trading style approach, with nice volatility without any of those gut-wrenching summer drawdowns.

Canopy Growth is currently 39% of my potfolio. I thought it might run this last week. I sort of expect it to take a breather, but it could still have some new upside. Wednesday was the all-time closing high for the stock. I will reduce and raise cash this next week whether it bounces or not, so I can enter a few new trades, but it remains the anchor, no matter what.

Understood Eddie, stocks that should be traded due to their valuations and low quality.

Being perfectly honest with you my heart isn't in them anymore. Have positions in the three that were mentioned by me, but my bearishness has become most intense of late. Fearful of a massive market collapse, both bond and stock markets and with it a systemic collapse. Alarm bells are ringing loudly in my frightened mind, stocks like Tesla and Facebook and the madness surrounding them have me really worried.

All my interest is in Gold and the gold miners at this point in time, totally focused there with just scant attention in other sectors.

Not to worry Eddie, have been this bearish for about a year now.  :dontknow:

                                         
                                            (http://themarketghana.com/docs/news/2/2576Gold_rises_as_Trump_policy_fuels_safe_haven_demandjpg.jpg)
Title: The Potfolio - Dr. Cannabis I presume...
Post by: azozeo on October 17, 2017, 04:50:21 AM
2017-10-15 - Northern Michigan University now offering degree in marijuana:
http://abcnews.go.com/Weird/wireStory/northern-michigan-university-offers-marijuana-degree-50479457 (http://abcnews.go.com/Weird/wireStory/northern-michigan-university-offers-marijuana-degree-50479457)
Title: Re: The Potfolio
Post by: Eddie on October 18, 2017, 05:39:02 AM
Alert: Buying  Opportunity.

The better pot stocks have been in beast mode for weeks. Yesterday was the first serious down day in more than a month. The sector took a 3-4% broad correction yesterday and I believe there is just a bit more downside left. However, any further weakness in the 1st tier LP's like Canopy Growth, CannTrust, MedReleaf, Aphria, and Aurora should be bought.

Aphria was hit really hard yesterday after announcing  a new capital raise on the same day that the Canadian stock exchanges were making more noises about hassling companies that do Federally illegal business in the US jurisdiction, of which the main one likely to be affected would be Aphria. I had just sold out at the top, and I bought it all the way back down. However, I don't think it quite bottomed, so it should be allowed to find a bottom, which should happen today or within a few trading days, imho.

Title: Re: The Potfolio
Post by: g on October 18, 2017, 05:48:16 AM
Yes Eddie, The Toronto exchange is threatening to delist them.

What a strange occurrence out of nowhere???

GO smells a rat.  :icon_scratch: :dontknow:
Title: Re: The Potfolio
Post by: Eddie on October 18, 2017, 05:54:35 AM
It's been ongoing for a few months.

Being delisted is not a big deal unless they go OTC, which is not tax advantaged for Canadians. Otherwise it's just be a nuisance.

Buying opportunity.
Title: Re: The Potfolio
Post by: g on October 18, 2017, 06:02:22 AM
It's been ongoing for a few months.

Being delisted is not a big deal unless they go OTC, which is not tax advantaged for Canadians. Otherwise it's just be a nuisance.

Buying opportunity.

I read last night somewhere, sorry can't find it, that the move is a fraud and makes no sense because they will just list in Vancouver.

Makes no sense to me, since when is an exchange enforcing supposed laws by delisting companies? Something seems screwy to me or I just don't understand the entire issue.

This is like the New York Exchange threatening to delist JPM because the were found guilty in fraud suits.  :icon_scratch: :icon_scratch:
Title: Re: The Potfolio
Post by: Eddie on October 18, 2017, 06:14:03 AM
It's only the TSX that is making noise. It is assumed they can go to Vancouver or OTC, or they could just spin off the US assets into an OTC company.  But because these stocks are mostly owned by Canadians, and because Canada is very generous in allowing its citizens to invest without much tax consequences, going OTC does create uncertainty among investors with those special accounts (better than IRA's or 401K's, but not allowing OTC's, as I understand it.)
Title: Re: The Potfolio
Post by: g on October 18, 2017, 06:21:28 AM
Whatever Eddie, I agree with your sentiments that it is most likely a good entry point for traders.

Have all I want currently, as explained earlier in a reply to you, and am just going to sit pat. Too bearish to be buying anything but Gold currently.

Good Luck, you have been trading well and that out on Aphria the other day was a good move.  :emthup: :emthup:
Title: Re: The Potfolio
Post by: Eddie on October 18, 2017, 12:49:11 PM
Being perfectly honest with you my heart isn't in them anymore. Have positions in the three that were mentioned by me, but my bearishness has become most intense of late. Fearful of a massive market collapse, both bond and stock markets and with it a systemic collapse. Alarm bells are ringing loudly in my frightened mind, stocks like Tesla and Facebook and the madness surrounding them have me really worried.

All my interest is in Gold and the gold miners at this point in time, totally focused there with just scant attention in other sectors.

Not to worry Eddie, have been this bearish for about a year now.  :dontknow:


There is no doubt that your bearishness is perfectly reasonable. There will be a massive market collapse, I think. And in Trump's 1st term (most likely), so it won't be long now. A year. Two? Some October soon...just not this October. I have an eye on the exits at all times. I can't really invest long term anymore.
Title: California wildfires torch the legalization hopes of pot growers
Post by: RE on October 25, 2017, 01:31:21 PM
http://grist.org/article/california-wildfires-torch-the-legalization-hopes-of-pot-growers/ (http://grist.org/article/california-wildfires-torch-the-legalization-hopes-of-pot-growers/)

Up in Smoke
California wildfires torch the legalization hopes of pot growers
By Stett Holbrook on Oct 20, 2017

(https://grist.files.wordpress.com/2017/10/californiawildfire.jpg?w=1024&h=576&crop=1)

The wildfires that swept across Mendocino, Sonoma, and Napa counties in Northern California last week devastated many of the region’s legal cannabis growers, torching their crops and facilities at peak harvest time and leaving smaller farmers at risk of collapse.

The fires, which continue to smolder, are the deadliest and most destructive in the state’s history — killing at least 41 people and claiming 220,000 acres and 5,700 homes. The blazes incinerated untold amounts of pot, just as legal sales are set to begin in the state in January.

“The opportunity of legal cannabis is in ashes for many longtime California growers and their communities,” wrote Hezekiah Allen, executive director of the California Growers Association, in a message to the trade group’s 1,200 members. “Over the course of the last 18 months, these growers have spent their life savings getting permits and preparing for state licenses.”

Allen said the fires had destroyed at least 21 farms and damaged two others. Even for farms that didn’t burn, the crops may die for lack of water, as many are in areas that are now off-limits. Unlike grape farmers who lost vines in the fires, cannabis growers don’t qualify for crop insurance and can’t apply for federal assistance grants.

Allen was working with state officials to create an insurance program for growers, but it wasn’t in place yet. The farms were already under pressure from growing competition from much bigger operations. “It was just really bad timing,” he told me.

PREVIOUSLY: In pot’s Napa Valley, legalization could wipe out small farmers

The cause of the fires is unknown. Some are pointing fingers at sparking Pacific Gas & Electric power lines on ridge tops. But the real culprit looks like climate change, which will put cannabis growers — and the state at large — at risk in the future, as reported by Sonoma County’s weekly newspaper, The Bohemian.

“That’s the way it is with a warming climate, dry weather and reduced moisture,” California Governor Jerry Brown said in a press conference last week. “These kinds of catastrophes have happened, and they are going to continue to happen.”

All the conditions in place before the fire — hot, dry weather, massive fuel loads, and hurricane-force east winds — are hallmarks of a changed climate. “Climate sets the stage, and we have strong evidence that the global warming that’s already happened has increased wildfire risk in the western United States, through the effects of temperature drying the landscape,” said Noah Diffenbaugh, a Stanford University climate scientist.

Terry Garrett, who serves on the Sonoma County Economic Development Board and its Cannabis Task Force, says damage reports are still coming in, but the losses could be substantial. A typical 10,000-square-foot operation would lose about $1 million in pot, plus infrastructure, he said.

Garrett estimates that Sonoma County produces about $2.5 billion in cannabis revenue per year. That includes indoor and mixed-light production, which is harvested three to five times a year. Outdoor production, the kind most likely to be damaged by the fire, represents the most potential for loss since that crop hadn’t been harvested and dried.

For the cottage-scale growers whose farms were destroyed in the blazes, the disaster intensifies financial pressure that was already pushing them to the brink. The first two weeks of October are generally peak harvest for cannabis growers. Flames got the crop before they could.

To help farmers who suffered losses, the growers association launched a recovery fund. But even that good-faith effort hit a snag. YouCaring, the platform receiving wildfire relief funds for the association, sent the $9,000 raised so far back to the group because of a policy against cannabis campaigns. So the association has moved its fundraising to a new platform.

Most of the losses were in Sonoma County, where the fires were largest. The Emerald Triangle, the traditional heart of Northern California’s cannabis country, begins just north of Sonoma County in Mendocino County; but with an estimated 5,000 cannabis farms, Sonoma County is as much cannabis country as it is wine country.

Just as the fire did not discriminate, incinerating homes in upscale ridge-top areas as well as a vast swath of more than 1,000 working-class homes in hard-hit Santa Rosa, the fire took out pot farms big and small, too.

CannaCraft is Sonoma County’s largest cannabis producer and distributor. The company lost 15 greenhouses in the fires, which represents about 5,000 plants. As a larger company, it will be able to absorb the losses, but smaller operations already struggling to afford often costly state and county permits and fees will have a harder time rebounding. CannaCraft has opened its offices to smaller competitors to help them get back on their feet.

“Getting hit at this time is going to be pretty devastating for some of these people, as they were just coming above board trying to create legitimate businesses,” said Dennis Hunter, CannaCraft’s founder.

A bit of good news: In Sonoma County, growers who had applied for permits are eligible for tax relief if their crops were destroyed or damaged. And although the losses may be extensive, dispensary owners say that because of the record amount of cannabis grown in California this year, they will backfill their supply from other sources. That will benefit small growers who made it through the fires and are struggling to adjust to the new, legal market.

Produced in collaboration with the Food & Environment Reporting Network, a nonprofit, investigative news organization.


Title: It Turns Out, Smoking Weed May Actually Be Good For Your Sex Life
Post by: RE on October 28, 2017, 05:52:50 AM
https://www.huffingtonpost.com/entry/good-news-about-sex-and-weed_us_59f21383e4b03cd20b8032b5 (https://www.huffingtonpost.com/entry/good-news-about-sex-and-weed_us_59f21383e4b03cd20b8032b5)

 LIFESTYLE 10/27/2017 04:00 pm ET Updated 15 hours ago
It Turns Out, Smoking Weed May Actually Be Good For Your Sex Life
A new study says pot smokers may have more sex than non-smokers.
By Brittany Wong

(https://img.huffingtonpost.com/asset/59f3a671140000ae528ca120.jpeg?cache=n20uhw6vov&ops=scalefit_720_noupscale)
Casarsa via Getty Images

Good news for pot smokers: Smoking weed regularly could actually be beneficial to your sex life.

While previous studies have suggested that frequent marijuana use may impair sexual desire or performance, new research out of Stanford University School of Medicine suggests the opposite may be true.

“Frequent marijuana use doesn’t seem to impair sexual motivation or performance. If anything, it’s associated with increased coital frequency,” said Michael Eisenberg, the study’s senior author and an assistant professor of urology at Stanford.

According to the study, which was published Friday in the Journal of Sexual Medicine, pot users are having about 20 percent more sex than pot abstainers.

Eisenberg and lead author Andrew Sun analyzed data from the National Survey of Family Growth, an annual survey sponsored by the federal Centers for Disease Control and Prevention that looks at marriage and divorce rates, pregnancy and men’s and women’s health overall. The data spanned from 2002 to 2015.

In all, Eisenberg and Sun looked at self-reported answers from more than 50,000 Americans, ages 25-45.

One of the questions in the annual survey explicitly asks respondents how often they’ve had intercourse with someone of the opposite sex in the past four weeks.

In another section, people are asked how often they’ve smoked marijuana in the past 12 months. Roughly 24.5 percent of men and 14.5 percent of women in the analysis said they’d done so.

The big takeaway? Those who had smoked generally reported having slightly more sex. Women who reported no marijuana use during the past 12 months reported having sex 6.0 times on average during the past four weeks compared with 7.1 times for women who smoked daily.

As for the men, daily marijuana users’ reported sexual frequency was 6.9 times on average in the previous month compared with 5.6 times for non-users.

The correlation held true among different demographics, too.

“Once we found the positive association between marijuana use and sexual frequency, I thought there were be some groups for whom this pattern did not exist,” Einsenberg told HuffPost. “For example, I thought there would be differences based on age, race/ethnicity, education and marital status but for every group examined, we saw the same association.”
Subscribe to the Lifestyle email.
We’re basically your best friend... with better advice.

    Frequent marijuana use doesn’t seem to impair sexual motivation or performance. If anything, it’s associated with increased coital frequency. Michael Eisenberg, an, assistant professor of urology at Stanford

What’s even more interesting? No such positive correlation was found when Eisenberg and Sun looked at the respondents’ use of other drugs or alcohol and sexual frequency.

In other words, this likely isn’t a matter of less inhibited types being more inclined to use drugs and have more sex, Eisenberg explained.

Keep in mind that this is just one of many studies that have looked into the relationship between marijuana and sexual health. A 2012 European study suggested that weed lowers testosterone levels for some men, which may ultimately lead to erectile dysfunction. This occurs when THC ― the active chemical in cannabis that gets you high ― blocks the release of GnRH, a hormone vital to successful reproductive function.

And Eisenberg stressed that the research shouldn’t be misinterpreted as “if I smoke more pot, I’ll have more sex.”

“Correlation does not equal causation,” he said. “More research in this area is needed. I think this represents an important opportunity to understand this association.”
Title: Re: The Potfolio
Post by: K-Dog on October 28, 2017, 07:17:30 PM
Weed good for your sex life?  Further research needed?  In the name of science I am here to help.  DOGGY STYLE!
Title: Re: The Potfolio
Post by: Surly1 on October 29, 2017, 06:55:32 AM
Weed good for your sex life?  Further research needed?  In the name of science I am here to help.  DOGGY STYLE!

 :icon_mrgreen: :icon_mrgreen: :icon_mrgreen:
Your selflessness and spirit of self-sacrifice are duly noted.
Title: Re: The Potfolio -A Game Changing Event
Post by: Eddie on October 29, 2017, 12:49:38 PM
Constellation brands, one of the most successful multi-company alcohol conglomerates, is buying into Canopy Growth, the world's leading pot stock.

You might remember that I predicted this would happen....many months ago, when I first made the case for buying pot stocks.

https://www.wsj.com/articles/big-brewer-makes-a-play-for-marijuana-beverages-1509300002 (https://www.wsj.com/articles/big-brewer-makes-a-play-for-marijuana-beverages-1509300002)
Title: Re: The Potfolio
Post by: azozeo on October 29, 2017, 01:02:44 PM
http://bloomsmag.com/smoking-marijuana-causes-complete-remission-of-crohns-disease-no-side-effects-new-study-shows/ (http://bloomsmag.com/smoking-marijuana-causes-complete-remission-of-crohns-disease-no-side-effects-new-study-shows/)

Blooms Mag

Marijuana – scientific name “cannabis” – performed like a champ in the first-ever placebo-controlled trial of the drug to treat Crohn’s Disease, also known as inflammatory bowel disease.

 

The disease of the digestive tract afflicts 400,000 – 600,000 people in North America alone causing abdominal pain, diarrhea (which can be bloody), severe vomiting, weight loss, as well as secondary skin rashes, arthritis, inflammation of the eye, tiredness, and lack of concentration.

Smoking pot caused a “complete remission” of Crohn’s disease compared to placebo in half the patients who lit up for eight weeks, according to clinical trial data to be published the journal Clinical Gastroenterology and Hepatology.

 

Researchers at Israel’s Meir Medical Center took 21 people with intractable, severe Crohn’s disease and gave 11 of them two joints a day for eight weeks. “The standardized cannabis cigarettes” contained 23 percent THC and 0.5 percent CBD (cannabidiol). (Such marijuana is available on dispensary shelves in San Francisco, Oakland, and other cities that have regulated access to the drug.) The other ten subjects smoked placebo cigarettes containing no active cannabinoids.

Investigators reported that smoking weed caused a “complete remission” of Crohn’s Disease in five of the 11 subjects. Another five of the eleven test subjects saw their Crohn’s Disease symptoms cut in half. Furthermore, “subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.”

The study is the first placebo-controlled clinical trial to assess the consumption of cannabis for the treatment of Crohn’s, notes NORML. All of the patients had intractable forms of the disease and did not respond to conventional treatments. Still, the United States government claims that marijuana is as dangerous as heroin and has no medical use. U.S. Attorney Melinda Haag is waging a war on safe access to medical cannabis in the Bay Area.
Title: The Potfolio 1st Med. Cannabis Drive Thru Opens in Phoenix, Az.
Post by: azozeo on October 30, 2017, 10:15:48 AM
2017-10-28 - Medical marijuana drive-thru opens near Phoenix (Arizona):
http://www.usatoday.com/story/news/nation-now/2017/10/28/arizonas-first-medical-marijuana-drive-thru-now-open/809611001/ (http://www.usatoday.com/story/news/nation-now/2017/10/28/arizonas-first-medical-marijuana-drive-thru-now-open/809611001/)
Title: Wildfires pile woes on California pot industry after tough year
Post by: RE on December 09, 2017, 12:47:09 AM
This is smoke you may WANT to inhale!  ;D

RE

https://www.aol.com/article/news/2017/12/07/wildfires-pile-woes-on-california-pot-industry-after-tough-year/23300893/ (https://www.aol.com/article/news/2017/12/07/wildfires-pile-woes-on-california-pot-industry-after-tough-year/23300893/)

Wildfires pile woes on California pot industry after tough year

(http://i2.cdn.turner.com/money/dam/assets/171011111423-california-cannabis-fires-780x439.jpg)

Thomson Reuters
Ben Klayman
Dec 7th 2017 6:29PM

Dec 7 (Reuters) - Wildfires blazing through Southern California are worrying marijuana growers, who fear that smoke could damage their crops, the basis of a newly legalized industry in the state.

For the cannabis industry, recovering like the rest of the state from devastating fires two months ago that killed 44 people and ravaged scores of pot farms north of San Francisco's Bay area, the new wave of wildfires comes at a challenging time.

"This year has been some of the highest highs and lowest lows, where we've made so much progress toward a legal, regulated, normal future," Hezekiah Allen, executive director of the California Growers Association, said by telephone. "But at the same time, we've had these catastrophic fires."

Four major fires in the Los Angeles area have forced 200,000 people to flee and destroyed hundreds of homes. And the region's westward Santa Ana winds blowing hot and dry from the California desert could exacerbate the situation.

Check out heart-stopping firsthand footage of the blaze:
X

Things could be worse for the marijuana industry in the state, Allen said, except for the fact that particularly hard-hit Ventura County does not issue permits for pot farms.

The smoke billowing from the latest blazes could be damaging for growers in San Luis Obispo County, up the coast to the north of the city, as well as in Los Angeles itself, he said.

"These are fires burning in a more urban-type development, and that smoke is going to contain potential contaminants that are not typically in wildfire smoke," Allen said.

San Luis Obispo County has scores of pot farms, some of them larger than one acre (0.4 hectare). Growers in Los Angeles, on the other hand, tend to set up indoor operations due to lack of open farmland, he said, meaning they are better protected from smoke. The city has more than 10,000 grows, the industry estimates, many of them small and tucked away in spare bedrooms or converted garages.

AdChoices
Slideshow preview image
25 PHOTOS
Wildfire in Ventura County, California
See Gallery

California voters approved medical marijuana in 1996, despite a federal ban, and last year approved recreational use of the drug by adults. Since then, the state has been developing rules to allow recreational sales.

At the same time, California is the source of most of the nation's illegal marijuana farming, Allen estimated, with more than 55,000 marijuana growers.

The wildfires that ravaged the state's world-famous wine country in October did not necessarily burn the vines - but the smoke did increase the risk of tainting the flavor of grapes, wine industry officials in Napa, Sonoma and adjacent counties said.

Insurance claims from those blazes have topped $9 billion, state officials said on Wednesday.

The October wildfires significantly damaged or destroyed 73 licensed pot farms in Mendocino and Sonoma counties, Allen said. Others without permits were also hit, he added, although most of those were unlikely to come forward.

"It's been a very intense year," Allen said.
Title: Re: The Potfolio
Post by: Eddie on December 11, 2017, 08:32:08 PM
I'm back up to 18 pot stocks. Split between high quality Canadians and the best US companies (which are a step down in quality). I am also holding some trading trash that I bought for momentum plays.. We seem to be entering a rally that might last a couple more months. I intend to be able to be in all cash by mid February.

For those of you who predicted I'd end up holding the bag (RE)  I can report that I'm up a solid 45% from when I started this thread, which amounts to over $40K in a little more than a year. Kaching. To be honest, I have made all that money since August. Over the summer I got gobsmacked. Live and learn. Perserverance furthers.

Right now I'm making nearly as much money every day on pot stocks as I am on fixing teeth. It's not sustainable, but will be fun while it lasts. If it were sustainable, I'd retire.

My short term goal is to pay off the mortgage on the stead, which is doable. Failing that I will at least be able to burn the mortgage on the storage property, which is a lot less than the stead. A great couple of months and maybe I could do both. That would be very cool.
Title: Re: The Potfolio
Post by: Eddie on December 14, 2017, 03:47:30 PM
The character of the pot stock market is shifting into a wider rally, and as many expected, it is a lot of the stupid stocks that are advancing instead of the good companies building a revenue base (the ones I favor).

When the gen pop hit the penny stock market, they have no time for due diligence and reading (what's that?) boring SEC filings. They go for the great names, like American Cannabis Company, and Marijuana Company of America, and tickers like BUDZ, and ERBB and so forth.

This is not investing. It's sheer speculation, no different from the people piling into bitcoin and al the other crypto plays. These people know nothing about the industry, they're just driven by what some traders call FOMO, or FEAR OF MISSING OUT.

The rally is just warming up, and already stocks that haven't done anything since the 2016 election are turning up into parabolic moves (which frequently are followed by gut-wrenching pullbacks as the traders who front-run the "usual suspects" sheer the sheep.

After a nice Monday, I've had a couple of mild red days. I've reloaded some names I previously sold,and now I'm waiting for the next up wave.

Cowabunga!



Title: Teens: Pretty Sober, Except For Marijuana And Vaping
Post by: RE on December 15, 2017, 12:35:58 AM
https://www.npr.org/sections/health-shots/2017/12/14/570767261/teens-pretty-sober-except-for-the-marijuana-and-vaping (https://www.npr.org/sections/health-shots/2017/12/14/570767261/teens-pretty-sober-except-for-the-marijuana-and-vaping)

Teens: Pretty Sober, Except For Marijuana And Vaping

December 14, 201711:34 AM ET

Angus Chen

(https://media.npr.org/assets/img/2017/12/14/vaping-1_custom-4a31d8a2fa6d44a2f3d6d3b0f6faf07a17dd4e80-s800-c85.jpg)
Teens' use of vape devices is increasing, and they're not always aware if nicotine is in the mix.
Jane Khomi/Getty Images

The number of teens abusing drugs is lower than it's been since the 1990s, according to a national survey.

"In particular, we see a tremendous decline in the portion of young people using cigarettes," Dr. Lloyd Johnson, a study researcher at the University of Michigan, said at a press conference on Thursday. "The changes we're seeing are very large and very important."

But there are a couple of key exceptions. "[One] is marijuana. It hasn't gone up, like in older populations, but it hasn't gone down, and it remains worrisome," Dr. Nora Volkow, director of the National Institute on Drug Abuse, which funds the survey. "Another concern is we see very high and very fast uptake of electronic vaping devices."
Teenagers Embrace JUUL, Saying It's Discreet Enough To Vape In Class
Shots - Health News
Teenagers Embrace JUUL, Saying It's Discreet Enough To Vape In Class

The survey, called Monitoring the Future, and conducted by the University of Michigan, has asked roughly 50,000 8th-, 10th- and 12th-grade students every year since 1991 about drugs and sex and attitudes on subjects ranging from race and ethnicity to career plans.

Last year, 1 out of every 3 high school seniors used a vape or e-cigarette, and 1 out of 6 high school seniors used a vape in the last month. Roughly 10 percent of high school seniors reported intentionally vaping nicotine, but many teens surveyed seemed unsure whether or not they were using a product with the drug. "Teens endorse that they don't really know what they are vaping. They may think they have just a strawberry flavor, and it may be mixed with nicotine," Volkow says.

That's particularly worrying to public health groups and officials. "The issue is nicotine is an addictive drug," Volkow says. "And if you are vaping it and not realizing it, you're still getting conditioned [to the drug]. That results in automatic wanting of the drug." Teens might be developing dependencies to nicotine without realizing they are at risk, and there is some evidence that young people who begin vaping nicotine are more likely to transition to tobacco cigarettes than teens who don't, Volkow says.

Teenagers are also using e-cigarettes for marijuana or hash oil, according to the survey, with roughly 11 percent of high school seniors saying they've done that. Hash oils can reach 95 percent pure THC, the psychoactive component in marijuana. Vaping such high concentrations of the drug can put people, particularly those who are not used to smoking weed, at a higher risk for undesirable side effects like temporary psychosis, Volkow says.

The rise in vaping drugs aside, public health advocates say this latest survey is a cause for optimism. "It is good to see consumption of most substances going down. It's consistent with what we know about, as we're calling them, Gen Z," says Robin Koval, the CEO and president of the anti-tobacco public health organization Truth Initiative. They were not involved with the study. "They are less risky, generally. It's reflective of a generation that is taking life more seriously a bit earlier on, which we are glad to see."

While the rest of the country struggles with high rates of opioid addiction and misuse, heroin and prescription painkiller use is at a historic low for teenagers. Five years ago, 1 out of every 10 high school seniors had tried synthetic marijuana. The survey results this year show that's down to 1 out of every 27 seniors. Combustible tobacco use has also hit an all-time low with only 9.7 percent of high school seniors smoking. "That's a milestone," Koval says.

Some of that reduction in drug use is probably the success of decades of public health campaigning and messaging, Volkow says. "The campaign against tobacco smoking has been one of the most successful campaigns. The same thing, but not as successful, are campaigns that go against binge drinking in teenagers," she says.

What are teens doing if not drugs? That's also hard to know, but there are some interesting ideas, Volkow says. One is that teens are hanging out online more and in person less. That gives them fewer opportunities to pass drugs to one another. Another might be that there are a lot of distractions at hand for teens. "Our brain is hardwired to seek out behaviors that are rewarding and reinforcing," Volkow says. Sports and video games can provide those kinds of rewards and act as "alternative reinforcers" she says.

And though the trends look like a victory for public health today, Volkow says, things can change so fast when it comes to drugs, especially with innovations coming from the black market.

Angus Chen is a journalist based in New York City. He is on Twitter: @angRChen.
Title: First Recreational Marijuana License Issued in California
Post by: RE on December 18, 2017, 02:28:49 AM
http://newburghgazette.com/2017/12/18/first-recreational-marijuana-license-issued-in-california/ (http://newburghgazette.com/2017/12/18/first-recreational-marijuana-license-issued-in-california/)

First Recreational Marijuana License Issued in California
Sheryl Bailey 18 December 2017, 07:42

(https://investorplace.com/wp-content/uploads/2017/12/marijuanaetfsmsn.jpg)

 On Thursday, the state issued its first group of business licenses to transport and sell recreational-use marijuana only 18 days prior to the kickoff of legal sales January 1. Torrey Holistics has just received the first temporary license from the Bureau of Cannabis Control (BCC). The key factors driving the growth of the marijuana/cannabis market are technological advancement, premium pricing due to high energy consumption in marijuana production, changing peoples attitude toward marijuana use and growing business opportunities, increasing business sophistication, large base of potential cannabis consumers, medical cannabis on the rise, increasing licensed producers and the growth of the vaporizer industry. The release of the initial 20 temporary licenses, good for 120 days, represents another steppingstone toward legal purchases, which were approved by voters past year. He sees recreational marijuana taking off like the wine and craft beer industries. "The taboo part is slowly going to be removed and this is going to be like any other business", Hall said. The state's cannabis laws state that adults 21 and older will be allowed to grow up to six marijuana plants and to carry up to an ounce. The route a year ago to legalization started when voters gave their approval to Proposition 64 that opened the door for recreational marijuana sales to adults in the most populous USA state, home to one in every eight Americans. Businesses expect it is likely to take an extended period of time prior to the society adjusting to the legality of marijuana. Come January, the newly legalized recreational sales will be merged with the state's two-decade-old medical marijuana market, which is also coming under much stronger regulation. Many cities and counties across the state are debating localized rules and regulations. To date, more than 1,900 users have registered with the online system, and more than 200 applications have been submitted. Primary sources are mainly industry experts from core and related industries and suppliers, manufacturers, distributors, service providers, and organizations related to all segments of the industry's supply chain. In the background is widespread uncertainty about whether President Donald Trump's administration will attempt to intervene in states where marijuana is legal. Newburgh Gazette http://newburghgazette.com/2017/12/18/first-recreational-marijuana-license-issued-in-california/ (http://newburghgazette.com/2017/12/18/first-recreational-marijuana-license-issued-in-california/)
Title: Re: The Potfolio
Post by: Eddie on December 26, 2017, 09:39:41 AM
Christmas came a day late for the potfolio. Markets are closed in Canada but open for a short day in the US. This creates some unique arbitrage opportunities sometimes.....especially if certain Canadian stocks are popular with US investors. These stocks often have "convenience tickers" on the OTC, which still trade. These low volume moves can be big.

I woke up late to see an 8% gain overall on my  account for the day. Not bitcoin, but not bad. I expect a correction in some of these stocks when Canada opens tomorrow, so I sold into the rally to lock in some profits.

Title: High Times in the Womb
Post by: RE on December 27, 2017, 04:38:34 AM
What happens if the Fetus gets the Munchies?  ???  :icon_scratch:

RE

http://www.newsweek.com/cannabis-pregnant-women-using-more-marijuana-posing-unknown-danger-babies-759603 (http://www.newsweek.com/cannabis-pregnant-women-using-more-marijuana-posing-unknown-danger-babies-759603)

Cannabis: Pregnant Women Are Using More Marijuana, Posing Unknown Danger to Babies

(https://files.merryjane.com/uploads/article/hero_image/884/MJ_Consume_Pregnant_WIDE.jpg)

By Kate Sheridan On 12/26/17 at 5:07 PM
Share
Tech & Science
Marijuana
Pregnancy

The number of pregnant women who have smoked marijuana might be more than you think—at least in California.

A new study, published Tuesday in JAMA, asked more than 275,000 pregnant women who were being treated at one of the facilities in the the Kaiser Permanente Northern California system to fill out a survey. On the survey, which the women completed early in their pregnancy, were questions about marijuana use. The women also took a urine test. The researchers looked at data from eight years and found that the number of women who reported smoking marijuana increased over time—especially for mothers who were less than 18 years old at the time and for those who were between 18 and 24. In 2016, nearly a quarter of pregnant teenagers had used marijuana, as had about one in five women between 18 and 24. However, for those women who denied using marijuana but had a positive urine test, it’s impossible to tell if she had used the drug after she realized she was pregnant.

"That was not surprising, necessarily, but definitely concerning," Kelly C. Young-Wolff, one of the authors of the paper, told Newsweek. Young-Wolff is a licensed clinical psychologist and research scientist at the Kaiser Permanente Northern California Division of Research. Overall, marijuana use during the first weeks of pregnancy increased from about 4 to 7 percent between 2009 and 2016. Given that both the percentage of people reporting using marijuana and those whose urine tests showed they'd used it increased, more people may be using it in the general, non-pregnant population and marijuana use may be more accepted and normalized than ever before—again, at least in California.

Keep up with this story and more by subscribing now

"California is a little different in that we were the first state to legalize medical marijuana in 1996," Young-Wolff said. "Our data might be very different if you looked in another state. But California does tend to be a leader in terms of trends, and it may be indicative of what will be happening in other states in the future."

Japan babies crawling Babies compete in a baby crawling competition hosted by a Japanese magazine on November 23, 2015. The competition was held to challenge the Guinness World Record for the largest crawling competition with the maximum number of participants. KAZUHIRO NOGI/AFP/Getty Images

In October, the American Congress of Obstetricians and Gynecologists put out an update to its committee opinion on marijuana use during pregnancy and while a woman is breastfeeding. (This kind of document is just an opinion based on the scientific evidence that’s available—it doesn’t lay out rules that OB-GYNs have to follow.)

The committee opinion stated that while most women believe that smoking marijuana is safe during pregnancy, it should be discouraged because scientists still don’t know exactly what it does to developing fetuses. Good studies on the actual effects just don’t exist yet. "The impacts of prenatal marijuana use haven't been very well studied," Young-Wolff said. Beyond birth weight, she said, "data are really limited by the number and the quality of existing studies. Definitely, more research is needed."

There are, however, “worrisome trends,” the committee wrote. “The effects of marijuana use may be as serious as those of cigarette smoking or alcohol consumption.”

Those effects include lower birth weights for the children of mothers who use a lot of pot, for example. Timing may be important, too; marijuana use in the first month of a pregnancy may increase the likelihood of a very rare birth defect called anencephaly. (However, the committee opinion notes, there may have been other confounding factors that could have contributed to the increased risk.)

The number reported in the JAMA paper falls outside the range that’s been reported in other studies using self-reported data—between 2 and 5 percent. However, self-reported data is notoriously unreliable. (The percentage of women who tested positive for marijuana use in this paper was quite a bit higher than those who had just said they did.) Presumably, women may have been reticent to report smoking marijuana if they actually did because they might not want to seem like they’ve done something that people believe might put their child at risk. Urine tests, which are more reliable, also have their limitations; marijuana can linger in a person's urine about 30 days—and even longer for those just light up more than every once in a while. "It does vary quite a bit, which makes it tricky," Young-Wolff said. The potency of the pot can also affect the results.

And women may even be using marijuana after they took the survey—on purpose. Anecdotally, Young-Wolff said, some women may take marijuana while they're pregnant to deal with morning sickness. However, she added, "there are many other ways to treat nausea and vomiting during pregnancy."
Title: Re: The Potfolio
Post by: K-Dog on December 27, 2017, 11:27:44 AM
Pregnant Women Are Using More Marijuana.

(http://www.deathandtaxesmag.com/wp-content/uploads/2012/06/Baby.jpg)

Probably untrue unless there are more pregnant women.  Use has not increasing dramatically since legalization began.  The twenty to thirty million stoners in America got their shit before weed got legalized and if it were all made illegal again tomorrow they would still get their shit.  Supply origin does not drive consumption and anybody who thinks it does is a fool.  The shit is easy as shit to grow. 

No Shit !

The great thing about it being made illegal again is that an income source is returned to all Americans who need some help meeting their bills.  It is an honest and fair income source that is only achieved by someone putting in the effort to care for their plants and process their harvest.  Growing plants is reasonably safe so there is no need to monitor the process intrusively. 

I advocate taking the corporate element away from the actual growing of the plant but keeping it through distribution although weed dealers had been normal businessmen themselves.  They would buy supply at a reasonable wholesale price and sell it at a reasonable consumer price.  I never knew a dealer that hung out on a street corner and was a bad influence to kids.  Dealers tended to be normal people of a social maven type.  You would visit them at home, find out what all your friends are doing and then you would leave.  Dealers could have been registered and taxed but it is more available to all in a store.  A grocery store.


Free Enterprise! Get the corporate influence out.  Structure things so taxes are paid and price discovery controls a free market where everyone has a place.  True socialism!  Not the phony fascist structure we have now which is claimed to be free enterprise.  It's not.

If weed has to be made illegal again so a few more people can have a decent life it should be done.

an aside:  I ponder all the idiots in the world and note: Then circular logic reminds me that they are idiots and this makes sense.
Title: Re: The Potfolio
Post by: K-Dog on December 27, 2017, 01:33:53 PM
The long term effects could make everybody resemble people from India.  They have had it for a few thousand years.
Title: Re: The Potfolio
Post by: Eddie on December 27, 2017, 06:55:40 PM
When I was young there was this joke.....

If you smoke pot when you're pregnant your babies will be born naked.

Mrs' Eddie smoked cigarettes when she was pregnant. Explains the four retards.  It's a wonder any of 'em made it through grad school.
Title: Re: The Potfolio
Post by: Eddie on December 27, 2017, 06:59:29 PM
Another stellar day in pot stock land. I was out most of the day winterizing the boats, the cottage, the well at the stead, and feeding the pigs.

When I came home I was up over 7% again. Not sure if it swings wildly back. My gut says no, not much. Not right now.
Title: Re: The Potfolio
Post by: Eddie on December 28, 2017, 03:24:12 PM
For some unknown reason, this is the week pot stocks decided to go full-blown tulip mania. It is absolutely unsustainable. I am trimming cash every day, but my holdings keep going up anyway.

From my modest beginnings, I am now approaching a double for the year, and the daily gains this week have been in five figures every day. I am getting more defensive. I have 25% in cash now. But one of my largest positions broke out today, and if it runs again tomorrow the year could end on a very upbeat note.

My goal is.....to, by President's Day: (1) Take out my original cash investment. (2) Pay off the stead. (3) have a decent position left to continue to try to trade through summer and Canada full legalization (and Massachusetts legal rec). In any case, I will use this money to get debt free. That is my first priority whether I make enough to keep playing the game or not.

Title: Re: The Potfolio
Post by: RE on December 28, 2017, 03:30:54 PM
For some unknown reason, this is the week pot stocks decided to go full-blown tulip mania. It is absolutely unsustainable. I am trimming cash every day, but my holdings keep going up anyway.

From my modest beginnings, I am now approaching a double for the year, and the daily gains this week have been in five figures every day. I am getting more defensive. I have 25% in cash now. But one of my largest positions broke out today, and if it runs again tomorrow the year could end on a very upbeat note.

My goal is.....to, by President's Day: (1) Take out my original cash investment. (2) Pay off the stead. (3) have a decent position left to continue to try to trade through summer and Canada full legalization (and Massachusetts legal rec). In any case, I will use this money to get debt free. That is my first priority whether I make enough to keep playing the game or not.

I thought you paid off the Toothstead with your life insurance policy?

RE
Title: Re: The Potfolio
Post by: Eddie on December 28, 2017, 05:33:54 PM
No, I still owe 135K.

I don't think I've done too bad. I paid 343K in 2009, and I've made extra payments since day one, because it's on a ten year note that has to be be renewed in a couple of years. My goal was always to get it paid off before I retire. But for while, it looked like I might need to sell it to reduce my monthly nut (due to erosion of my core business, which is ongoing due to all the stuff we all know about with reduced bennies for all Americans). Now, maybe not.


The life insurance now has some decent cash value (because markets have done better than I for one expected, since 2008).  The insurance company has done okay. For years that was my one BAU investment (insurance). I don't want to spend that, because it reduces my survivor benefit dollar for dollar. When I retire for real, I'll probably cash it out. There is a lot of risk in life insurance, because in a collapse the companies will all fail. There is a state back-up thing , sort of like FDIC, but it's pathetic and would give me pennies on the dollar if the company went BR. But as long as the company is solvent, the cash value of my life insurance is a decent investment for the last years, because it is tax free on the back end. If I pay the premiums until I'm 75, it will be one of my largest holdings. I probably won't make it. Like all such plans the final years are where you get the most accumulation.

That was always my fall-back position. If they called my loan, I could use the insurance money to pay off the note. But now I won't have to, I don't think.

Title: Legal marijuana arriving in California after decades of underground dealing
Post by: RE on December 29, 2017, 03:24:58 AM
https://www.usatoday.com/story/news/2017/12/28/legal-marijuana-arriving-california-after-decades-underground-dealing/975323001/ (https://www.usatoday.com/story/news/2017/12/28/legal-marijuana-arriving-california-after-decades-underground-dealing/975323001/)

Legal marijuana arriving in California after decades of underground dealing

Legal marijuana arriving in California after decades of underground dealing

, USA TODAY Published 6:00 a.m. ET Dec. 28, 2017 | Updated 12:31 p.m. ET Dec. 28, 2017

California begins legal recreational marijuana sales in 2018 and along with that, there are a host of questions about exactly how the system will work and the rules people need to follow. Wochit

45 LINKEDIN 66 COMMENTMORE

A new gold rush is sweeping California as the state prepares to launch legal marijuana sales Monday, bringing the powerful and largely underground economy finally into public view. 

Marijuana has long been one of California’s most important cash crops, albeit one many visitors would never see amid the vineyards and avocado farms. Now, tens of thousands of entrepreneurs are rushing to carve out a slice of an about-to-be-legal market that has grass-growing cannabis evangelists colliding with out-of-state suits eager to make a now-legal buck.

And there's a lot to be made: The state's existing marijuana black market is worth $13.5 billion, according to cannabis financial analysis firm GreenWave Advisors, while the legal market could be worth $5.1 billion in 2018.

More: Marijuana's legalization fuels black market in other states

“You’re taking an industry that was completely underground and making it the most regulated product of all time,” said Jessica Lilga, who runs a medical cannabis distribution service in Oakland, Calif., and hopes to expand into recreational pot. “It’s just insane.”

Legalization through voter approval of Prop. 64, which created a system for legally growing and selling cannabis, also raises concerns about whether kids will start using more marijuana thanks to increased visibility and whether the state is creating a new Big Tobacco industry that puts profits ahead of public health.

Marijuana plants at PSA Organica in Palm Springs

Marijuana plants at PSA Organica in Palm Springs (Photo: Lance Gerber/DESERT magazine)

While five other states already offer legal marijuana sales, the Golden State’s sheer size is expected to reshape the pot industry worldwide, potentially driving down prices for consumers while generating hundreds of millions of dollars in taxes. It also holds the promise of wiping out criminal records for some people with previous cannabis convictions and helping longtime illegal drug dealers go legal by getting them licensed.

Eight states and the District of Columbia have legalized marijuana, but only Colorado, Oregon, Nevada, Alaska and Washington have functioning marketplaces. Massachusetts and Maine expect to begin sales sometime later next year. Marijuana remains illegal at the federal level, but the Trump administration has made no high-profile moves against any state where pot is openly sold to adults.

Marijuana at Desert's Finest in Desert Hot Springs

Marijuana at Desert's Finest in Desert Hot Springs (Photo: Lance Gerber/DESERT magazine)

That has store owners scrambling to erect billboards near Los Angeles International Airport and flooding bars with street marketers. California rules limit marijuana advertising, so dispensaries are getting creative in how they reach potential customers. Med Men, which sells medical cannabis but hopes to offer recreational pot come Monday, is wrapping 30 trucks with advertisements for its four existing high-end dispensaries. Cannabis firm American Green even bought an entire town — Nipton, Calif. — to create a marijuana mecca.

Because California’s marijuana law requires all cannabis to arrive in stores pre-packaged, growers and distributers are frantically developing branding and packaging to set their wares apart.

“You’re seeing a lot more sophisticated people from other industries starting to move into the space,” said B.J. Carretta, Med Men’s chief marketing officer. “If traffic doubles in January, it can’t be amateur hour.”

California’s marijuana growers are already highly sophisticated when it comes to operating illegal farms in the mountains of the Emerald Triangle north of San Francisco. But playing by these new rules is a different proposition. California’s pot regulations require a variety of water and environmental considerations, along with tight accounting and tracking.

More: California's illegal marijuana farms force cops to wield 'green' stick

Many longtime cannabis farmers are struggling with whether to go legal, in part because getting licensed can cost tens of thousands of dollars. Additionally, many longtime marijuana moonshiners are culturally opposed to playing by the rules. For generations, they have secretly grown vast quantities of pot destined for black-market users across America.

Clear containers allow customers to see and smell the

Clear containers allow customers to see and smell the 20 strains of marijuana offered at the MedMen marijuana dispensary on Santa Monica Blvd in West Hollywood. Tablets offer addition information. Photo taken on Tuesday, November 15, 2016.  (Photo: Richard Lui/The Desert Sun)

Matt Karnes of GreenWave Advisors estimates at least half of all the cannabis grown in California is illegally shipped across state lines and sold at two or even three times the price it would fetch if sold locally as medical marijuana. Those growers have an extensive network of distributors built through mutual trust over decades of underground dealing. 

“What we are going to see is not only a legal shift but a cultural shift,” said Michael Steinmetz, the CEO of cannabis distribution company Flow Kana.

Steinmetz bought an abandoned vineyard and winery in Mendocino County to serve as a centralized processing marijuana center for small growers. He envisions dozens of farmers pooling their crops to be trimmed, packaged and distributed as a premium umbrella brand.

“Commodity cannabis is going to be a race to the bottom. We want to be more like wine and less like wheat,” he said.

A worker at Harborside Health Center in Oakland, Calif.,

A worker at Harborside Health Center in Oakland, Calif., packages marijuana cigarettes -- joints -- for customers. Harborside's founder recruits his staff from the city, offering good-paying jobs and health insurance. (Photo: Trevor Hughes, USA TODAY)

Like other states that have legalized recreational marijuana, California is creating a network of privately owned but tightly regulated pot shops that will offer shoppers a wide variety of products, from the smokeable “flower” most people are familiar with to cannabis-infused foods called edibles, and increasingly popular marijuana extracts used for vaping. The state requires quality testing and will regulate the kinds of pesticides and other chemicals used in growing.

“Consumers at large haven’t seen that,” Steinmetz said. “In the black market, you buy whatever the dealer has and you want him out of your house as soon as possible.”

Lilga said she expects to see retail prices drop as newly formed cannabis conglomerates use their size to price out smaller players. While there's a state tax on marijuana, the government isn't regulating how much consumers will pay, leaving that largely up to the free market.

“There’s a lot of culture and community and soul being sucked out,” she said. “We see that inevitably that a lot of people will not survive the next year.”

'Budtender' Jason Coleman describes the effects of

'Budtender' Jason Coleman describes the effects of a marijuana-infused lubricant to customers inside the Medicine Man cannabis dispensary in Denver on April 19, 2017. Thousands of marijuana tourists are visiting Denver -- and stocking up in stores like Medicine Man -- for the annual 420 celebration. (Photo: Trevor Hughes, USA TODAY)

Steve DeAngelo, one of California’s best-known medical marijuana business owners and advocates, said he worries the new regulations will artificially limit the supply early next year, potentially driving up prices. 

“Cannabis consumers deserve the same choices enjoyed by shoppers at the grocery store. While everybody would like to be able to afford heirloom tomatoes, meticulously tended in small patches and selling for $5.99 a pound — most families can’t afford them,” said DeAngelo, the CEO of Oakland-based Harborside cannabis dispensary. “Most can only afford the lower-priced tomatoes grown by larger, more efficient farms. And thankfully for these consumers, regulations allow the existence of such tomato farms.”

A box of joints awaits customers at Harborside Health

A box of joints awaits customers at Harborside Health Center in Oakland, Calif. (Photo: Trevor Hughes, USA TODAY)

Still, the state faces major challenges in the coming months, said Kevin Sabet, the director of the anti-legalization group Smart Approaches to Marijuana, which warns that California's legalization of marijuana is creating a new Big Tobacco industry because many Americans don’t see the broader consequences of widespread cannabis cultivation and consumption.

Data about how legalization has affected cannabis use rates, particularly among kids, remains consistently unreliable. Marijuana remains entirely illegal at the federal level, most banks refuse to handle cannabis cash and employers are struggling with how to handle routine drug testing for workers in states where pot is legal. 

More: Recreational pot is coming to California. Here's a map of dispensaries in the Coachella Valley

Knowing those challenges, Sabet said California should have taken more time to work out the kinks.

“Prop. 64 was written with this expedited timeline because the industry was its main author. And the industry only makes money if things are rolled out quickly, without much thought about the actual way this will operate. California is not ready for recreational legalization,” Sabet said. “The only people who will benefit from this rollout are the Silicon Valley billionaires who have invested in this whole thing.”

Silicon Valley billionaires heavily backed Prop. 64, particularly Napster co-founder and former Facebook president Sean Parker, who donated more than $1 million to the November 2016 ballot measure. 

Some industry experts say they believe venture capitalists hope to commoditize cannabis production and create a legitimate cash crop. “We’re going to have more Budweiser than craft brewers,” said Lilga, the distributor. “I can tell you it’s not fun at all. This is the epitome of the corporate model.”

That corporate model is expected to generate hefty tax returns for the state: $300-$500 million in marijuana taxes in the first year, according to cannabis analytics firm New Frontier Data. That estimate doesn’t include local sales taxes and depends heavily on how quickly the industry ramps up.

Former California Attorney General Bill Lockyer counts himself as both a responsible member of the community and someone who thinks legal cannabis can be done right. Lockyer, who was in office as medical marijuana became widespread in California, said he thinks the new recreational pot regulations are far better than the state's original medical marijuana rules — so much that he's co-founding a marijuana distribution company with colleagues drawn from the brewing and alcohol-distribution fields.

“This is the right thing for California, and we’re trying to do it in a legal and smart way,” he said. “If it winds up helping pay for my kids’ college education, I won’t complain about that.”

Jars of legal recreational marijuana sit on the shelf

Jars of legal recreational marijuana sit on the shelf of a Denver pot shop. A new study says nearly 60% of Americans now support marijuana legalization. (Photo: Trevor Hughes/USA TODAY)

 

45 LINKEDIN 66 COMMENTMORE
Share your feedback to help improve our site experience!
POPULAR STORIES
Atlanta reporter Amanda Davis dies following massive stroke
usatoday.com
a day ago
How many drinks are too many per week?
usatoday.com
15 hours ago
Stunning satellite image shows lake effect snow over Great Lakes
usatoday.com
a day ago
Trump slams Vanity Fair for apologizing to Clinton
usatoday.com
11 hours ago
At least 12 dead in Bronx apartment fire, NYC mayor says
usatoday.com
6 hours ago
Title: Re: The Potfolio
Post by: Eddie on December 31, 2017, 02:53:54 PM
I am now ahead 86K since August of 2016, and I started small. I have put in 88K of cash savings total, but not all at once. I added slowly as I went along.

That turned out to be good, since April thru August 2017 turned bearish and I had some serious drawdowns. I was able to add some more cash when the sector turned up again, which made the last four months exceptionally good ones.

I've almost doubled my money. I think there might be one more double to be had in this rally, which would put me well past the goals I've shared with you here. I am sitting on 45K in cash in the trading account, so I currently have 43K at risk on 128K worth of stocks (at last Friday's sp).

Not a ganja millionaire, but the fiat gains will make a noticeable difference in my debt service and make my work life less stressful, as I enter what is surely my last decade of paying work. I like the idea of cashing out as I go. I do think it's easy to keep putting your eggs in one basket and then get creamed when you least expect it. That I've learned from veterans of pot stock investing who've gained and lost (and regained) fortunes in less than five years.
Title: On Jan. 1, pot becomes just another legal business in California
Post by: RE on January 01, 2018, 12:39:37 AM
https://www.seattletimes.com/nation-world/on-jan-1-pot-becomes-just-another-legal-business-in-california/ (https://www.seattletimes.com/nation-world/on-jan-1-pot-becomes-just-another-legal-business-in-california/)

On Jan. 1, pot becomes just another legal business in California
Originally published December 31, 2017 at 4:03 pm Updated December 31, 2017 at 4:35 pm

(https://static.seattletimes.com/wp-content/uploads/2017/12/6603283c-ee82-11e7-953c-8b5fe436f9ca-640x480.jpg)
Golden State Greens “budtender” Olivia Vugrin, right, waits on a customer in San Diego. (Elliot Spagat/The Associated Press)

Local rules and regulations vary widely across the state. In some places, marijuana remains completely banned. In others, such as San Francisco and L.A., it won’t be legal immediately.
Share story
By KATIE ZEZIMA
The Washington Post

Jane Futcher and her wife, Erin Carney, were thrilled that California voters legalized marijuana last November. Their cannabis farm in Laytonville, in Northern California, would be completely compliant with the new laws, and they loved the sense of community that came with long-underground growers coming together and shaping a legal marketplace.

But by May, the couple had enough. Despite plowing nearly $15,000 into making the farm where they grew medical marijuana with a county permit comply with new state and local rules for recreational use, they scrapped it all, frustrated with the layers of bureaucracy and seemingly endless government edicts.

“It seemed like everywhere we turned there was a new regulation that was making it difficult,” Futcher said.

The drug will be legal for adults older than 21 in the state starting Monday. (Medical marijuana has been legal for years.) Along the way, an edgy, sexy industry has become beholden to reams of regulations and compliance issues — in other words, marijuana has become just another business in California, except that it remains illegal federally.
Featured Video
Kelley's journey toward independence (4:10)
Most Read Stories

    Deaths among King County's homeless reach new high amid growing crisis
    Seattle settles sexual-abuse lawsuit with Ed Murray accuser
    No playoffs, no 10th victory, no nothing as Blair Walsh misses FG for Seahawks
    The Huskies have come a long way under Chris Petersen, but the final step is proving tough | Larry Stone
    Promoting health at a hefty price: Seattle’s soda tax starts Jan. 1  VIEW

In 2012, Colorado and Washington became the first states to legalize recreational marijuana. California is one of five states, plus Washington, D.C., that followed suit. Retail sales are scheduled to begin in Massachusetts in July.

Even with other states as models for what works and what can go wrong as marijuana strains known as Sweet Skunk, Trainwreck and Russian Assassin hit the street, the next year is expected to be a bumpy one as more shops open and more stringent regulations take effect.

To be above board, businesses must comply with regulations from the state and the city or county where they operate. The state’s rules were only released in mid-November. San Francisco and Los Angeles approved theirs in December.

Local rules and regulations vary widely across the state. In some places, marijuana remains completely banned. In others, it won’t be legal immediately.

“On January 1, people are going to want to go out and buy cannabis,” said Alex Traverso, spokesman for the California Bureau of Cannabis Control. “They’re going to have to be patient in that not every place will be up and running.”

Pot-friendly San Francisco, a counterculture hub where marijuana smoke has been a fixture for half a century, was late to establish local regulations and won’t have any retail outlets open for business until later in the week. It’s a similar situation in Los Angeles.
ADVERTISING

Meantime, Fresno, Riverside, Anaheim, Bakersfield and all of surrounding Kern County have prohibited pot shops, and Long Beach has a temporary ban.

In San Diego, which has fully embraced the marijuana business, facilities must be at least 1,000 feet from parks and child-care facilities. Neighboring National City has banned all cannabis businesses. Los Angeles requires video surveillance of businesses.
Sign up for the Morning Brief

Delivered bright and early weekday mornings, this email provides a quick overview of top stories and need-to-know news.

For shop owners lucky enough to receive temporary licenses from the state and clear local red tape, anticipation is high.

Will Senn, founder of Urbn Leaf in San Diego, said the shop’s four phone lines have been ringing off the hook for three months, but he’s not sure what to expect when doors open at 7 a.m. with extra security and more than 60 employees at the ready for sales and deliveries.

“We’re preparing for the worst and hoping for the best,” Senn said. “We never want lines out the door and around the block. That’s not what we’re trying to accomplish here.”

Shops at first will be able to sell marijuana harvested without the regulatory controls that eventually will require extensive testing for potency, pesticides and other contaminants. Regulations touch every aspect of the cannabis business, including farming, water use, shipping, retail and consumption, and required the construction of an online licensing system. A program to track all pot from seed to sales will be phased in, along with other protections such as childproof containers for pot products.

Pot-shop founder Jamie Garzot said she’s concerned that when the current crop dries up, she’ll encounter a shortage of marijuana that meets state regulations. The irony is that her 530 Cannabis shop in Shasta Lake is close to some of California’s most-productive growing areas, yet most of the surrounding counties won’t allow cultivation that could supply her.

“Playing in the gray market is not an option,” Garzot said. “California